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Abstract 
 
Non-medical prescribers make an increasing contribution to healthcare across 
the UK yet little is known about influences on their prescribing decision-making.  
The aim of this programme of research was to explore and describe prescribing 
decision-making by non-medical prescribers.  A two stage programme of 
research was carried out. 
 
Stage 1 was a systematic review of the social and cognitive influences on 
prescribing decision-making by non-medical prescribers.  Despite a paucity of 
research, various influences on prescribing decision-making were reported 
including evidence based guidelines, peer support and patient (or parental) 
relationships and expectations.  While confidence and clinical experience as a 
practitioner were cited as influences, the lack of prescribing experience and 
aspects of pharmacological knowledge also impacted on prescribing decision-
making, resulting in a cautious approach. 
 
Stage 2 of the research employed a phenomenological methodology underpinned 
by the Theoretical Domains Framework of behavioural determinants (TDF).  It 
comprised three phases.  In Phase 1, semi-structured interviews with five nurse 
prescribers and eight pharmacist prescribers in NHS Grampian explored their 
experiences and perceptions of influences on their prescribing decision-making, 
and the impact of these influences.  Multiple and sometimes contradictory 
influences were uncovered.  Twelve of the fourteen domains of the TDF were 
found to be influential along with multi-disciplinary working and experience; 
optimism and reinforcement did not feature. 
 
In Phase 2, these participants recorded reflections on prescribing decisions which 
they considered noteworthy in relation to their practice, and in Phase 3 
participants were interviewed about their reflections.  Complexity was a feature 
of many, in the patients’ clinical or social circumstances or in relation to wider 
concerns.  The same 12 domains were found to be influential as were multi-
disciplinary working, experience and complexity.   
This programme of research has produced original findings which it is hoped will 
impact on the education, training and practice of these increasingly important 
prescribers. 
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Foreword 
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course.  One module has stayed in my mind: Medicines, prescribers and people, 
with the topic Non-clinical factors influencing prescribing behaviour.  My interest 
in prescribing started then and continues.  My MSc project was An exploration of 
the views and attitudes of Robert Gordon University pre-registration trainee 
pharmacists towards a possible future role as pharmacist prescribers, again 
evidencing my interest in prescribing.  At the beginning of my studies I set up 
electronic alerts with relevant organisations and with the British Library and I 
pass this valuable suggestion on to my students.  
 
I achieved Distinction in my MSc Prescribing Science and also in my postgraduate 
Certificate in Higher Education, Learning and Teaching, and was encouraged to 
consider PhD studies.  In 2012 as part of preparation and assessment of my 
suitability I carried out Non-clinical factors influencing prescribing decisions: a 
scoping review of the literature.  Almost all of the literature I retrieved and 
reviewed focused on doctors’ prescribing, demonstrating a gap in the literature 
on non-medical prescribing and indicating an area for my PhD.   
 
I was very fortunate to be allocated experienced supervisors for my PhD with 
whom I have worked closely.  My Principal Supervisor (and Teaching Group 
Leader) is Dr Scott Cunningham; he and Professor Derek Stewart are both 
pharmacists and colleagues.  They have researched and published in the area of 
pharmacist prescribing since its inception as has Dr Dorothy McCaig, a 
pharmacologist and former colleague now retired.  Dr Katrina Forbes-McKay is a 
 
 
psychologist from the School of Applied Social Studies with a special interest in 
the application of social and cognitive theories to clinical decision-making.     
 
For the last several years I have taught on the School’s Pharmacist Independent 
Prescribing course and on the School of Nursing and Midwifery’s Non-medical 
Prescribing and Community Practitioner Nurse Prescriber courses.  I am now 
School Lead for pharmacist and non-medical prescribing and a member of NHS 
Education for Scotland’s Pharmacist Prescribing Advisory Group.    
 
My teaching on the Non-medical Prescribing and Community Practitioner Nurse 
Prescriber courses has given me a very good understanding of the different roles, 
scope of prescribing and formularies of non-medical prescribers and Community 
Practitioner Nurse Prescribers.  Given these differences and through discussion 
with my supervisors it was decided to exclude Community Practitioner Nurse 
Prescribers from my study.  For the same reason Optometrist Independent 
Prescribers were also excluded.  
 
As I come to the end of my PhD studies I am sure my involvement with non-
medical prescribing research will continue and possibly expand in new directions.  
In March this year I was asked to speak at the West African Postgraduate College 
of Pharmacists’ Scientific Symposium on Pharmacist prescribing: lessons from 
the Scottish experience and on my PhD research.  My trip to Monrovia, Liberia 
was one of the highlights of my career.  Pharmacists in the WAPCP are 
determined to do as much as they can to improve healthcare in their region in 
sometimes very difficult circumstances, and see pharmacist prescribing as one 
way to do this.  I met many dedicated pharmacists, have helped a little already 
and hope to do more. Who knows? 
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Chapter 1 Introduction 
 
 
In this first chapter of the thesis an overview of prescribing will be given: the 
background including models of non-medical prescribing (NMP) in the United 
Kingdom (UK), the policy context, education and training of non-medical 
prescribers (NMPs) and what is known about their practice including the 
contribution made to patient care.  A review of the literature will describe 
influences on prescribing decision-making including the current research base on 
those influences on NMPs’ prescribing decision-making.  The complexities of 
prescribing will also be explored.  The programme of research will then be laid 
out. 
 
1.1 Introduction 
 
Prescribing is one of the principal interventions related to patient care made by 
those with the legal right to prescribe; in 2010 the British Pharmacological 
Society asserted that it was:   
 
“the main approach to the treatment and prevention of disease in modern 
healthcare.” 
(British Pharmacological Society 2010) 
 
Prescribing authority remained the preserve of doctors, and latterly of dentists 
and vets, for centuries.  More recently other suitably trained non-medical 
healthcare professionals have been granted prescribing rights as NMPs (Crown 
1999, Department of Health 2005, Health and Care Professions Council 2017a). 
 
Prescribing is complex.  Patient safety and wellbeing are vital concerns but 
prescribing also impacts more widely on resource availability within health and 
social care, the economy and on important current and future public health 
issues such as antimicrobial stewardship (Department of Health 2016).  It is 
important that prescribing decision-making is understood so that it may be 
optimised; this thesis describes a programme of research exploring influences on 
NMPs’ prescribing decision-making.   
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1.2 Prescribing 
 
1.2.1 Overview of prescribing 
 
Various definitions of what constitutes “good prescribing” have been proposed.  
In 1973 Parish defined “good” prescribing as that which is appropriate, safe, 
effective and economic (Parish 1973). This definition stood until the early 1990s 
when as part of a doctoral thesis Bradley published a study on uncomfortable 
prescribing decisions among GPs in England (Bradley 1992a).  He showed that 
their prescribing decisions were based on a variety of clinical and non-clinical 
factors including patient expectations, the doctor-patient relationship and the 
doctor's previous behaviour.  GPs' discomfort around some of these decisions 
was again multifactorial.  
 
In view of changes to medical practice since the 1970s and Bradley’s seminal 
work, Barber (1995) proposed what he considered should be the aims of a 
prescriber: to maximise effectiveness, minimise risks, to minimise costs and to 
respect the patient’s choices.  Barber recognised that some of these aims might 
be in conflict and encouraged resolution of such conflict.  Building on this, Cribb 
and Barber (1997) described prescribing as having three aspects: 
 
 prescribing as a discrete clinical act 
 
 prescribing as a health professional process  
 
 prescribing as a policy process 
 
They defined appropriate prescribing as a balance between the right technical 
properties, what the patient wants done and the greater good.  The right 
technical properties include diagnosis, drug selection and regimen, monitoring 
and review with further adjustment of diagnosis and/ or treatment as required.  
The process is complex and challenging, but should be informed by good quality 
evidence, rather than being empirical (National Prescribing Centre 2012). 
 
Since the 1990s there has been increasing emphasis on the importance of 
evidence-based practice, defined by Sacket (1996) as: 
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“the conscientious, explicit, and judicious use of current best evidence in 
making decisions about the care of individual patients. The practice of EBM 
[evidence-based medicine] means integrating individual clinical expertise 
with the best available external clinical evidence from systematic 
research.” 
 
Evidence-based practice has been supported by the establishment of 
organisations such as the National Institute for Health and Care Excellence 
(NICE) (National Institute for Health and Care Excellence 2017a) and the 
Scottish Intercollegiate Guidelines Network (SIGN) (Scottish Intercollegiate 
Guidelines Network 2017) which develop and publish evidence-based guidelines 
on a wide range of health-related conditions.  Single condition organisations with 
a more specific focus contribute to the development of these and other 
guidelines.    
 
In parallel with increasing emphasis on evidence-based practice came a growing 
recognition of the importance of addressing the patient’s ideas, concerns and 
expectations about their condition/s and treatment (MacFarlane et al. 1997, 
Barry et al. 2000).  The previous paternalistic role of the medical prescriber was 
changing (O’Flynn and Britten 2006) with recognition that it was not sufficient to 
instruct the patient on how to take their medicine and expect them always to do 
so.  In 2009 the National Institute for Health and Care Excellence (NICE) 
published its guideline on adherence (National Institute for Health and Care 
Excellence 2009) highlighting the importance of involving the patient in 
discussions about their care with the aim of reaching a concordant agreement on 
treatment.  It was hoped that the patient would then follow/ adhere to the 
agreed treatment plan leading to better outcomes.  Patient representatives are 
now directly involved in guideline development (Scottish Intercollegiate 
Guidelines Network 2008). 
 
Notwithstanding the existence and use of evidence based guidelines to support 
prescribing, it is not a straightforward task.  Prescribing is complex, requiring 
information gathering, decisions on appropriate treatment, monitoring and 
review all informed by evidence-based guidelines and clear communication.  With 
an ageing population and attendant multi-morbidity, increasing numbers of 
patients are experiencing polypharmacy, commonly defined as taking five or 
more medicines (Scottish Government Model of Care Polypharmacy Working 
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Group 2015).  This may be entirely appropriate (Payne et al. 2014) or may be 
potentially inappropriate (Cullinan et al. 2014) but in either case polypharmacy is 
likely to increase the risk of medicines misadventure (Scottish Government Model 
of Care Polypharmacy Working Group 2015).  Part of prescribing for a patient 
experiencing polypharmacy or indeed any patient, particularly as he or she nears 
the end of life, may be de-prescribing (Jansen et al. 2016) to reduce this risk 
(Scottish Government Model of Care Polypharmacy Working Group 2015).      
 
Prescribing requires the judicious application of a range of appropriate 
knowledge, skills and attitudes and a person-centred approach is essential (Royal 
College of General Practitioners 2014, Calderwood 2016).  In 2010 the British 
Pharmacological Society outlined what is required in its publication 10 Principles 
of Good Prescribing (see Table 1.1) (British Pharmacological Society 2010).  
 
Table 1.1 The British Pharmacological Society’s 10 Principles of Good Prescribing  
10 Principles of Good Prescribing 
1. Be clear about the reasons for prescribing. 
 
2. Take into account the patient’s medication history before prescribing. 
 
3. Take into account other factors that might alter the benefits and risks of 
treatment. 
 
4. Take into account the patient’s ideas, concerns and expectations. 
 
5. Select effective, safe, and cost-effective medicines individualised for the 
patient. 
  
6. Adhere to national guidelines and local formularies where appropriate. 
 
7. Write unambiguous legal prescriptions using the correct documentation. 
 
8. Monitor the beneficial and adverse effects of medicines. 
 
9. Communicate and document prescribing decisions and the reasons for them. 
 
10. Prescribe within the limits of your knowledge, skills and experience. 
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1.2.2. Non-technical skills approach to prescribing 
 
The British Pharmacological Society provides descriptions of the behaviours 
which contribute to achievement of each of the 10 principles; underpinning many 
of these are “non-technical skills”.  These are defined as:  
 
“a combination of cognitive, social and personal resource skills which 
compliment knowledge and technical skills, and contribute to safe and 
effective performance.”  
(Dearden et al. 2015) 
 
Prescribing is not without risk; if errors are made the consequences for the 
patient and the prescriber may be serious.  Concerning levels of prescribing 
errors by doctors and particularly by junior doctors have been identified in both 
primary (Avery et al. 2012) and secondary care (Dornan et al. 2009, Ross et al. 
2009).  Definitions and reasons for prescribing errors vary but "error-producing 
conditions" in primary care (Slight et al. 2013 p.e713) and "complexity" in 
secondary care (Pownall 2009 p.1334) have been identified as contributing.  In 
response to these error rates and particularly to some of the reasons ascribed, a 
nontechnical skills approach to prescribing has been suggested (Ross, Patey and 
Flin 2013).  
 
Research into NMPs’ prescribing error rates is limited.  A national early evaluation 
of nurse and pharmacist independent prescribing in England found that 
prescribing by NMPs was clinically appropriate in most cases (Latter et al. 2012).  
The addition of a Diabetes Specialist Nurse prescriber reduced error rates for in-
patients with diabetes in one hospital trust (Carey et al. 2008) and in another, 
pharmacists’ prescribing error rates were found to be 0.3% (Baqir et al. 2015).  
This compares very favourably with doctors’ prescribing error rates of around 5% 
in general practice (Avery et al. 2012) and an overall error rate of 8.9% in 
secondary care (Dornan et al. 2009).  That said, although the scopes of practice 
of medical and non-medical prescribers may be different, “error producing 
conditions” and “complexity” are likely to impact on all. 
 
A systematic review of studies analysing prescribing behaviours and errors by 
junior doctors identified several relevant behavioural elements, as shown in 
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Table 1.2 below (Dearden et al. 2015).  It may be that some or all of these are 
equally relevant for NMPs.   
 
 
Table 1.2 Non-technical skills required by junior doctors to prescribe safely  
Adapted from Dearden et al. 2015 
Category Element 
Situational awareness Awareness of own skills and limitations 
Awareness of external and internal factors 
affecting performance 
Gathering, interpreting and checking 
information 
Projection to future states 
 
Decision making Defining the problem 
Deciding whether to prescribe 
Applying norms, guidelines and protocols 
Sending information clearly and concisely 
Actively receiving information 
 
Communication and team 
working 
Identifying and utilizing the skills of other team 
members 
Speaking up 
 
 
Task management Being prepared and utilizing resources 
Prioritizing tasks and patients 
Maintaining standards 
 
 
 
1.2.3 Prescribing competences for all prescribers 
 
In 2012 the then National Prescribing Centre developed core competences for all 
prescribers (National Prescribing Centre 2012).  These were reviewed in 2016 by 
representatives of all professions with prescribing authority resulting in a new 
Competency Framework for all Prescribers (Royal Pharmaceutical Society 2016).  
At present the Nursing and Midwifery Council (NMC) have their own Standards of 
proficiency for nurse and midwife prescribers (Nursing and Midwifery Council 
2006) but in May 2017 they agreed to consult on adopting the Competency 
Framework for all Prescribers as their standards for proficiency for nurse and 
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midwife prescribers (Nursing and Midwifery Council 2017a).  The Health and Care 
Professions Council (2013) also have their own Standards for Prescribing.  
 
The competencies in the Competency Framework for all Prescribers (Figure 1.1) 
centre on the patient and are considered under two headings: the consultation 
and prescribing governance (Royal Pharmaceutical Society 2016). 
 
 
Figure 1.1 The prescribing competency framework 
(Royal Pharmaceutical Society 2016) 
 
 
1.3 Non-medical prescribing 
 
Until recent years, prescribing was the preserve of medical doctors and dentists 
but suitably qualified members of other healthcare professions may now train, 
register with a regulatory body and practise as prescribers.  Non-medical 
prescribing has been developed to improve patient care, maintain patient safety, 
enhance access to medicines and to make best use of healthcare professionals' 
skills (Department of Health 2005, Department of Health 2006). 
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1.3.1 Background to non-medical prescribing  
 
In 1986 the Cumberledge report Neighbourhood nursing: a focus for care 
recommended that district nurses and health visitors should be given prescribing 
rights for a limited range of medicines and appliances (Cumberledge 1986).  
Following this the Crown report (1989) recommended that:  
 
“Suitably qualified nurses working in the community should be able, in 
clearly defined circumstances, to prescribe from a limited list of items and 
to adjust the timing and dosage of medicines within a set protocol.”   
(Crown 1989) 
 
In 1992 legislation was enacted which allowed nurses to prescribe a limited 
range of drugs in specified circumstances (Medicinal Products: Prescription by 
Nurses, etc. Act 1992) and by 1994 certain suitably qualified district nurses and 
health visitors (community nurse practitioners) were able to prescribe for their 
patients from the Nurse Prescribers’ Formulary (British Medical Association and 
the Royal Pharmaceutical Society 2015).  The success of this initiative led to a 
second Crown report in 1999 (Crown 1999) which recommended that additional 
suitably qualified healthcare professionals should be given prescribing authority.  
Nurse prescribing developed via two routes: extended formulary nurse 
prescribing which continued until 2006 (Department of Health 2001, Courtenay 
and Griffiths 2010) and dependent, later called supplementary prescribing which 
was also made available to pharmacists (Department of Health 2002) and 
subsequently over time to various allied health professions i.e. physiotherapists, 
podiatrists/ chiropodists, diagnostic and therapeutic radiographers and most 
recently to dietitians (Health and Care Professions Council 2017a).  As 
highlighted in the Foreword to this thesis, prescribing by community practitioner 
nurse prescribers is out with the scope of this research and will not be considered 
further. 
   
 
 
 
 
9 
 
1.3.2 Definitions and scope of non-medical prescribing 
 
Supplementary prescribing is defined as:  
 
“A voluntary prescribing partnership between an independent prescriber 
and a supplementary prescriber (nurse or pharmacist) to implement an 
agreed patient-specific clinical management plan (CMP) with the patient’s 
agreement.  The independent prescriber must be a doctor (or dentist).” 
(Department of Health 2005) 
 
There are no restrictions on the conditions or medicines which may be included 
in the CMP provided they are within the self-assessed competence of the NMP.  
The condition/s must have been previously diagnosed by a doctor.  
 
Following successful implementation of supplementary prescribing independent 
prescribing was enabled in 2006.  Again this must be within the independent 
prescriber’s self-assessed competence.  Independent prescribing is defined as:  
 
“Prescribing by a practitioner responsible and accountable for the 
assessment of patients with undiagnosed or diagnosed conditions and for 
decisions about the clinical management required, including prescribing.”  
(Department of Health 2006) 
 
In 2009 nurse and pharmacist independent prescribers were permitted to 
prescribe un-licensed and off-license drugs while other NMPs could prescribe 
unlicensed drugs in accordance with a clinical management plan (Medicines and 
Healthcare products Regulatory Agency 2009).  Finally in 2012 nurse and 
pharmacist independent prescribers were able to prescribe all drugs controlled 
under Schedules 2 – 5 of the Misuse of Drugs Act with the exception of 
diamorphine, dipipanone and cocaine for the treatment of addiction (Department 
of Health 2012).  Nurse and pharmacist independent prescribers now have the 
same prescribing rights as the vast majority of doctors.   
 
Nonmedical prescribing has developed according to different models across the 
world, reflecting very different healthcare systems; NMP in the UK is among the 
most permissive with NMPs here having one of the widest scopes of practice 
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(Tonna, Stewart and McCaig 2008, Kroezen et al. 2011, Bhanbhro et al. 2011, 
Kroezen et al. 2012, Kroezen et al. 2013, Maier and Aiken 2016).  Table 1.3 
gives details of the scope of supplementary and independent non-medical 
prescribing at April 2017.   
 
Optometrist independent prescribers may only prescribe within their competence 
for conditions affecting the eye (General Optical Council 2017).  Their education, 
training and scope of practice are very different from those of other non-medical 
prescribers and for that reason they were not included in this programme of 
research.  They are included in Table 1.3 below for completeness.   
 
Table 1.3 Details of supplementary and independent prescribing authorities and 
requirements  
Adapted from Stewart, MacLure and George 2012 
 Supplementary 
prescribing (SP) 
Independent  
prescribing (IP) 
Eligible health 
professionals 
Nurses, pharmacists, 
physiotherapists, 
podiatrists, diagnostic and 
therapeutic radiographers, 
and dieticians   
Nurses, optometrists, 
pharmacists, 
physiotherapists, podiatrists, 
therapeutic radiographers   
Clinical conditions 
managed 
Any, within their clinical 
competence 
Any, within their clinical 
competence 
Diagnostic 
responsibility  
A doctor (or dentist) must 
diagnose the condition 
before prescribing may 
commence 
Independent prescriber may 
assess and manage patients 
with diagnosed or 
undiagnosed conditions 
Need for clinical 
management plan 
(CMP) 
A written or electronic 
patient-specific CMP must 
be in place before 
prescribing may commence 
No need for a CMP 
Need for formal 
agreement 
The CMP must be agreed 
between IP, SP and patient  
before prescribing may 
commence 
No need for any formal 
agreement 
Medicines 
prescribed 
Any medicine within their 
clinical competence 
Any medicine within their 
clinical competence 
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 1.3.3 Policy context for non-medical prescribing 
 
This programme of research was carried out in Scotland and the policy context 
will be considered in relation to Scotland.  As part of devolution arrangements, 
health is devolved to the Scottish Parliament and is the responsibility of the 
Scottish Government Health and Social Care Directorate.  Primary legislation 
supporting non-medical prescribing is however not devolved; any amendments 
to legislation such as the Medicines Act must be implemented separately by the 
Scottish Government.  Delivery of healthcare in Scotland is the responsibility of 
NHS Scotland (Scottish Government 2014); the health of the Scottish population 
has historically been poor although it is improving (Calderwood 2016, Scottish 
Government 2016).   
 
The Right Medicine, a strategy for pharmaceutical care in Scotland highlighted 
the key role pharmacists could play in working with others to improve health and 
increase access to better quality services for people in Scotland (Scottish 
Executive 2002).  In 2006 Non-medical prescribing in Scotland provided strategic 
guidance for nurse and midwife independent prescribers (Scottish Government 
2006); this was built on and developed in A Safe Prescription. Developing nurse, 
midwife and allied health profession (NMAHP) prescribing in NHS Scotland 
(Scottish Government 2009).  In 2011 the Scottish Government published its 
2020 Vision for achieving sustainable quality in the delivery of healthcare 
services across Scotland (Scottish Government 2011).  Prescribing by suitably 
qualified healthcare professionals in Scotland has helped to meet the aims of 
these government documents and has been adopted proportionately more by 
pharmacists in Scotland than England and Wales (personal communication, 
GPhC, 2017).   
 
In 2013 Prescription for Excellence: a vision and action plan for the right 
pharmaceutical care through integrated partnerships and innovation was 
published.  The vision articulated was that:  
 
“…all pharmacists providing NHS pharmaceutical care will be NHS 
accredited clinical pharmacist independent prescribers working in 
collaborative partnerships with medical practitioners who will 
continue to have overall responsibility for diagnosis.” 
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(Scottish Government 2013 p.4)   
 
Prescription for Excellence has stimulated increased interest in pharmacist 
prescribing and demand for training courses; there has been a commensurate 
increase in funding for these courses by NHS Education for Scotland (personal 
communication F. Reid, NHS Education for Scotland).  In 2016 there were 1096 
pharmacist prescribers on the NHS Scotland database of whom 48.8% were 
actively prescribing (NHS Education for Scotland 2017a).  Prescribing by nurses 
in Scotland continues to grow and aligns to the advanced practice agenda 
(Department of Health 2010). 
 
Despite government support for NMP some healthcare professionals train and 
qualify as NMPs but do not then go on to practise.  A lack of a clear role for 
prescribing and a lack of organisational support have been identified as reasons 
(McIntosh et al. 2015).  A recent ‘Return to prescribing’ course offered for non-
prescribing pharmacist prescribers was cancelled due to lack of interest (personal 
communication F. Reid, NHS Education for Scotland). 
 
In 2016 the Chief Medical Officer for Scotland published Realistic Medicine 
(Calderwood 2016) challenging doctors and by extension all healthcare 
professionals in Scotland to: 
 
 build a personalised approach to care 
 change their style to shared decision-making 
 reduce unnecessary variation in practice and outcomes 
 reduce harm and waste 
 manage risk better 
 become improvers and innovators 
 
1.3.4 Education and training for nurse, pharmacist and AHP 
supplementary and independent prescribers 
 
At present nurses and AHPs wishing to train and practise as supplementary and 
independent prescribers must have been registered with either the NMC or the 
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Health and Care Professions Council for three years; nurses must have spent the 
previous year in an appropriate clinical area (Nursing and Midwifery Council 
2006, Health and Care Professions Council 2017b).  The NMC has proposed that 
some theories relating to prescribing should be incorporated into the 
undergraduate nursing course to allow nurses to access prescribing training more 
quickly after registration (Nursing and Midwifery Council 2017a).  Pharmacists 
must have been registered with the General Pharmaceutical Council for at least 
two years before starting prescribing training (General Pharmaceutical Council 
2017a).  All applicants must have the support of their employing organisation 
and have identified a suitable area for prescribing on qualification.    
 
Applicants must undertake an accredited university-based education and training 
programme.  The pharmacist prescribing training is at Master’s level and requires  
 
 200 hours university-based education, delivered by a combination of face 
to face and distance learning 
and 
 12 days period of learning in practice (PLP) supervised by a designated 
medical practitioner with suitable practice, education and training 
experience 
 
Non-pharmacist non-medical prescribing students’ training is at degree or 
Master’s level and requires 
 
 26 days of content with a minimum of 8 face to face days and 10 days 
protected learning time 
and 
 12 days period of learning in practice supervised by a designated medical 
practitioner with suitable practice, education and training experience. 
 
The university-based education is generic as is the qualification gained; students 
develop and refine their knowledge and skills in their proposed area of 
prescribing during the PLP.  Assessment is by a combination of university and 
practice-based assessment (Nursing and Midwifery Council 2006, Stewart, 
MacLure and George 2012, General Pharmaceutical Council 2017b, Health and 
Care Professions Council 2017b).  Successful students become eligible for 
annotation on the relevant Register as supplementary or independent prescribers 
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and must ensure that they practise and prescribe within their self-assessed 
competence (Nursing and Midwifery Council 2006, General Pharmaceutical 
Council 2017b, Health and Care Professions Council 2017b). 
 
1.3.5 Diagnosis by independent non-medical prescribers 
 
The inclusion of previously un-diagnosed conditions in the remit of independent 
non-medical prescribers was contentious, particularly among some doctors (Day 
2005) but “clinical management including prescribing” (Department of Health 
2006 p.2) does not mean that the independent non-medical prescriber must 
treat any new condition diagnosed.  If the prescriber feels that the condition is 
out with their competence then “clinical management” will involve referral to 
another suitably qualified healthcare professional, very often to a doctor.  
Pharmacist supplementary prescribers’ lack of diagnostic ability was identified as 
a concern for doctors (Stewart et al. 2009a), for pharmacist supplementary 
prescribers themselves and for their mentors (Lloyd, Parsons and Hughes 2010).  
The need for appropriate consultation and clinical assessment skills have been 
addressed by the GPhC, NMC and HCPC in their requirements for prescribing 
training (Nursing and Midwifery Council 2006, General Pharmaceutical Council 
2017b, Health and Care Professions Council 2017b).  
 
1.4 Literature review of research into non-medical prescribing 
 
Little published research has been identified on NMP other than by nurses and 
pharmacists.  Physiotherapists have had prescribing rights since 2005 yet a 
systematic review of the literature on extended roles for physiotherapists, 
occupational therapists and speech pathologists made no mention of prescribing 
(Saxon, Gray and Oprescu 2014).  Much of the research into NMP is descriptive 
using self-reporting, qualitative methods although there have been some larger 
scale questionnaire-based studies.  
 
Research into NMP has focused largely on: 
 
 NMPs’ views of their prescribing-related education and training 
 
 Implementation and practice of NMP 
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 Views of patients and the public on NMP 
 
 Views of doctors on NMP 
 
 Clinical outcomes from NMP 
 
Influences on NMPs’ prescribing decision-making will be considered along with 
those on medical prescribers’ prescribing decisions making later in this chapter. 
 
1.4.1 Non-medical prescribers' views of their prescribing-related education 
and training 
 
Research into nurse prescribers' perceptions of their prescribing-related 
education and training has identified a range of views.  An early nationwide study 
in England found that educational programmes for both nurse and pharmacist 
independent prescribers were fit for purpose (Latter et al. 2010).  An evaluation 
of the expansion of nurse prescribing in Scotland similarly found the educational 
programmes for nurse prescribers suitable, and described the underpinning 
knowledge of pharmacology in the course as a strength (Watterson, Turner, et 
al. 2009).  On the other hand nurse prescribers have expressed concern about a 
perceived lack of pharmacology in their prescribing course (Creedon et al. 2009, 
Scrafton, McKinnon and Kane 2012). 
 
Concern had already been expressed about a lack of pharmacology and 
therapeutics in medical education for prescribing; this led to recommendations 
for prescribing practice for all prescribers from the British Pharmacological 
Society in Education for new prescribers (Leathard et al. 2007) and from the 
Royal College of Physicians in N=1. Why people matter in medicine (Royal 
College of Physicians 2011). 
 
Continuing professional development (CPD) is a requirement for all healthcare 
professionals and must be appropriate to support individuals’ practice.  Nurse 
prescribers have identified a lack of CPD opportunities as an issue impacting on 
their confidence and their practice (Courtenay and Carey 2008, Courtenay and 
Gordon 2009, Scrafton, McKinnon and Kane 2012, Coull et al. 2013, Creedon et 
al. 2015, Nimmo, Paterson and Irvin 2017).  Weglicki and colleagues (2015) 
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found high levels of anxiety among primary and secondary care nurse prescribers 
interviewed about their CPD needs.   Revalidation was introduced by the NMC in 
2015; prescribers are likely to require specific evidence of CPD relevant to their 
roles and this may help to address perceived gaps in their CPD (Nursing and 
Midwifery Council 2017b).   
 
Pharmacists prescribers found their education and training useful and appropriate 
(Cooper et al. 2008) with clinical assessment skills (Cooper et al. 2008, Tann et 
al. 2010), communications skills training (Cleland et al. 2007, Cooper et al. 
2008) and the period of learning in practice (Tann et al. 2010) particularly 
valued.  CPD needs have been identified primarily to allow pharmacist 
prescribers to extend their scope of practice (Winstanley 2010); pharmacist 
prescribers in the north east of England felt a lack of CPD opportunities limited 
their prescribing for chronic pain (Adigwe et al. 2013).  All non-medical 
prescribers employed by NHS Scotland must engage with the Knowledge and 
Skills Framework (NHS Scotland 2017); this process will help with identifying 
learning needs and opportunities for CPD.  
  
1.4.2 Implementation and practice of non-medical prescribing 
 
Nurse and pharmacist non-medical prescribing has been widely implemented and 
accepted in all settings across the UK, as shown in Table 1.4 below (personal 
communications, Nursing and Midwifery Council, General Pharmaceutical Council, 
Pharmaceutical Society of Northern Ireland and Health and Care Professions 
Council, 2017).    
 
Table 1.4 Non-medical prescribers in the UK by profession 
 Nurse  Pharmacist  Chiropodist/ 
podiatrist  
Physio-
therapists 
Radiographers 
Total 
in UK 
36871 5077 522 1150 96 
 
 
Most prescriptions are written in primary care where indeed most patient care 
occurs.  Again no peer reviewed literature has been identified on prescribing by 
allied health professionals although there are case study reports.  As an example 
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two physiotherapist supplementary prescribers have published a report on 
prescribing for adults with cystic fibrosis (Forster, Henry and Bell 2015).  
 
Nurse independent prescribers (IPs) in one study in primary and secondary care 
described prescribing "as opportunity presents, for specific conditions and for 
individuals" (Bowskill, Timmons and James 2013, p.2077).  There was some 
evidence in this study that nurse IPs in primary care had more autonomy over 
their prescribing decisions than those in secondary care (Bowskill, Timmons and 
James 2013). 
 
NMPs have been found to be developing expertise in their roles, facilitated by 
integration of knowledge and skills with practice which allows contextualisation of 
both (Abuzour, Lewis and Tully 2017).  Supportive colleagues and the use of 
evidence-based guidelines were also found to be helpful in development of 
expertise among NMPs (Abuzour, Lewis and Tully 2017).  NMP was found to 
improve patient access to medicines thereby improving choice and convenience 
for patients (Bhanbhro et al. 2011, Coull et al. 2013, Carey, Stenner and 
Courtenay 2014, Tinelli et al. 2015, Crooks et al. 2016, Famiyeh and McCarthy 
2016). 
 
Facilitators to NMP implementation include supportive colleagues (Adigwe et al. 
2013) and in secondary care, easy access to patient notes and laboratory testing 
facilities (Bourne, Baqir and Onatade 2016).  Barriers include time constraints 
(Bourne, Baqir and Onatade 2016), a lack of organisational support (Coull et al. 
2013, Bourne, Baqir and Onatade 2016), and a lack of underpinning 
organisational and professional strategies (Baqir, Clemerson and Smith 2010, 
Courtenay, Carey and Stenner 2011, Hinchliffe 2015, Coull et al. 2013, McIntosh 
et al. 2015).  Where such strategies were in place NMP was implemented more 
successfully (Courtenay, Carey and Stenner 2011).   
 
NMPs derive professional satisfaction from their role (Bradley, Hynam and Nolan 
2007), enjoying the enhanced autonomy and opportunities to improve patient 
care (Stewart et al. 2009a, Coull et al. 2013, Carey, Stenner and Courtenay 
2014, Stewart et al. 2017) but are very aware of the additional responsibility 
inherent in the role (Bradley, Hynam and Nolan 2007, Cousins and Donnell 2012, 
Maddox et al. 2016) and of the attendant additional stress (Cousins and Donnell 
2012).   
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1.4.3 Views of patients and the public on NMP 
 
Patient awareness of pharmacist prescribing was initially limited (Stewart et al. 
2008a, McCann et al. 2012b) although it improved with time (Stewart et al. 
2011) as pharmacist and NMP became more widespread.  One or two studies 
identified general acceptance by patients but a preference for seeing a doctor 
rather than a pharmacist prescriber (Stewart et al. 2008b) particularly for initial 
diagnosis or if the illness was perceived as serious (McCann et al. 2012b).  The 
importance of the multidisciplinary team in non-medical prescribing was 
emphasised by patients in one study (McCann et al. 2012); participants identified 
differing areas of expertise and hence responsibility, shared input and a holistic 
approach to patient care as benefits of the multi-disciplinary approach.  Some 
patients expressed concern about a possible lack of resources in community 
pharmacies to support pharmacist prescribing in that setting (Hobson, Scott and 
Sutton 2010) and some members of the general public had concerns about a lack 
of privacy in community pharmacy settings (Stewart et al. 2009b).  Other early 
research identified some doubts about nurse prescribers' qualification and 
training (Dhalivaal 2011, Banicek 2012).   
 
Patients are now very accepting of NMP and patient satisfaction with NMP has 
been found to be high (Courtenay, Carey and Stenner 2009, Stewart et al. 2011, 
Coull et al. 2013, Tinelli et al. 2015).  Patients being treated by NMPs for acute 
respiratory tract infections were very satisfied with almost 90% treated with 
"patient centred management strategies" (Courtenay et al. 2017, p.1).  A 
Cochrane review (see later) identified comparable patient satisfaction levels for 
non-medical and medical prescribers (Weeks et al. 2016). 
 
1.4.4 Views of doctors on NMP 
 
Early research showed a lack of understanding of the NMP role by some doctors 
(Bradley and Nolan 2007, Cooper et al. 2012).  Other GPs in early research were 
found to have retained control over prescribing by dictating the scope of 
prescribing by NMP colleagues (Blenkinsopp et al. 2008, Weiss and Sutton 2009, 
Cooper et al. 2012); arguably this is still the case (Weiss et al. 2016).  None the 
less non-medical prescribing within multi-disciplinary teams is effective where 
the team is suitably structured and trust exists between team members (Lloyd, 
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Parsons and Hughes 2010, Bowskill, Timmons and James 2013, Weiss et al. 
2016); this is particularly the case where doctors have acted as mentors to the 
NMPs (Lloyd, Parsons and Hughes 2010).  There is however some debate as to 
whether NMP relieves pressure on doctors (Bradley and Nolan 2007, Lloyd, 
Parsons and Hughes 2010, Coull et al. 2013). 
 
In a large-scale evaluation of nurse prescribing in Scotland patients, the public, 
nurse prescribers, physicians and other healthcare professionals were all very 
positive about the patient benefits of nurse prescribing, particularly for those in 
remote and rural areas where access to doctors can be limited (Coull et al. 
2013).  GPs and physicians in another, smaller Scottish study were found to have 
limited awareness of the scope of prescribing by heart failure specialist nurses 
but none the less viewed the service very positively, recognising the benefits to 
patient care of optimal professional working (Shannon and Spence 2011). 
 
1.4.5 Clinical outcomes from non-medical prescribing 
 
As non-medical prescribing has become more the norm in healthcare research 
has broadened to include patient and health service outcomes.   
NMPs' prescribing practice has been found to be comparable in many ways to 
that of doctors.  The performance of Scottish pharmacist prescribers in the 
Prescribing Safety Assessment (PSA), an on-line test of prescribing proficiency, 
was found to be similar to that of final year medical students (Reid et al. 2017).  
Latter and colleagues found that purposively selected nurse and pharmacist 
prescribers working across a range of settings in England made clinically 
appropriate prescribing decisions (Latter et al. 2012). 
 
Antimicrobial resistance is of increasing concern to health services worldwide 
(World Health Organisation 2014) and a focus for prescribers in the UK (National 
Institute for Health and Care Excellence 2017b).  There is evidence that despite 
variability, nurse prescribing of antibiotics in primary care in Scotland improved 
overall between 2007 - 2013 (Ness et al. 2015a).  More recently NMPs across the 
UK were found to be providing patient-centred care for patients with respiratory 
tract infections which did not result in an antibiotic prescription in response to 
perceived patient expectation (Courtenay et al. 2017).  A recent systematic 
review found strong similarities between nurses' and doctors' prescribing 
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regarding types of medicines prescribed and patient health outcomes (Gielen et 
al. 2014).  Most notably, a Cochrane review found that non-medical prescribing 
delivered comparable results to that of medical prescribing for measures of 
systolic blood pressure, glycated haemoglobin, low-density lipoprotein, 
medication adherence, patient satisfaction, and health-related quality of life in 
acute and long term conditions, in primary and secondary care (Weeks et al. 
2016). 
 
This brief review of the literature demonstrates that nurse and pharmacist 
prescribers are embedded into practice where they are making a strong 
contribution to patient care.  The overarching aim of this programme of research 
is to explore influences on their prescribing; it will be useful next to outline what 
is already known about influences on prescribing decisions albeit that most of the 
literature focuses on medical prescribing.  
 
1.5 Literature review: influences on prescribing decision-
making 
 
Prescribing is a complex process informed by the patient's clinical condition, by 
social and cognitive influences related to both prescriber and patient and by the 
interaction between these dyads.  The first formal research into prescribing in 
the UK appears to have been completed in 1949, when medical academics at the 
University of Edinburgh reviewed 17,301 prescriptions written by GPs in England 
and commented in broad terms on the prescribing of certain drugs and 
formulations (Dunlop 1952).  Since this time much of the research has been 
carried out in primary care, where indeed most prescribing occurs.  Research has 
continued, much of it in the 1990s and early 2000s and among medical 
prescribers, driven by Bradley's seminal work on influences on GPs' prescribing 
decision-making (Bradley 1992a, Bradley 1992c).  This review of the literature 
will consider what is known about social and cognitive influences on doctors' and 
NMPs' prescribing decision-making and identify the research methods used. 
 
1.5.1 Prescriber-patient relationship  
 
Doctors' relationships with their patients have been found to be paramount and 
frequently influence their prescribing decision-making (Butler et al. 1998, 
Stevenson et al. 1999, Britten et al. 2000, Little et al. 2004, Petursson 2005, 
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Lewis and Tully 2011, Lucas et al. 2015, Strumiło et al. 2016, Horwood et al. 
2016).  Doctors in both primary (Butler et al. 1998, Petursson 2005) and 
secondary care (Lewis and Tully 2011) admitted to prescribing inappropriately on 
occasion to maintain good relationships with their patients.  Some GPs over-
estimated the strength and importance of patient demand for prescriptions in an 
effort to protect this relationship (Stevenson et al. 1999, Coenen et al. 2006, 
Peters et al. 2011).  
 
Hospital consultants treating patients with a range of long-term conditions 
reported having a more enduring relationship with some patients than might be 
expected and admitted that they sometimes gave in to patient pressure to 
prescribe for the sake of this relationship (Lewis and Tully 2011).  More junior 
doctors in the same study without this on-going patient relationship felt a lack of 
patient trust as a result.  Sometimes the junior doctors found it easier than their 
seniors to resist perceived pressure to prescribe (Lewis and Tully 2011) but 
sometimes they too "capitulated" (p.9) and prescribed as they thought 
inappropriately in order to preserve their relationship with patients and with 
other healthcare professionals.   
 
The absence of a doctor-patient relationship could be perceived as problematic.  
GPs in Iceland, where patients do not register with a doctor, reported feelings of 
insecurity due to unfamiliarity with patients; these feelings, along with a fear of 
conflict, sometimes led to inappropriate prescribing of antibiotics (Petursson 
2005).  Lack of knowledge of the family was identified as an influence on nurse 
prescribers’ decisions whether or not to prescribe antibiotics during out of hours 
consultations (Philp and Winfield 2010).  The nature of general practice in the UK 
is changing; consultations are shared out between doctors and other health care 
professionals and patients no longer see “their own” GP each time.  It may be 
that this will impact on various aspects of healthcare provision including 
prescribing.   
 
In a study of prescribing of antibiotics for sore throats, GPs asserted that 
patients came to them "wanting something done" (Butler et al. 1998, p.638).  
The GPs preferred to fulfil the patients' perceived expectations for antibiotics 
where practicable, even when they were probably not indicated, primarily in 
order to build and maintain beneficial therapeutic relationships with their 
patients.  More recently, GPs and nurse prescribers treating children with 
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respiratory tract infections would sometimes prescribe antibiotics for a range of 
non-clinical influences including to preserve their relationship with parents 
(Horwood et al. 2016). 
 
Nurse prescribers similarly had experienced patient pressure to prescribe for the 
sake of their relationship with the patient or parent (Philp and Winfield 2010), 
particularly antibiotics (Rowbotham et al. 2012, McIntosh et al. 2014).  Both GPs 
(Björnsdóttir and Hansen 2001, Peters et al. 2011), non-medical prescribers 
(Courtenay et al. 2017) and particularly nurse prescribers (Peters et al. 2011, 
Rowbotham et al. 2012, McIntosh et al. 2014) felt that they had a role in 
educating patients in the appropriate use of antibiotics.  
 
1.5.2 Communication between prescriber and patient  
 
The General Medical Council describes the doctor-patient partnership as one 
based on openness, trust and good communication (General Medical Council 
2012) and several of the competencies in the Competency Framework for all 
Prescribers are concerned with communication (Royal Pharmaceutical Society 
2016).  As will be seen research in this area has extended over two decades, 
evidencing its on-going importance.  Patients want a patient-centred approach 
within consultations involving clear communication, partnership (centred on 
communication) and health promotion, and possibly a prescription (Little et al. 
2001).  Effective communication improves health outcomes (Stewart 1995) and 
problems with communication between GPs and their patients result in poor 
adherence-associated outcomes (Jenkins et al. 2003) but communication 
between doctors and their patients is not always good or clear (Butler et al. 
1998, Barry et al. 2000, Britten et al. 2000, Stevenson et al. 2000, Barry et al. 
2001, Lewis and Tully 2011, Cabral et al. 2014).   
 
Doctors and patients may be speaking a different language.  One study of 
consultations in primary care found patients used Mishler’s “voice of the 
lifeworld” (Mishler 1984) to express their health concerns in the context of their 
daily lives, while GPs used the “voice of medicine”, focussing only on the clinical 
condition and ignoring the context (Barry et al. 2001, p.487).  Not surprisingly, 
where this linguistic mismatch existed it was found to result in poorer outcomes 
for patients.  There was evidence that both patients and GPs could and did switch 
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between the two “languages” and it was suggested that GPs be encouraged to 
recognise and deal with patients' “lifeworld” issues.  
 
In a study of GP-patient communication, Britten and colleagues found a lack of 
patient involvement in the consultation resulted in numerous misunderstandings 
which resulted in potential or actual adverse consequences, generally around 
adherence (Britten et al. 2000).  In a meta-ethnography of lay experiences of 
medicine taking GPs seemed unaware of the relevance of patients' ideas and 
preferences for treatment and particularly of their reluctance to take medicines 
(Pound et al. 2005).  Clear and effective communication between healthcare 
professionals and their patients is one of the cornerstones of the NICE guideline 
Medicines adherence: involving patients in decisions about prescribed medicines 
and supporting adherence (National Institute for Health and Clinical Excellence 
2009). 
 
Barry and colleagues identified complex patient agendas in general practice 
consultations which were neither expressed by patients nor elicited by GPs (Barry 
et al. 2000).  Patients were explicit about their desires for diagnosis and 
treatment; unvoiced agendas included their concept of what might be wrong, 
worries about the diagnosis, pharmacotherapy-related concerns and the social 
context of their illness, linking to the “voice of the lifeworld” above (Barry et al. 
2001).  Researchers found that "in consultations, patients seem only partially 
present" (Barry et al. 2000 p. 1249).  Most of the associated misunderstandings 
resulted in potential or actual problems for patients, again often related to non-
adherence with un-sought medicines.  The researchers recommended that 
doctors be encouraged to address their communication with patients in order to 
encourage fuller exchange of information (Barry et al. 2000).   
 
In a systematic review and meta-ethnography, Cabral and colleagues (2014) 
found a disconnect between doctor and parents’ communication within 
consultations for acute illness in children, which affected prescribing decisions.  
Parents expressed their concerns and need for information while doctors were 
focussed on diagnosis and treatment options.  In relation to the treatment of 
children's respiratory tract infections (RTIs), clinicians' perception of parental 
requests for antibiotics might also have been interpreted as more general 
comments and information-seeking (Cabral et al. 2014).  Cabral and colleagues 
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recommended targeted training to help clinicians interpret parents’ 
communication in a more neutral way. 
 
In secondary care a critical incident study of prescribing decisions found 
examples of problematic communication between doctors and patients, some of 
whom were perceived by doctors as aggressive, manipulative and emotional 
(Lewis and Tully 2011).  A narrative review of the literature in the specific area of 
cancer treatment found that good communication between professionals and 
patients, along with a patient-centred approach, facilitated chemotherapy 
decision-making in elderly patients.  Poor health literacy, possibly combined with 
sensory and cognitive impairment in participants, acted as a barrier (Johnson 
2012).  Finally in a study using a discrete choice experiment patients with 
symptoms indicative of cancer risk were prepared to wait up to 3.5 weeks to 
consult a doctor with good listening skills and an extra week to consult their 
preferred GP (Whitaker et al. 2017).  This behaviour may or may not be 
replicated in real life but indicates the importance patients place on doctors’ 
communication skills.  
 
In a small scale interview-based study, primary care nurses in Cornwall treating 
otitis media in children acknowledged that prescribing antibiotics might 
contribute to their relationship with patients’ parents (Philp and Winfield 2010).  
Research among NMPs has suggested that effective communication with patients 
by NMPs could support their decisions not to prescribe antibiotics (Rowbotham et 
al. 2012 McIntosh et al. 2014, Courtenay et al. 2017).   
 
1.5.3 Patient pressure and perceived patient pressure to prescribe  
 
Patient pressure on doctors to prescribe, and doctors' perception of this, have 
been found to be strong influences on prescribing decision-making; again 
research has been on-going (Britten and Ukoumunne 1997, Björnsdóttir and 
Hansen 2001, Little et al. 2004, Coenen et al. 2006, Lewis and Tully 2011, 
Murphy, Byrne and Bradley 2011, Peters et al. 2011, Murphy, Bradley and Byrne 
2012, Coenen et al. 2013, Dempsey et al. 2014, Lucas et al. 2015).  Doctors’ 
perceptions may however be faulty (Britten and Ukoumunne 1997, Britten et al. 
2000, Gunnarsdóttir and Kinnear 2005, Coenen et al. 2013, Cabral et al. 2014).      
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Patient demands were influential on Scottish GPs' decisions whether to prescribe 
conventional or cyclo-oxygenase 2 inhibitor non-steroidal anti-inflammatory 
drugs (Gunnarsdóttir and Kinnear 2005).  Little and colleagues (2004) in a study 
of consecutive patients found that although the patient’s perceived medical need 
was most influential, GPs' perceptions of patient pressure were strongly 
associated with examination, prescribing and referral decisions and were more 
influential than the GPs' perception of patient preferences.  
 
In secondary care, pressure from patients, relatives or carers to prescribe, 
particularly for controlled drugs, sedatives and antibiotics, was a source of 
discomfort for doctors and especially those working in the Accident and 
Emergency department (Lewis and Tully 2011).  In almost half of cases doctors 
prescribed what the patient asked for, sometimes as the doctors thought 
inappropriately, generally for the sake of the doctor-patient relationship or to 
avoid conflict with the patient which might have impacted on the multi-
disciplinary team.  Junior doctors issued "tactical prescriptions" (p.8) in response 
to pressure but tended to feel badly afterwards; some junior doctors found not 
knowing the patient helpful in resisting pressure to prescribe.  Doctors working in 
nursing homes faced pressure from staff to prescribe in response to elderly 
residents’ challenging behaviour (Wood-Mitchell et al. 2008) and depression 
(Iden, Hjørleifsson and Ruths 2011).  
  
Flemish GPs were found to prescribe antibiotics for acute cough more frequently 
when they perceived patient demand for this, but only when the patients were 
not unduly ill (Coenen et al. 2006).  Lucas and colleagues (2015) identified 
clinicians' perceptions of parental pressure for antibiotics as influencing their 
decisions to prescribe these for acute childhood infections.  Parental preference 
to avoid antibiotics or indeed any treatment for their children was also identified.  
 
NMPs have similarly reported feeling subject to patient pressure to prescribe, 
most commonly antibiotics for the treatment of respiratory tract infections (Philp 
and Winfield 2010, Rowbotham et al. 2012, McIntosh et al. 2014, Courtenay et 
al. 2017), and also antibiotics more generally (Ness et al. 2016).  Provision of 
patient education about the condition and on appropriate self-care was felt to be 
helpful in managing this pressure, particularly in relation to antibiotics 
(Rowbotham et al. 2012).   
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Rowbotham and colleagues felt that NMPs in their study did not explore their 
perceptions of patient pressure sufficiently.  In a larger scale, mixed methods 
study, NMPs' perceptions of patient expectations for antibiotics to treat acute 
respiratory tract infections were found frequently to match patients' actual 
expectations (Courtenay et al. 2017 p.40).  NMPs in this study prescribed 
antibiotic and non-antibiotic treatments and adopted "patient centred 
management" of the conditions.  
 
Delayed prescribing of antibiotics is recommended as one strategy to promote 
antimicrobial stewardship in the treatment of self-limiting respiratory tract 
infections (National Institute of Health and Care Excellence 2014) and may help 
in managing patient demand.  Its use varies.  Peters and colleagues (2011) 
found that GPs, GP trainees and nurse prescribers in the north west of England 
used this infrequently as did GPs in a large-scale, Europe-wide study (Francis et 
al. 2012).  On the other hand NMPs treating otitis media in children used delayed 
prescribing frequently to aid in managing parental demands for antibiotics (Philp 
and Winfield 2010) while other NMPs used it for certain high-risk conditions 
(Courtenay et al. 2017).  A recent survey of households in England found that 
most members of the public did not understand the term ‘delayed prescribing’; 
those who did had mixed views of the practice (McNulty et al. 2015). 
 
Much of the literature reviewed concerns patient or family pressure for antibiotics 
although as in Lewis and Tully’s study (2011) pressure can also be perceived for 
controlled drugs and sedatives.  There will be specialist research in this area; it 
may be that prescribers manage pressure for substances liable to abuse 
differently.   
 
1.5.4 Patients' ideas, concerns and expectations and prescribers' 
perceptions of patient expectations  
 
The tension between perceived patient "wants" and "needs" has been described 
as "one of the handful of fundamental questions in the philosophy of health” 
(Cribb and Barber 1997, p.294).  Most patients believe their medicines are 
necessary but some have strong concerns about their long-term effects (Britten 
1994, Horne and Weinman 1999) and may resist taking even those for long term 
conditions (Pound et al. 2005), a subsection of prescribing where adherence is 
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poor (World Health Organisation 2003).  These beliefs and concerns influence 
adherence (Pound et al. 2005, National Institute for Health and Care Excellence 
2009) but are not always expressed by patients nor elicited by doctors (Britten 
1994, Barry et al. 2000, Britten et al. 2000, Stevenson et al. 2000, Matthys et al. 
2009).  
 
Matthys and colleagues (2009) found that the concerns of general practice 
patients in Belgium centred on diagnosis and treatment and were expressed in 
42% of consultations and more frequently during consultations for a new 
condition; when patients' concerns and expectations were expressed, GPs 
prescribed fewer new drugs.  
 
GPs’ perceptions of patient expectations can be highly influential, particularly in 
the area of upper respiratory tract infections (Britten and Ukoumunne 1997, 
Butler et al. 1998, Coenen et al. 2013).  Coenen and colleagues (2013) 
researching across 13 European countries found that GPs' and nurse 
practitioners' perceptions somewhat matched patients' expectations, hopes for 
and requests for antibiotics to treat acute cough, and that these significantly 
influenced antibiotic prescribing.  In an Australian study, independent of the 
condition, patients who expected a prescription were three times more likely to 
get one than those who did not, while those whom the GP thought wanted a 
prescription were ten times more likely to get one (Cockburn and Pit 1997).  
 
Independent nurse and pharmacist prescribers were criticised in an early 
nationwide evaluation of their prescribing for failing to elicit their patients’ beliefs 
about medicines, and particularly their beliefs about whether the medicines were 
necessary for them (Latter et al. 2010).  Patients in this study considered this 
attribute the most important for prescribers for long-term conditions.  Sibley and 
colleagues (2011) analysed medication discussion between nurse prescribers and 
people with diabetes and found a focus on "instruction-based discussion" with 
little consideration of the patients' perspectives.  More recently, pharmacist and 
nurse prescribers were found to be better than GPs at picking up patients' 
emotional cues and concerns in primary care consultations (Riley et al. 2013) 
albeit that the pharmacist prescribers had much longer consultations than 
others.  Courtenay and colleagues found that clear communication regarding 
patients’ concerns, provision of information including that on treatment 
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decisions, physical examination and adequate consultation time all contributed to 
patient satisfaction with NMPs’ consultations for respiratory tract infections 
(Courtenay et al. 2017).  In this study patients’ expectations regarding their 
treatment matched NMPs’ perceptions of their expectations; those perceived as 
wanting an antibiotic who did not receive one were less satisfied with their 
consultations. 
 
1.5.5 Shared decision making  
 
Shared decision making between patient and prescriber regarding treatment is a 
key component in promoting adherence and requires communication, increasing 
patient involvement, understanding the patient's knowledge, beliefs and 
concerns about medicines and providing information (National Institute for 
Health and Care Excellence 2009).  Not all patients however want this and rather 
trust their doctor to make decisions for them (Solomon et al. 2012).  GPs in the 
Netherlands wanted shared decision making when managing patients with multi-
morbidity (Luijks et al. 2012); on the other hand, in the specialist area of cancer 
treatment shared decision making was found to have weak or no influence on 
patients' quality of life (Kashaf and McGill 2015).  In a vignette-based study, GPs 
felt that shared decision making would be helpful with parents of children with 
co-morbidities presenting with respiratory tract infections (Ashdown et al. 2016).  
GPs, Primary Care Trust (PCT) prescribing advisors and patients were found to 
prioritise elements contributing to shared decision-making differently; patients 
had a very personal perspective, PCT prescribing advisors prioritised evidence-
based practice and GPs were somewhere in the middle (Solomon et al. 2013).  
 
Nurses prescribing for patients with diabetes asserted that they resisted pressure 
to "medicalise" their consultations (Stenner, Carey and Courtenay 2010, p.29), 
claiming to take a more holistic, patient-centred approach.  Non-specialist nurses 
in this study who may not have had diagnostic skills preferred to prescribe 
according to protocols, whereas diabetes specialist nurses were comfortable with 
more complex decision-making.   
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1.5.6 Influence of evidence-based guidelines  
 
Potential conflicts between the use of evidence-based guidelines and maintaining 
a GP-patient partnership were identified in a mixed methods study carried out in 
the North of England (Solomon et al. 2012).  Most GPs in this survey supported 
both guidelines and the doctor-patient partnership but where they felt these 
were incompatible prioritised their relationship with the patient and took a 
"flexible" approach to prescribing (p. 277).  Other GPs adhered closely to 
guidelines at the expense of their relationship with patients.  Some patients in 
this study perceived clinical guidelines as proscriptive and restrictive and 
considered the idea of a doctor-patient partnership unrealistic.  A focus-group 
study carried out among GPs in Merseyside found similar doubts about the 
applicability of guidelines to individual patients (Cranney et al. 2001).  Shared 
decision-making requires that the patient’s values and beliefs about treatment 
options are taken in to account and these may conflict with evidence-based 
treatment options (McCartney et al. 2016).  
 
Research on NMPs’ adherence to guidelines has identified a range of approaches.  
A systematic review of independent nurse prescribers' antimicrobial prescribing 
behaviour found that guidelines and protocol influenced both whether to 
prescribe an antimicrobial and which one to prescribe (Ness et al. 2016).  This 
two-step approach to prescribing decisions has previously been identified 
(Bradley 1992c, Maddox et al. 2016).  Some evidence of prescribing out with 
guidelines was found in an early nation-wide evaluation of nurse independent 
prescribers and pharmacist independent prescribers, although their prescribing 
was judged to be safe and effective (Latter et al. 2012).  Nurse prescribers (Philp 
and Winfield 2010) and non-medical prescribers (Rowbotham et al. 2012) 
treating upper respiratory tract infections and otitis media said that they 
occasionally prioritised other influences such as clinical uncertainty and 
experience over evidence-based guidelines, where they perceived this would be 
best for their patients (McIntosh et al. 2014).   
 
1.6 Research methods used in these studies 
 
Methodological approaches to research will be considered in Chapter 2 but it is 
useful to note that a wide range of methods have been used singly or at times in 
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combination to research influences on prescribing decisions.  All have strengths 
and limitations.   
 
Quantitative research methods used:  
 
 local, regional and nation-wide postal and online questionnaires 
 scenario-based questionnaires 
 analysis of prescriptions written 
 review of patient notes 
 retrospective analysis of a national prescribing dataset 
Qualitative research methods used: 
 
 semi-structured telephone and face to face interviews 
 focus groups 
 vignettes 
 observation 
 audio or video-taped consultations 
 field notes 
 participants’ diaries 
 patients’ symptom diaries 
 critical incident-based interviews 
 case studies combining two or more approaches 
 literature review including systematic review 
 
An example of the complexity of qualitative research is seen in a multi-method 
case study undertaken by a team of researchers exploring influences on medical 
prescribing decision-making and doctor-patient communication about drugs 
(Stevenson et al. 1999, Barry et al. 2000, Britten et al. 2000, Barry et al. 2001, 
Stevenson et al. 2002).  Patients were interviewed before and after consultations 
with a purposive sample of GPs in England, the consultations were recorded and 
field notes taken and GPs were interviewed after each consultation.  The 
researchers acknowledged limitations.  Patient recruitment methods varied: 
some patients were interviewed at home a day or two before the consultation 
whereas others were interviewed in the surgery waiting room immediately prior 
to it.  Patients were then interviewed again one week after the consultation when 
memories might have begun to fade or perceptions change.  Interestingly 
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although the researchers gathered data from 62 patients they decided only to 
analyse data from 35.  This research was regarded as of very high quality and 
culminated in a report for the Department of Health (Stevenson et al. 2001). 
 
1.7 Programme of research 
 
Research into NMP then has focused on NMPs’ views of their 
prescribing-related education and training; implementation and practice of NMP; 
views of patients, the public and doctors on NMP and clinical outcomes from 
NMP.  NMPs are making a substantial contribution to patient care across a wide 
range of areas in primary and secondary care yet much less research has been 
undertaken into influences on their prescribing decisions, and this was the area 
for this programme of research.   
 
The overall aim of the programme of research was to explore and describe 
prescribing decision-making by non-medical prescribers. 
 
The following programme of research was designed: 
 
Stage 1: synthesis of findings from the literature 
 
A systematic review was undertaken of social and cognitive influences on 
prescribing decision-making by non-medical prescribers.   
(McIntosh et al. 2013, McIntosh et al. 2014, McIntosh et al. 2016).  
 
The aim of the systematic review was to identify and characterise social and 
cognitive factors and perceived factors influencing the prescribing decision-
making process among non-medical prescribers. 
 
The objectives of the systematic review were:  
 
 to determine the social and cognitive influences on prescribing  
decision-making among supplementary and independent non-medical 
prescribers in the UK  
and 
 to report on the methodologies and methods used and quality of peer 
reviewed published studies in this area 
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Stage 2: data generation 
Phase 1: semi-structured interviews exploring prescribing decision-making by 
NMPs (McIntosh et al. 2017). 
 
The overall aim of Stage 2 of the programme of research was to explore 
participants’ experiences and perceptions of influences on their prescribing 
decision-making, and the impact of these influences.   
 
The objectives of Stage 2 Phase 1 of the research were to explore: 
 
 participants' in-depth descriptions of their experiences of making 
prescribing decisions 
 
 their views and reflections of influences on the prescribing decisions they 
make 
and 
 
 their opinions on the impact of these influences on their prescribing 
decision-making    
 
Stage 2 Phase 2: self-recorded reflections on individual prescribing decisions 
participants felt were noteworthy in some way 
 
 
 
Phase 3: semi-structured interviews based on these recorded reflections 
 
The objective of Stage 2 Phases 2 and 3 was to explore: 
 
 participants’ experiences and perceptions of influences on their prescribing 
decision-making, and their impact in relation to noteworthy 
prescribing decisions. 
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Chapter 2 Research Methodologies 
 
2.1 Introduction 
 
Chapter 1 provided the background to this programme of research, outlining 
what is already known and demonstrating the need for further research into 
influences on prescribing decision-making by NMPs.  This research was 
undertaken in two stages, the second of which had three phases: 
 
Stage 1: synthesis of findings from the literature 
A systematic review of social and cognitive influences on prescribing decision-
making by non-medical prescribers was undertaken; see Chapter 3 and 
publications (McIntosh et al. 2013, McIntosh et al. 2014, McIntosh et al. 2016a).   
 
Stage 2: data generation 
Phase 1: semi-structured face to face interviews with NMPs exploring their 
prescribing decision-making (McIntosh et al. 2017) 
 
Phase 2: self-recorded reflections on individual prescribing decisions participants 
felt were noteworthy in some way 
 
Phase 3: semi-structured face to face interviews with participants based on their 
recorded reflections 
 
In this chapter systematic review as a research tool will be described.  Then the 
philosophical approaches, research methodologies, theoretical frameworks and 
methods which may inform the design of a programme of research will be 
considered.  At each stage the approaches taken in this study will be identified 
and justified.  Information on the setting and context of this study will be given.  
Finally the steps taken throughout to ensure good research governance will be 
described.   
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2.2 Systematic review of the literature 
 
The first step in undertaking a programme of research is to review the literature 
to establish what is already known; this will make the case for the research and 
inform study design.  Grant and Booth (2009) identified fourteen types of 
literature review.  These are listed in Table 2.1 below along with their key 
characteristics; note that there is some overlap between study characteristics.  
Grant and Booth’s typology has been criticised for not including narrative reviews 
and reviews of reviews (MacLure, Paudyal and Stewart 2016) and these have 
been included for completeness.  
 
Table 2.1 Types and key characteristics of literature reviews  
Adapted from Grant and Booth 2009 
Label Description Label  Description 
Critical review Extensive critical 
evaluation; often 
results in a 
hypothesis or 
model 
Rapid review Systematic but 
time-limited 
review of 
literature on 
policy or practice   
Literature 
review 
Generic term 
 
 
Scoping review Preliminary 
assessment of 
nature and extent 
of literature 
Mapping 
review/ 
systematic map 
Maps and 
characterises 
existing literature 
to identify gaps 
State of the art 
review 
Examines more 
current matters 
Meta-analysis Statistical 
combination of 
results of 
quantitative 
research to 
enhance reliability 
of results 
Systematic 
review 
Systematic 
search, appraisal 
and synthesis of 
evidence; often 
used in guideline 
development 
Mixed methods 
review 
Combines results 
from different 
research 
approaches e.g. 
quantitative and 
qualitative 
research 
Systematic 
search and 
review 
Comprehensive 
search strategy + 
critical review of 
literature over a 
broad area 
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Label Description Label  Description 
Overview Generic term for a 
summary of the 
literature 
Systematised 
review 
Uses some but 
not all elements 
of the systematic 
review process 
Qualitative 
systematic 
review 
 
Thematic 
integration of 
findings from 
qualitative 
research 
Umbrella review Compiles 
evidence from 
multiple reviews 
(not primary 
research).  Broad 
focus 
Narrative 
review 
Generally 
descriptive with 
often no 
systematic search  
Review of 
reviews 
A systematic 
review of 
systematic 
reviews 
 
 
As stated in the Foreword, prior to commencement of MRes/ PhD studies the 
doctoral student carried out a scoping review of literature on non-clinical factors 
influencing prescribing decisions.  This identified several areas of interest and 
provided the foundation for this study.  A more detailed understanding of what 
was known specifically about influences on NMPs’ prescribing decision-making 
was needed and this was achieved by means of a systematic review of the 
literature.  The aim of a systematic review is to identify, appraise critically and 
synthesise relevant literature to answer specific research question/s (MacLure, 
Paudyal and Stewart 2016).    
 
Grant and Booth characterise systematic reviews as requiring comprehensive 
searching, quality assessment which may determine inclusion or exclusion and 
narrative synthesis with the use of tables of evidence; these requirements are 
set out in a protocol developed in advance.  Findings will include an evaluation of 
the quality of the research and may be used to inform future practice and/ or 
highlight areas for further research.   
 
Booth (2006, p.422) described qualitative systematic review as:  
 
“a method for integrating or comparing the findings from qualitative 
studies.  The accumulated knowledge resulting from this process may lead 
to the development of a new theory, an overarching narrative, a wider 
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generalization, or an interpretative translation. [The goal is] interpretative 
in broadening understanding of a particular phenomenon.” 
 
By definition a systematic review, whether qualitative or not, should have a 
protocol which specifies exactly what is to be done.  This protocol should include 
the review question/s, inclusion criteria, search strategy, study selection, quality 
assessment, data extraction, data synthesis and plans for dissemination (Centre 
for Reviews and Dissemination 2013 p.6).  Publication of the protocol provides 
evidence of peer review and therefore of the quality of the protocol.  It also 
alerts other researchers that the review is being undertaken and reduces the 
possibility of duplication of the work.   
 
Several organisations exist to promote the production and use of systematic 
reviews to inform evidence-based practice, for example the Cochrane 
Collaboration (Cochrane Central Executive 2017), the Joanna Briggs Institute 
(Joanna Briggs Institute 2017) and the Centre for Reviews and Dissemination 
(CRD) at the University of York (University of York 2017).   
 
2.2.1 Approach taken to systematic review in this programme of research 
 
Chapter 3 of this thesis provides details of a systematic review carried out of the 
social and cognitive influences on prescribing decision-making among non-
medical prescribers.  The review was undertaken according to guidance provided 
by the CRD and used a narrative synthesis approach to analysis (Popay et al. 
2006).  According to the CRD: 
 
“The defining characteristic of narrative synthesis is the adoption of a 
textual approach which provides an analysis of the relationships within and 
between studies and an overall assessment of the robustness of the 
evidence.” 
(Centre for Reviews and Dissemination 2009 p. 48) 
 
The review protocol was published by the CRD (McIntosh et al. 2013). Findings 
from the review have also been published (McIntosh et al. 2014, McIntosh et al. 
2016a).   
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2.3 Philosophical approaches to research 
 
Various philosophical approaches to research exist.  Until recently explicit use of 
such philosophies and associated “theoretical lenses” was rare in reporting of 
pharmacy practice research (Stewart and Klein 2016, p.616) and in research in 
medical education (Bunniss and Kelly 2010), although more common research 
into nursing practice (Bunniss and Kelly 2010).  It is important that the 
appropriate philosophical approach is selected at the beginning of a programme 
of research so as to ensure alignment with the methodological choice, research 
strategy, time horizon and data collection methods, thus producing a coherent 
research design (Creswell 2013).  These terms are clarified below:  
 
 philosophy has been defined as “the study of the fundamental nature of 
knowledge, reality, and existence, especially when considered as an 
academic discipline” (Oxford Dictionaries 2010).  Research philosophy is 
therefore the way in which some aspect of the fundamental nature of 
knowledge, reality, and existence is studied 
 
 the methodological choice made sets out the broad approach to the 
research taken i.e. quantitative or qualitative research 
 
 the research strategy outlines the type/s of study design to be used 
 
 the time horizon is the time over which the research will be carried out, for 
example a snap shot in time or a longitudinal study such as a cohort study 
 
 the method/s used in this study describe in more detail how data will be 
collected and analysed  
 
Saunders and colleagues developed the research onion (Figure 2.1 below) as a 
way of illustrating the relationships between research philosophies, 
methodological choices, research strategies, the time horizon and data collection 
methods (“techniques and procedures”) (Saunders, Lewis and Thornhill 2012, 
p.59). 
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Figure 2.1 The research onion 
(Saunders, Lewis and Thornhill 2012) 
 
2.3.1 Research philosophies  
 
Several research philosophies exist: Creswell (2013) lists positivism, 
postpositivism; interpretivism, constructivism, hermeneutics; feminism; 
radicalised discourses; critical theory and Marxist models; cultural studies 
models; queer theory and postcolonialism.  Positivism and interpretivism will be 
considered further as these philosophies are frequently used in social science and 
health research (Bowling 2002). 
 
Positivism assumes that reality exists and can be measured; a deductive 
approach is taken where a hypothesis is developed and tested for veracity 
generally by quantitative means, possibly resulting in the positing of a new 
theory.  Interpretivism takes an inductive approach and uses observation to 
develop fresh understandings and possibly theories (Bowling 2002).  Contrasting 
aspects of these philosophies in social science and health research may be 
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considered with regard to their ontological, epistemological, axiological and 
methodological beliefs, as in Table 2.2 below.  First these terms will be 
explained: 
 
 ontology in philosophy is “the branch of metaphysics that deals with the 
nature of being” (Oxford Dictionaries 2010).  Ontological beliefs therefore 
concern the nature of reality and inform the choice of research philosophy 
 
 epistemology is defined as “the theory of knowledge, especially the critical 
study of its validity, methods and scope” (Oxford Dictionaries 2010).  
Epistemological beliefs concern the source, formation and structure of 
knowledge 
 
 axiology is “the theory of moral and aesthetic values” (Chambers 2017).  
Axiological beliefs relate to the role of values in the research 
 
 methodology describes the approach to enquiry taken within the research 
i.e. quantitative or qualitative  
 
Table 2.2 Contrasting aspects of the research philosophies positivism and 
interpretivism in social science and health   
Adapted from Creswell 2013 p.36 and 37  
 Positivism Interpretivism 
Ontological beliefs  
(the nature of 
reality) 
A single objective reality exists Multiple realities are 
constructed through our lived 
experiences and interactions 
with others 
Epistemological 
beliefs 
(how reality is 
known)  
Reality can only be 
approximated. Interaction with 
subjects is kept to a minimum 
Reality is co-constructed 
between the researcher and 
the researched and shaped by 
individual experiences 
Axiological beliefs  
(the role of values) 
Researchers’ biases need to be 
controlled and not expressed 
in a study 
Individual values are honoured 
and are negotiated among 
individuals 
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 Positivism Interpretivism 
Methodology 
(the approach to 
inquiry) 
 
Use of scientific method.  The 
objective is to create new 
knowledge; deductive methods 
are important e.g. testing 
theories, specifying variables, 
comparing groups.  
Methods used are quantitative 
and include randomised 
controlled trials, cohort studies 
and questionnaires 
Use of an inductive method to 
identify emerging ideas. 
Methods used are qualitative 
and include interviewing, 
observing and analysis of texts 
 
 
The approaches taken to research within these two philosophies are different but 
not mutually exclusive.  It is possible to include interpretivist, qualitative 
elements within a positivist quantitative methodology for example by asking for 
additional comments within a questionnaire (McColl et al. 2001, Bowling 2002).  
It is also possible to use mixed methods to explore an area of research.  As an 
example, themes may be identified in a small qualitative study and then explored 
more widely using a questionnaire to survey a much larger but similar 
population.  Equally, participants in a questionnaire study may be asked whether 
they would participate in interviews or focus groups to allow more in-depth 
exploration.  Aspects of the use of positivism and interpretivism in social science 
and health research are shown in Table 2.3. 
 
Table 2.3 Aspects of the use of positivism and interpretivism in social science and 
health research   
Adapted from Bowling 2002 and Creswell 2013 
Positivism Interpretivism 
Deductive approach Inductive approach 
Quantitative approaches Qualitative approaches 
Include surveys, experimental methods Include interviews, focus groups 
Statistical analysis of data (numbers, 
percentages, scores etc) 
Thematic analysis of data (transcribed 
recordings, field notes etc) 
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2.4 Methodological approaches 
 
As above, although quantitative and qualitative approaches align most naturally 
with positivism and interpretivism respectively there can be some overlap.  
Awareness of the characteristics, strengths and limitations of each approach is 
important to ensure that the most appropriate one is used to answer the 
research question.  These are outlined in Table 2.4 below.   
 
Table 2.4 Characteristics, strengths and limitations of quantitative and qualitative 
research approaches in social science and health   
Adapted from Bowling 2002 
 Quantitative approaches Qualitative approaches 
Examples of 
data collection 
methods 
Questionnaires, surveys Interviews, focus groups  
(see Table 2.7)  
Aim Descriptive survey; hypothesis 
testing; aiming for generalisability of 
results 
Exploring in-depth views, 
attitudes, experiences; 
aiming for trustworthiness of 
findings 
Numbers of 
participants 
More suited to larger numbers; 
power calculation needed to 
facilitate robust statistical analysis.  
May produce only descriptive 
statistics if response rate is lower   
More suited to smaller 
numbers e.g.one to one 
interviews or focus groups 
with ideally 6 – 10 
participants for each group  
Mode of 
administration 
Postal, on-line or questionnaire 
administered face to face 
Face to face, telephone, 
video conferencing, Skype® 
Content Standardised questions with fixed 
responses; psychological tests, 
scales e.g. Likert scale 
Some open questions or requests for 
comment 
Structured, semi-structured 
or unstructured interview 
schedule or free association 
narrative interview 
Topic guide for focus groups  
Development of 
data collection 
tool 
Demands rigorous development 
from the literature using appropriate 
theoretical underpinning  
Demands rigorous 
development from the 
literature using appropriate 
theoretical underpinning 
Ease of use for 
researchers 
Postal and on-line questionnaires 
relatively straightforward to send 
once contact details obtained 
Time-consuming, expensive 
and require highly trained 
researchers to undertake 
interviews and facilitate focus 
groups 
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 Quantitative approaches Qualitative approaches 
Ease of use for 
participants 
Should be designed to minimise 
cognitive burden for participants. 
Pre-coded response options may not 
be sufficiently comprehensive to 
allow participants to make a choice 
which accurately reflects their 
opinion 
Should be designed to 
minimise cognitive burden 
for participants but likely to 
make more demands than 
quantitative methods 
 
Data generated Largely quantitative with some 
qualitative elements  
Qualitative with some 
quantitative data e.g. 
demographics 
Sources of bias 
(Sackett 1979 
and Bowling 
2003) 
During development of data 
collection tool, sampling bias, social 
desirability bias, “yes-saying” bias 
During development of data 
collection tool, sampling bias, 
interviewer bias, social 
desirability bias 
Analysis Descriptive and inferential statistical 
analysis used to characterise 
participants and to try to establish 
statistically significant results.  
These may then be used to infer 
what the views of a wider, similar 
population may be 
Thematic analysis using most 
commonly the Framework 
Approach (Ritchie et al.  
2014) or Grounded Theory 
(Glaser 1967) 
 
 
2.4.1 Justification of the use of the interpretivism philosophy in this 
programme of research 
 
The interpretivism philosophy was used in this programme of research.  The 
programme of research explored influences on NMPs’ prescribing decision-
making.  Use of the interpretivism philosophy may be justified by application of 
the philosophical beliefs associated with interpretivism to this study (see Table 
2.5). 
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Table 2.5 Aspects of the interpretivism research philosophy applied to this 
programme of research   
Adapted from Creswell 2013, p.36 
 Interpretivism In this programme of 
research 
Ontological beliefs  
(the nature of reality) 
Multiple realities are constructed 
through our lived experiences and 
interactions with others 
NMP participants: 
different professions, 
settings and scopes of 
practice.  Likely that 
multiple realities will 
have been constructed 
through participants’ 
lived experiences   
Epistemological beliefs 
(how reality is known)
  
Reality is co-constructed between 
the researcher and the 
researched and shaped by 
individual experiences  
 
Data generated via 
semi-structured 
interviews undertaken 
by doctoral student; 
one “general” phase and 
one based on 
participants’ reflections 
Axiological beliefs  
(the role of values) 
Individual values are honoured 
and are negotiated among 
individuals 
Bracketing (LeVasseur 
2003) used to describe 
and acknowledge 
doctoral student’s 
professional role.  
Neutral stance taken 
throughout 
Methodological beliefs  
(the approach to 
inquiry) 
 
Use of an inductive method to 
identify emerging ideas; methods 
used are qualitative and include 
interviewing, observing and 
analysis of texts 
Inductive method used 
i.e. semi-structured 
interviews including one 
phase based on based 
on participants’ 
reflections 
 
 
2.5 Research methodologies used within interpretivism 
 
Creswell (2013) lists five qualitative approaches to inquiry within the 
interpretivism research philosophy: narrative research, phenomenology, 
grounded theory, ethnography and case studies.  Qualitative observational 
methods may also be used.  Key aspects of these are considered in Table 2.6.  
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Table 2.6 Key aspects of narrative research, phenomenology, grounded theory, 
ethnography, case studies and qualitative observational approaches in research 
Adapted from Creswell 2013 
Research method Key aspects 
Narrative research “Experiences as expressed in lived and told stories of [one or 
two] individuals” p. 70 
Phenomenology Examines the lived experience of a phenomenon as 
experienced by research participants 
Grounded theory Research starts in the absence of a hypothesis or a priori 
theoretical underpinning.  Data are gathered into themes 
which are used to construct a new theory 
Ethnography Used to explore cultural phenomena; the researcher embeds 
him/herself in the community or group being studied 
Case studies A case or a small number of cases are explored through 
detailed examination using different methods and several 
sources of information 
Qualitative 
obervational methods 
The researcher acts as a neutral observer and makes field 
notes, recordings and videos which are then analysed 
thematically 
 
 
2.5.1 Phenomenology 
 
A phenomenological approach was used in this programme of research.  
According to Creswell (2013, p.76):  
 
“A phenomenological study describes the common meaning for several 
individuals of their lived experiences of a concept or a phenomenon.”  
 
Creswell (p.81 and p.82) goes on to describe the steps in conducting 
phenomenological research:  
 
 the suitability of the research area for a phenomenological approach 
should be assessed.  Creswell suggests using phenomenology when 
exploring “individuals’ common or shared experiences of a phenomenon” 
to understand it further or to develop practice or policies 
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 the researcher should acknowledge and bracket out his/ her own 
experiences; this is particularly the case in psychological or transcendental 
phenomenology  
 
 potential participants are identified who have experienced the 
phenomenon.  Data are generated often by means of in-depth interview/s 
although other methods of data generation such as observation and diaries 
may also be used 
 
 participants are asked a few open questions about their experience of the 
phenomenon and influences on this  
 
 data are analysed, looking for “significant statements” which offer an 
insight into participants’ lived experiences of the phenomenon.  These may 
be synthesised to produce themes 
 
 “significant statements” and themes are used to produce a “textural 
description” of the phenomenon and a “structural description” of the 
context or setting that influenced participants’ experience of the 
phenomenon 
 
 finally, these are used to create a composite statement of the “essence” of 
the phenomenon   
  
2.5.2 Justification for the use of phenomenology in this programme of 
research   
 
Alternative research approaches as in Table 2.6 will be considered briefly, then 
aspects of phenomenology will be outlined and considered in relation to this 
programme of research thereby justifying the use of this approach.   
 
As in Table 2.6, narrative research focuses on the stories of one or two 
individuals and would not therefore be suitable.  As described in Chapter 1, 
influences on medical prescribing have been identified and some related research 
has been carried out among NMPs.  A theory could be proposed based on what is 
already known so grounded theory would not be appropriate for this study, nor 
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would ethnography, which looks closely at a particular social group over a period 
of time.  This programme of research is concerned with the personal views and 
experiences of several individuals experiencing the phenomenon of prescribing 
decision-making and so a case study approach would not be suitable.  Qualitative 
observational methods have been used in combination with pre-and post-
consultation interviews in case study research on influences on medical 
prescribing (Barry et al. 1999, Barry et al. 2000, Britten et al. 2000, Stevenson 
et al. 2000, Stevenson et al. 2001, Barry et al. 2001, Jenkins et al. 2003).  This 
multi-method, case study research was carried out by a team of researchers who 
none the less acknowledged limitations in the approach.   
 
In this study, the lived experience of the phenomenon of prescribing decision-
making was explored among a sample of non-medical prescribers who make 
these decisions as part of their usual professional roles.  In-depth semi-
structured interviews (Chapter 4), participants' self-recorded reflections on 
"noteworthy" prescribing decisions and critical incident-type interviews based on 
these (Chapter 5) were used to generate data.  Interviews were recorded 
verbatim and analysed thematically using the Framework Approach (Ritchie et al. 
2014), the domains of the Theoretical Domains Framework (TDF) being used to 
create the initial framework (Cane, O’Connor and Michie 2012).  "Significant 
statements" (p.82) were synthesised to produce themes, which were illustrated 
using representative quotations (Bowling 2002).  "Structural descriptions" (p.82) 
of influences on participants' prescribing decision-making in general and more 
specifically may be found in Chapters 4 and 5 respectively.  Finally Chapter 6 
provides a composite statement of the "essence" (p.82) of the phenomenon of 
prescribing decision-making by non-medical prescribers.  
 
Two types of phenomenology have been identified: 
 
 hermeneutical phenomenology (van Manen 1990) where the researcher 
takes an overt role, interpreting or mediating between participants’ lived 
experiences 
 
 psychological or transcendental phenomenology (Moustakas 1994) where 
the researcher brackets his/her own experiences and focuses on describing 
the experiences of research participants. 
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As above, Creswell (2013, p.36) describes the epistemological approach in 
interpretivism as when “Reality is co-constructed between the researcher and the 
researched and shaped by individual experiences”.  Notwithstanding this, the 
doctoral student believes that as far as possible the researcher should 
acknowledge his or her previous experience then bracket it to minimise his/ her 
influence on the data generation process.  The doctoral student and her 
supervisors felt that transcendental or psychological phenomenology resonated 
with this belief and this approach was taken.  This will be considered in a 
structured way in the section on Reflexivity.  
 
2.5.3 Bracketing 
 
LeVasseur (2003) considered the role of bracketing in phenomenology and used 
the analogy of a familiar object hidden from view inside a paper bag.  
Preconceptions based on previous knowledge of the object are bracketed by the 
researcher’s inability to see and therefore recognise it.  The researcher must 
explore the object afresh and will develop new understandings through this 
exploration.  LeVasseur (p.419) goes on to assert that: 
 
“The project of bracketing attempts to get beyond the ordinary 
assumptions of understanding and stay persistently curious about new 
phenomena.” 
 
Creswell (2013) suggests that bracketing should be addressed by an initial 
statement of the researcher’s background and relevant experience of the 
phenomenon, as has been done in the Foreword to this thesis and in Section 
2.11 Reflexivity.   
 
2.6 The time horizon 
 
The time horizon or time frame for a research study must be appropriate to the 
aim of the research.  If for example the aim is to follow patients from the point of 
diagnosis of a particular condition until a specified end point then a prospective 
longitudinal study would be appropriate.  If on the other hand the aim is to 
obtain a “snap shot” in time then the study will be cross-sectional with the time 
horizon dictated by logistical factors.    
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2.6.1 The time horizon in this programme of research 
 
This overall aim of this programme of research was to explore and describe 
prescribing decision-making by NMPs.  This was done by means of interviews 
with no need for a prolonged, longitudinal study design.  
 
 2.7 Qualitative data generation methods 
 
As above and as in Tables 2.2 and 2.3, the interpretivist paradigm and 
phenomenology are more aligned to qualitative methods of data generation.  The 
most common of these are interviews and focus groups and aspects of these are 
compared in Table 2.7 below.  
 
Table 2.7 Comparison of aspects of interviews and focus groups as data 
generation tools 
Adapted from Bowling 2002 and Creswell 2013  
 Interviews Focus groups 
Participant/s One participant per interview. 
Each interview gathers data from 
one participant 
Several participants (often 6-
10) per focus group.  
Participants may be purposively 
selected to have similar or 
disparate backgrounds.  
Interaction between participants 
may generate additional 
perspectives  
Data 
generation 
tool 
Interview schedule: various 
approaches.  May be structured, 
semi-structured or unstructured 
and may be based on critical 
incident/s.  
Development of schedule from the 
research; should have relevant 
theoretical underpinning.  
Development may be iterative 
based on analysis of data from 
previous interviews 
Topic guide: key themes to be 
explored identified in advance 
but direction of discussion less 
structured than interview. 
Development of topic guide 
from the research; should have 
relevant theoretical 
underpinning.  
Development may be iterative 
based on analysis of data from 
previous focus groups 
Researcher/s Interviewer Facilitator plus observer/ note 
taker 
Suitability Suitable for all topics Less suitable for confidential/ 
sensitive topics 
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 Interviews Focus groups 
Data capture Interview digitally recorded and 
transcribed. Notes not usually 
made as may disrupt flow of 
interview 
Discussions digitally recorded 
and transcribed + field notes 
made by observer 
 
Data analysis. Themes identified from individuals’ 
experiences/ views etc.  
Framework Approach (Ritchie et al.  
2014) or grounded theory 
approach (Glaser 1967) to 
analysis; may be theoretically 
informed.  
Themes identified from 
individuals’ experiences/ views 
etc. and from interactive 
discussions between two or 
more participants.  Framework 
Approach (Ritchie et al. 2014) 
or grounded theory approach 
(Glaser 1967) to analysis; may 
be theoretically informed 
 
 
2.7.1 Justification for the use of interviews in this programme of research   
 
The focus of this programme of research was participants’ prescribing decision-
making behaviour.  Notwithstanding the opportunities for generation of rich data 
through focus group discussions (Bowling 2002) it was anticipated that since 
participants’ reflections might be very personal they might feel more comfortable 
sharing these in anonymised one to one interviews rather than with several 
strangers in a focus group (Bowling 2002).  The research was undertaken in the 
NHS Grampian area and all locations were within three hours of the doctoral 
student’s home.  Face to face interviews were therefore chosen as the primary 
method of data generation.  Interviews will be considered further in Section 2.8. 
 
2.8 Theoretical underpinning of the programme of research 
 
2.8.1 The need for theoretical underpinning 
 
This programme of research will use an interpretivist, phenomenological, 
qualitative approach to explore in-depth influences on non-medical prescribers’ 
prescribing decision-making.  Qualitative research has been criticised as lacking 
rigour (Greenhalgh et al. 2016) with a lack of clarity about the role of theory (Wu 
and Volker 2009).  A strong theoretical underpinning enhances the rigour of 
qualitative research and the robustness of quantitative research (Stewart and 
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Klein 2016) and is particularly important for translation of research findings into 
practice (Meyer and Ward 2014).   
 
Bradbury-Jones and colleagues (2014) assert that theory may be used in 
qualitative research at five different levels, ranging from being apparently absent 
to being consistently applied throughout, where it drives all stages of the 
research.  They recommend the latter approach wherever possible to achieve 
methodological congruence (Morse and Richards 2002), where theory informs 
and is explicit throughout the research aim, questions, methods, analysis and 
results.   
 
It is important that the appropriate theoretical perspective is used (Stewart and 
Klein 2016).  The aim of this programme of research was to explore NMPs’ 
behaviour of prescribing decision-making so as to clarify influences on this.  It is 
already known that doctors’ prescribing decisions are subject to influences other 
than the patient’s clinical condition and evidence-based guidelines; the limited 
evidence available suggests that the same is true of NMPs.  It was thought 
possible that one of the outcomes from this study might be recommendations 
about educational interventions to support and possibly improve NMPs’ 
prescribing decision-making, should the research suggest this is necessary, for 
example to promote the uptake of evidence into their practice.  
 
Any intervention targeting behaviour change must be appropriate (Bandura 
1998) and must be delivered in the right way; this too will be enhanced by a 
strong theoretical basis.  A summary of 44 systematic reviews of methods of 
promoting implementation of evidence-based practice in healthcare found that 
educational outreach i.e. education delivered in person to health professionals in 
their own settings, was broadly effective (Grimshaw et al. 2001).  Such 
education should be delivered at an individual level (Scottish Intercollegiate 
Guidelines Network 2008) thus any theory underpinning research into influences 
on prescribing decision-making should also focus at this level.   A systematic 
review of educational interventions to improve prescribing competency in medical 
and non-medical prescribers identified continuing medical education and 
individual feedback on prescribing as being helpful (Kamarudin et al. 2013); this 
too suggests that interventions should be designed and delivered at the 
individual level.  The Competency Framework for all Prescribers emphasises the 
importance of all prescribers assessing and maintaining their own competence 
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(Royal Pharmaceutical Society 2016); this again emphasises the importance of 
understanding influences on prescribing decision-making at an individual level.   
 
2.8.2 The Theoretical Domains Framework 
 
Numerous theories of behaviour change at the individual level exist.  In 2005 a 
large group of health researchers, psychologists and health psychologists 
identified 33 psychological theories with 128 explanatory constructs (parts of 
theories) which were relevant to the implementation of evidence-based practice.  
They classified and simplified these theories and constructs to form an 
integrative framework of theories of behaviour change, the Theoretical Domains 
Framework, initialially 12 domains.  The aim was:  
 
“to simplify psychological theory relevant to behaviour change and to 
make it accessible to those involved in EBP [evidence based practice] 
implementation.”  
(Michie et al. 2005 p.29).  
 
The framework was later refined and validated by a group of behavioural experts 
in 2012; domains were adjusted resulting in 14 domains (Cane, O’Connor and 
Michie 2012) which are given in Table 2.8.  The TDF encompasses both the 
automatic and the reflective elements of behaviour and has been used in several 
approaches to promoting implementation of evidence-based practice.   
 
In recognition of the complexity of behaviour change interventions and their 
determinants, Michie and colleagues developed the behaviour change technique 
taxonomy (BCTTv1) with the aid of 400 researchers and stakeholders across 
several countries (Michie et al. 2015).  They suggest that this taxonomy is used 
to identify the content of complex behaviour change interventions and to support 
related research.  Michie and colleagues classified ninety three distinct, non-
overlapping behaviour change techniques within the taxonomy but recognised 
that these are likely to be impractical to use individually.  They mapped eighty 
seven of the techniques into the fourteen domains of the TDF (Michie et al. 
2015), demonstrating its usefulness as a theoretical underpinning for research 
into implementation-related behaviour change.   
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The TDF has been used in a wide range of studies to examine the determinants 
of health-related behaviour, including research into implementation of evidence-
based guidelines (Francis, O'Connor and Curran 2012) and into prescribing errors 
by junior hospital doctors (Duncan et al. 2012).  Other recent studies using the 
TDF include behavioural determinants to healthcare professionals reporting 
medication errors (Alqubaisi et al. 2016); adherence to evidence-based 
indicators in primary care (Lawton et al. 2016) and in healthcare implementation 
projects (Phillips et al. 2015).  French and colleagues used the TDF to identify 
barriers and facilitators to implementation of evidence-based practice and 
suggested specific behaviour change techniques to address these (French et al. 
2012). 
 
2.8.3 Justification of the use of the Theoretical Domains Framework in this 
programme of research 
  
This programme of research was undertaken using an interpretivist, 
phenomenological, qualitative approach in which data was gathered by means of 
interviews with individual NMPs.  Most interventions in healthcare occur at the 
individual level between a healthcare professional and a patient.  Given that the 
focus of the research was individual participants’ prescribing decision-making 
behaviour it is appropriate that underpinning should be provided by a theory 
which encompasses a number of validated domains influential in behaviour and 
behaviour change at an individual level.     
 
The TDF was used in this programme of research to inform development of data 
collection tools, create an initial framework for data analysis (Ritchie et al. 2014) 
and to report and discuss findings in this thesis and via dissemination elsewhere 
(McIntosh et al. 2017).  The domains of the TDF are given in Table 2.8 along 
with descriptors.  
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Table 2.8 Descriptions of TDF domains  
Adapted from Stewart and Klein 2016 and Cane, O’Connor and Michie 2012  
TDF domains Descriptors 
Knowledge An awareness of the existence of something 
Skills An ability or proficiency acquired through practice 
Social/professional 
role and 
identity 
A coherent set of behaviours and displayed personal qualities of 
an individual in a social or work setting 
Beliefs about 
capabilities 
Acceptance of the truth, reality, or validity about an ability, 
talent, or facility that a person can put to constructive use 
Optimism The confidence that things will happen for the best or that 
desired goals will be attained 
Beliefs about 
consequences 
Acceptance of the truth, reality, or validity about outcomes of a 
behaviour in a given situation 
Reinforcement Increasing the probability of a response by arranging a 
dependent relationship, or contingency, between the 
response and a given stimulus 
Intentions A conscious decision to perform a behaviour or a resolve to act 
in a certain way 
Goals Mental representations of outcomes or end states that an 
individual wants to achieve 
Memory, attention 
and decision 
processes 
The ability to retain information, focus selectively on aspects of 
the environment and choose between two or more alternatives 
Environmental 
context and 
resources 
Any circumstance of a person’s situation or environment that 
discourages or encourages the development of skills and 
abilities, independence, social competence, and adaptive 
behaviour 
Social influences Those interpersonal processes that can cause individuals to 
change their thoughts, feelings, or behaviours 
Emotion A complex reaction pattern, involving experiential, behavioural, 
and physiological elements, by which the 
individual attempts to deal with a personally significant matter 
or event 
Behavioural 
regulation 
Anything aimed at managing or changing objectively observed 
or measured actions 
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2.9 Interview design 
 
Interviews were used to generate data in Stage 2 of this programme of research.  
Various types of interviews exist and these are considered below.   
 
2.9.1 Structured interviews 
 
Structured interviews are similar to self-completed questionnaires in that a fixed 
set of questions is asked although participants may be able to make additional 
comments.  There may also be structured guidance for the interviewer, for 
example a form of words to use should clarification of a question be needed.  
 
2.9.2 Semi-structured interviews 
 
Semi-structured interviews are the most commonly used type of interviews in 
qualitative research (Smith 2005).  A semi-structured interview schedule is used; 
this comprises mainly open questions and is designed to elicit more in-depth 
data than with structured interviews.  There is scope for the interviewer to probe 
if required using for example “Can you tell me a bit more about that?” or to use a 
follow up question should this be felt appropriate or necessary.  
 
2.9.3 Unstructured interviews 
 
Unstructured interviews use an interview guide to set broad parameters for the 
interview but the content is participant-driven with data likely to reflect the 
participant’s perspective rather than that of the interviewer.  
 
2.9.4 Free association narrative interviews  
 
In free association narrative interviews the researcher uses a very few, very 
broad questions such as “Tell me about your experience of…?” The aim is to 
uncover the participant’s sometimes subconscious perspectives of experiences 
which may have been troubling in some way (Hollway and Jefferson 2008).  
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2.9.5 Critical incident-based interviews 
 
Critical incidents may be the focus of any of the above types of interview but the 
term has a more particular meaning.  Critical incident-based interviews have 
been developed from Flanagan’s early critical incident technique used in selection 
of aircrews for the US Army Air Forces during World War 2 (Flanagan 1954).  
Flanagan defined a critical incident as one:  
“… where the purpose or intent of the act seems fairly clear to the 
observer and where its consequences are sufficiently definite to leave little 
doubt concerning its effects.” 
(Flanagan 1954, p.327) 
 
Flanagan used four methods to generate data: individual interviews, group 
interviews, questionnaires and record forms, and considered that accuracy was 
determined by the levels of clarity, honesty and detail in participants’ 
contributions (Flanagan 1954).  Flanagan’s original technique has been 
extensively adapted as he himself predicted it would be.  It has been used to 
examine practice across a very wide range of settings, often by means of 
retrospective self-report of a critical incident (Butterfield et al. 2005).  Critical 
incident interviews still rely on participants’ honesty and openness as do all 
interview-based studies but additional steps have been developed to enhance the 
trustworthiness of findings from qualitative studies in general (Shenton  2004) 
and from critical incident studies (Butterfield et al. 2005). 
 
Critical incident interviews have been used in several studies of prescribing-
related behaviour (Bradley 1992a, Bradley 1992c, Lewis and Tully 2009, Lewis 
and Tully 2009, Lewis and Tully 2011, Lewis et al. 2014) and several techniques 
have been used to capture participants’ recollections of the critical incidents.  In 
most cases participants were asked to focus on one particular type of critical 
incident, for example those generating feelings of discomfort in the participant 
(Bradley 1992a, Bradley 1992c, Lewis and Tully 2009).  Some participants were 
contacted in advance and sent a form on which to record incidents prior to the 
interview (Bradley 1992a, Bradley 1992c, Lewis and Tully 2011, Lewis et al. 
2014); others were asked to think of incidents in advance (Lewis and Tully 
2009).  Some researchers did not state the way in which the recollection was 
triggered. 
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2.9.6 Justification of the use of critical incident-type interviews in this 
programme of research 
 
Critical incident interviews allow the phenomenon of interest to be explored 
within its context and from the participants’ perspectives.  Data is generated by 
the participant, gathered by the researcher during interviews and analysed 
inductively.  These aspects resonate with the qualitative, phenomenological 
approach taken in this programme of research and therefore critical incident 
interviews were used in this study for Phase 2 (self-recordings of individual 
reflections i.e. a form of retrospective self-report) and Phase 3 (interviews based 
on these reflections).   
 
2.10 Sampling 
 
It may be logistically impossible to include the whole of a population of interest 
in qualitative research; instead various approaches to sampling may be used as 
outlined in Table 2.9. 
 
Table 2.9 Approaches to sampling in qualitative research  
Adapted from Bowling 2002 
Sampling method Features 
Convenience/ opportunist 
sampling 
Recruitment on the basis of convenience e.g. ease of 
access, personal knowledge of participants, or by 
taking advantage of an opportunity to recruit 
Purposive sampling Criteria are set for participants i.e. that they will share 
a certain characteristic.  This method is also used 
when piloting a data collection tool; criteria will match 
those of the target population to allow testing of the 
data collection tool 
  
57 
 
Sampling method Features 
Snowballing Research participants are asked whether they know of 
others who are in the target group; these contacts are 
then recruited and asked to recruit others.  This 
method can impact on participant diversity 
Theoretical sampling Used in grounded theory research (Glaser 1967).  An 
initial small sample is recruited and interviewed to 
gain an understanding of the research area; additional 
participants who may challenge developing 
understandings are then recruited.  Recruitment stops 
when data saturation appears to have been reached 
 
 
2.10.1 Sample size in qualitative research 
 
As above, qualitative research is used to explore in-depth participants’ views,  
attitudes and experiences.  Whereas in quantitative research a power calculation 
is used to determine the optimum sample size (Bowling 2002), in qualitative 
research the optimum sample size is influenced by several study-specific and 
more general factors.  These include the complexity of the study, the diversity of 
the target population, methodological approach, data generation methods used 
and the financial and human resources available (Mason 2010).  
 
Some authors have suggested guidelines as to a range of suitable sample sizes 
depending on the methodological approach being taken; Polkinghorne (1989) 
suggested between 5 – 25 interviews for phenomenological studies.   
 
2.10.2 Data saturation 
 
Data saturation is an important concept in qualitative research and is defined as:  
 
“…the point in data collection when no new additional data are found that 
develop aspects of a conceptual category.” 
(Francis et al. 2010 p.1230). 
 
Guest and colleagues (2006 p.60) asserted that:  
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“…saturation has … become the gold standard by which diversity samples 
are determined in health science research” 
 
Mason reviewed sample size and saturation across 560 qualitative interview-
based PhD studies (Mason 2010).  In phenomenology studies he found a range 
of 7 – 89 participants/ interviews required to reach data saturation with a mean 
of 25 and a mode and median of 20 (Mason 2010).  Mason also found a 
significantly high proportion of studies which had reached data saturation at a 
sample size of some multiple of 10 and pointed out that there was “no logical (or 
theory driven) reason” why that should be.   
 
Francis (2010) reviewed studies published between June 2006 – September 2007 
in the multidisciplinary journal Social Science and Medicine.  Eighteen studies 
mentioned data saturation of which fifteen claimed to have achieved it but there 
was very little information about how this had been established.  Francis 
proposed a method of establishing whether data saturation had been reached 
(p.1235): 
 
 a priori setting of an “initial analysis sample” using stratified sampling and 
based on the research question/s, interview schedule, diversity of 
participants and analytical approach used 
 
 a priori setting of a “stopping criterion” i.e. how many more interviews 
would be conducted and analysed beyond the point where no new themes 
emerge 
 
 rigorous analysis conducted independently by at least two researchers 
 
 provision of details of how data saturation was established  
 
Francis’ somewhat quantitative method does not fit well with the qualitative 
approach taken in this study and so the method was adapted: no a priori targets 
or criteria were set but graphical representation was used to illustrate the 
emergence of themes.   
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2.10.3 Information and justification for setting and sampling used in this 
programme of research 
 
2.10.3.1 Information on setting: NHS Grampian 
 
The research was carried out among non-medical prescribers employed by or 
contracted to NHS Grampian.  This serves a population of half a million people 
living predominantly in and around the city of Aberdeen and in several towns, 
numerous villages and an extensive rural area.  Healthcare is delivered locally 
where possible via a primary care network of 86 GP practices, community 
pharmacies and others providing professional health-related services.  Again 
where possible primary care provision includes specialist services formerly 
available only in secondary care.  Secondary care is provided in large hospitals in 
Aberdeen and Elgin and in local community hospitals across the region.  The NHS 
Grampian Clinical Strategy 2016-2021 highlights the importance of staff working 
together and with partner health and social care organisations to deliver on the 
priorities of primary and secondary prevention, self-management of health 
conditions, planned care and unscheduled care (NHS Grampian 2016a).  
Integration of health and social care recognises the importance of multi-
disciplinary working and is a key part of the Scottish Government’s 2020 Vision 
(Scottish Government 2011).  In recognition of this, increasingly the term 
“person-centred” is used in preference to “patient-centred”.  Participants in the 
study were healthcare professionals and invariably described those for whom 
they were caring as “patients”.  This term is also used throughout the literature 
which informs this thesis and so “patient-centred” has been used in this thesis.  
  
At the time of the study in 2015 there were 612 nurse independent prescribers 
and 52 pharmacist independent prescribers employed by or contracted to NHS 
Grampian.  Given that data was to be collected by face to face interviews it was 
decided to set the research in the NHS Grampian area. 
 
2.10.3.2 Justification for sampling 
 
The aim of this programme of research was to explore and describe prescribing 
decision-making by non-medical prescribers.  The sampling frame was non-
medical prescribers employed by or contracted to NHS Grampian.  As stated in 
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Chapter 1, at the start of the study in 2015 there were 667 of these nurse and 
pharmacist independent prescribers.  It was anticipated that recruitment might 
be limited; potential participants would be busy people and would not necessarily 
prioritise participation in research.  It was therefore decided to ask that the 
recruitment e-mail be sent to all.  At the time of this study NHS Grampian 
employed a senior pharmacist to lead on pharmacist prescribing (the Pharmacist 
Prescribing Lead) and a senior nurse to lead on prescribing by non-pharmacist 
NMPs (the NMP Lead).  Using purposive sampling recruitment e-mails were sent 
by these professionals to all non-medical prescribers employed by or contracted 
to NHS Grampian.  Snowballing was also used to increase participant numbers.  
Had recruitment allowed, further purposive sampling would have been used to 
ensure representation from nurse and pharmacist prescribers in primary and 
secondary care.   
 
2.11 Trustworthiness in qualitative research 
 
Rigour in qualitative research is represented by the concept of trustworthiness 
(Guba 1981).  Guba proposed four constructs which ensure trustworthiness in 
qualitative research.  They are given below with their quantitative research 
equivalents:  
 
 credibility (rather than internal validity) 
 
 transferability (rather than external validity/ generalisability) 
 
 dependability (rather than reliability) 
 
 confirmability (rather than objectivity) 
 
Shenton (2004) elaborated on these constructs, identifying approaches 
necessary to promote trustworthiness in a study.   
 
2.11.1 Approaches in this programme of research contributing to 
trustworthiness 
 
Some of Shenton’s recommended approaches to promoting trustworthiness have 
been used in this programme of research, as shown in Table 2.10.  
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Table 2.10 Elements in this programme of research contributing to 
trustworthiness  
Adapted from Shenton 2004  
Constructs 
contributing to 
trustworthiness in 
qualitative research 
 
Used in this programme of research 
Credibility • adopting a recognised research method used previously by 
researchers working in the area 
• being familiar with the culture of participating organisations 
(in this case NHS Grampian) 
• giving potential participants the opportunity to refuse to 
participate and to withdraw at any time 
• encouraging honest participation 
• emphasising the independence of the interviewer 
• having frequent meetings between researcher and 
supervisors 
• having peer scrutiny of the research project 
• providing thick description of the phenomenon  
• examining previous research in the field carefully 
Transferability 
 
Providing information on the context of the research 
 the employing organisation (NHS Grampian) 
 any restrictions on the types of participants 
 the number of participants  
 the data collection methods 
 the number and length of interviews 
 the data collection time period 
Dependability 
 
 
 
Dependibilty 
Providing information on  
 the research design and its implementation 
 the operational detail of data gathering 
 reflective appraisal of the project 
Use of overlapping methods i.e. general and critical incident-
based interviews  
Confirmability Providing  
 detailed methodological descriptions 
 justification of methods used 
 reflexive approach 
 critical review 
 
 
 
62 
 
2.11.2 Approaches contributing to trustworthiness in critical incident-
based interview studies  
 
Butterfield and colleagues at the University of British Columbia have developed 
expertise in using modified versions of Flanagan’s critical incident technique in a 
range of research areas (Butterfield et al. 2005).  They describe the evolution of 
a series of credibility checks (p.484) which they believe are congruent with 
Flanagan’s ideas and which enhance the robustness of critical incident-based 
research.   
 
2.11.3 Approaches contributing to trustworthiness in this programme of 
research 
 
Several of Butterfield’s credibility checks were included in the design of Phases 2 
and 3 of this study, again enhancing the credibility and trustworthiness of 
findings: 
 
 interviewing participants after thematic categorisation of their “critical 
incident” recording 
 
 verbatim transcribing of recorded interviews  
 
 duplicate analysis of a sample of data [in this case, all data] 
 
 establishing the point of data saturation  
 
 reviewing of tentative themes by relevant experts, and  
 
 establishing theoretical agreement by reference to the literature   
 
2.12 Reflexivity 
 
In qualitative research the researcher has a particular and integral role in data 
generation and analysis, in addition to other elements common to all research, 
and there is potential for him or her perhaps unconsciously to exert influence on 
these processes.  The professional identity of a researcher may in any case 
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impact on participants’ contributions in interviews (Richards and Emslie 2000); 
this may particularly be the case where the focus of the interview is prescribing 
decision-making (Stevenson et al. 2000) and perhaps even more so if the 
interviewer is known to be a pharmacist.  Again during data analysis and 
interpretation the researcher’s personal, perhaps unacknowledged opinions and 
beliefs may bias findings.    
 
Measures described elsewhere were taken throughout the programme of 
research to try to minimise the impact of the doctoral student’s profession and 
professional background.  During interviews the shared frame of reference with 
participants was however beneficial, ensuring a shared understanding of allusions 
and ideas, for example “a Friday afternoon prescription”.  According to the 
interpretivist philosophy such a shared understanding is essential to the 
development of knowledge (Bunniss and Kelly 2010). 
 
LeVasseur (2003) suggested that “bracketing” is a natural part of qualitative 
research.  In some way researchers have to suspend their previous knowledge or 
understanding in order to approach the research area free of assumptions and 
preconceptions.  The doctoral student has extensive experience of prescribing: 
 
 as Module Coordinator for the Pharmacist Independent Prescribing module 
 
 as a lecturer contributing to the education of non-pharmacist NMPs 
 
 previous published research on aspects of NMP 
 
 as a member of the NHS Education for Scotland Non-medical Prescribing 
Pharmacy Advisory Group  
 
 as a pharmacist, counter prescribing for a wide range of minor ailments 
and supplying medicines under Urgent supply and the Chronic Medication 
Service (Community Pharmacy Scotland 2017) 
 
 as a patient 
  
These experiences and particularly the doctoral student’s teaching, research and 
reading have informed her interest in the process of prescribing decision-making.  
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As described in the Foreword the research student is already an experienced 
researcher and supervisor of Masters and degree level research.  She has been 
aware throughout of the potential for her background to “cloud” the research 
process and has been scrupulous, as have her supervisors, in attempting to 
avoid this.    
 
2.13 Bias 
 
Bias is a threat to the quality of all research, including to the trustworthiness of 
this study.  Awareness of potential sources of bias allows development of a 
method which mitigates these; the potential for bias in this programme of 
research will also be considered in the discussion of findings. 
 
2.13.1 Approaches taken to mitigate bias in this programme of research 
 
 Bowling (2002) lists a number of biases which are considered in Table 2.11 
along with steps taken in this study to mitigate them.  In addition, as described 
earlier the approaches recommended by Shenton (2004) and Butterfield (2005) 
which have been incorporated in the study design will also promote 
trustworthiness.   
 
Table 2.11 Possible sources of bias and steps taken to mitigate these  
Adapted from Bowling 2002 
Bias Steps taken in this programme of research 
Acquiescence (‘yes-
saying’) bias 
Rigorous development of Phase 1 interview schedule; open 
questions used throughout Phase 1 and 3 
Assumption 
(conceptual) bias 
Study designed by experienced, multi-disciplinary team with 
input from relevant external experts 
Design bias As above 
Information bias Rigorous approach taken to analysis of data: coding frame 
developed from the literature and agreed with supervisors, 
doctoral student used NVivo® to support analysis and all 
transcripts analysed by two researchers 
Interviewer bias Researcher aware of potential for this; trained and 
experienced in carrying out qualitative research including 
interviews.  Neutrality of researcher explained before each 
interview 
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Bias Steps taken in this programme of research 
Non-response bias Participants self-selected and may have been different in 
some way to those who chose not to participate.  No attempt 
was made to survey non-responders 
Reactive effect Related to social desirability bias below.  Participants were 
given assurances of anonymity and confidentiality, except if 
they chose to share information relating to possible patient 
harm  
Recall bias Participants were asked to record their Phase 2 reflections in 
a timely way.  These were replayed to participants before 
their Phase 3 interviews to mitigate recall bias 
Sampling bias and 
selection bias 
As above; sampling frame was all NMPs employed by or 
contracted to NHS Grampian and participants self-selected 
Social desirability bias Participants assured of anonymity and confidentiality as 
above and encouraged to be honest.  Some shared 
information which did not portray the participant in a good 
light, suggesting candour 
 
 
2.14 Confounders 
 
Confounders are variables which are not themselves being studied but which 
may be linked to study findings.  In quantitative research randomised controlled 
trials attempt to match as many of these confounders as possible as one way of 
optimising the reliability of results.  In qualitative research rigorous data analysis 
is required and purposive sampling may mitigate the effects of confounders.  
 
2.14.1 Approaches taken to mitigate confounding in this programme of 
research 
 
Analysis of data was carried out by two researchers independently and any 
disagreements resolved by discussion.  Purposive sampling of all the NMPs 
employed by or contracted to NHS Grampian was used.  
 
2.15 Data analysis 
 
Data analysis is the means by which results (or “findings” in qualitative research) 
are generated from research data.  Analytical rigour is required to prevent 
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information bias and ensure that findings reflect the data.  Several broad 
approaches to analysis of qualitative data have been developed and are 
considered in Table 2.12 below. 
 
Table 2.12 Approaches to analysis in qualitative research  
Adapted from Bowling 2002 
Approach Features 
Grounded theory  
(Glaser 1967) 
Used to generate or discover a general 
explanation or theory to explain a process, 
action or interaction.  No pre-conceptions; 
open coding followed by axial then selective 
coding.  Findings and hence any theory are 
grounded in and emerge from the data 
Framework Approach  
(Ritchie et al. 2014)  
Used where there is pre-existing knowledge 
from the literature about the research area, 
and/ or an appropriate theoretical 
underpinning, allowing construction of an 
initial framework to be used for analysis.  
Categories may be added or removed as 
required. 
See Chapters 4 and 5 
Narrative approach 
(Creswell 2013) 
Used in narrative research.   
Participants’ narratives may be re-organised 
(sometimes chronologically) into a general 
framework; participant validation checks 
may be included 
Analysis in ethnographic studies 
(Creswell 2013) 
Detailed description and analysis of data 
from field work focuses on the aspects of the 
culture-sharing group and emerging themes, 
producing an overall interpretation and a 
cultural portrait of the group 
Analysis in case studies 
(Creswell 2013) 
Detailed description of the case followed by 
holistic analysis of the whole case or 
embedded analysis of particular aspects.  
The context of the research is important and 
used in creating the meaning of the case 
study   
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2.15.1 Justification for method of data analysis used in this programme of 
research 
 
This programme of research was underpinned by reference to the TDF and to the 
literature.  Given this theoretical underpinning and pre-existing knowledge it was 
appropriate that a Framework Approach to data analysis was taken using the 14 
domains of the TDF to form the initial coding framework (Cane, O’Connor and 
Michie 2012, Ritchie et al. 2014).  The Framework Approach has five steps 
(Pope, Ziebland and Mays 2000): 
 
 familiarisation with the data: listening to recordings, reading transcripts, 
going over field notes, studying any other data sources 
 
 identifying a thematic framework from the literature or underpinning 
theoretical framework; this may be added to as analysis progresses 
 
 indexing: ascribing all “significant statements” (Creswell p. 82) to the 
appropriate part or parts of the framework 
 
 charting: synthesising and arranging the data thematically 
 
 mapping and interpreting: a process whereby broader themes are 
identified from the data and in relation to the framework categories 
 
Use of specialist software has been found to enhance the rigour of analysis in 
qualitative research (Kelle, Prein and Bird 1995).  NVivo® (QSR International Pty 
Ltd. 2016) was used by the doctoral student to support data analysis.  
 
2.16 Research ethics 
 
Medical ethics have been described as having four components: beneficence, 
non-maleficence, respect for autonomy and justice (Beauchamp and Childress 
2013).  
 
In relation to this programme of research, beneficence required that the study 
was carried out in a way that offered benefits to all participants.  Non-
maleficence required the avoidance of causing harm to participants or others.  
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Respect for autonomy was achieved by providing sufficient information to allow 
participants to give informed consent at each stage of the study and by 
reporting/ reflecting their contributions honestly.  Justice in this study had two 
components: it required that all participants were treated in the same way and 
that the study design ensured compliance with relevant policies and legislation.   
 
In addition to these four components, pharmacists, of whom the doctoral student 
is one, are guided by the requirement to adhere to the General Pharmaceutical 
Council’s Standards for Pharmacy Professionals (General Pharmaceutical Council 
2017d).  The ethical issues of this study will be considered with respect to these 
components and standards. 
 
2.16.1 Beneficence and non-maleficence 
 
Research participants were pharmacist and nurse independent prescribers.   
These are relatively new roles requiring extensive study at postgraduate level 
and participants, particularly those who had been prescribing for some time, 
might be considered as “early adopters” (Rogers 2003).  Participants were 
informed in the recruitment e-mail (Appendix 2.1) that findings from the 
research “may help to improve education and training around prescribing 
decision-making and hence patient care.”  Participation therefore offered 
opportunities for beneficence but also maleficence for example should 
participants’ contributions become identifiable.  Conduct of the study was 
designed to ensure that participants’ identities remained confidential; they were 
described only by their profession, practice setting and gender and any 
identifiers were removed following transcription.   
 
Again in the recruitment e-mail and before the start of each interview 
participants were reminded that if they chose to disclose an issue which in the 
opinion of the doctoral student might compromise patient-safety then this would 
be discussed with the supervisory team and shared with the NHS Grampian 
pharmacist or non-medical prescribing Lead.  In any case all transcripts were 
discussed with the supervisory team and analysed by the doctoral student plus 
one of SC, DS and KFM.  Healthcare professionals in Scotland have a legal duty 
of candour (Health (Tobacco, Nicotine etc. and Care) (Scotland) Bill.2016) in 
addition to the requirements of their professional Code and Standards (Nursing 
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and Midwifery Council 2105, Health and Care Professions Council 2016, General 
Pharmaceutical Council 2017d).  Participants could choose what to disclose to the 
doctoral student, satisfying autonomy and possibly beneficence.  The reminder 
about the potential for information to be shared satisfied non-maleficence and 
the doctoral student’s own obligation to act with candour.    
 
2.16.2 Respect for autonomy 
 
Participants were provided with initial information about the study via the 
recruitment e-mail (Appendix 2.1).  This included a link to an on-line consent and 
copyright form providing additional information including a ‘frequently asked 
questions’ section.  Participants were asked to provide written consent to 
participating in each of Phases 1, 2 and 3 separately and to having their 
anonymised data shared with the research team and published.  Participants 
were reassured that their responses would be kept confidential.  Notwithstanding 
that they were asked to consent to any information which might compromise 
patient safety, including participant identity, being discussed with the research 
team and the NHS Grampian Pharmacist and Non-medical prescribing Leads if 
required, following the principle of non-maleficence.  Participants were also told 
that they could withdraw from the study at any time without giving a reason, 
again respecting their autonomy.  
 
In Phase 1 of the programme of research participants were asked to take part in 
a semi-structured, face to face interview lasting approximately 30 minutes, 
exploring influences on their prescribing decisions.  The interview schedule was 
designed to elicit the required information while minimising the cognitive burden 
on participants.  Participants were asked to choose the interview locations; all 
chose their places of work which again minimised any burden to them.  
 
In Phase 2 of the programme of research participants were provided with digital 
recorders, instructed in their use and asked to record a short reflection on a 
prescribing decision they made which they felt was noteworthy in some way.  No 
direction was given as to the type of decision on which they should reflect, 
upholding their autonomy.  
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In Phase 3 of the programme of research participants were interviewed by the 
doctoral student on their Phase 2 reflection/s.   
 
2.16.3 Justice and ethics  
 
Conduct of the research was informed by the School of Pharmacy and Life 
Science Standard Operating Procedure for good research conduct (School of 
Pharmacy and Life Sciences 2011).  It was also carried out in accordance with 
the requirements of the Data Protection Act (1998) and RGU Data Protection 
(Robert Gordon University 2016a), Research Ethics (Robert Gordon University 
2016b) and Research Governance and Integrity (Robert Gordon University 
2016c) policies.  Measures taken by the doctoral student to ensure compliance 
with these procedures and legislative controls are described in Chapter 4 and 
Chapter 5. 
 
Ethics approval was obtained from the Research Ethics Committee, School of 
Pharmacy and Life Science, RGU (4th September 2014, Appendix 2.2 and 
amended proposal approved 19th December 2014, Appendix 2.3).  The North of 
Scotland Research Ethics Service advised that NHS ethics approval would not be 
needed (13th August 2014, Appendix 2.4).  Approval was obtained from NHS 
Grampian Research and Development (23rd July 2015, Appendix 2.5; approval 
for extension to the study duration 26th April 2016 Appendix 2.6).  
  
The doctoral student is trained in qualitative research methods and is 
experienced in supervising and carrying out qualitative research including 
interview-based research.  She has completed NHS Grampian Good Clinical 
Practice core training for researchers (non-drug) (NHS Grampian 2016b) and 
applied for and was granted a Research Passport as part of the NHS Research 
and Development approval process (National Institute for Health Research 
2010). 
 
The General Pharmaceutical Council’s Standards for Pharmacy Professionals 
(2017b) outline responsibilities which match those inherent in good research 
governance, for example with regard to taking responsibility for one’s own 
working practices, showing respect for the autonomy of others and ensuring the 
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well-being of all those involved.  These responsibilities were met throughout this 
study.   
  
2.17 Summary 
 
Stage 1 of this programme of research was a systematic review of the literature 
on social and cognitive influences on prescribing decision-making by NMPs 
(McIntosh et al. 2013, McIntosh et al. 2014, McIntosh et al. 2016a).  Results 
from this systematic review informed the development of Stage 2 of the 
programme.  This was undertaken according to an interpretivism philosophy 
using a qualitative research methodology and was underpinned by reference to 
the TDF.  A phenomenological, cross sectional study was designed.  Data were 
generated by means of three phases carried out with NMPs in NHS Grampian:  
 
Stage 2 Phase 1: semi-structured face to face interviews exploring their 
prescribing decision-making (McIntosh et al. 2017) 
 
Stage 2 Phase 2: participants’ self-recorded reflections on individual prescribing 
decision/s which they felt were noteworthy in some way 
 
Stage 2 Phase 3: semi-structured face to face interviews with participants based 
on their reflections 
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Chapter 3 Systematic review 
 
3.1 Introduction 
 
A systematic review of the literature on social and cognitive influences on 
prescribing decision-making among non-medical prescribers was carried out to 
inform development of the programme of research.  As described in Chapter 2, 
systematic reviews identify, appraise critically and synthesise relevant literature 
to answer specific research question/s (MacLure, Paudyal and Stewart 2016).   
 
It has been suggested that synthesising i.e. combining the findings of qualitative 
studies in some way does not align with the epistemological and ontological 
beliefs of the interpretivist philosophical approach which informs qualitative 
research (Pope, Mays and Popay 2007).  If multiple realities exist, constructed 
and known by lived experiences and interactions with others perhaps it is 
artificial to try to combine these to present one definitive version of reality.  Be 
that as it may, the benefits of drawing together the results of multiple studies in 
facilitating the accumulation of research-derived knowledge are well recognised.  
Systematic reviews provide Level 1 evidence in the hierarchy of evidence 
(Scottish Intercollegiate Guidelines Network 2008).   
 
Various approaches to synthesis of evidence from qualitative research exist; 
these are outlined in Table 3.1 below. 
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Table 3.1 Approaches to synthesis of evidence from qualitative research 
Adapted from Pope, Mays and Popay 2007 
Approach to synthesis Used 
Interpretive synthesis A process of qualitative re-interpretation 
and re-analysis of text-based forms of 
evidence using constant comparison.  
Includes grounded theory, comparative 
case study and meta-ethnography 
Thematic analysis Identifies the most prominent or most 
relevant themes for the research 
question again by a process of 
comparison 
Realist synthesis Tests the causal mechanisms or theories 
of change which underlie a particular 
type of intervention 
Narrative synthesis Uses text to explore and synthesise the 
findings of multiple studies 
The EPPI approach 
(Evidence for Policy and Practice 
Information and coordinating (EPPI) 
Centre at the Institute for Education, 
London) 
Combines the results of multi-mixed 
methods studies in a meta-synthesis 
 
 
A narrative synthesis approach was taken throughout this review, facilitating 
analysis of relationships between and within studies (Popay et al. 2006, Centre 
for Reviews and Dissemination 2009).  This choice of method is discussed further 
in Section 3.6.  The review was published in 2016 (McIntosh et al. 2016)    
 
3.2 Database search for any pre-existing systematic review  
 
An initial search for pre-existing systematic reviews was carried out in the 
following databases: The Centre for Reviews and Dissemination, the Cochrane 
Database of Systematic Reviews, the National Institute for Health and Care 
Excellence, Science Direct, Medline, International Pharmaceutical Abstracts 
(IPA), Web of Knowledge and Google Scholar (Gehanno, Rollin and Darmoni 
2013).  No systematic review was found.  
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3.3 Systematic review objectives  
 
The overall aim of the systematic review was to identify and characterise social 
and cognitive factors and perceived factors influencing the prescribing decision-
making process among non-medical prescribers (McIntosh et al.  2013). 
 
The objectives of the systematic review were:  
 
 to determine the social and cognitive influences on prescribing  
decision-making among supplementary and independent non-medical 
prescribers in the UK  
 
 to report on the methodologies and methods used and quality of peer 
reviewed published studies in this area  
 
3.4 Development of protocol  
 
Protocol development was informed by the Guidance for undertaking reviews in 
healthcare: systematic reviews published by the Centre for Reviews and 
Dissemination (CRD) (2009), whose approach and recommended structure were 
followed.  Discussions with the supervisory team clarified the objectives, 
particularly in relation to the term “social and cognitive influences”, and specialist 
librarians advised on the search strategy and searching techniques (Grant and 
Booth 2009).  The systematic review protocol (Appendix 3.1) was accepted for 
registration and published by Prospero, the international prospective register of 
systematic reviews in health and social care maintained by the CRD (Centre for 
Reviews and Dissemination 2013), registration number CRD42013004729 
(McIntosh et al. 2013).  
 
A search strategy was developed iteratively through discussion as above and 
through study of the search strategies of several key systematic reviews in the 
separate areas of prescribing decision-making and non-medical prescribing 
(Ostini et al. 2009, Bhanbhro et al. 2011, Kroezen et al. 2011, Teixeira Rodrigues 
et al. 2012, Brennan and Mattick 2013). 
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3.4.1 Inclusion and exclusion criteria 
  
Inclusion criteria: 
 Peer-reviewed studies published since 2003 (the date of implementation of 
supplementary and independent non-medical prescribing in the UK) 
reporting primary and secondary (if any) research focussing on the 
prescribing decision-making of these non-medical prescribers.   
 
 
 Studies published in English 
 
Exclusion criterion: 
 Studies where data from prescribers other than supplementary and 
independent non-medical prescribers were included but this was not 
reported according to the prescribers’ professions.  
 
3.4.2 Databases  
 
The following databases were searched separately during June 2013 and results 
combined:  
MEDLINE, PsycARTICLES, Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), International Pharmaceutical Abstracts (IPA), Education 
Resources Information Centre (ERIC), the Cochrane Library and Google Scholar.  
Table 3.2 shows the characteristics of these databases. 
 
Table 3.2: Characteristics of databases used in systematic review search 
Database Description from webpage 
Medline 
(U.S. National Library of 
Medicine 2017) 
The US National Library of Medicine® premier 
bibliographic database containing more than 23 
million references to journal articles in life 
sciences with a concentration on biomedicine 
PsycARTICLES 
(American Psychological 
Association) 
The database of full-text peer-reviewed articles 
published by the American Psychological 
Association and affiliated journals 
Cumulative Index to Nursing 
and Allied Health Literature 
(EBSCO Industries 2017a) 
CINAHL Database provides indexing of the top 
nursing and allied health literature available 
76 
 
Database Description from webpage 
International Pharmaceutical 
Abstracts 
(EBSCO Industries 2017b) 
Provides indexing and abstracts for 
pharmaceutical and medical journals published 
worldwide 
Education Resources 
Information Centre 
(Institute of Education 
Sciences) 
An internet-based digital library of education 
research and information   
 
 
The Cochrane Library 
(Wiley Online Library 2017) 
A collection of databases in medicine and other 
healthcare specialties provided by Cochrane and 
other organizations 
Google Scholar 
(Google 2017) 
Provides a simple way to search for scholarly 
literature across many disciplines and sources 
 
 
3.4.3 Search terms  
 
Search terms were discussed and agreed with the supervisory team and 
specialist librarians.  Boolean terms AND and OR and truncations were used to 
expand the search.  Search terms were: 
prescrib*  
AND 
the (truncated) names of relevant non-medical professions ie  
pharm* OR nurs* OR physiotherap* OR podiatr* OR radiograph*  
AND 
influenc* or decision* or decid* or judge* or factor*.  
 
Citation searching was used to expand the search and electronic current 
awareness alerts were set up with NHS Evidence, Google Scholar and the British 
Library.  Medical Subject Headings (MeSH) terms were not used as there was no 
MeSH term for “prescribe” (US National Library of Medicines 2017).  
 
3.4.4 Recording and managing the search  
 
All documentation was stored in a folder on the University shared drive 
accessible to supervisory team members.  Search results were recorded using 
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Microsoft Word®.  References were stored in Refworks® bibliographic software 
(ProQuest 2017).  
 
3.4.5 Study selection  
 
A sequential, three stage search was carried out.  Search terms were used in the 
title and/or abstract within MEDLINE, PsycARTICLES, CINAHL and IPA or (within 
ERIC) in keywords to identify papers for initial inclusion.  A similar approach was 
taken when searching in the Cochrane Library, and the advanced search facility 
in Google Scholar was used (Gehanno, Rollin and Darmoni 2013, Google 2017).   
 
Stage 1: duplicate studies were removed.  Titles of all retrieved studies were 
considered alongside inclusion and exclusion criteria.  Those which did not meet 
these were excluded and the reason documented; where there was doubt they 
were included and reviewed again at the next stage. 
  
Stage 2: abstracts of retained studies were assessed for relevance as above. 
Again where there was doubt studies were included. 
 
Stage 3: full texts of all studies retained after Stage 2 were obtained and their 
relevance assessed as above.  References from papers included were hand 
searched.  
 
Decisions were made by the doctoral student; at each stage a 10% sample was 
independently assessed by one of supervisory team members SC, DS and KFM 
and any disagreements resolved by discussion.  
 
The selection process was piloted on 50 studies and discussed with the 
supervisory team; no adjustments were deemed necessary.  A PRISMA flow chart 
(Moher et al. 2009) summarising the study selection process is given in the 
results section (Figure 3.1, page 88).  
 
3.5 Quality assessment 
 
Studies were assessed for quality using the Critical Appraisal Skills Programme 
tool for qualitative research (CASP-UK 2013) which has clear guidelines to 
support its use (Katrak et al. 2004).  Had any quantitative research papers been 
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included they would have been critically appraised using an appropriate tool 
(CASP-UK 2013, Institute of Social and Preventive Medicine 2009).  As above, 
decisions were made independently by the doctoral student and one of the 
supervisory team and any disagreement resolved by discussion.  
 
3.6 Data extraction  
  
A data extraction form was prepared based on the review objectives, guidance 
from the CRD (2009) and in consultation with the supervisory team.  Publication 
details, study aims/ objectives, setting, recruitment and participant details, unit 
of analysis, approach to analysis, theoretical underpinning (if any) and a 
summary of outcome data and conclusions were included.  The data extraction 
form was piloted on one paper and found to be suitable.  
 
Data extraction was carried out independently by the doctoral student and one of 
the supervisory team as above and results compared; any disagreements were 
resolved by discussion.  
 
 
3.7 Method of data synthesis  
 
Study findings were synthesised using the narrative synthesis approach 
developed by Popay and colleagues (2006) on behalf of the Economic and Social 
Research Council Methods Programme.  This was endorsed in CRD guidance on 
undertaking reviews in healthcare (Centre for Reviews and Dissemination 2009).  
 
Popay’s approach uses text to summarise studies and synthesise findings; given 
the largely textual nature of the data this was considered appropriate.  The 
method is systematic and transparent; a framework including various tools and 
techniques is used to facilitate robust evaluation of quality and synthesis of 
findings.  The synthesis process itself is then subjected to critical reflection by 
the author (Busse et al. 2002).   
 
3.8 Findings of systematic review  
 
3.8.1 Literature search results  
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The results of the literature search are shown in the PRISMA flow chart (Moher et 
al. 2009) (Figure 3.1) below. 
 
Figure 3.1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses  
(Moher et al. 2009) 
 
 
After exclusion of duplicates, 886 titles, 349 abstracts and 40 full studies were 
sequentially screened.  Thirty seven studies were excluded for the following 
reasons:  
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 no NMP prescribing decision-making (n=27) 
 
 Extended Formulary Nurse Prescribers (EFNP) (n=3) 
 
 setting out with the UK (n=2) 
 
 
 recruitment pre-2003 therefore prescribers were EFNP or community 
practitioner nurse prescribers (n=2) 
 
 medical and non-medical prescribers not differentiated in reporting of 
results (n=3)  
 
Three studies were included in the review:  
 
• Philp and Winfield, 2010. Why prescribe antibiotics for otitis media in children? 
 
• Rowbotham, Chisholm, Moschogianis, Chew-Graham, Cordingly, Wearden and 
Peters, 2012. Challenges to nurse prescribers of a no-antibiotic strategy for 
managing self-limiting respiratory tract infections. 
 
• Offredy, Kendall and Goodman, 2008. The use of cognitive continuum theory 
and patient scenarios to explore nurse prescribers' pharmacological knowledge 
and decision-making. 
 
Tables 3.3, 3.4 and 3.5 provide summaries of quality assessments of the three 
papers.  Tables 3.6, 3.7 and 3.8 provide data extraction summaries. 
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Table 3.3 Quality assessment summary Philp and Winfield 2010 
Author 
year  
Clear 
state-
ment of 
aims  
Qualitative 
method-
ology 
appro-
priate  
Design 
appro-
priate  
Recruitment 
strategy 
appropriate  
Data 
collection 
appropriate  
Reflexivity 
considered  
Ethical 
issues  
considered  
Rigorous 
data 
analysis  
Clear 
statement 
of findings  
How 
valuable is 
the 
research  
Philp and 
Winfield  
2010  
Yes  
But only 
stated 
clearly in 
abstract  
Yes  
Justified:  
in-depth 
exploration  
Partial  
Semi-
structured 
interviews; 
topic guide 
used, no 
detail on 
this  
Partial  
Invitation/ 
information 
letters sent via 
practice 
managers; no 
follow up  
Partial  
Semi-
structured 
interviews 
lasting 30 – 
45 minutes. 
Setting not 
considered or 
justified; no 
detail on 
topic guide; 
no discussion 
of data 
saturation; 
no theoretical 
framework  
Partial  
No detail on 
research 
team; no 
attempt to 
bracket. 
Extent of 
involvement 
of 
researchers 
in 
constructing 
a version of 
participants’ 
world not 
clear  
Partial  
Good detail 
re obtaining 
consent but 
not clear 
whether this 
was oral or 
written. No 
detail on 
organi-
sations 
giving ethics 
approval; no 
consid-
eration of 
potentially 
trouble-
some “fall-
out”  
Partial  
Detailed 
description 
No 
discussion 
of 
reflexivity; 
may have 
benefitted 
from a 
theoretical 
framework  
Yes  
Explicit; also 
clear 
statement of 
implication. 
No real 
discussion of 
evidence for 
and against 
the re-
searchers’ 
arguments  
Valuable  
Provides 
useful 
information 
on nurse 
prescribers’ 
perspective; 
findings 
discussed in 
relation to 
what is 
known about 
medical 
prescribing  
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Table 3.4 Quality assessment summary Rowbotham et al. 2012 
Author 
year  
Clear 
statement 
of aims  
Qualitative 
method- 
ology 
appropriate  
Design 
appropriate  
Recruitment 
strategy 
appropriate  
Data 
collection 
appropriate  
Reflexivity 
considered  
Ethical 
issues 
considered  
Rigorous 
data 
analysis  
Clear 
statement 
of findings  
How 
valuable is 
the 
research  
Rowbotham 
et al.  
2012 
 
Yes  
 
But slightly 
different 
between 
abstract & 
paper  
Yes  
 
In-depth 
exploration 
of 
participants’ 
experiences 
and thereby 
issues  
Partial  
 
Interviews & 
focus groups 
but not clear 
why both; 
allocation of 
participants 
not clear. 
Topic guide 
used for 
interviews; 
no detail on 
focus groups  
Partial  
 
More detail 
needed of 
setting and 
sampling 
frame; 
recruitment 
not clear; 
focus groups 
part of a 
training 
intervention  
Partial 
  
Semi- 
structured 
interviews & 
focus group 
discussions 
appropriate.  
No detail of 
interview 
schedule; no 
mention of 
focus group 
topic guide. 
No 
theoretical 
framework 
described, 
no 
discussion of 
sample size. 
Mentioned 
reaching 
thematic 
saturation  
Partial 
 
No details on 
researchers.  
Possibility of 
social  
desirability 
bias  
acknowledged 
but non-
judgemental 
stance 
claimed and 
supported by 
reference to 
participants’ 
sometimes 
un-edifying 
responses 
Yes  
 
NHS ethics 
approval 
received. 
Clear detail 
of 
procedure 
for 
obtaining 
informed 
consent and 
ensuring 
security of 
data  
Partial 
  
Detailed 
description 
of method 
of analysis 
but no 
theoretical 
framework 
or 
discussion 
of 
researcher 
roles  
Yes 
  
Themes 
with 
supporting 
quotations 
clearly set 
out.  
Focus 
groups: 
participants’ 
professions 
not clear 
but over-
whelmingly 
nurse 
prescribers 
Valuable 
  
Recent study 
addressing 
prescribing 
decision- 
making 
processes of 
nurse & to a 
lesser but 
unknown  
extent 
pharmacist    
and physio-
therapist 
prescribers  
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Table 3.5 Quality assessment summary Offredy, Kendall & Goodman 2008 
Authors 
year  
Clear 
statement 
of aims  
Qualitative 
methodology 
appropriate  
Design 
appropriate  
Recruitment 
strategy 
appropriate  
Data 
collection 
appropriate  
Reflexivity 
considered  
Ethical 
issues 
considered  
Rigorous 
data 
analysis  
Clear 
statement of 
findings  
How 
valuable is 
the research  
Offredy 
Kendall 
& Good-
man 
2008  
No  
 
Different 
in abstract 
and inside 
paper  
Partial  
 
Qualitative 
method 
appropriate for 
“in-depth” 
understanding  
Quantitative 
approaches 
included; 
appropriate to 
test knowledge  
Partial 
 
Some 
justification 
for method in 
discussion. 
Describe 
testing 
knowledge of 
pharmacology 
then later use 
the more 
accurate term 
“medication-
related 
issues”  
Partial  
 
Not clear. 
Purposive 
sampling 
stated but 
no details  
Partial  
 
Exploring 
knowledge & 
decision-
making; 
semi-
structured 
interviews 
appropriate. 
Rating 
scheme used 
to assess 
knowledge 
and Cognitive 
Continuum 
Theory (CCT) 
used to 
categorise 
decision-
making. 
Unclear how 
confidence 
was rated. No 
consideration 
of sample size 
or data 
saturation  
No  
 
No mention 
of 
Researchers 
back-
grounds, 
stances or 
potential bias  
Partial 
 
Relevant 
ethics 
approval 
obtained.  
Some 
aspects of 
data 
governance 
not clear  
Partial 
  
Mainly 
quantitative 
analysis 
(frequency 
of 
participants 
within a 
category, 
ratings etc); 
limited 
elaboration 
of themes or 
how the 
content was 
analysed in 
relation to 
CCT. No 
coverage of 
own role, 
bias etc. 
Unclear how 
data 
presented 
were 
selected  
Partial  
 
Mix of 
nurse 
prescribers 
and trainee 
nurse 
prescribers 
but some 
results not 
separated 
by groups; 
quotations, 
categories 
and 
decision-
making 
types not 
ascribed to 
participant 
type  
Reasonably 
valuable  
 
Relatively 
recent study 
addressing 
prescribing 
decision-
making 
processes of 
nurse 
prescribers. 
Claims that 
cognitive 
continuum 
theoretical 
framework 
can help 
explain 
these 
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Table 3.6 Data extraction summary Philp and Winfield 2010 
Authors,  
years  
Aims/ objectives  Study design  Inclusion/ 
exclusion 
criteria  
Recruitment  Participants/ 
setting  
Unit of 
analysis  
Method of 
analysis  
Findings  
Philp and 
Winfield  
2010 
Describe evidence-
based guidelines 
used by nurse 
prescribers in their 
prescribing 
practice.  
Explore their 
perceptions of this 
guidance.  
Explore how they 
think through their 
prescribing 
practice and 
influences upon 
this.  
Explore 
perceptions held 
about their 
prescribing 
practice when 
treating otitis 
media in children  
Qualitative  
Audio taped 
semi-structured 
interviews  
Nurse 
practitioners 
(n=8) with 
independent 
prescribing 
privileges who 
had undergone 
the Royal 
College of 
Nursing training 
pathway  
Letters sent via 
practice 
managers of all 
medical 
practices in 
Cornwall for 
forwarding to 
potential 
participants. No 
second mailing, 
no enquiries 
about whether 
the practices 
had any nurse 
practitioners as 
detailed  
8 nurse 
independent 
prescribers 
working as 
nurse 
practitioners in 
general practice 
in Cornwall  
Individual 
audio-taped 
semi-
structured 
interviews 
based on topic 
guide and 
lasting 30 – 45 
minutes  
Thematic 
analysis using a 
framework 
developed from 
transcripts. 
Iterative 
process with “a 
considerable 
amount of 
abstraction and 
synthesis”  
Participants 
aware of clinical 
guidance but 
unsure of 
quality; didn’t 
always follow.  
Contexts, 
situations or 
patient groups 
also influenced 
prescribing 
decision-
making.  
Parents’ 
expectations 
and prescriber-
patient 
relationship also 
influential.  
Participants 
comfortable with 
their prescribing  
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Table 3.7 Data extraction summary Rowbotham et al. 2012  
Authors, year  Aims/ 
objectives  
Study design  Inclusion/ 
exclusion 
criteria  
Recruitment  Participants/ 
setting  
Unit of analysis  Method of 
analysis  
Findings  
Rowbotham et 
al.  
2012  
To explore how 
nurse 
prescribers and 
other NMPs 
experience 
consultations 
for respiratory 
tract infections 
+ challenges 
faced in trying 
to implement a  
no-prescribing 
strategy  
Qualitative  
Semi-
structured 
interviews 
(n=15) + 3 
focus groups 
(n=5, 4 & 12)  
Not 
reported  
Not clear  
Direct contact 
with practices 
+ via local 
training event. 
Purposive 
sampling: 
location, 
discipline, age 
& scheduled/ 
unscheduled 
care  
Not clear  
Abstract:  
34 NPs, 1 PP & 
1 Physio P.  
Paper:  
31 NPs, 1 PP & 
1 Physio P 
(both only in 
focus groups).  
North West of 
England.  
 
(NP = nurse 
prescriber 
PP = 
pharmacist 
prescriber 
Physio P = 
physio-
therapist 
prescriber) 
15 audio-recorded 
interviews (NPs). 
Quotations ascribed 
to individuals.  
3 audio-recorded  
focus groups (NPs 
n=19 + 1 PP & 1 
Physio P).  
Quotations ascribed 
only to one of three 
focus groups.  
No interview 
schedule; no topic 
guide; no detail on 
development but 
interviewers were 
responsive to issues 
emerging from 
participants’ 
accounts  
Iterative 
thematic 
analysis. 
Thematic 
saturation 
reached  
Consultations found 
challenging; most 
felt they possessed 
some appropriate 
skills to manage 
these without 
prescribing 
antibiotics. Protocols 
supported decision-
making; peer 
support helpful 
particularly with 
“demanding” 
patients. Newness of 
role resulted in a 
cautious approach by 
some.  
Little on prescribing 
decision-making 
other than the 
decision not to 
prescribe 
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Table 3.8 Data extraction summary Offredy, Kendall & Goodman 2008 
Authors, year  Aims/ 
objectives  
Study 
design  
Inclusion/ 
exclusion 
criteria  
Recruitment  Participants/ 
setting  
Unit of 
analysis  
Method of 
analysis  
Findings  
Offredy, 
Kendall & 
Goodman  
2008  
Abstract: to 
explore & test 
nurse 
prescribers’ 
pharmacological 
knowledge & 
decision-making.  
Paper: to use an 
exploratory 
approach to test 
the usefulness of 
patient scenarios 
in addressing the 
reasons why 
nurses decide 
whether or not to 
prescribe  
Qualitative.  
Semi-
structured 
interviews 
(n=25) 
based on 
case 
scenarios  
Nurse 
prescribers 
(n=18) and 
those training 
as nurse 
prescribers 
(n=7)  
Purposive 
sampling (no 
detail).  
Information 
sent to 
managers of 
two primary 
care trusts for 
onward posting 
to all nurse 
prescribers & 
those 
undertaking a 
nurse-
prescribing 
programme  
Total of 25 
nurse 
prescribers 
and those 
training as 
nurse 
prescribers, 
in two 
primary care 
trusts in 
south east 
England  
Transcriptions 
of individual 
audio-taped 
semi-structured 
interviews 
based on 
patient 
scenarios.  
Quotations 
ascribed to 
individuals  
Content 
analysis: text 
coded and 
categorised to 
assess 
participants' 
knowledge of 
medication-
related issues 
and identify the 
type of 
cognition used 
to respond to 
the scenarios  
Disparate prescribing 
rates & areas, commonly 
prescribed items.  
Most participants unable 
to identify clinical issues, 
failed to provide an 
acceptable solution, 
claimed issues were out 
with their competence & 
said they would refer to 
the GP.  
All rated themselves 
“knowledgeable” about 
drugs commonly used in 
their own clinical areas; 
most felt confident in their 
own clinical areas.  
Most commonly used 
modes of decision-making 
were moderately strong 
quasi-rational thought 
and weak quasi-rational 
thought. Knowledge (or 
lack of it) may dictate the 
mode of decision-making 
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3.9 Summary of studies 
 
Critical appraisal of studies 
All three studies justified the qualitative approach taken.  Offredy and colleagues’ 
study (2008) included additionally a quantitative, theoretically-derived element 
designed to explore participants’ pharmacological knowledge.  Theoretical 
underpinning was absent from the other two studies.  Details on study design 
and recruitment were limited in all three studies as was any consideration of 
reflexivity.  Data analysis was not always clear, with consequent lack of clarity in 
the statements of some findings. 
 
All three studies were small-scale and carried out in primary care in separate 
areas of England.  Philp and Winfield (2010) interviewed eight nurse practitioner 
prescribers about their treatment of otitis media.  Rowbotham and colleagues 
(2012) explored the challenges of a no-antibiotic policy when treating self-
limiting respiratory tract infections largely among nurse prescribers through 
interviews and focus groups (but included two other non-medical prescribers); 
numbers of participants were not clear.  Offredy (2008) examined 25 nurse 
participants’ knowledge of pharmacology and their prescribing decisions in 
general.   
 
Systematic review inclusion criteria specified a focus on prescribing decision-
making by supplementary and independent non-medical prescribers, however 
Offredy and colleagues also included trainee nurse prescribers.  Some of their 
participants were extended formulary nurse prescribers, treating a limited list of 
conditions with a specific formulary of medicines.  Given the small number of 
studies retrieved it was decided to include all three studies in data extraction and 
synthesis.  
 
3.10 Synthesis of findings from systematic review  
 
3.10.1 Approach to synthesis 
 
Synthesis is one aspect differentiating a systematic review from a review of the 
literature (Centre for Reviews and Dissemination 2009); several approaches may 
be taken.  
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All three studies used qualitative research methods to explore aspects of non-
medical prescribers’ prescribing decision-making, although this was not the 
specific focus of any of them.  Rather they focused more broadly and included 
perceptions of clinical guidance, patient and parental expectations, participants’ 
levels of comfort with their prescribing decisions, participants’ experiences of 
their consultations and scenario-based tests of participants’ pharmacological 
knowledge.  The largely qualitative nature of the data precluded meta-analysis 
while disparate study types and participants meant that results could not simply 
be ‘pooled’.  Instead, a robust narrative approach including critical reflection was 
needed to combine and synthesise study findings, generating original 
understandings.  Such an approach should include combining the results of 
studies, evaluating the evidence, identifying any consistencies and exploring any 
discrepancies (Centre for Reviews and Dissemination 2009).  
 
3.10.2 Narrative synthesis 
 
Narrative synthesis considers not only study findings but also the relationships 
within and between studies, and evaluates the evidence to support its 
conclusions.  The process should be transparent and robust (Centre for Reviews 
and Dissemination 2009).  Various methods may be used; the Centre for 
Reviews and Dissemination endorses framework-based guidance produced as a 
result of work carried out for the Economic and Social Research Council Methods 
Programme (Popay et al. 2006).  This takes a narrative approach, using text to 
summarise and synthesise studies and findings.  This was thought appropriate 
given the largely textual data reported. 
 
The framework has four stages which should be worked through iteratively, 
revisiting stages and techniques as appropriate: 
 
 developing a theory 
 
 developing a preliminary synthesis 
 
 exploring relationships within and between studies 
 
 assessing the robustness of the synthesis 
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The framework includes various tools and techniques which may be used as 
appropriate to support analysis and enhance transparency and ultimately the 
rigour of the final synthesis. 
 
Popay’s method is multi-stage; an iterative, integrated approach is described 
where the reviewer moves between the different stages, revisiting some as a 
result of insights obtained from others.  This was done; at each stage it was 
necessary to select appropriate tools and techniques, encouraging an inductive, 
reflective approach which was felt to be very beneficial.  In Tables 3.9, 3.10 and 
3.11 selection or rejection of tools/ techniques and approaches has been justified 
briefly. 
 
Guidance is only available by application to Professor Popay at the Division of 
Health Research at Lancaster University; those using it must undertake to 
provide Professor Popay with copies of any publications arising from its use. 
 
Stages in the synthesis 
3.10.2.1 Developing a theory 
 
Social and cognitive influences are known to impact prescribing decision-making 
by doctors (Britten 1994, Butler et al. 1998, Stevenson et al. 1999, Britten et al. 
2000 and Stevenson et al. 2001).  Non-medical prescribers come from different 
disciplines and different traditions from those of doctors (Weiss and Fitzpatrick 
1997, Weiss and Sutton 2009) and it was not known whether similar or 
additional social and cognitive influences might impact on their prescribing 
decision-making.  This systematic review of social and cognitive influences on 
prescribing decision-making among non-medical prescribers was carried out to 
explore this. 
 
Objectives 
The review had two objectives which informed development of the review 
protocol (Appendix 3.1): 
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 to determine the social and cognitive influences on prescribing decision-
making among supplementary and independent non-medical prescribers in 
the UK 
 
 to report on the methodologies and methods used and the quality of peer-
reviewed published studies in this area.  Consideration of the quality of the 
studies will be given in detail as part of the synthesis process  
 
3.10.2.2 Developing a preliminary synthesis 
 
This provides an overview of study findings.  Various elements may contribute; 
Popay and colleagues (2006) suggest that reviewers select whichever of the tools 
and techniques they consider appropriate for the types of studies and data i.e. 
quantitative, qualitative or a mixture of both.   
Table 3.9 illustrates the range of tools and techniques, comments on these and 
states whether and why they were used. 
 
Table 3.9 Tools and techniques for preliminary synthesis of findings 
Adapted from Popay et al. 2006 
Name of tool/ 
technique 
Comment Selected? 
Textual 
descriptions 
A very brief textual 
summary of each study 
Yes.  Helped to identify key 
points, provided a useful 
summary and generated 
questions which informed 
subgroup analyses when 
exploring relationships in the 
data 
Tabulation Provided clear “at a glance” 
summaries of papers 
Yes.  Data extraction and 
quality assessment summaries 
prepared prior to synthesis 
Groupings and 
clusters 
 
Sorting according to 
populations, settings, study 
design or another aspect. 
Useful when considering 
larger numbers of disparate 
studies 
No.  Settings and target 
populations similar (almost all 
nurse prescribers/ trainees 
working in primary or acute 
care).  Only three studies 
included in review 
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Name of tool/ 
technique 
Comment Selected? 
Transforming data:  
constructing a 
common measure 
Useful when considering 
data from quantitative 
studies  
No.  Not applicable to textual 
data from qualitative research  
Translating data 
(integrating 
themes and 
concepts reported 
across studies) 
Would be useful in a larger 
systematic review to help 
make sense of possibly quite 
disparate studies 
No.  Only three studies included 
so not necessary at this stage. 
Used when exploring 
relationships within and 
between studies 
Vote-counting as a 
descriptive tool  
Useful when considering 
quantitative research  
No.  Not relevant  
 
 
Textual descriptions of studies  
These provided a summary of the studies and identified possible moderator 
variables and areas to be explored in sub-group analysis.  
 
Philp and Winfield, 2010. Why prescribe antibiotics for otitis media in children? 
Philp and Winfield (2010) explored nurse prescribers’ treatment of otitis media in 
children using semi-structured, audio-taped interviews with eight nurse 
prescribers working in primary care in Cornwall.  Iterative thematic analysis of 
transcripts included researcher and participants “[being] interactively engaged in 
constructing a version of the participants’ world” (p.15).  
 
Participants valued and used evidence-based guidelines but felt that they were 
not appropriate in all circumstances; all described situations where external 
influences and/or concerns about possible clinical complications were more 
influential.  All participants had been aware of parental pressure to prescribe 
antibiotics as they felt inappropriately; experience, confidence, knowledge of the 
patient and the support of colleagues were helpful in resisting this pressure.  All 
but one reported having prescribed antibiotics against guideline 
recommendations as a result of external influences.  Participants all reported 
feeling comfortable with their prescribing, citing knowledge of the patient and 
experience as contributing to their level of comfort.  
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Methodological weaknesses are described in Table 3.3 quality assessment 
summary and in Section 3.12.2 Methodological approaches, methods and quality 
of studies included in the systematic review.  
 
Rowbotham et al., 2012. Challenges to nurse prescribers of a  
no-antibiotic strategy for managing self-limiting respiratory tract infections 
Rowbotham and colleagues (2012) sampled purposively non-medical prescribers 
in the northwest of England based on practice locations, age, discipline and care 
setting.  They conducted one to one semi-structured interviews (nurse 
prescribers) and focus groups (nurse prescribers, one pharmacist prescriber and 
one physiotherapist prescriber) to study participants’ experiences of managing 
patients with self-limiting respiratory tract infections.  
 
Participants felt that some patients sought reassurance that their condition was 
not serious.  Others wanted treatment with antibiotics, generally due to a lack of 
understanding of the condition and/ or previous treatment with antibiotics.  
Consultations could be time consuming and complex and participants worried 
about misdiagnosis, leading to a cautious approach.  Some had prescribed 
antibiotics in the past in response to time pressure, patient expectation and/or 
clinical uncertainty but most said that they would no longer do so.  Patient 
education and good communication skills were considered important and peer 
support and the use of guidelines helpful in resisting patient pressure for 
antibiotics.  
  
Methodological weaknesses are described in Table 3.4 quality assessment 
summary and in Section 3.12.2 Methodological approaches, methods and quality 
of studies included in the systematic review. 
 
Offredy, Kendall and Goodman, 2008.  The use of cognitive continuum theory 
and patient scenarios to explore nurse prescribers' pharmacological knowledge 
and decision-making  
Offredy and colleagues (2008) sampled purposively nurse prescribers and trainee 
nurse prescribers working in primary care and in the acute sector in the 
southeast of England, to get a “mixed group of prescribers” p.860.  They used 
semi-structured interviews including previously-validated clinical scenarios to 
score participants’ pharmacological knowledge and ascribe their decision-making 
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in response to the scenarios to one of six modes according to Hammond’s 
Cognitive Continuum Theory (Hammond 1978).  They also asked participants 
about medication-related issues, and “to rate their knowledge and confidence of 
medication used in their area of practice” (p.858).  Participants were not allowed 
access to the British National Formulary (BNF) (Joint Formulary Committee of the 
British National Formulary 2017) when responding to the scenarios.  
 
It was found that participants working in general practice and some community 
settings prescribed more frequently than those in the acute sector, due regular 
patient contact and a good working relationship with the GP.  Participants 
commonly prescribed for abdominal problems, infections, family planning, wound 
dressings, some antibiotics and analgesics.  Some described extensive peer and 
organisational support for prescribing.  Participants’ knowledge of pharmacology 
was poor; most could not respond appropriately to the scenarios, particularly 
without access to the BNF, which some said they would consult before 
prescribing or offering advice. Participants who were unable to respond said they 
would refer the patient to the GP as the situations were out with their experience 
and competence.  Most participants rated themselves as confident in dealing with 
medication-related issues.  Participants’ prescribing decision-making was 
categorised by Offredy and colleagues as involving moderately-strong or weak 
quasi-rational thought although the method by which this was done was not 
always clear.  
 
Methodological weaknesses are described in Table 3.5 quality assessment 
summary and in Section 3.12.2 Methodological approaches, methods and quality 
of studies included in the systematic review.  
 
Tabulation 
Quality assessment and data extraction and forms were prepared according to 
the methods described in Section 3.5 (quality assessment) and Section 3.6 (data 
extraction).  Results may be seen in Tables 3.3, 3.4 and 3.5 (quality 
assessment) and Tables 3.6, 3.7 and 3.8 (data extraction).  
 
3.10.2.3 Exploring relationships within and between studies 
 
According to Popay, findings of individual studies should be considered in relation 
to various aspects of the studies themselves, then all findings should be 
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considered together.  Various tools and techniques are suggested to support this; 
details, a brief commentary and justification for use or not are given in Table 
3.10 below. 
 
Table 3.10 Tools and techniques to be used in exploring relationships within and 
between studies 
Adapted from Popay 2006  
Name of tool/technique  Comment  Selected?  
Graphs, frequency 
distributions, funnel plots, 
forest plots and L’Abbe plots  
Provide visual, generally 
descriptive summaries of 
quantitative data  
No.  Not appropriate for 
qualitative data  
Moderator variables (yes) 
and subgroup analysis (no)  
Moderator variables 
analysis used to explore 
variables within studies 
which may influence their 
findings  
Yes.  Study designs, 
sampling strategies and 
theoretical underpinning 
and methods of analysis 
considered 
Concept mapping  Useful to model key 
aspects relevant to the 
review and any 
relationships between 
them.  
Yes.  Concept map 
prepared. See Figure 3.2 
Quantitative case 
descriptions  
Textual descriptions which 
attempt to explain 
differences in quantitative 
findings  
No.  Not appropriate for 
qualitative data  
Visual representation of 
relationships between study 
characteristics and results  
Concept mapping displays 
relationships between 
various elements of 
studies  
Yes.  Concept map 
prepared as above, Figure 
3.2  
Concept triangulation  This allows the same 
concept to be examined in 
two different ways  
Yes.  Offredy ‘scored’ 
participants’ knowledge of 
pharmacology/ medicine-
related issues; the 
relationship (if any) 
between this and 
participants’ self-assessed 
knowledge and confidence 
of medication used in their 
area of practice was 
explored  
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Name of tool/technique  Comment  Selected?  
Reciprocal translation  Integrates themes and 
concepts reported across 
studies  
Yes.  “Pharmacological 
knowledge” and confidence 
in prescribing role were 
explored across all studies  
Investigator (no) and 
methodological (yes) 
triangulation  
Compares and contrasts 
findings from studies with 
respect to the 
investigators’ backgrounds 
and disciplines or the 
study design  
No mention in any study of 
investigators’ backgrounds. 
Studies will be compared 
with respect to study 
designs  
 
Concept mapping 
A diagrammatic representation of all three studies was created and is reproduced 
below (Figure 3.2).  Construction of the map showed that pharmacological 
knowledge was not identified as influential in the studies by Philp and Winfield 
(2010) and Rowbotham and colleagues (2012), and that the relationship 
between pharmacological knowledge and prescribing decision-making was not 
clear from Offredy’s study (2008).  
The following abbreviations are used to represent the papers: 
P = Philp and Winfield 2010  
R = Rowbotham et al. 2012 
O = Offredy et al. 2008 
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Figure 3.2 Concept map showing links between concepts in studies 
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3.10.2.4 Assessing the robustness of the synthesis 
 
The last stage in Popay’s narrative synthesis process is to assess the robustness 
of the synthesis.  A number of approaches are offered which may be used to 
support this; Table 3.11 lists the approaches along with brief commentary and a 
justification for their use or not. 
 
Table 3.11 Approaches to assessing the robustness of the synthesis 
Adapted from Popay et al. 2006 
Approach  Comment  Selected?  
Weight of evidence 
(Gough 2007)  
Studies are assessed first 
according to relevance 
criteria set for the review, 
then according to 
methodological quality  
No.  All studies meeting 
the criteria were included 
due to small number  
 
Best evidence synthesis 
(Slavin 1995)  
Focus is on inclusion of 
studies based on the 
strength of evidence  
No.  All studies meeting 
the criteria were included 
due to small number  
Use of validity 
assessment (Task Force 
on Community Preventive 
Services et al. 2005)  
A method of categorising 
studies on the basis of 
study quality then 
deciding on inclusion  
No.  All studies meeting 
the criteria were included 
due to small number  
Reflecting critically on the 
synthesis process  
(Busse et al. 2002)  
A critical discussion: of 
the synthesis method, 
evidence used, any 
assumptions made, 
identifying discrepancies  
Yes.  The multi-stage 
approach taken in 
previous sections 
facilitated this  
Checking the synthesis 
with authors of primary 
studies (Britten et al. 
2002)  
Allowing authors to 
comment on validity of 
interpretation and 
synthesis-derived findings  
No.  The synthesis was 
discussed with 
supervisory team  
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3.11 Results 
 
3.11.1 Study designs 
 
All studies used qualitative methodologies; this was appropriate as they aimed to 
explore in-depth not only behaviours but motivations, perceptions and decision-
making processes (Pope and Mays 1995).  All reports included details of ethics 
approval; Philp and Winfield (2010) went in to some detail but it was unclear 
whether they obtained written or verbal informed consent.  Both Philp and 
Winfield and Rowbotham and colleagues (2012) explored antibiotic prescribing 
for self-limiting conditions: Philp and Winfield for otitis media in children and 
Rowbotham and colleagues for self-limiting respiratory tract infections.  
Interviews were audio-recorded and transcribed.  
 
Philp and Winfield (2010) gave detailed justification of their use of semi-
structured, in-depth interviews to gain insights into participants’ “attitudes, 
beliefs and perceptions” (p. 15).  They described using a topic guide with mainly 
open ended questions but gave no further details.  
 
Rowbotham and colleagues (2012) used semi-structured interviews and focus 
groups “to allow in-depth exploration” of their participants’ experiences (p.2624) 
and to permit triangulation of data.  They did not justify the use of one rather 
than (sometimes as well as) the other method.  A topic guide (no detail given) 
was used for interviews; little detail or justification was given for the use of focus 
groups and participants were recruited and the groups run at a training event, 
which researchers acknowledged may have resulted in recruitment bias (Sackett 
1979).  Essentially, the design of these two studies was broadly similar, with the 
addition of focus groups by Rowbotham, and there was some overlap of results. 
 
Offredy and colleagues (2008) used validated patient scenarios including a 
scoring system (Sodha et al. 2002) within semi-structured interviews to assess 
participants’ pharmacological knowledge and characterise their cognition when 
deciding how to respond, according to Hammond’s Cognitive Continuum Theory 
(Hammond 1978).  They also asked participants to rate their confidence in 
dealing with medication matters; these aspects resulted in a combination of both 
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quantitative and qualitative reporting of their results.  They categorised 
participants’ decision-making according to the Cognitive Continuum Theory 
(Hammond 1978) although little justification was provided for this categorisation.  
 
The design and focus of Offredy’s study was thus quite different from those of 
the others but all three studies found that external influences in addition to 
patients’ clinical condition and evidence-based guidelines impacted on 
participants’ prescribing decision-making. 
 
3.11.2 Sampling strategies 
 
All authors could usefully have given more information on recruitment and 
sampling, for example none gave details beyond the number of participants.  
Potential numbers and those (if any) initially accepting then subsequent refusing 
might have been included.  There were also apparent deficiencies in the 
recruitment strategies reported. 
 
Philp and Winfield (2010) wrote to nurse practitioners throughout Cornwall via 
practice managers but did not check whether the practices had nurse 
practitioners or follow up their initial approach.  They interviewed eight nurse 
prescribers. 
 
Rowbotham’s study (2012) was carried out as part of a larger study examining 
the views and experiences of different prescribers.  It was the only study to 
include a pharmacist prescriber and a physiotherapist prescriber albeit only in 
one of three focus groups.  Recruitment was purposeful according to practice 
location, discipline, age and care setting, through direct contact (no details) with 
medical practices in the northwest of England and at a training event.  It is 
possible that those attending this training were in some way different from other 
non-medical prescribers, as indeed may participants in all three studies have 
been. 
 
Offredy and colleagues (2008) recruited via letters sent to the managers of two 
primary care trusts and used purposive sampling to recruit a mixture of qualified 
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and trainee nurse prescribers.  Some participants were extended formulary nurse 
prescribers and results were not differentiated according to the type of nurse 
prescriber.  Given that only two other studies met the inclusion and exclusion 
criteria this was this was deemed acceptable and the study was included in the 
review. 
 
3.11.3 Method of analysis and theoretical underpinning (if any) 
  
Philp and Winfield (2010) used a complex, iterative method of data analysis.  A 
thematic framework was created from issues identified during interviews along 
with the aims and objectives of the study.  Matrices were used to categorise the 
transcribed data in a “flexible and dynamic way” (p.15) and “a considerable 
amount of abstraction and synthesis” (p.15) resulted in core themes which were 
reported.  They described using illustrative quotations to support their 
assertions. 
 
Philp and Winfield (2010) made no reference to theoretical underpinning.  They 
described the chief investigator and participants as being “interactively engaged 
in constructing a version of the participants' world, rather than merely reporting 
them" (p.15).  Despite this the writers did not describe their own backgrounds 
and experiences which might have been influential during this process.  
 
Rowbotham and colleagues (2012) described an iterative, thematic approach to 
analysis of data, with themes and sub-themes identified and used to inform 
subsequent development of topic guides.  Digital recording and verbatim 
transcribing was used but there was no mention of field notes having been made 
during focus group discussions.  By using two complementary methods 
researchers hoped to triangulate their data but there was little differentiation in 
reporting of results from the two methods and participant details were not clear.  
Again, theoretical underpinning was absent. 
 
Only Offredy and colleagues (2008) described using theory to support their 
approach to study design.  Very clear textual and diagrammatic descriptions of 
Hammond’s six modes of cognition were given but it appeared that at least three 
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of the modes, based on experimental designs, could not be applicable.  Offredy 
and colleagues did not make clear the basis on which participants’ decisions were 
assigned to a mode of cognition and in fact seemed unclear themselves, for 
example when they said “This response could indicate an organising principle 
which used both analytical and intuitive thinking but this cannot be said with 
certainty because of the partial response by participants” (p. 864). 
 
Reporting of data analysis focused on scoring participants’ responses to the 
patient scenarios, which were included, and identifying the type of cognition.  No 
information was given on the method of analysis of other data from the semi-
structured interviews for example on participants’ self-rated knowledge and 
confidence in medication-related issues.  10% of transcripts were returned to 
participants for critical comments, resulting in some clarification but no change in 
meaning. 
 
3.11.4 Assumptions made by authors 
 
Philp and Winfield (2010, p. 18), with only eight participants, claimed that their 
study “informs us how nurse practitioners think through their prescribing practice 
for OM [otitis media]”.  Rowbotham and colleagues (2012, p.2630) with around 
32 participants stated that “the results are likely to be applicable to the rest of 
the UK and to other countries where nurses have prescribing powers”.  Only in 
Offredy’s study (2008, p.866) was it acknowledged that “the study covered a 
small sample of nurse prescribers.”  
 
3.11.5 Conceptual triangulation of pharmacological knowledge and self-
rated knowledge and confidence:  
 
Offredy et al. 2008 
Eighteen of Offredy’s twenty five participants were nurse prescribers; the 
remainder were training for this role.  Most results were not reported according 
to prescribing status making differentiation difficult.  Most participants scored 
zero or (less commonly) one out of a possible three when responding to the 
clinical scenarios; they were unable to identify potentially problematic issues or 
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suggest acceptable solutions other than referring the patient to the GP.  None of 
the scenarios related to prescribing decision-making although in one participants 
were asked to recommend an over the counter remedy for sinusitis in a patient 
taking anti-hypertensive medicines.  Trainee prescribers scored less well than 
prescribers in response to the scenarios. 
 
All participants rated themselves “knowledgeable” about commonly used 
medicines in their own fields and most as “confident” about medicine-related 
governance issue, adverse effects of drugs and advising patients about medicines 
including over the counter medicines.  Again trainees’ self-rated confidence was 
lower.  Confidence was ascribed to a supportive working environment and 
knowledge of the patients and their medical conditions.  Four prescribers rated 
themselves as “not confident” in these areas, attributing this to inadequate 
pharmacological knowledge, heightened awareness of issues of prescribing 
governance and logistical difficulties delaying their prescribing.  A few expressed 
concern about dealing with patients receiving polypharmacy.  
 
No attempt was made to link individual participants’ scenario-response scores 
with their “self-rated knowledge and confidence levels in medication”  
p. 862).  Data suggested a mismatch in general between participants’ self-
assessed knowledge and confidence and what Offredy and colleagues described 
as their “lack of appropriate pharmacological knowledge” (p.865) 
  
3.12 Discussion 
 
3.12.1 Findings from the systematic review 
 
Several important findings emerge from this systematic review. 
 
Limited research currently 
A major finding is the paucity of research in this important area.  Only three 
studies were identified which matched the inclusion and exclusion criteria (Philp 
and Winfield 2010, Offredy, Kendall and Goodman 2008, Rowbotham et al. 2012) 
and none focussed primarily on prescribing decision-making. 
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Social and cognitive influences on prescribing decision-making 
All studies examined wider aspects of NMP prescribing (two, the practice of 
antibiotic prescribing for self-limiting conditions (Philp and Winfield 2010, 
Rowbotham et al. 2012) and one, aspects of pharmacological knowledge 
(Offredy, Kendall and Goodman 2008) but none focused solely on prescribing 
decision-making.  Studies were carried out in primary care almost exclusively 
among nurse prescribers; this may have implications for the transferability of 
findings to secondary care and to other non-medical prescribers. 
 
Participants in all three studies perceived consultations as challenging and 
complex.  Participants with more experience in their role felt that this led them to 
feel more knowledgeable and confident about medicine-related issues (Philp and 
Winfield 2010, Offredy, Kendall and Goodman 2008, and when making 
prescribing decisions (Philp and Winfield 2010).  The prescribing decision-making 
process was also complex.  Some nurse prescribers and trainee prescribers 
appeared to rely on intuition and experience in the absence of adequate 
knowledge in their responses to clinical scenarios, although they maintained that 
they felt knowledgeable about medicines used in their own clinical areas 
(Offredy, Kendall and Goodman 2008).  There was no evidence that participants’ 
confidence and prescribing decision-making was informed by knowledge of 
pharmacology (Offredy, Kendall and Goodman 2008). 
 
Evidence-based guidelines were perceived as offering rigorous, clear guidance on 
treatment for ear and respiratory tract infections (Philp and Winfield 2010, 
Rowbotham et al. 2012).  Most participants claimed to follow such guidelines 
(Philp and Winfield 2010, Rowbotham et al. 2012) yet others had chosen to 
ignore them and prescribe antibiotics in response to clinical uncertainty and 
perceived risk of complications (Philp and Winfield 2010, Rowbotham et al. 
2012).  Some felt this was appropriate given their experience and hence insight 
into particular circumstances where they felt antibiotics were warranted (Philp 
and Winfield 2010).  They also prescribed in response to external factors such as 
previous experience, perceived patient pressure for antibiotics, patients’ socio-
economic status and prescriber’s knowledge of the patient or family (Philp and 
Winfield 2010, Rowbotham et al. 2012).  Antibiotic prescribing against guidelines 
  
 
 
104 
 
was also more likely to happen during out of hours services partly as a 
consequence of the attendant lack of knowledge of the patient or family (Philp 
and Winfield 2010).  
 
On the other hand, evidence-based guidelines were perceived as useful in 
helping participants to resist patient pressure for antibiotics; this was particularly 
the case for inexperienced prescribers (Rowbotham et al. 2012).  Opportunities 
for patient education were seized (Rowbotham et al. 2012); participants felt that 
this was a key part of their role and was also helpful in explaining why antibiotics 
were not necessary and would not be prescribed. 
 
The context within which prescribing occurred was important; a team approach 
to prescribing with peer support and encouragement from doctors helped to build 
participants’ confidence (Offredy, Kendall and Goodman 2008) and helped them 
to resist patient pressure to prescribe antibiotics inappropriately (Philp and 
Winfield 2010, Rowbotham et al. 2012).  That said, some GPs prescribed 
antibiotics against guidelines themselves, after nurse prescribers turned to them 
hoping for support for their no-antibiotic stance (Rowbotham et al. 2012). This 
was not felt to be helpful. 
 
Despite evidence from Offredy’s study (2008) that participants’ pharmacological 
knowledge in response to clinical scenarios was generally poor and in some cases 
impacted on their confidence as prescribers, this was not identified as an issue 
among participants in the other two studies (Philp and Winfield 2010, 
Rowbotham et al. 2012).  Despite their low scores in the assessment of their 
pharmacological knowledge, all Offredy’s participants described themselves as 
knowledgeable about medicines commonly used in their own areas of practice 
(Offredy, Kendall and Goodman 2008).  If participants in the other two studies 
felt similarly this might explain why pharmacological knowledge did not feature 
as an influence on their prescribing decision-making. 
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3.12.2 Methodological approaches, methods and quality of studies 
included in the systematic review 
 
The second objective of the systematic review was to report on the 
methodologies and methods used and quality of peer-reviewed published studies 
in this area. 
 
Two of the three studies used qualitative methodologies: semi-structured 
interviews (Philp and Winfield 2010) and a combination of semi-structured 
interviews and focus groups (Rowbotham et al. 2012).  Offredy and colleagues 
(2008) used a combination of qualitative semi-structured interviews and 
quantitative methodology, scoring participants’ responses to patient scenarios 
and using graphs and diagrams to represent findings on participants' modes of 
decision-making and knowledge of pharmacology.  None of the studies described 
the process of prescribing decision-making itself including generating, 
implementing, evaluating and adjusting a patient-specific plan for prescribing.  
 
Methods of data generation were justified and appropriate and some indication 
was given of areas covered in semi-structured interviews and focus groups 
(Offredy, Kendall and Goodman 2008, Philp and Winfield 2010, Rowbotham et al. 
2012).  More detail might have been provided however, particularly in the case 
of Rowbotham and colleagues (2012) who provided very little information on 
their focus groups processes. 
 
Analytical methods were generally described in detail although Offredy and 
colleagues (2008) acknowledged a lack of clarity in the assigning of decision-
making according to Hammond’s cognitive continuum theory (1978) and the 
approach appeared somewhat contrived. 
 
Findings were generally stated clearly but some results were not reported 
according to profession (Rowbotham et al. 2012) or in some cases category of 
nurse prescriber (Offredy, Kendall and Goodman 2008).  Only one pharmacist 
prescriber and one physiotherapist prescriber were included in one study and 
results were not differentiated according to profession meaning that no 
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conclusions could be drawn specifically about prescribing decision-making by 
pharmacist and physiotherapist prescribers (Rowbotham et al. 2012). 
 
All studies had methodological limitations although these would have been 
unlikely to have resulted in the studies being excluded from the review even had 
a larger number of papers made this potentially possible.  Only one study 
described having a theoretical underpinning although as above its application 
was not always clear (Offredy, Kendall and Goodman 2008).  Methods of 
recruitment were not always optimal, perhaps due to issues of research 
governance precluding direct initial contact between researchers and the sample 
population (Offredy, Kendall and Goodman 2008, Philp and Winfield 2010, 
Rowbotham et al. 2012) and more detail on recruitment would have been 
beneficial.  
 
Issues of reflexivity were not mentioned at all and none of the authors discussed 
their own professional background, experience or stance (Philp and Winfield 
2010, Offredy, Kendall and Goodman 2008 and Rowbotham et al. 2012).  These 
cannot help but inform the approach to research, particularly in a qualitative 
study (Bowling 2002) and should have been made explicit and discussed (Barry 
et al. 1999). All authors acknowledged the possibility of social desirability bias 
(Sackett 1979) in their results (Offredy, Kendall and Goodman 2008, Philp and 
Winfield 2010 and Rowbotham et al. 2012).  All studies gave details of research 
governance issues and had received ethics approval. 
 
Despite limitations in the three studies, some of which the authors acknowledge, 
they were the only ones to meet inclusion and exclusion criteria and so provide 
the only evidence in this area.  Philp and Winfield’s (2010) and Rowbotham’s 
(2012) studies were published recently and so may be particularly relevant. 
  
A strength of this review is the use of Popay’s method of narrative synthesis.  
The multi-stage, step-wise approach facilitated critical, repeated examination of 
the review papers from a variety of viewpoints in order to create the final 
inductive synthesis.  A different perspective was developed through each step, 
sometimes uncovering elements which might have been missed; these “partial 
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pictures” (Popay 2006, p.21) were then combined to form a whole, allowing the 
objectives of the review to be met in a robust way.  
 
A limitation is that two of the three papers (Philp and Winfield 2010, Rowbotham 
et al. 2012) explored almost exclusively nurse prescribing only in response to 
minor self-limiting conditions where antibiotics were one of the treatment 
options.  Participants in the third study (Offredy, Kendall and Goodman 2008) 
generally prescribed for acute, relatively minor conditions.  The review 
necessarily focuses on these areas of prescribing and can offer no insights into 
prescribing decision-making by non-medical prescribers working in other areas, 
where it is likely that most prescribing occurs.  Transferability of findings may 
also be limited by the inclusion of only three papers in the review and by the 
small study sample sizes of the papers included.  
 
3.13 Comparison with the literature 
 
Notwithstanding the small number of studies included in this review it is evident 
that prescribing decision-making by NMPs is complex and informed by a variety 
of sometimes contradictory influences, as is the case with medical prescribers.  
In addition to evidence-based guidelines (not always followed), experience, 
clinical uncertainty and perceived risk of complications, patient expectations, 
logistical pressures and peer support were found to influence the prescribing 
decisions of participants in the studies included in this review.  
 
Knowledge of pharmacology was not found to have influenced prescribing 
decisions made.  In 2005 the British Pharmacological Society recommended that 
pharmacology teaching for nurse prescribers must be basic and practically 
grounded (Leathard et al. 2007) but there remains  concern about nurse 
prescribers’ lack of pharmacological knowledge and the need to augment this 
(Creedon et al. 2009, Scrafton, McKinnon and Kane 2012, Creedon et al. 2015).  
 
In an early but (then) comprehensive evaluation of nurse and pharmacist 
independent prescribing, non-medical prescribers asserted that their prescribing 
decisions were evidence-based and contrasted this with those of their medical 
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colleagues (Latter et al. 2010).  Maddox (2011) found several other influences on 
the prescribing decisions of NMPs working in primary and community care 
including patient and colleague factors, the prescribing culture and professional 
experience.  A recent systematic review of influences on independent nurse 
prescribers’ antimicrobial prescribing behaviour found guidelines/ protocols and 
most commonly diagnostic uncertainty influenced the decision whether or not to 
prescribe antimicrobials (Ness et al. 2016).  Thereafter, guidelines/ protocols, the 
clinical profile of the antimicrobial, patient/ parent pressure and prescriber 
experience and training were found to influence the choice of antimicrobial 
agent.  
 
The importance of previous experience was highlighted in this systematic review.  
Other nurse prescribers have been similarly influenced (Ness et al. 2016) and 
recently-qualified nurse prescribers cited their experience as nurses as 
contributing to their safety as prescribers (Bradley, Hynam and Nolan 2007).   
 
Experience notwithstanding, clinical uncertainty has also been found to increase 
doctors’ prescribing of antibiotics for children with respiratory tract infections in 
scenario-based (Arnold et al. 2005) and vignette studies (Ashdown et al. 2016).  
Clinical uncertainty was also found to be influential in an interview-based study 
of GPs’ and nurse prescribers’ decisions about diagnosis and management of 
respiratory tract infections in children (Horwood et al. 2016).   
 
Participants in studies included in the systematic review identified the importance 
of colleagues’ support for their prescribing.  NMPs prescribing for chronic pain in 
the UK similarly emphasised the importance of colleagues’ knowledge and 
experience (Adigwe et al. 2013).  Nurse prescribers from UK primary and 
secondary care identified the importance of support for their prescribing from the 
multidisciplinary team and the importance of collaborative working (Bradley, 
Hynam and Nolan 2007).  Ward-based junior hospital doctors also recognised the 
importance of the team around them when making prescribing decisions doctors 
(Bull, Mattick and Postlethwaite 2013).  
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Participants in the studies included in the review were aware of patient pressure 
to prescribe, particularly for antibiotics, and sometimes prescribed in response to 
that pressure.  Other nurse prescribers have been subject to the same pressure 
and have done similarly (Ness et al. 2016).  Medical prescribers have also 
prescribed in response to patient pressure or perceived pressure in primary 
(Little et al. 2004, Petursson 2005, Strumiło et al. 2016) and secondary care 
(Lewis and Tully 2011).  
 
None of the studies included identified the prescriber-patient relationship as 
influential yet this has been found to be a key influence on medical prescribing 
decision-making in general practice (Cockburn and Pit 1997, Butler et al. 1998, 
Stevenson et al. 1999, Lewis and Tully 2011, Peters et al. 2011, Dempsey et al. 
2014).  Medical prescribers in secondary care, particularly those with a regular 
caseload of patients with long-term conditions, have also been found to prescribe 
to maintain their relationship with patients (Lewis and Tully 2011). 
 
Non-medical prescribers come from a variety of professional backgrounds but 
none comes from a tradition of paternalistic relationships with patients or from a 
position at the top of the healthcare hierarchy (Weiss and Fitzpatrick 1997, Weiss 
and Sutton 2009).  The non-medical prescribers in the studies included in this 
systematic review were treating acute, generally self-limiting conditions in 
primary care and may not have had pre-existing long-established relationships 
with their patients.  That said, a lack of relationship continuity has also been 
identified as influencing prescribing decisions for antimicrobials (Petursson 
2005).  As healthcare delivery changes, relationships between healthcare 
providers and recipients will also change with possibly unforeseen impact.  
 
None of the studies included in the systematic reviewed focused directly on the 
processes of prescribing decision-making by NMPs and more, detailed research is 
warranted to explore and elucidate influences on individual NMPs’ prescribing 
decisions.  In-depth interviews with a range of NMPs focusing on their prescribing 
decisions would be likely to add to what is known currently.  These were carried 
out in the next phase of this doctoral study.  
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3.14 Conclusions 
 
Very little research has been carried out into the social and cognitive influences 
on prescribing decision-making by non-medical prescribers in the UK.  The 
studies included in this review had methodological limitations which the authors 
acknowledged.  Evidence-based guidelines, peer and GP support and patient or 
parental expectations were found to be influential, as was the context within 
which prescribing occurred.  Confidence and clinical experience as a practitioner, 
or lack of it, were also cited as influences.  
 
Non-medical prescribers continue to make an increasingly important contribution 
to patient care in the UK.  The results of this systematic review suggest that 
there is a need for further research into their prescribing decision-making and in 
particular into the social and cognitive influences impacting this. 
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Chapter 4 Stage 2 Phase 1 interviews 
 
4.1 Introduction 
 
This chapter will report on Stage 2 Phase 1 of the programme of research: semi-
structured interviews with non-medical prescribers in the NHS Grampian area, 
exploring their experiences and perceptions of influences on their prescribing 
decision-making and the impact of these influences.  The objectives of this phase 
of the research were to explore: 
 
 participants' in-depth descriptions of their experiences of making 
prescribing decisions 
 
 their views and reflections of influences on the prescribing decisions they 
make 
and 
 
 their opinions on the impact of these influences on their prescribing 
decision-making    
 
4.2 Methods  
 
4.2.1 Research design 
 
An inductive, phenomenological approach was taken; as was discussed in 
Chapter 2 this is the most appropriate approach to answer the research 
questions.  Qualitative, semi-structured, face to face interviews were carried out 
with non-medical prescribers in their places of work across the NHS Grampian 
area.  As outlined in Chapter 2, this approach allowed exploration of participants’ 
experiences and perceptions, generating rich data from which relevant themes 
were identified.  Individual interviews were carried out, providing participants 
with the opportunity to respond without having to consider the possible impact of 
their words on others, as might be the case for example in focus groups.   
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4.2.2 Setting 
 
The study was carried out in primary and secondary care and in community 
pharmacies across the NHS Grampian area.   
 
4.2.3 Sampling frame  
 
The sampling frame was all supplementary and independent non-medical 
prescribers employed by or contracted to NHS Grampian.  
 
Inclusion criterion: 
 
 Those who considered that they prescribed as an integral part of their role, 
to ensure currency of practice.   
 
Exclusion criterion:  
 
 Optometrist independent prescribers 
 
4.2.4 Recruitment 
 
As outlined in Chapter 2, at the time of the study two senior NHS Grampian staff 
had overall responsible for non-medical prescribing: the Pharmacist Prescribing 
Lead and the Non-medical Prescribing Lead, who was responsible for all other 
non-medical prescribers.  A recruitment e-mail providing outline study 
information (Appendix 2.1) was sent by the doctoral student via these individuals 
on 18th September 2015 to all independent and supplementary non-medical 
prescribers employed by or contracted to NHS Grampian i.e. 612 nurse 
independent prescribers and 52 pharmacist independent prescribers.  The e-mail 
addresses were known to the Prescribing Leads and as outlined in Chapter 1 the 
Leads endorsed the study.  The e-mail specified that only those who prescribed 
as an integral part of their role were eligible for the study.  A reminder e-mail 
was sent on 1st December 2015.   
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“Snowballing” i.e. word of mouth recruitment was also used to increase 
recruitment.  Participants were asked by the doctoral student at the time of their 
interview whether any colleagues might be interested in taking part in the study; 
if so they were asked to pass on the doctoral student’s e-mail address.  The 
doctoral student also spoke in person to the colleague of one participant just 
after her interview.   
 
The recruitment e-mails included a link to a study-specific online recruitment and 
consent form (Snap Surveys 2016).  This included a participant information 
section (Appendix 4.1) providing detail to allow recipients to make an informed 
decision to participate.  Both the consent form and the information section were 
based on information provided by the NHS Health Research Authority (NHS 
Health Research Authority 2017); the content of both was developed through 
discussions among the research team.  Those choosing to participate were asked 
to consent separately within the form to participating in Phases 1, 2 and 3 of the 
study and to having their interviews and reflections recorded and anonymised 
data disseminated.    
 
It was made clear in the information section that participants could withdraw 
from the study at any point.  Participants were also informed that if they chose 
to disclose information with implications for patient safety this would be 
discussed with the research team and possibly shared with the Pharmacist and 
non-medical Prescribing Leads in NHS Grampian.  The doctoral student is a 
pharmacist with 35 years’ experience; two members of the supervisory team are 
also very experienced pharmacists and another is a retired lecturer and 
researcher in pharmacology.  Had the doctoral student had any concerns she 
would have raised them with the supervisory team, who in any case also 
reviewed all study data during analysis.  If the team considered it necessary the 
doctoral student would have contacted the appropriate Lead.  
 
4.2.4.1 Study demographic data 
 
Participants were asked in the recruitment form for the demographic data below.  
This was recorded to provide background information including preferred contact 
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details and to allow limited characterisation of participants, consistent with the 
requirement to ensure anonymity (Data Protection Act 1998, Robert Gordon 
University 2016a, Robert Gordon University 2016b, Robert Gordon University 
2016c).  These demographic data were also gathered to allow purposive 
sampling if necessary, to ensure a representative sample of NMPs in NHS 
Grampian.  In fact all recruits to the study were interviewed in Phase 1.  Data 
gathered were:  
 
 name, e-mail address, phone number, preferred contact method 
 
 age: 29 years or under; 30 - 39 years; 40 - 49 years; 50 - 59 years; 60 
years or over 
 
 professional role: nurse; pharmacist; radiographer; physiotherapist; 
podiatrist 
 
 number of years in this profession 
 
 supplementary or independent prescriber?  How long in each role? 
 
 prescribing setting: hospital; out of hours centre; health centre; 
community pharmacy; patient’s home; other (please specify) 
 
 full time or part time working; if part-time, how many hours per week? 
 
 proportion of the week spent in prescribing-related activities  
 
Completion and submission of the online consent form triggered an e-mail 
notification for the doctoral student who then contacted the participant by their 
preferred method to arrange a suitable time and place for the interview. 
 
Participants were give a small honorarium (a £25 Marks and Spencer voucher) at 
the end of the first interview, Phase 1, in recognition of their contribution to the 
study. 
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Figure 4.1 Process of recruitment to Phase 1 interviews 
 
4.2.5 Development of interview schedule  
 
The interview schedule was developed iteratively during extensive discussions 
with supervisors and others.  At an early stage in the study and before finalising 
the schedule the doctoral student and supervisors met with the NHS Grampian 
Leads for Pharmacist and Non-medical Prescribing so that their views could be 
gathered and incorporated into the study design.  The issue of disclosure of 
possible patient harm was discussed at these meetings.   
18th September 2015 
Initial e-mail sent via NHS Grampian 
pharmacist and non-medical 
prescribing Leads 
Snowballing: no effect 
1st December 2015 
Reminder e-mail sent via NHS 
Grampian pharmacist and non-
medical prescribing Leads 
via NHS Grampian pharmacist and 
Snowballing: + 4 participants 
Participants + participant for pilot 
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Supervisory team discussions took the form of weekly face to face meetings 
during which possible amendments to the schedule were identified and agreed 
then incorporated by the doctoral student and discussed again the following 
week.  Discussions were informed by: 
  
 the research objectives  
 
 the 14 domains of the TDF (Cane, O’Connor and Michie 2012)  
 
 specific research papers where domains of the TDF have been mapped to 
individual questions in interview schedules or questionnaires (Islam et al. 
2012, Patey et al. 2012, Huijg et al. 2014a, Huijg et al. 2014b) 
 
 a systematic review of the influences on prescribing decision-making 
among NMPs in the United Kingdom (McIntosh et al. 2013, McIntosh et al. 
2014, McIntosh et al. 2016a) 
 
 the results of an earlier scoping review of the literature on medical 
prescribing decision-making carried out by the doctoral student   
  
A draft interview schedule was developed then reviewed for credibility (Guba 
1981, Shenton 2004) by three senior prescribers with experience in education 
and training: a GP, a hospital medical consultant and a pharmacist prescriber.  
They were selected based on their current roles, experience as prescribers and 
their previous and/or current experience in teaching undergraduate and 
postgraduate students including pharmacist prescriber students, in the School of 
Pharmacy and Life Sciences.  Reviewers were sent an e-mail with the draft 
schedule attached and asked for their comments.  Minor comments were 
received by e-mail from all three and were incorporated into a revised version.   
 
This version was trialled face to face with a pharmacist prescriber in primary care 
and one in secondary care and a nurse prescriber in primary care and one in 
secondary care.  Three of these prescribers were known to the doctoral student, 
one was recommended by colleagues and all were approved in advance by the 
supervisory team.  The doctoral student met the NMPs at their places of work, 
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explained the study and its aims and asked them for any comments as she read 
through each interview question in turn.  The doctoral student took notes during 
this process.  All four NMPs considered the interview schedule easy to 
understand, appropriate and likely to gather information relevant to the aims of 
the study.  None suggested any changes to the schedule, which became the final 
version (see Figure 4.2 for the process of development of the interview schedule 
and Appendix 4.2 for the interview schedule itself).  This review by prescribers 
from broadly similar practice settings to those of potential participants was 
included as a way further to enhance the credibility of the interview schedule 
(Gillham 2000, Smith 2005). 
 
Piloting was carried out with one pharmacist prescriber; he had completed the 
recruitment form but during his interview explained that he no longer prescribed 
and so was ineligible for inclusion in the study.  His data were not included.   
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Figure 4.2 Development of interview schedule for Phase 1 interviews 
 
As above and in Chapter 2 the interview schedule was developed from the 
literature to incorporate questions relating to the 14 domains of the TDF (Cane, 
O’Connor and Michie 2012) and informed by others’ use of this technique (Islam 
Initial discussions with supervisory team and NHS 
Grampian Leads for non-medical and pharmacist 
prescribing.   
Schedule development informed by the 
Theoretical Domains Framework and from the 
literature. 
September – December 2014 
Schedule reviewed by senior prescribers  
(GP, hospital medical consultant and pharmacist 
prescriber) and refined based on comments 
received. 
January 2015 
Sense check: schedule talked through with 
pharmacist and nurse prescribers from primary 
care and secondary care. 
February - August 2015  
Final interview schedule  
August 2015  
Piloted with one pharmacist prescriber 
September 2015 – no changes made 
 
  
 
 
119 
 
et al. 2012, Patey et al. 2012, Huijg et al. 2014a, Huijg et al. 2014b).  The 
schedule also included questions on participants’ current patient groups and 
prescribing and also their views on how prescribing fits with their professional 
roles now and in the future.  It was felt that some interview questions would 
elicit information relevant to more than one domain; Table 4.1 maps each 
question only to the domain/s from which it was derived.   
 
Table 4.1 Mapping of interview questions to domains of the TDF  
(Cane, O’Connor and Michie 2012) 
Interview question TDF domain  
  
First, you’ve said you work as a [from demographic 
questionnaire]; please would you tell me a bit about the 
patient groups you prescribe for and the types of medicines 
you prescribe? 
Social/professional role 
and identity  
 
Can you talk me through how you decide whether or not to 
prescribe for a patient?  
Memory, attention and 
decision-processes 
Once you've decided to prescribe something, can you talk 
me through how you decide what to prescribe?  
Memory, attention and 
decision-processes, goals  
How confident do you feel in your ability to make these 
decisions? 
Prompt: can you tell me more about that? 
Beliefs about capabilities, 
optimism 
 
I’d like to know about how easy you find it to make 
prescribing decisions.  Does this vary sometimes?  Please 
tell me more about this. 
Beliefs about capabilities, 
optimism 
 
Do you feel you have the necessary knowledge to decide 
what to prescribe?  What sort of knowledge do you draw 
on? 
Knowledge 
 
Do you feel you have the necessary skills to decide what to 
prescribe?  What sort of skills do you use? 
Skills 
 
Have you had occasions where you became aware that 
there was a gap in your knowledge in relation to 
prescribing decision-making? 
Knowledge, beliefs about 
capabilities  
What about a skills gap; have you ever been aware that 
you lacked a particular skill in relation to prescribing 
decision-making or weren’t proficient in it?  
Skills, beliefs about 
capabilities 
 
How do you deal with any of these gaps during the 
consultation? 
What about more generally? 
Beliefs about capabilities, 
environmental context 
and resources, intentions 
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Interview question TDF domain  
  
Can you tell me a bit about the information sources you 
use whilst making a prescribing decision? 
Knowledge, environmental 
context and resources 
Are there things you might forget to consider when you’re 
making a prescribing decision?   
What about things that might distract you? 
Memory, attention and 
decision processes, 
environmental context 
and resources, social 
influences 
How does your expertise or experience both as a 
practitioner and as a prescriber influence your prescribing 
decision-making? 
Social/ professional role 
and identity, knowledge, 
skills 
Are there resources or ways of working that might have an 
effect on the prescribing decisions you make? 
 
Environmental context 
and resources; 
knowledge, skills 
I’m interested in finding out about whether other people 
might influence you when you’re making a prescribing 
decision. 
Social/ professional role 
and identity, social 
influences, environmental 
context and resources, 
reinforcement, goals  
Is there anything about where you work which influences 
the prescribing decisions you make? 
Social/ professional role 
and identity, social 
influences, environmental 
context and resources, 
reinforcement   
How, if at all, might your emotions influence your 
prescribing decision-making? 
Emotions 
 
Can you tell me about any possible consequences for the 
patient/ you/ colleagues that might influence your 
prescribing decision-making? 
Of these possible consequences, which do you think might 
be the most influential? 
Beliefs about 
consequences, 
reinforcement  
 
Before this interview, had you ever reflected on how you 
make prescribing decisions? 
 
Memory, attention, 
decision-making, 
behavioural regulation. 
And finally, I wonder if you can let me have your thoughts 
around how prescribing fits with current and future roles 
for your profession? 
Social/ professional role 
and identity 
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Outcome measures were: 
 
 participants' in-depth descriptions of their experiences of prescribing 
decision-making 
 
 their views and reflections of influences on their prescribing decision-
making 
 
and 
 
 
 their opinions on the impact of these influences on their prescribing 
decisions-making.    
 
 
4.2.6 Interviews: doctoral student’s training and expertise, data 
generation, recording, data processing and transcription, and data 
storage. 
 
4.2.6.1 Doctoral student’s training and experience 
 
As in the Foreword, the doctoral student is an experienced pharmacist academic.  
She has received training in qualitative research methods and specifically in 
carrying out interviews and in using NVivo® as a tool to facilitate analysis of 
qualitative data (QSR International PTY Ltd 2016).  The doctoral student has 
attended Good Clinical Practice Core for Researchers (non-drug) training and 
attends update training every two years.  
 
The doctoral student’s MSc Prescribing Science project gathered data by means 
of interviews with pre-registration trainee pharmacists (McIntosh and Stewart 
2015).  She has extensive experience in supervising degree, Masters and 
postgraduate Masters level projects including several which were interview-
based.   
 
Prior to carrying out interviews for this study the doctoral student and her 
supervisory team discussed how this would be done and agreed a standard 
operating procedure (Appendix 4.3).   
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4.2.6.2 Data generation 
 
At participants’ requests, interviews were carried out in their places of work 
across the NHS Grampian area between September 2015 and April 2016.  
Interviews lasted between 22 and 58 minutes; details are shown in Table 4.2 
below.  
 
Table 4.2 Details of Phase 1 interviews: participant, date and duration of 
interview 
Participant Date Duration 
Pharmacist 2 25th September 2015 26 minutes 40 seconds 
 
Pharmacist 3 2nd October 2015 48 minutes 21 seconds 
 
Pharmacist 4 12th October 2015 58 minutes 15 seconds 
 
Pharmacist 5 20th October 2015 51 minutes  31 seconds 
 
Pharmacist 6 2nd November 2015 30 minutes 14 seconds 
 
Pharmacist 7 3rd November 2015 52 minutes exactly 
 
Pharmacist 8 6th January 2016 53 minutes 39 seconds 
 
Pharmacist 9 13th April 2016 46 minutes 50 seconds 
 
Nurse 1 28th October 2015 29 minutes 5 seconds 
 
Nurse 2 29th October 2015 39 minutes 36 seconds 
 
Nurse 3 13th April 2016 50 minutes 12 seconds 
 
Nurse 4 13th April 2016 31 minutes 11  seconds 
 
Nurse 5 13th April 2016 22 minutes 46 seconds 
 
  
 
 
123 
 
4.2.6.3 Recording of interviews 
 
As above interviews were recorded according to a standard operating procedure 
developed through discussion with the research team (Appendix 4.3).  Two 
Olympus® WS-832 digital voice recorders were used simultaneously; these 
recorders were checked immediately prior to each interview to ensure that they 
were recording.  
 
Interviews took place in participants’ places of work, either in the participant’s 
consulting room or in a private office elsewhere in the building.  The doctoral 
student introduced herself and the interview process and read the preamble at 
the start of the interview schedule before recording began.  She asked the 
participant whether s/he was ready, switched on both recorders and started the 
interview.  Recording continued until the interview was finished, the doctoral 
student checking visually from time to time to ensure that the recorders were 
recording.   
 
4.2.6.4 Data processing and transcription 
 
Recordings were uploaded as soon as possible into password-protected computer 
files on the doctoral student’s RGU H-Drive.  Participants’ names were not 
recorded and any information which might identify them, others or their places of 
work was removed from the transcripts during accuracy checking.  Participants 
were allocated an identification code e.g. Pharmacist 3 or Nurse 5 which was 
used throughout; names and codes were stored securely and separately from the 
transcripts.  Uploaded recordings were checked for audibility and clarity by the 
doctoral student then erased from the digital recorders.   
 
The doctoral student had arranged for a member of the university staff trained 
and experienced in transcribing to transcribe the interviews.  Recording files 
were too large to be sent by e-mail from the doctoral student to this person so 
were uploaded on to a memory stick which was passed by hand to her.  She 
transcribed each interview separately verbatim i.e. using exactly the same words 
(Collins Dictionaries 2013), returned the memory stick and e-mailed the 
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transcripts back to the doctoral student, who checked them with the original 
recording for accuracy and completeness.  Occasionally the doctoral student 
corrected a mis-heard word or inserted for example a drug name with which the 
transcriber was not familiar.  
 
4.2.6.5 Data storage 
 
Documents were stored in password-protected computer files; paper copies were 
stored under lock and key and only removed for data checking and analysis.  
Audio recordings and transcripts will be kept in password-protected computer 
files for 5 years after the date of the last publication from the study, as per 
School of Pharmacy and Life Sciences Standard Operating Procedures for good 
research practice (School of Pharmacy and Life Sciences 2011)  
 
4.2.7 Data analysis  
 
Data were analysed using a Framework Approach (Ritchie et al. 2014) i.e. data 
familiarisation, identifying constructs (categories of analysis), indexing, charting, 
and mapping and interpreting (see Table 4.3 below).  The initial framework was 
based on the 14 domains of the TDF (Cane, O’Connor and Michie 2012).  One 
transcript (Nurse 1) was reviewed, discussed and coded by TM, SC, DS and KFM 
together.  Remaining transcripts were analysed by the doctoral student and one 
of SC, DS and KFM and any differences in coding resolved by discussion.   
 
4.2.7.1 Data handling and analysis using NVivo® 
 
As in Chapter 2 the doctoral student used NVivo® 10 software (QSR International 
Pty Ltd. 2016) to facilitate data handling and analysis including identification of 
representative illustrative quotations (Creswell 2013).  NVivo® provides a flexible 
matrix within which interview transcripts may be stored at “nodes”, and sections 
classified into different categories of analysis.  The terminology used is particular 
to NVivo®: principal categories of analysis are referred to as “parent nodes” with 
subordinate categories within each principal one referred to as “child nodes”.  For 
clarity the terms “principal” and “subordinate” categories of analysis will be used 
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throughout the thesis, with “node” being used to describe the location of these 
categories within the NVivo matrix.   
 
Categories may be added to or condensed as necessary; this process facilitates 
close analysis, allocation of text to categories of analysis, and identification of 
suitable text to be used for illustrative quotations.  Quotations were reviewed by 
supervisors and agreement on which to include reached by discussion.  In the 
selection of quotations for this thesis care was taken to ensure that all 
participants were represented and that where possible a balance of professions 
was maintained.  Sources have been identified using participants’ codes, practice 
settings and gender. 
 
To allow the doctoral student to become familiar with using the software the first 
seven interviews were coded only to the principal categories of analysis i.e. the 
14 domains of the TDF plus two additional principal categories which emerged, 
multidisciplinary working and experience.  
 
Text from these transcripts, coded initially at these principal categories of 
analysis was then re-coded, creating several subordinate categories from each 
principal one.  Remaining transcripts were coded using this expanded framework 
with fresh principal and subordinate categories or analysis being added as 
required; again sections of text were allocated to the nodes.  Figure 4.3 is a 
screen shot showing how the principal category of analysis “knowledge” was sub-
divided into 14 subordinate categories, each with associated text.  Finally 
categories of analysis were considered in relation to each other allowing the 
identification of themes and sub-themes. 
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Table 4.3 Steps in thematic analysis of Phase 1 transcripts using the Framework 
Approach (Ritchie et al. 2014)  
Step Process 
Data familiarisation Recordings were listened to by the doctoral student 
after each interview, during transcription accuracy 
checking and during analysis.  Transcripts were 
similarly read, annotated and reviewed repeatedly 
by the doctoral student and her supervisory team 
to allow familiarisation with the data and to 
facilitate analysis 
Identifying constructs 
(categories of analysis) 
TDF domains were used a priori as principal 
categories of analysis and additional emerging 
principal and subordinate categories of analysis 
added as transcripts were coded.  Coding was done 
by the doctoral student and by one of the 
supervisory team; duplicate analysis of transcripts 
was shared.  Coding was discussed and agreed with 
any disagreements being resolved through 
discussion   
Indexing Use of NVivo® software facilitated creation and 
ordering of principal and subordinate categories of 
analysis, creating hierarchies 
Charting 
 
Representative illustrative quotations were selected 
from the categories of analysis.  These quotations 
were reviewed, discussed and agreed by the 
supervisory team 
Mapping and interpreting Principal and subordinate categories of analysis 
were considered in relation to each other and 
grouped thematically, creating themes and sub-
themes.  This allowed influences on participants’ 
prescribing decisions to be elucidated 
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Figure 4.3 Screen shot showing coding of “Knowledge” in NVivo® 10 
 
 
4.2.7.2 Data saturation 
 
As described in Chapter 2 data saturation in qualitative research is assumed to 
have been reached when no new themes emerge from analysis of the data 
(Glaser 1967, Francis et al. 2010) although the method by which this point is 
established is not always described clearly in the literature.  A modified version 
of Francis’ approach (Francis et al. 2010) was used to assess whether data 
saturation had been reached; the finite number of participants precluded 
following the method exactly.  As described above the initial 7 interviews were 
coded first at the principal categories of analysis.  All seven were then re-coded 
using principal and subordinate categories.  At this point i.e. mid-way through 
coding, a cumulative frequency graph was plotted of numbers of subordinate 
categories of analysis identified against interviews carried out, to provide a 
pictorial representation of the results of the initial process of analysis i.e. 
indexing.  After analysis of each subsequent interview the cumulative number of 
subordinate categories was plotted onto the graph (see Figure 4.4).  It should be 
noted that this was done before the mapping and interpreting stage of analysis; 
the number of themes and sub-themes resulting from this final stage was far 
fewer.   
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4.3 Findings 
 
4.3.1 Recruitment 
 
Eight pharmacist prescribers and two nurse prescribers were recruited directly 
via the online recruitment process.  At the time of their own interviews 
Pharmacists 3 and 6 each encouraged a colleague to participate; these 
colleagues provided their e-mail addresses and one completed the online form.  
Both were sent two further e-mails but neither responded.  Some months after 
his own interview Pharmacist 7 recruited four other non-medical prescribers to 
the study: three nurses and one pharmacist.   
 
One pharmacist (Pharmacist 1) completed the online recruitment form and was 
interviewed but revealed during the interview that he no longer prescribed.  This 
precluded him from taking part in the study; the interview was used as a pilot 
and the data not included in the study.   
 
Eight pharmacist prescribers and five nurse prescribers thus met the inclusion 
criterion and were recruited to Phase 1.  Participants’ demographics are given in 
Table 4.4; profession, gender and practice setting were used as descriptors. 
 
Table 4.4 Participants’ demographics 
Participant Gender Age Number of 
years in 
profession 
Practice 
setting 
Number 
of years 
as 
prescriber 
Proportion 
of time 
spent as 
prescriber 
Pharmacist 2 Female 30 – 39 
years 
12 years Secondary 
care 
4 years 25% - 50% 
Pharmacist 3 Female 30 – 39 
years 
10 years Secondary 
care 
3 years Almost all 
Pharmacist 4 Female 60 years 
or over 
30+ years Primary 
care and 
community 
pharmacy 
8 years 50% - 75% 
Pharmacist 5 Female 50 – 59 
years 
30 years Primary 
care 
10 years Almost all 
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Participant Gender Age Number of 
years in 
profession 
Practice 
setting 
Number 
of years 
as 
prescriber 
Proportion 
of time 
spent as 
prescriber 
Pharmacist 6 Female 40 – 49 
years 
20+ years Community 
pharmacy 
6 years Less than 
25% 
Pharmacist 7 Male 50 – 59 
years 
30 years Community 
pharmacy 
3 years Less than 
25% 
Pharmacist 8 Female 40 – 49 
years 
20 years Primary 
care 
7 years Less than 
25% 
Pharmacist 9 Female 40 – 49 
years 
23 years Primary 
care 
1 year 25% - 50% 
Nurse 1 Female 40 – 49 
years 
26 years Primary 
care 
8 years Less than 
25% 
Nurse 2 Female 50 – 59 
years 
39 years Primary 
care 
7 years Less than 
25% 
Nurse 3 Male 30 – 39 
years 
10 years Primary 
care 
8 months Almost all 
Nurse 4  Female 50 -59 
years 
13 years Primary 
care 
8 years Almost all 
Nurse 5 Female 60 years 
or over 
40 years Primary 
care 
11 years Less than 
25% 
 
 
4.3.2 Data from interviews 
 
4.3.2.1 Participants’ areas of practice  
 
Participants were asked first about the patient groups they prescribed for and 
types of medicines they prescribed.  This was a logical starting point and was felt 
to offer an “easy introduction” to the interview while gathering important 
contextualising information. 
 
While some participants prescribed for a very specific clinical area others 
prescribed much more widely particularly nurses in acute care.  Other nurses 
prescribed for related long term conditions, sometimes including palliative care, 
and one was a specialist in this area. 
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Most pharmacist participants prescribed for one or more related conditions 
although one prescribed in a number of unrelated areas.  One practice 
pharmacist had additional responsibilities, prescribing in her own specialism, for 
minor ailments and dealing with other prescribing-related issues.  The two 
secondary care pharmacist prescribers prescribed in “their own” ward setting, 
one for a very specific patient group. 
 
Table 4.5 gives a brief summary of participants’ areas of prescribing and their 
own descriptions of these.  
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Table 4.5 Participants’ areas of prescribing and their description of these 
Participant Patient group and/ or 
area for prescribing 
Supporting quotation 
Pharmacist 2 Very specific patient group 
in secondary care 
“Well I prescribe predominantly on the ward, for in-patients, mostly it's obviously the wards that I work in which 
included an intensive care, high dependency area and ward.  The patient groups that I prescribe for are both pre 
and post-op patients.” 
Pharmacist 3 Very specific patient group 
in secondary care 
“So I'm primarily based in Ward ? which is the out-patient chemotherapy day unit, so we've no patients staying 
overnight or we've no kind of prescribing on our standard drug kardexs.  It's mainly chemotherapy prescriptions 
and supportive medication that we're involved in the prescribing of.” 
Pharmacist 4 Small, varied range of long 
term conditions 
 
“Okay, so I started off as respiratory only … and generally speaking emphysema, COPD but of course asthma 
gets thrown in … then I think, if I remember rightly, we decided to start a hypertension clinic.  Then another 
opportunity came up to do contraception as in, sexual health to some extent … So I got involved with the pilot 
for pain and we did two days training on that… So, you've got the respiratory, the hypertension and the sexual 
health with a wee dash of pain thrown in.” 
 
Pharmacist 5 Range of related long term 
conditions 
“The types of patients I prescribe for are mainly cardiac in nature.  I suppose with the occasional medication 
review or ACP polypharmacy review, but normally it's cardiovascular patients, that includes blood pressure, 
stroke, heart failure, ischemic heart disease and also patients on warfarin regarding their anticoagulation or it 
might be on a NOAC.” 
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Participant Patient group and/ or 
area for prescribing 
Supporting quotation 
Pharmacist 6 One specific area “We prescribe specifically to a group of substance misuse patients and predominantly methadone but we do now 
have now some suboxone patients that we're prescribing independently.” 
Pharmacist 7 One specific area 
+ very occasional acute 
conditions 
“So the majority of the prescribing I do is linked to foreign travel and that's both for holiday and business travel.  
That's obviously an area that's growing so do a fair bit of occupational health stuff in that respect.” 
Pharmacist 8 One specific long term 
condition 
“It's generally patients who have hypertension only as their chronic disease, although hypertension with asthma, 
obesity, thyroid, I see, but anybody with hypertension with CKD or diabetes or IHD, I don't see, the doctors 
review them.” 
[CKD = chronic kidney disease. IHD = ischaemic heart disease] 
Pharmacist 9 One specific long term 
condition + more generally 
as practice pharmacist 
 
“I prescribe, I run a heart failure clinic so I see patients with left ventricular systolic dysfunction … At other 
times if there's calls throughout the day and I'm at work and there's minor ailments calls that a pharmacist can 
deal with then again I'll deal with those ad hoc calls as they come in.  So, yeah, that's, a broad range I would 
say.  If there are medication issues throughout the day then I get the chance to deal with them…”    
Nurse 1 Community-based acute and 
end of life care  
 
“Okay, so in this role that I'm in just now I'm prescribing primarily for sort of palliative care patients I think.  
Sometimes for chronic disease as well and also things like winter care as well I would be prescribing at this 
moment.” 
Nurse 2 Community-based end of 
life care 
“Right, I, the patient group I prescribe for are patients who are receiving palliative care … I, I limit myself 
completely to medications used in palliative care.” 
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Participant Patient group and/ or 
area for prescribing 
Supporting quotation 
Nurse 3 Acute and long term 
conditions 
 
“Predominately, you know, infections, exacerbations of things, pain, you know, musculoskeletal injuries and, 
you know, we do get some quite acute things as well that require some sort of emergency type interventions 
but it's, a bit of everything really, to be honest.” 
 
Nurse 4 Acute and long term 
conditions 
 
“Mainly things that, you know, sort of acute conditions, so lots of infections but all sorts of stuff, you know, 
gout, you know things that crop up acutely but also, the other thing I suppose is patients who are dying, we 
quite often get involved with them if they're sort of deteriorating quickly, or you know, there's a sudden change 
in condition so, yeah, a lot of palliative work as well.” 
Nurse 5 Long term conditions 
 
“Mostly cardiovascular, I do.  I'm sort of the cardiovascular nurse lead for the practice so, hypertensives, 
statins, anything like that, diabetes as well, very limited in the diabetes, but yeah diabetes, what else? That's 
mostly, some minor illness things but now since we've got the two advanced practitioners that's, that's less.” 
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4.3.2.2 Data saturation 
 
The cumulative number of subordinate categories of analysis identified after each 
interview was plotted against the interview number; note that these subordinate 
categories of analysis were subsequently subject to a process of mapping and 
interpreting.  As may be seen from Figure 4.4 it appears that data saturation was 
reached with the subordinate categories of analysis; given that far fewer themes 
and sub-themes were identified after mapping and interpreting it is highly likely 
that data saturation was reached.   
    
 
Figure 4.4 Graph of subordinate categories of analysis identified against 
interviews carried out 
 
4.3.3 Thematic analysis of interviews 
 
As above, transcripts were analysed thematically using a coding framework 
derived initially from the domains of the TDF (Cane, O’Connor and Michie 2012).  
Themes matched the domains with the exception of optimism and reinforcement 
which did not emerge as influences on participants’ prescribing decision-making, 
while multidisciplinary working and experience were found to be influential.  
Within each theme sub-themes were identified and these are given in Table 4.6 
below.   
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Table 4.6 Themes and sub-themes identified from Phase 1 interviews as 
influences on participants’ prescribing decision-making 
Theme Sub-theme 
Knowledge Knowledge of the patient 
Knowledge of evidence-based guidelines 
Specific knowledge of particular patient groups or drugs 
Knowledge of limitations 
Skills Communication skills 
Interpersonal and negotiation skills 
Physical assessment skills 
Documentation and IT skills 
Social/professional role 
and identity    
 
Background and scope of practice 
Responsibility as a prescriber 
Approach to prescribing 
Professional boundaries 
Awareness of limitations 
Beliefs about capabilities Competence 
Consultation skills 
Doubts about capabilities 
Complexity 
Sources of support 
Beliefs about 
consequences 
Consequences for the patient  
Consequences for the wider care team 
Consequences of prescribing particular drugs. 
Experience informing beliefs about consequences 
Consequences for the prescriber 
Consequences for the prescriber-patient relationship 
Consequences for colleagues 
Goals and intentions Optimise patient care 
Encourage self-management  
Take a rigorous approach 
Prescribe according to evidence-based guidelines 
Memory, attention and 
decision processes 
Memory 
Attention 
Distractions 
Telephone consultations 
Complexity 
Patient pressure to prescribe 
Decision processes 
Environmental context 
and resources 
Guidelines, formularies and protocols 
Other written sources of information   
Colleagues and others 
Physical assessment 
Practice setting 
Social influences Respecting others 
Learning from others' experiences  
The influence of the patient 
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Theme Sub-theme 
Prescriber-patient relationship 
Patient pressure to prescribe 
Patient’s lifestyle 
Emotion No sub-themes 
 
Behavioural regulation 
 
Prescribing within competence 
Reflecting on practice 
Broader targets for prescribing decision-making 
Dealing with uncertainty 
Prescribing by proxy 
Experience Experience in general 
Experience of patients 
Experience vs guidelines etc 
Experience with medicines 
Experience of condition 
Multi-disciplinary working This emerged as a separate theme as well as being an 
element in several other themes   
 
  
During analysis two additional themes emerged strongly: multi-disciplinary team 
working and experience.  Aspects of these will be considered within individual 
themes but the influences of multi-disciplinary working and experience pervade 
much of participants’ testimony and they are considered here separately.  
Illustrative quotations (Creswell 2013) have been provided to evidence the 
thematic analysis. 
 
4.3.3.1 Multi-disciplinary working 
 
 
All participants described working within a multi-disciplinary team with resulting 
benefits both for themselves and their patients.  The team could encompass 
healthcare professionals from out with the practice setting, particularly where 
uncertainty about treatment and hence prescribing decision-making required 
specialist advice.  Participants in primary care were comfortable discussing and 
negotiating patient care with GPs and described local community pharmacists as 
valued resources when making prescribing decisions. 
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“Yes, yes, I would either come back here and discuss it with a colleague, 
discuss with a GP, discuss it with a local pharmacist or contact [name of 
hospice]” 
Nurse 2, primary care, female. 
 
“The [name of local substance misuse clinic], the substance misuse, the 
same as the [name of city clinic], in [name of small town].  So we could 
contact them any day, any time, if we weren’t sure about a particular 
situation ‘cause some things still surprise you and some patient still 
surprise you.” 
Pharmacist 6, community pharmacy, female. 
 
In secondary care Pharmacist 2 prescribed in a pharmacist- and nurse-led ward 
with no full time medical staff.  She worked closely with nurse prescribers and 
also referred to colleagues in other departments. 
 
“But also, when I get into a situation where I’m not comfortable knowing 
who to contact, you know I’ll quite often phone the antibiotic pharmacist, 
speak with the pain team, if it’s, if it’s complex pain issues, things like 
that.” 
Pharmacist 2, secondary care, female.   
 
 
4.3.3.2 Experience 
 
All participants were experienced practitioners and all but one were experienced 
prescribers.  Experience emerged strongly as a theme and is considered here and 
as a sub-theme later.  Experience in general was influential as was specific 
experience of patients and conditions.  Participants recognised the importance of 
evidence-based guidelines but felt that there was scope for prescribing out with 
these in certain situations, based on their expertise and previous experience.  
They generally regarded experience as beneficial but were aware of the potential 
impact of a bad experience.  
 
Prior experience as a practitioner and a prescriber was valued as a good 
foundation for prescribing; it was felt to enhance participants’ confidence in the 
role, and their practice. 
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“There's certain things a couple of years ago, that I just wouldn't 
prescribe, and wouldn't be happy to and I would actually, you know refer 
to a doctor to, you know, 'Would you mind just signing this for me? I'm 
just', you know, but I think that just comes with experience and, when, 
you know, as you're working, yeah.” 
Pharmacist 3, secondary care, female. 
 
 
Participants were able to draw on previous experience when making prescribing 
decisions; one described a very specific incident which continues to influence her 
prescribing in the same circumstances. 
 
“For instance, a patient I had years and years ago had a particularly 
unpleasant nausea which was very difficult to control and it was set off by 
smells ...  And I discovered that levomepromazine made a huge, huge 
difference … That gentleman had prostate cancer, and I discovered quite 
often men with prostate cancer when they start having problems with 
nausea and vomiting levomepromazine is the one that seems, because 
they all have, often have this thing about smells or tastes.  I have no idea 
why, I don't understand all the dynamics or mechanics of it but things like 
that I suppose I remember say 'Oh, oh, gosh I remember I used that for 
this and it worked.'” 
Nurse 2, primary care, female. 
 
Some participants on occasion prioritised their clinical experience over evidence-
based guidelines when making prescribing decisions.  Participants’ personal 
circumstances could also be influential, albeit subconsciously. 
 
“You’re limited to the formulary or the local guidance policies but not every 
patient fits into a formulary or a guidance document so I think, you know, 
you have to draw on your experience or your own clinical judgement to 
say ‘Actually, I don’t think this appropriate.’” 
Pharmacist 3, secondary care, female. 
 
“I have been aware of other people being influenced, obviously having the 
sort of oversight of prescribing in the practice there's other clinicians that 
I've, I am aware that they've been influenced by their own personal 
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experiences in the way that they prescribe, so it, I know it happens.  
Again, we're human so it's, it's the way we work isn't it?” 
Pharmacist 9, primary care, female. 
 
Most regarded experience as a positive influence but one or two reflected on the 
possible impact of a bad experience on future thinking. 
 
“…just previous experiences things like that, yeah, would influence you if 
you had a bad experience of something in the past it would keep in your 
mind, you would always be thinking back on that previously, yeah.” 
Nurse 5, primary care, female. 
 
Participants described prescribing in response to complex situations, as 
illustrated by the overarching themes of multi-disciplinary working and 
experience.  Using the domains of the TDF in the coding framework was found to 
be helpful in making sense of that complexity but sometimes multiple influences 
were identified for one prescribing behaviour.  As an example, the decision 
whether and what to prescribe for pain might be influenced by the patient’s 
social influence, knowledge of evidence-based guidance and knowledge of and 
availability of certain resources.  Only optimism and reinforcement were found 
not to be influential on participants’ prescribing.   
 
4.3.3.3 Knowledge 
 
Participants described drawing on a wide knowledge base when making 
prescribing decisions.  Knowledge of the patient was influential as was knowledge 
of evidence-based guidelines and particularly of local formularies.  Specific 
knowledge of particular patient groups or drugs was also valued.  All participants 
were aware of their limitations and would not prescribe where they felt their 
knowledge was inadequate. 
 
Knowledge of the patient   
Participants relied on a broad and carefully gathered knowledge of the patient 
and highlighted the importance of knowing their expectations and needs in 
relation to treatment of their condition.   
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“I would prescribe something based on the symptoms that are being 
described by the patient, what is the, what we have in our formulary, it’s 
not actually a formulary is it, the one for palliative care but we do have 
guidelines.  Also based on the patient's age and their other medications 
that they have and any other pre-existing conditions that they have so it, 
it's kind of trying to look at everything and getting a broad history of 
medication and medical conditions and current medication of that 
particular person and whether or not what we would normally use for them 
would be appropriate and reasonable to use.” 
Nurse 2, primary care, female.  
 
“… that's probably the most useful thing to find out, what it is they're 
looking for and then, you know often the things we're dealing with are 
self-limiting anyway so, you know, trying to point that out to patients, you 
know, that it's a self-limiting infection, it will just get better itself and 
doesn't always need antibiotics.” 
Nurse 4, primary care, female. 
 
Knowledge of the patient’s previous experience of their treatment was also 
important. 
 
“If they're not taking something because they don't like, they don't like 
the flavour, they don't like the side effects, it's making them feel sick, 
whatever, then obviously, you're faced with 'Well what can we do?'” 
Pharmacist 4, primary care and community pharmacy, female. 
 
In secondary care too, learning about the patient’s perspective was considered 
valuable.  
 
 
“I quite often go and just have a catch up with the patient, really just 
asking them about their symptoms, what they've tried already, you know, 
obviously I have full access to their medical notes and electronic records 
so I would be taking, obviously, all the clinical factors into account as well 
for that patient.” 
Pharmacist 3, secondary care, female. 
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On occasion participants requested specific tests to be carried out by others and 
took account of the clinical information provided. 
 
“If they were allergic or so on, or if they had been on something 
previously that had worked then sometimes we use that.  We would tend 
to do wound swabs and things and take some advice from that.” 
Nurse 1, primary care, female. 
 
Knowledge of the patients’ social circumstances and family support (if any) could 
be important when making decisions about possibly complex regimens, 
particularly but not only for the elderly and infirm. 
 
“… all of my patients I now see at home, in their own home and that gives 
me a benefit I didn't have in a consultation room because I know exactly 
what their home situations are like, I know who they've got at home, I 
know how able they are.” 
Nurse 1, primary care, female.  
 
Knowledge of local formulary and guidelines 
All participants were influenced strongly by their knowledge of evidence-based 
guidelines and in particular by the NHS Grampian Joint Formulary (NHS 
Grampian Medicines Management 2017) and occasionally individual medical 
practice or ward formularies. 
 
“Within the formulary you've got your first choice and you've got your 
second choice.  So, I'll go for the first choice, so for example, the ACE 
inhibitors, our’s is ramipril, first choice, lisinopril, second choice.  Calcium 
channel blockers you've got your amlodipine first choice, felodipine only if 
you need it.” 
Pharmacist 5, primary care, female. 
 
Within this, patient circumstances were also taken in to account. 
 
“So I generally get the ACE inhibitor up to the maximum dose first but if 
they're a bit dubious about getting bloods done for a particular reason 
‘cause they can't come to other appointments then I may be more likely to 
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put their beta blocker dose up first because they don't then need an 
interim blood appointment.”   
Pharmacist 9, primary care, female. 
  
Knowledge of specific patient groups or drugs  
Some knowledge was specific to a particular patient group or drug; for some 
drugs participants had to consider co-prescribing in anticipation of the patient 
experiencing side effects. 
 
“If I'm giving them morphine for the first time, you know, I have explain 
to them it might make them sick and it might, it will very likely make 
them constipated and we have to go through all that and I have to then 
give them some anti-emetics so if they are very sick for the first wee 
whiley [sic, a short while] they can use them and also I give laxatives as 
well.” 
Nurse 2, primary care, female. 
 
Knowledge of limitations  
Participants were aware of their limitations and would not prescribe out with 
what they perceived as their areas of competence.  Some pharmacists felt unable 
to interpret the results of blood tests fully, impacting on their ability to make a 
prescribing decision. 
 
“So including my knowledge of, let’s say for example, biochemistry.  I 
could have a situation where I could access a patient's GP notes, I can 
look at the screens, I can see the information but because information is 
not something that's within my level of expertise then I don't know 
enough to know whether I can prescribe safely in that situation.” 
Pharmacist 7, community pharmacy, male. 
 
4.3.3.4 Skills 
 
Participants identified a range of skills which they used during their consultations 
and prescribing decision-making.  Good communication, interpersonal and 
negotiation skills were perceived as being essential, as was the ability to use 
information technology (IT) to support and document prescribing decision-
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making.  Pharmacist participants’ ability to undertake appropriate physical 
assessment varied.     
 
Communication skills  
The ability to communicate effectively with the patient during the consultation 
was seen as a key skill influencing prescribing decisions.  Participants spoke 
about the importance of gathering information on which to base their prescribing 
decisions.  This was not always easy.  
 
“History taking’s probably still the key and, and, dare I say it, listening is 
the most important thing within that, so that we collect all the information 
before we start to make any decisions about what to prescribe.” 
Pharmacist 7, community pharmacy, male. 
“I just have to, I give people the opportunity to tell the truth.  I walk 
round the houses with them, I word questions slightly differently just to 
try and make sure we've covered everything and, really, with the best will 
in the world that's all I can do.” 
Pharmacist 4, primary care and community pharmacy, female. 
 
For those prescribing in substance misuse, information gathering could include 
testing for illicit substances in patients’ urine so as to check for abstinence; this 
information could then be used during the consultation. 
 
“We can test on site [for illicit substances] so it's quite good sometimes to 
ask them what they've been doing and then test them because then you 
find out if they're lying or not, as opposed to just test them, or does that 
make sense?” 
Pharmacist 6, community pharmacy, female. 
   
Interpersonal and negotiation skills  
Participants described the importance of good interpersonal and negotiation skills 
which they felt contributed to reaching a concordant agreement with the patient 
as to the need for a prescription.   
 
“You have to have concordance with your patient of course, so, I would 
like to think that my background in community pharmacy years ago has, 
 144 
 
as an old fashioned pharmacist, has given us this good communication 
skills and able to talk to the patient and form a good relationship with the 
patients and, so that the patients'll be honest with you about compliance 
etc.” 
Pharmacist 5, primary care, female. 
 
Nurse 3 described the negotiation skills he used when deciding whether a 
prescription was needed. 
 
“You’re assessing people, you know, to try and assess the severity of the 
problem and do we actually need to prescribe, you know?  I think there's 
this expectation that people come in that we're going give them something 
and we're keen not to reinforce that so I think a lot of the skills are kind of 
negotiation with the patient as to why you're not doing something.” 
Nurse 3, primary care, male.  
 
Pharmacist 9 described her approach to assessing and promoting patient 
compliance before deciding how to proceed.  
 
“In the heart failure clinic I assess their symptoms, I assess their 
compliance with treatment and if I think a symptom needs treating and 
they have been compliant I will prescribe but if I, if their symptom, if 
they're symptomatic and they haven’t been complying I will reinforce 
compliance.” 
Pharmacist 9, primary care, female. 
 
Nurses 3 and 4 occasionally made prescribing decisions based on a telephone 
conversation rather than seeing the patient.  Negotiating in those circumstances 
was perceived as more difficult.  
 
“It's probably not an urgent problem, it's something that's self-limiting, 
and trying to quickly switch the focus away from, you know, the patient 
thinking they're going to get something, to self-management advice really 
and trying to sort of give them things they can do, do by themselves.  So 
that, I've personally found that the trickiest on the phone I think, but it's, 
it's a developing skill.” 
Nurse 3, primary care, male. 
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Physical assessment skills  
As part of the consultation, physical assessment skills were sometimes needed.  
Some pharmacists had appropriate skills and described how they would use 
these when making prescribing decisions. 
 
“And the heart failure clinic, if they're not euvolaemic and they're still 
symptomatic and I can hear fluid in their chest I'm going to give them 
diuretics and maybe increase other medication.” 
Pharmacist 5, primary care, female. 
 
Others felt they lacked clinical assessment skills and therefore relied on other 
healthcare professionals to provide some of the information on which prescribing 
decisions were made. 
 
“For example, I don't really have clinical assessment skills and I very 
much rely on the registrar or the nursing staff for physical examination or 
things like blood pressure, heart rate, those kind of things.  I don't, I can't 
measure those myself, or don't have the skills to measure those myself.” 
Pharmacist 2, secondary care, female. 
 
Documentation and IT skills  
Participants regarded having effective IT skills as essential in making and 
documenting prescribing decisions safely.  Some recognised a personal 
development needs in this area.   
 
“…and sometimes it's so much easier just to go through and ask a GP for a 
prescription rather than get logged onto the computer but that will have to 
change, you know, we're going to have to do that.” 
Nurse 1, primary care, female. 
 
4.3.3.5 Social/ professional role and identity. 
 
Participants were clear about their professional roles and scopes of practice and 
were very aware of the additional responsibilities inherent in prescribing.  Some 
contrasted their approach to making prescribing decisions with that of other 
prescribing professionals; others described boundaries to their own prescribing 
and working with other healthcare professionals.   
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Background and scope of practice 
Participants’ backgrounds and areas of current practice varied but all 
characterised their prescribing in relation to their professional role and described 
how this role influenced their prescribing.   
“My role really is to ensure the safe prescribing of the chemotherapy and 
then as an add on to that it's the prescribing of supportive medicines.”  
Pharmacist 3, secondary care, female. 
 
“I was a district nurse prescriber before for like five or six years and it 
was, I suppose hard to get out, you know, there's a different kind of ethos 
doing that, I think, and most of my work was in sort of palliative care up 
until the last, so I've been doing this, you know, the last 18 months or 
whatever, so that definitely had an influence.”  
Nurse 3, primary care, male. 
 
Scope of prescribing decision-making varied according to participants’ roles and 
areas for prescribing.  Participant 6, prescribing for substance misuse, felt that 
the scope of her decision-making in this role was quite limited.  
 
“That's a bit unique I suppose to Substance Misuse, that the patients come 
to us already being prescribed for.  We don't titrate anybody.  So although 
we can move their prescription a small way up or down and we certainly 
will take patients off of their methadone, we don't make the initial 
prescribing decision and we don't add anything to their prescribing.” 
Pharmacist 6, community pharmacy, female. 
 
Pharmacist 4 prescribed across four clinical areas and was clear about her 
boundaries. 
 
“Because I don't do prescribing for depression and I don't think I'm about 
to start on that, so that would be back to the GP, for example.” 
Pharmacist 4, primary care and community pharmacy, female. 
 
Nurse participants’ professional roles and hence scope for prescribing similarly 
varied; some were in very specific roles and limited their prescribing accordingly 
while others’ roles and hence scope was much wider.  
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“Even if I think that a patient is particularly low in mood and had discussed 
that with them, I wouldn't prescribe an anti-depressant.  I would refer that 
on to the GP and discuss that with them.” 
Nurse 2, primary care, female.  
 
“I think not assuming problems are something because that's the only 
thing you know, for instance, when I was a district nurse the mainstay was 
swollen, fluidy legs … and it's hard maybe doing this job seeing people 
that the cause of the swelling might be different … it could be a DVT, it 
could be an injury, it could be a, something unusual or something 
horrendous …”  
Nurse 3, primary care, male.  
 
Responsibility as a prescriber 
Participants were well aware of the added responsibility they assumed when they 
prescribed; all accepted that responsibility although with greater or lesser 
degrees of comfort. 
 
“Pharmacists who are not prescribers, we can recommend medicines to 
medical staff but when it's you putting your name to it, you are assuming 
responsibility for that decision.” 
Pharmacist 3, secondary care, female. 
 
“I take that responsibility, it's on my head.  I sign that prescription and 
I'm happy to do it. I don't have a problem with it.” 
Pharmacist 4, primary care and community pharmacy, female. 
 
“…as a nurse I hesitate sometimes and think 'No, I'll ask the GP if this is 
right', yeah.” 
Nurse 5, primary care, female. 
 
Pharmacist 3 had had a role for several years prior to becoming a prescriber in a 
specialised team with a particular focus on one type of cancer.  She felt that her 
experience in this area enhanced her confidence in her role as a prescriber. 
“…as I’ve got more experience and more affiliated to the [name of team], 
where this happens quite a lot, em, I think, I think it's through experience 
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you gain more confidence to prescribe that, a wider range or for maybe 
more difficult patients.” 
Pharmacist 3, secondary care, female. 
 
Approach to prescribing 
Some primary care participants contrasted their approach to prescribing with 
that of GPs, asserting that as non-medical prescribers they were more motivated 
to prescribe within evidence-based guidelines.   
 
“As a pharmacist with full knowledge of the formulary I think I'm probably 
a bit more dogged in that you like to stick between the rules and the lines 
and all the rest of it so I'm probably more likely to stick to formulary 
choices.” 
Pharmacist 9, primary care, female.   
 
“I would imagine the GPs exercise a lot more of their own artist licence in 
what they do then perhaps the nurse practitioners here do ‘cause we're 
much more guideline driven I think because we don't have the, the 
training and also, you know, the status and protection perhaps that they 
have.” 
Nurse 3, primary care, male. 
 
Nurse 1 went further, highlighting what she saw as the more holistic, all-
encompassing approach taken by nurses and contrasting it to GPs’ prescribing. 
  
“The big difference between GPs and nurses is that doctor'll go out and do 
a house visit and they'll hand over a prescription.  Nurses are the ones 
that think 'Well how are you going to get that to the chemist? How's the 
chemist going to get it back to you and who's going be giving you the 
drug?' and I don't think, I think that's the benefit in having a nurse that 
does do all that because just last week I had to admit a patient to hospital 
who had his antibiotics in the cupboard for 5 days because nobody knew 
to give him it.” 
Nurse 1, primary care, female. 
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Professional boundaries  
Participants spoke about their awareness of professional boundaries and about 
the potential or actual contribution other healthcare professionals could make to 
their own prescribing decisions.  
 
“The nurses are really good at, what I kind of call the ‘touchy feely’ stuff 
like chatting with the patients and kind of teasing out what's going on or 
symptoms and recognising where there's, you know, 'I'm fine' but actually 
no, there's a serious problem going on here.  And then I come in from the 
medicine expert, you know, kind of hat on and help with the appropriate 
selection and based on kind of their clinical assessment.” 
Pharmacist 3, secondary care, female. 
 
Awareness of limitations 
Participants were clear about their roles and the inherent limitations. 
 
“I’m not a consultant, I'm not a specialist.  I'm an independent prescriber/ 
surgery/ community, so there is a limitation on what you know but, on day 
to day patients with respiratory problems, with hypertensive problems, in 
the area that I work in, yes, I'm pretty sure.” 
Pharmacist 4, primary care and community pharmacy, female. 
 
“Because I'm only dealing with a limited number of patients and for limited 
conditions I feel really confident doing that.” 
Nurse 1, primary care, female. 
 
4.3.3.6 Beliefs about capabilities 
 
Participants were all aware of the requirement to prescribe within their area/s of 
self-assessed competence and were careful to do so.  They believed themselves 
capable and felt confident in their ability to prescribe within these areas including 
in circumstances where complexity and clinical uncertainty were felt to present 
additional challenges.  Where they had any doubts about their ability they used a 
range of resources to support their prescribing decisions or did not prescribe.  
Their beliefs could be categorised as being about: 
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Competence  
Non-medical prescribers must prescribe within their own areas of self-assessed 
competence.  All participants were aware of this and asserted that they did so. 
 
“It's very much about sticking to your own competencies, your own area 
of expertise and not, not trying to go outside of that.” 
Nurse 2, primary care, female. 
 
“So I think we would both feel pretty confident and I think we would also 
both be quite aware of our limitations when we would need to seek further 
guidance.” 
Pharmacist 6, community pharmacy, female. 
   
Pharmacist 8’s previous experience as a community pharmacist influenced her 
when deciding whether to prescribe for minor conditions out with her own 
specific areas. 
 
“Yeah, so mostly anti-hypertensives but things that I will, I will also 
prescribe things that I feel are within my competence, if it's something 
that back in the day I would've sold over the counter [as a community 
pharmacist], I'm quite comfortable with that.” 
Pharmacist 8, primary care, female.  
 
Participants generally felt very confident in their abilities to make prescribing 
decisions.  This was largely due to experience in the clinical area, including 
familiarity with a sometimes narrow range of drugs. 
 
“… if somebody is reasonably straightforward and it's, it's something that 
we deal with frequently I'm very confident in, in prescribing and I suppose 
things like anti-emetics, laxatives, I am more confident about than with 
analgesia.” 
Nurse 2, primary care, female. 
 
“I suppose with being focused mainly on hypertension it’s quite a nice 
little, relatively straightforward group of drugs that I’m, is my bread and 
butter I suppose, on my own prescription forms.” 
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Pharmacist 8, primary care, female 
 
Consultation skills 
While participants were generally happy with their consultations skills there were 
aspects which they found more challenging and which could influence their 
choice of therapy.   
 
“And it's very, very hard to get people to motivate themselves to swallow 
something for two weeks while they're on holiday but [also for] four weeks 
after they come back.” 
Pharmacist 7, community pharmacy, male. 
[In connection with decision on which antimalarial to prescribe.] 
 
Doubts about capabilities 
Participants described situations where they had doubts about their capabilities 
to prescribe; in response they sought advice from colleagues or indeed refused 
to prescribe.  
 
“If it was something I really didn't know about, you know, I would feel 
quite comfortable just say 'Look, you know, I'm not going to be able to 
help you with this but let’s get someone who can', you know.  We've 
always got a duty doctor alongside us, you know, to refer to.” 
Nurse 3, primary care, male. 
 
Complexity 
Clinical, social or other complexity was felt to be particularly challenging when 
prescribing.  Pharmacist 9 felt that her specialist knowledge was needed 
sometimes, in addition to her more routine prescribing decision-making.  
 
“Yeah, route of administration, what can they take, what's a suitable route 
for them, a lot of time the things that come across my desk are more 
complex ‘cause other people have dealt with all the easy answers first, so 
sometimes it's routine issues as well, and patient preference, I suppose to 
a certain extent as well.  What is it they're actually wanting?” 
Pharmacist 9, primary care, female. 
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Nurse 3 identified the possibility of complexity when making what might initially 
seem a straightforward prescribing decision.  
 
“You know, looking at the interactions, and I think that's where I can get 
in a bit of a muddle sometimes ‘cause you might be dealing with an 
infected toe nail but that person's on something vastly complicated from a 
haematologist that you know very little about.  This thing, you know, does 
that interact with that, and you know that takes a bit of, a bit of head 
scratching sometimes.” 
Nurse 3, primary care, male. 
 
Nurse 1 spoke about her ability to make complex prescribing decisions as 
patients neared the end of life. 
 
“We are quite good, I think, at assessing, you know, when to start 
introducing ‘Just in case’ boxes, when do you need to start introducing 
syringe drivers and so on, and symptom control drugs as well.” 
Nurse 1, primary care, female. 
[‘Just in case’ prescribing = prescribing of specified drugs in a ‘Just in case’ box for the end 
of life] 
 
Sources of support 
Participants described their responses to situations where they had doubts about 
their ability to respond appropriately to complexity or other difficulties.  The use 
of evidence-based resources such as guidelines and protocols was felt to be 
helpful when negotiating such complexity. 
 
“There are some complicated situations, you know, the patients are very 
chaotic, they surprise you, they do things you don't expect but I think 
because of the protocol that we work to, the guidelines are quite strict and 
therefore you're not really making big decisions of your own because 
you're just sticking to a protocol which you know is safe and tested.  So, I 
think I would find it very easy to make those decisions.” 
Pharmacist 6, community pharmacy, female.  
 
Participants described the importance of being able to refer to more experienced 
colleagues for advice and support in times of clinical uncertainty. 
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“As you come across situations where, that you've maybe not come across 
before or scenarios where, you know, you're running into sort of more 
complicated options then, yeah, you will come across decisions where you 
think 'Oh, actually I'm not so confident with this or I think I need a bit of 
extra advice or someone else to say “Yeah I'd do the same.”'” 
Pharmacist 2, secondary care, female. 
 
4.3.3.7 Beliefs about consequences  
 
Participants described being aware of and taking cognisance of the consequences 
of their prescribing decisions. They considered these consequences primarily in 
relation to their patients but also in relation to colleagues, the wider care team 
and for themselves.  There was little mention of any financial consequences of 
prescribing.  
 
Consequences for the patient  
The consequences of prescribing decisions for the patient were considered 
paramount.  Participants were aware of the risks to patients associated with 
treatments they prescribed, but also the risks of not prescribing.  Certain patient 
groups were perceived as being more at risk of adverse consequences. 
 
“Well if I make them ill, really don't want that to happen, so yeah, I think 
that's always at the back at of my mind ‘cause a lot of my patients are frail 
or elderly or they're already very, very unwell, because I'm going into 
them.” 
Nurse 1, primary care, female 
 
Those prescribing for acute conditions felt it was important initially to explore the 
patient’s expectations from the consultation.  Nurse 4 believed that if possible, 
not prescribing was best for the patient. 
 
“Finding out what the patient’s expectation is is useful, ‘cause, you know, 
if they come in and they’re just wanting advice then, you know, that's, 
that's, obviously that's better than giving them a prescription, so that's, 
that's probably the most useful thing to find out.” 
Nurse 4, primary care, female. 
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Participants were also aware of the potential for a ‘watchful waiting’ decision to 
go wrong. 
 
“If I make the decision not to prescribe something and maybe think 'I'll 
wait and see how it goes over the next couple of days' and things could 
get worse so there's potentially that as a consequence as well.” 
Nurse 1, primary care, female. 
 
Prescribing in substance misuse, Pharmacist 6 was aware of the possibility, albeit 
infrequent, of very good consequences for patients as a result of her prescribing 
of opiate substitution therapy and other support provided.  
 
“We've transformed the lives of a few patients. I have a couple who I've 
worked with for maybe 5 years who've now had a baby and bought a 
house and they're both working, you know, it's amazing to see but that's 
unusual, you know.” 
Pharmacist 6, community pharmacy, female. 
 
Pharmacist 2 described how clinical uncertainty influenced her readiness to 
prescribe; again possible consequences for the patient were at the centre of her 
decision-making. 
 
“If I wasn't sure what to prescribe at that particular moment then I would, 
you know, speak to the patient about it and say 'Okay, we maybe need to 
go discuss this with someone else or I'll have to go and look, you know, do 
a bit more research till we find the best treatment for you' rather than just 
going ahead and doing something I wasn't comfortable with or it wasn't 
best for the patient.” 
Pharmacist 2, secondary care, female. 
 
Pharmacist 7 perceived both his prescribing decision and the patient’s response 
to it as having potentially serious consequences. 
 
“The two things that I always have to consider are the potential danger to 
the patient if I choose not to prescribe something which I believe they 
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need, or if I allow them to decide not to, to have something which I 
believe they need, that could be life threatening.” 
Pharmacist 7, community pharmacy, male. 
 
Once the decision to prescribe had been made, participants described balancing 
the risks and benefits of treatment to the patient.  Participants appeared to be 
more focused on the risks while acknowledging the benefits.   
 
“If there has to a degree of accepted risk, you know, I think we have sort 
of balance that up quite carefully as to whether we, you know.  ‘Are you 
going to get more unwell if we don't give you this, but you possibly, we 
might skew your INR off for a few days but that might be worthwhile 
‘cause you're so sore you can't get up to feed yourself.’” 
Nurse 3, primary care, male. 
 
Consequences for the wider care team 
The potential impact on those caring for patients also influenced prescribing 
decisions. 
 
“I've got carers to worry about as well because if I'm prescribing a 
medication then sometimes I'm reliant on carers come in at certain times, 
and sometimes that can involve changes in care packages and things.  So 
the care manager would then be involved with that or families would be 
involved in that and that can be quite complex.” 
Nurse 1, primary care, female. 
 
Consequences of prescribing particular drugs 
Some participants described prescribing a particular drug in certain 
circumstances despite potential adverse consequences, because of the overall 
patient benefit. 
 
“I love dexamethasone.  For some patients it makes a huge difference to 
their quality of life but sometimes the down side to that is they lose a lot 
of their, their, their muscle strength in their thighs and you know, you 
know that's one of the side effects.” 
Nurse 2, primary care, female. 
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Experience informing beliefs about consequences 
Participants all described how previous experience helped them to assess the 
likely consequences of their treatment decisions at various stages in the 
treatment pathway.  
 
“… again past experience, you know, I'm able to look at a wound and think 
‘Well that probably just needs something to, topically, rather than, you 
know, a full system antibiotic that's probably going to give the patient 
diarrhoea and things like that.’  So, again that's experience isn't it?” 
Nurse 1, primary care, female.  
  
Most participants described occasions where, based on previous experience, they 
would prescribe out with guidelines for the patient’s benefit.  None appeared to 
be troubled by this.  The decision was often but not always made during the 
palliative stage, where there was perceived to be more leeway in treatment.  
Nurse 3 had spent much of the previous several years providing palliative care as 
a district nurse, and described taking a broader approach to prescribing in 
palliative care.  Nurse 2 described her experience with prescribing steroids for a 
specific purpose.    
 
“And I think in palliative care there's, there's a bit more room to be, I can't 
think of the right, experimental’s not the right word, but, you know, 
you've got a bit more licence I think to be able to do things because it'll 
help the patient, you know, rather than perhaps because of what the 
guidelines says.  We'll use the specialist to sort of recommend things that, 
you know.  Our pharmacist will cross her eyebrows when she looks at 
them.” 
Nurse 3, primary care, male. 
 
“For instance, one of the things that I will commonly do is if a palliative 
care patient who is really fast approaching the end of life has something, 
event, in particular they desperately, desperately want to get to, I would 
have no compunction if it's, safe to do so, to prescribe them some steroids 
for a limited period of time to get them through whatever it is they want, 
and I have done that often.” 
Nurse 2, primary care, female. 
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Consequences for the prescriber 
Participants were aware that the prescribing decisions they made could have 
adverse consequences for them, and this could influence their actions.  
 
“So for example, I'll prescribe quite a lot of things like vancomycin, which 
require ongoing monitoring and the consequences for me, as a prescriber, 
if that patient has side effects from the vancomycin, you know, obviously 
could be, could be severe for the patient, and severe for me.” 
Pharmacist 2, secondary care, female. 
 
“I mentioned INRs ‘cause that comes up a lot in our elderly folk.  
Everything you want to prescribe interacts with warfarin and makes life 
difficult so I think the more the consequence of, or the more the chance of 
harm the more chance there are of consequences for me, the less likely 
perhaps I am to, to want to try and add new things in or, you know, find a 
solution, they're more likely to, you know, deal with immediate acute 
problem then pass them on to somebody else in that case I think.” 
Nurse 3, primary care, male.  
 
Consequences for the prescriber-patient relationship  
Only one participant specifically mentioned possible consequences of prescribing 
decisions on the prescriber-patient relationship but the patient emerged as a key 
social influence on participants’ prescribing decision-making.   The prescriber-
patient relationship will be considered under social influences.  
 
Consequences for colleagues  
Participants were aware that their prescribing decisions could impact on their 
colleagues. 
 
“Yeah, if you're making bad decisions or prescribing things that are not, 
not good, it will have consequences on other people ‘cause, you know, if 
you're prescribing every, antibiotics for every, you know, everything that 
comes in that would be difficult for other people who are then faced with 
that patient at the next infection or whatever it is and giving different 
advice.  So you need to make sure you're in line with what everybody else 
is doing.” 
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Nurse 4, primary care, female. 
 
“My employers are probably taking a bit more of a risk than they were 
before because obviously they didn't have nurses who could prescribe and 
now they do, so probably it's a bit more of a liability for an employer.” 
Nurse 1, primary care, female. 
 
Participants believed that their prescribing decisions could have consequences 
not only for patients but also for the prescriber, colleagues and the wider care 
team.  Participants expressed less concern about specific consequences for the 
prescriber-patient relationship, employers and for financial consequences.  
Participants' beliefs were often informed by experience and they balanced what 
they believed were likely consequences so as to achieve the best outcome for 
patients.   
 
4.3.3.8 Goals and intentions 
 
As previously the research team felt that there was some overlap between 
“goals” and “intentions”.  Cane and colleagues (2012) similarly found this and 
goals and intentions are considered together here.  
 
For all participants their overarching goals were to ensure patient safety and 
wellbeing through safe and effective prescribing, including non-prescribing, for 
their patients.  This could encompass optimising patient care, encouraging self-
management and taking a rigorous approach to prescribing including prescribing 
according to evidence-based guidelines. 
 
Optimise patient care 
Throughout the interviews, and whatever the setting or condition, participants 
put their patients first and would do what they could to optimise their care while 
minimising patient harm.  Nurse 3 was clear about his priority.  
 
“But, yeah, generally try not to do them any more harm than they had 
before they came in, is the main thing for me.” 
Nurse 3, primary care, male. 
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Participants tried to work with their patients but sometimes had to accept the 
limitations of this approach. 
 
“I will try my best to, if I think the treatment is the right treatment I will 
try my best to convince them to take it, and, you know, just present the 
pros and cons and all the rest of it, but, if at the end of the day they have 
very set ideas about a particular drug and you know they're not going to 
take it then that, I wouldn't prescribe, that's just silly.”  
Pharmacist 8, primary care, female. 
 
Encourage self-management rather than treat unnecessarily  
In some instances, and where possible, the intention was not to treat and 
participants considered how they might manage that. 
 
“I think people are often expecting, I mean, and people often say ‘Well 
aren’t I getting antibiotics for this?’  So you know, it’s about trying to 
point out the reasons why that wouldn’t be appropriate or educating the 
patient.” 
       Nurse 4, primary care, female.  
 
Take a rigorous approach 
Participants described taking a rigorous, stepwise approach to prescribing 
decision-making. 
 
“I don't know if everyone has this, but I have my own mental check list 
before I prescribe something, similar to what, how you would check a 
prescription, you know, check.  So, yeah, just making sure you adhere to 
your process.” 
Pharmacist 3, secondary care, female. 
 
Prescribe according to evidence-based guidelines 
Participants generally felt that prescribing according to evidence-based guidelines 
or formularies was best and did so.  However in some circumstances they chose 
knowingly to deviate from these where they perceived this to be in the patient’s 
interest. 
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“I think I try to extract full information out of patients and try and make 
valid decisions based on what should be our first formulary choices and 
what are most effective treatments.” 
Pharmacist 9, primary care, female.  
 
“So, you prescribe off the guideline to some extent, but it's because it's 
the best of a bad lot and you're trying to do your best for the patient.” 
Pharmacist 4, primary care and community pharmacy, female. 
 
4.3.3.9 Memory, attention and decision processes 
 
Participants were aware that prescribing decision-making could be challenging 
and required complex cognitive and other skills.  Participants described 
employing a rigorous, step-wise process in making and documenting their 
prescribing decisions.  They had to gather and process a wide range of 
information; some acknowledged that their ability to do this was not always 
optimal and described steps that they would take to address any perceived 
difficulties.   
 
Memory 
Some participants admitted having difficulty in remembering specific facts or 
processes, particularly those concerned with new or unfamiliar medicines and 
procedures.  Some described ways of working which circumvented the need to 
remember particular details. 
 
“I've looked up things online in my anti-coag [sic] clinic for like the 
Hasbled score and the CHAD [sic] score.  I've, I've looked up to remind 
myself, and there's little tools online that you can just tick and it does it 
almost for you.  So I've used that, ‘cause it’s quite hard to remember what 
it all stands for sometimes if you only have a new patient maybe every 
couple of months.” 
Pharmacist 5, primary care, female. 
[Hasbled score and CHAD score = ways of assessing a patient’s need for anticoagulation] 
 
One participant who visited patients at home returned to the surgery where she 
had access to all the relevant information, before writing her prescriptions. 
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“I don't tend to ever hand write a prescription which I think a lot of district 
nurses do.  Because we're working in the home I always tried to come 
back to the health centre and do it on the patient's record once I've got 
the record open because obviously, you know, I can have a quick look 
before I go out but I can't remember all the allergies and things like that.” 
Nurse 1, primary care, female.  
 
Attention 
Participants were aware of the potential to make errors when prescribing and 
tried very hard to avoid this.   
 
“With analgesia, I tend to recheck things over and over again, and 
quantities and breakthrough doses and things like that…” 
Nurse 2, primary care, female. 
 
Distractions 
Notwithstanding their determination to avoid errors, some participants described 
being distracted by external influences such as colleagues, patients and their 
families during the consultation.   
 
“I had a lady had six children with her the other day, three were her's and 
three were her neighbour’s and, you know, they're jumping up and down 
on the couch and tipped the toy box out, one's playing drums on the bin, 
and you're trying to listen to somebody's chest and it's, you know, that 
can be a little bit distracting…” 
Nurse 3, primary care, male. 
 
Telephone consultations 
Assessment of the patient is one of the cornerstones of patient care yet some 
participants treating patients for acute conditions routinely consulted and made 
prescribing decisions over the phone when the patients were perceived to have 
relatively straightforward conditions. 
 
“It's a little bit more difficult when you lose the, I suppose the objective 
look of not having somebody in front of you, you know, to decide how sore 
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they are or what have you, but generally I think the ones we speak to on 
the phone are probably the ones that we're less likely to prescribe for…” 
Nurse 3, primary care, male. 
 
Complexity 
Several participants described the influence of complexity on their prescribing 
decision-making.  Some found it challenging and preferred to pass some complex 
patients on to more experienced colleagues. 
 
“You look at repeat list sometimes and it goes onto a second page … and, 
the more complicated it gets, particularly in an emergency surgery like 
this, the more complicated it gets the less likely I think I possibly am to do 
something there and then.  You're more likely to just do something to put 
a sticky plaster on it, to book them into an appointment tomorrow to see 
somebody else.” 
Nurse 3, primary care, male. 
 
Other participants would decide to prescribe out with a product licence where 
they perceived this would be the best solution to clinical complexity. 
  
“So, I will prescribe, for example, an unlicensed MDI for COPD, as in 
unlicensed for COPD, it's still a licenced product, with a spacer, because 
that may be my only option by the time I've worked my way through 
everything else [laughs], and that's what I do.” 
Pharmacist 4, primary care and community pharmacy, female. 
  
Patient pressure to prescribe 
Participants were aware that they could be subject to patient pressure to 
prescribe.  This will be considered under “Social influences.” 
 
Decision processes 
Participants described various approaches to the process of making a prescribing 
decision, sometimes informed by experience or the involvement of other 
colleagues.  Nurse 3, a relatively inexperienced prescriber, sometimes found 
making the decision difficult but felt reassured that he had a robust approach 
which would quality assure this process.  
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“It very much varies depending on the patient but I think what I am 
confident about is the process and the safety net and that steps that I 
would go through to get to a decision hopefully is reasonably steady.” 
Nurse 3, primary care, male. 
 
Pharmacist 2, a much more experienced prescriber in secondary care, went over 
the details of her prescribing decision-making with the patient. 
 
“If for example I'm talking to the patient about changing therapy I would 
go back to them and say 'Oh yeah, we spoke about this, this, this and this' 
and get them to agree so I knew in my head that I'd gone through that.  
So it's almost like I go back to the start and go through it again.” 
Pharmacist 2, secondary care, female. 
 
Most participants faced circumstances where they found prescribing decisions 
particularly difficult, for example where several other options had been tried 
unsuccessfully. 
 
“If you've got someone on a very complex pain regimen and they're 
struggling with nausea and they've tried everything and you, and you can't 
think of any more options really.  Obviously that's a lot more difficult 
because you want to try and do the best for the patient but you're kind of 
running out of avenues to go.” 
Pharmacist 3, secondary care, female. 
 
Nurse 2 described sometimes worrying about a prescribing decisions she had 
made, and checking the outcome with the patient the following morning. 
  
“I do, I do often go home at night and think 'Oh, you know, I did that and 
I hope that was the right decision, you know, think that's the best thing 
but, you know, I'll phone them tomorrow morning and make sure.'” 
Nurse 2, primary care, female. 
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4.3.3.10 Environmental context and resources 
 
With regard to their environmental context and resources, participants used 
guidelines, formularies, protocols and other resources to support their 
prescribing decision-making.  They described the benefits of working as part of 
multi-disciplinary teams and were respectful of other team members.  
Participants routinely sought advice and support from colleagues, most 
commonly GPs for those in primary care, and from others with relevant 
expertise.  Environmental contexts i.e. practice settings and facilities were 
important and pharmacist prescribers in primary care regarded their inability to 
prescribe electronically as a major barrier to safe and effective practice. 
 
Nurse 1 listed the spectrum of resources which she had at her disposal when 
prescribing for patients at the end of their lives. 
 
“So I mentioned the Grampian Formulary, so I would definitely go to that 
first.  We've got the palliative care guidelines and [name of local hospice] 
have got some really good guidelines on the internet about ‘Just in case’ 
prescribing and symptom control and palliative care.  Got the BNF, we've 
got doctors’ meetings once a week that we meet up with the GPs and we 
can chat about, you know, prescribing there if we need to.” 
Nurse 1, primary care, female. 
[Just in case prescribing = prescribing of specified drugs in a ‘Just in case’ box held in the 
patient’s home in preparation for the end of life]  
 
Guidelines, formularies and protocols  
Guidelines, formularies and protocols were considered very influential and 
participants drew on a wide range of these when prescribing.  The term 
“guidelines” was used generically and also to refer to evidence-based clinical 
guidelines developed and published by organisations such as NICE, SIGN and 
others.  When speaking about “the formulary” participants were generally 
referring to the NHS Grampian Joint Formulary (NHS Grampian Medicines 
Management 2017) but could also mean individual medical practice or ward 
formularies, developed with input from their pharmacists or perhaps they 
themselves.  The term “protocols” was used to describe more prescriptive 
documents which often included some sort of algorithm to guide treatment 
decisions.  The terms “guidelines” and “formularies” also appeared to be used 
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interchangeably by some participants so that it was not always clear exactly 
what was meant. 
 
Most participants were very aware of the content of guidelines and used them to 
guide their prescribing decisions.   
 
“There are some excellent guidelines for the area.  Respiratory’s fantastic, 
the asthma and COPD guidelines are wonderful and you’d really have to be 
pretty dim to not be able to follow them.” 
Pharmacist 4, primary care and community pharmacy, female. 
 
“A lot of what I prescribe is guideline driven.  To be honest we've come up 
with and mostly been myself or maybe the consultants and registrars, for 
general sort of background prescribing guidance in each different scenario, 
mainly to support the non-medical prescribers that are coming through, so 
a lot of our guidelines are based around that.” 
 Pharmacist 2, secondary care, female.  
 
Nurse 3, relatively new to prescribing, had tried to restrict his options even 
more. 
 
“I've personally, have almost sort of developed, well as part of the course 
that I did, obviously that you're aware of, like your personal formulary.  
Okay that's grown quite a bit in the 9 months since I finished that, so the 
things on it, yeah, I feel, I feel quite confident because I've spent time, 
you know, through the, sort of formulary stuff I'm doing has helped.” 
Nurse 3, primary care, male. 
 
Protocols similarly were felt to be helpful; this was particularly the case for 
Pharmacist 6 who prescribed methadone and suboxone for patients with 
substance misuse difficulties.  She and her pharmacist prescriber colleague 
prescribed within a very strict protocol.  
 
“So we have a protocol in which we work if they happen to start using 
again or they're struggling where we can increase their prescription by 
5mLs, up to three times, without consulting the Substance Misuse Team, 
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but we tend to work very closely together anyway so we probably would 
be discussing that anyway for our own reassurance that we're doing the, 
doing the right thing.” 
Pharmacist 6, community pharmacy, female. 
 
Pharmacist 8, treating patients for hypertension, contrasted her own attitude to 
evidence-based guidance with what she perceived to be that of her GP 
colleagues.  
 
“I do like a nice policy and protocol and I know some of the GPs in the 
practice don't and like to be a bit more free-rein with their prescribing 
decisions, but I do feel more comfortable with policies and formularies and 
protocols.” 
Pharmacist 8, primary care, female.  
 
Notwithstanding participants’ awareness of and respect for evidence-based 
guidance, as before several described situations where they felt this did not allow 
them to meet patients’ needs.  There could also be tensions with colleagues over 
off-guideline requests.  
 
“For example, one of the nurses has seen someone.  ‘She really likes 
Caphosol®.  Can we use Caphosol®?  Can you prescribe Caphosol®?  Can I 
prescribe Caphosol®?' and it's, it's the, the rela…, you know, it's like ‘I 
don't want to say “No” to you and affect our professional relationship but 
these are the guidelines and this is the reason they're there and this is 
why you should not be using it.’  And it's pressure from other people 
‘cause of their preferences, both professionals and other patients I think, 
it's quite difficult to deal with sometimes I think.” 
Pharmacist 3, secondary care, female. 
[Caphosol® is a solution used to moisten, lubricate and clean the oral cavity] 
 
Other written sources of information   
In addition to guidelines, formularies and protocols, participants described using 
the following written sources of information when prescribing, often accessing 
these electronically: 
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British National Formulary; Clinical Knowledge Summaries; condition-specific 
websites; the electronic medicines compendium; the emergency care summary; 
GP notebook; ‘the Green Book’ Immunisation against infectious diseases; 
Martindale; Medicines Complete website; the NHS Grampian medicines 
information department; Stockley’s Drug Interactions; Scottish Medicines 
Consortium website and Travax. 
 
More broadly, participants described using resources of the National Pharmacy 
Association and the Royal Pharmaceutical Society, professional discussion 
forums, courses and conferences to support their prescribing. 
 
Colleagues and others 
Participants all described working as part of a multi-disciplinary team of 
colleagues and sometimes external experts, and greatly valued the advice and 
support afforded.  Those within a primary care practice setting had a range of 
options for referral and GPs were a trusted and important source of support.  
 
“There's lot of stuff that comes in that I wouldn't feel confident with and 
it's, they're managed in a different way, you know, we pass them on to 
GPs, book them in for appointments, get a different practitioner to phone 
them back...” 
Nurse 3, primary care, male.  
 
“Sometimes I'll go and I've got a mentor GP, and I'll just go and just run it 
through with him and I know I'm going to give it but I'm just discussing it 
through and that just helps you to know 'Yeah, that's definitely, definitely 
fine, that's, that's absolutely fine' and discuss the plan with him.” 
Pharmacist 5, primary care, female.  
 
Nurse 3 acknowledged that some prescribing decisions could also challenge GPs.  
 
“… somebody comes in with a sticky green eye that's obvious as they walk 
down the corridor, you know, you've made your decision half the time 
before you've sat down but on another time you can be sitting scratching 
your head for half an hour trying to decide and you've had to ask two GPs 
who don't know either.” 
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Nurse 3, primary care, male.  
 
Neither of the secondary care pharmacist prescriber participants mentioned 
doctors specifically as a source of information or support. 
 
Physical assessment 
Pharmacist participants described requiring help from nurses and doctors with 
physical assessment and interpretation of blood results.   
 
“The other, the other resource is like, like for example, if I was looking at 
an ECG before I can titrate a beta-blocker and I've been a bit worried 
about whether the PR interval’s too long or something there's a nurse and 
she's very, very good and I'll maybe run it past her, we'll have a look at it, 
so that's resource as well.” 
Pharmacist 5, primary care, female. 
[PR interval = part of the tracing from an electrocardiogram used to monitor heart 
function]   
 
“… so it's a bit of comfort blanket for me that if I am unsure then, yes, I, 
there is some there that I can go and ask and even if it just a case of 'I 
have no idea what this blood significance is, can you tell me?'” 
Pharmacist 8, primary care, female. 
 
Practice setting 
Participants’ practice settings also influenced their prescribing.  Pharmacists 2 
and 3 worked in secondary care where access to specialist services facilitated 
certain prescribing decisions.   
 
“I suppose the ability to closely monitor a patient.  I would probably 
prescribe things here that I wouldn't be happy to prescribe to a patient 
who's going to walk out the door.” 
Pharmacist 2, secondary care, female.   
 
Notwithstanding their electronic access to patients’ records, at the time of 
recording the interviews pharmacist prescribers in primary care could not 
prescribe electronically; they had to hand-write their prescriptions then record 
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them in the electronic patient record.  This was seen as a barrier to safe and 
effective practice and was a major issue for those affected.   
 
“A huge, huge, huge, huge, huge resource problem is the fact that we 
don't have electronic prescribing stationery to prescribe and I can't say 
this strongly enough, this is the one thing that would revolutionise what I 
do because I have to, it's unsafe in a way, it is unsafe.  I have to do 
everything with a patient, counsel, everything, give them a leaflet, then I 
have to hand write the prescription.” 
Pharmacist 5, primary care, female.    
 
“And because we have to hand write them actually the whole process 
actually takes you longer than if you were doing it electronically because 
to do a prescription electronically, seconds, and to hand write it takes 
much longer so there are probably are more chances of you being 
interrupted in a hand written prescription then there would be in an 
electronic prescription.” 
Pharmacist 9, primary care, female. 
 
[Note that an electronic prescribing pilot started in NHS Grampian and several 
other Health Boards in November 2016.] 
 
4.3.3.11 Social influences  
 
Participants all worked with others in multi-disciplinary teams and these and 
other relationships, or sometimes the lack of them, influenced their prescribing 
decisions.  Participants acknowledged the social influences of the patient and the 
prescriber-patient relationship on their prescribing decisions.  As part of the goal 
of “putting the patient first” participants were sometimes aware of pressure from 
the patient or the patient’s family to prescribe, particularly antibiotics.  
Participants used various means to withstand this pressure but acknowledged 
that occasionally they would prescribe as they saw it inappropriately, in response 
to patient or family pressure rather than clinical need.   
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Respecting others 
Participants were keen to respect the prescribing decisions of other healthcare 
professionals, even when they did not agree with them. 
 
“So, to ensure that we're getting consistency and continuity, what I would 
hate to do is, is be in a situation where I would be prescribing something 
that one of my other colleagues has disagreed with…” 
Pharmacist 7, community pharmacy, male. 
 
“But if somebody's under the care of a specialist or something I think we'd 
be even less likely ‘cause you think of the consequence of upsetting Mr 
Whoever, the surgeon at the hospital, you know, by changing what he's 
done.”  
Nurse 3, primary care, male. 
 
Participants found ways to navigate these potential inter-professional tensions.    
 
“But it's quite, you know, obviously you want to maintain a decent 
professional relationship with people and you don't want to look as if 
you're trying to be subversive or whatever but, I think there are times 
when I wouldn't necessarily agree with a choice of anti-emetic or pain 
management even.  GPs use a lot of, well some GPs use a lot of 
dihydrocodeine or tramadol and those aren't drugs that I would generally 
use, so it's just a difference.” 
  Nurse 2, primary care, female.  
[Dihydrocodeine and tramadol are opiate analgesics] 
 
Learning from others' experiences 
Pharmacist 9 worked within a primary care medical practice and would refer to 
GP colleagues if she felt unsure about prescribing something. 
 
“Generally, if it's, if it's very important and I consider that I'm not happy 
to prescribe I would actually pass it to the GP to deal with the next day 
with a full spiel of all the things I considered and all the things I want 
them to ask or consider.” 
Pharmacist 9, primary care, female. 
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Working in secondary care, Pharmacist 3 described learning from informal 
discussions with colleagues.  In a similar setting Pharmacist 2 also considered 
and learned from the experiences of others. 
 
“We regularly catch up and reflect on, without actually doing it in a formal 
way, but we do it all the time, we reflect on our prescribing decisions or 
recommendations that we've made and we, we learn from each other that 
way as well.” 
Pharmacist 3, secondary care, female. 
 
“I suppose other people's experiences might, might influence you or if 
they've prescribed something in the past that they've had a bad 
experience with, we would meet as a pharmacy sort of peer group and 
discuss these kind of things.  And sometimes you know, you think to 
yourself  'Oh, my colleague’s prescribed that and this went wrong, or this 
didn't happen’, so it might influence the way either you deal with that 
prescription or it might influence you not to go forward with a prescription 
as well.  So it does make you think twice about it.” 
Pharmacist 2, secondary care, female.  
 
The influence of the patient 
Participants were all very focused on the needs of the patient, and all described 
aspects other than the patient’s clinical condition as being influential. 
 
“I suppose it's, because the guideline's quite influential and, and the BNF, 
and you know, the bits that keep you safe, I would like to think are the 
most influential on the decisions I make but, you know, there's always 
that thing, I think the patient, what they want and what they're expecting 
you to do.  I think sometimes has, has quite an effect.” 
Nurse 3, primary care, male. 
 
Prescriber-patient relationship  
Participants described varying degrees of relationships with their patients but all 
put the patient at the centre of their prescribing decisions.  Pharmacist 3 
prescribed repeatedly for the same patients receiving treatment in hospital.   
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"The thing with our patients here as well, they're back every two, three 
weeks, so you see them all the time so sometimes you build up quite a 
relationship with them and if you get to know them, and I hate to use this 
word, but empathise or feel sorry for them..." 
Pharmacist 3, secondary care, female.  
 
In this sort of situation, participants found satisfaction in helping patients to 
achieve personal milestones in difficult circumstances. 
 
“A lady who wanted to get to her son's wedding, prescribed her steroid 
and she died two days later but she got to the wedding and, and to me it's 
things like that are really, really, the goals they have or the important 
events for the families as well and for them to be able to have those 
memories.” 
Nurse 2, primary care, female. 
 
Prescribing for substance misuse can also allow long-term prescriber-patient 
relationships to develop but Pharmacist 6 was careful not to be influenced by her 
relationship with her patients into prescribing in a way that potentially put them 
at risk.  
 
“We wouldn't put anybody on to a take away prescription unless they were 
working, that would be the only reason, no matter how much we trusted 
them or how clean they were.” 
Pharmacist 6, community pharmacy, female. 
 
Other participants similarly placed importance on there being a relationship of 
trust between them and their patients; Nurse 1 spoke particularly about the 
impact a prescribing decision might have on that relationship. 
  
“If I make that decision not to prescribe and then, you know, things get 
worse then obviously there's a lack of trust gone there, isn't there?” 
Nurse 1, primary care, female. 
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Pharmacist 2 described the consultation as a two-way process, highlighting that 
a difficulty within the consultation might impact on the patient’s willingness to 
reach agreement with the prescriber. 
 
“If you had a prescribing consultation that's maybe not gone so well you 
might, don't know, that might come across to the patient … it might 
influence the patient as well, in that you're, you know, when you're 
making that sort of joint decision to go ahead with the prescription, that 
might influence the patient and what they're doing.” 
Pharmacist 2, secondary care, female. 
 
Patient pressure to prescribe 
Most participants described situations where they were aware of patient or family 
pressure to prescribe in a certain way.  Participants described responding to this 
pressure in various ways.   
 
“So I wouldn't necessarily prescribe something because the patient 
wanted, wanted it; and if they didn't want it then have a discuss around 
why they didn't want it, if there's an alternative they were happy to have 
that I was happy to prescribe and make sure that you've got agreement 
with, with the patient, or if it happens to be the patient's family, that, you 
know, that are involved in that discussion.” 
Pharmacist 2, secondary care, female. 
 
“Yeah, I mean patients come in sometimes with very fixed ideas of what 
they like and what they don't like and what they want and what they don't 
want, so in some scenarios you almost do have to just give in to what they 
want because they'll, there is no point in prescribing and them actually not 
taking it ‘cause they don't have any belief in it.” 
Pharmacist 9, primary care, female. 
 
Participants prescribing for acute conditions in primary care described feeling 
under pressure from patients to prescribe, as they thought, inappropriately.   
 
“Dare I say, parents of small children that have been on Google®.  Fine, 
you know, we listen to everybody but it's when they come in with a very 
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set idea that little Johnny needs antibiotics because he's had a cough for 
48 hours and they're not going to leave without, you know, we come up 
against that quite a lot.  I find that difficult…” 
Nurse 3, primary care, male. 
 
“I'm just thinking about this morning for instance.  I had a, three people 
looking for prescriptions for conjunctivitis in kids, and you know, I always 
try very hard not to be prescribing these sorts of things ‘cause, you know, 
there's all sorts of complications of, you know, or dangers of prescribing, 
but I do find that very difficult, you know.  Parents want a fix for this and 
they don't want to wait for it to get better by itself so, you know, your own 
emotions and, you know, your own resilience does play a part there, you 
know, if they're really keen to get a prescription off you.” 
[Doctoral student: So how might you respond to that kind of pressure?]  
“Might cave in and give it, yeah.” 
Nurse 4, primary care, female. 
 
In secondary care too, participants were subject to pressure from the patient, or 
their family, to prescribe what they wanted.  Participants sometimes found this 
pressure hard to resist. 
 
“Yeah, because a patient doesn't care about a guideline the patient just 
cares about their own, how they're feeling, what their treatment is, or 
their mum's or their dad’s or, you know.  They see someone who's 
suffering, or they're suffering themselves, and you know, you say that 
we're not allowed to use this in the hospital, 'Why not, why not? I had this 
last…'” 
Pharmacist 3, secondary care, female. 
 
“Your heart goes out to them and you are wanting to help them and, you 
know.  Maybe it's not the most appropriate thing to give them the 
zopiclone or give them the extra couple of days of steroids but sometimes 
you feel like 'Oh, you really need this.'” 
Pharmacist 3, secondary care, female. 
[Zopiclone is a hypnotic] 
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Patients’ lifestyles 
Patients’ behaviours or lifestyle choices, either short or long term, could also 
exert an influence on the prescribing decisions participants made.   
 
“Someone also may have a variable itinerary within a country, so they 
may wish to do certain activities that would you know, increase the risk, 
so again that would be the conversation we'd have and we would have an 
agreement.” 
Pharmacist 7, community pharmacy, male. 
 
“So we agreed 'Right, you try and get a bit more exercise, cut back on the 
booze and stop smoking'.  Six months later there was no difference.  So 
the negotiation there was, 'Well, are you prepared to cut back on the 
smoking?' and he had to admit, no, probably not.  So we had to put him 
on tablets.  That was the only alternative.” 
Pharmacist 4, primary care and community pharmacy, female. 
 
4.3.3.12 Emotion 
 
Some participants asserted that their professionalism precluded an emotional 
response when making prescribing decisions while others acknowledged that 
their emotions did play a part.  Some identified to a degree with certain patients’ 
circumstances which was emotionally difficult, while others found patient 
demands challenging at the end of a long day. 
 
“ … you tend to leave your emotions, you know, behind your 
professionalism.  So it doesn't matter how I'm feeling, if I'm having a good 
day or a bad day I wouldn't take that to work with me, you know.” 
Nurse 1, primary care, female. 
“I would never not give them the pill or the morning after pill just because 
I'm in a bad mood with them, no.” 
Pharmacist 4, primary care and community pharmacy, female. 
 
That said, participants acknowledged that they might be influenced by their 
emotional response to certain patients or situations.  Some, and especially those 
prescribing for patients with life-threatening or terminal conditions, described 
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feeling sympathy and/ or empathy for their patients and being influenced 
accordingly.   
 
“I think the, the social circumstances, your previous experience with the 
patient, the relationship you have with the patient and how you relate to 
them I think definitely influences your prescribing.  Can be tough 
sometimes, yeah.” 
Pharmacist 3, secondary care, female. 
 
Participants described how they felt and behaved in response to what they 
perceived as challenging patient expectations.  Nurse 5 used the term “Friday 
afternoon prescription” to describe her response on occasion. 
 
“I suppose if it's been a long hard day and you're under pressure from 
somebody to prescribe something that you wouldn't normally or that you'd 
be reluctant to normally, you know, I guess they can wear you down.  So 
yeah, I guess your emotions do have an impact certainly, you're only 
human at the end of the day, yeah.” 
Nurse 4, primary care, female.  
 
“Just prescribe something for like a ‘Friday afternoon prescription’ sort of 
thing…” 
Nurse 5, primary care, female. 
  
Several participants described worrying over prescribing decisions they had 
made. 
  
“It's certainly things that you think about, yeah, if this, if this treatment 
goes wrong, if there is a, you know, a significant risk of harm, that you 
know, you wouldn't want to take that risk yourself, yeah, you do.  It's 
certainly a consideration, it does worry you. Sometimes it keeps you 
awake at night.” 
Pharmacist 4, primary care and community pharmacy, female. 
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4.3.3.13 Behavioural regulation 
 
Participants monitored and reflected on their practice, particularly in relation to 
prescribing within their areas of competence, broader targets for prescribing 
decision-making and dealing with uncertainty.  This behavioural regulation then 
informed future practice.   
 
Prescribing within competence 
Participants were very aware of the limits of their competency and described 
taking a rigorous, reflective approach which facilitated self-regulation in their 
prescribing decision-making.   
 
“It's about having the, the right to prescribe something, having the 
authority to prescribe something, being in a situation where I believe it 
may be in the patient’s best interest for me to prescribe but not having the 
relevant knowledge either of what I would prescribe or the patient's own 
circumstances or background to allow me to do that with 100% safety.” 
Pharmacist 7, community pharmacy, male. 
 
“I generally won't prescribe out with my competence.  If I've been asked 
to prescribe something, for example by one of the consultants that I'm not 
happy with, then I will pull back from that.” 
Pharmacist 2, secondary care, female. 
 
Participants were similarly careful in the processes of prescribing so as to 
minimise errors.  
 
“I'd like to think I've got quite a methodical way of going through and just 
sort of go through each stage at time making sure I've checked this and 
this and this...and this.” 
Pharmacist 2, secondary care, female. 
 
Reflecting on practice 
Participants also reflected on their own behaviour in relation to prescribing 
decision-making.  Pharmacist 4 identified what she perceived as a shortcoming 
when considering her options for prescribing. 
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“And I've also fallen into the trap that GPs fall into, you prescribe what 
you're familiar with, and I know I'm doing it and every now and then I have 
to give myself a stern talking to and say 'Right, get a grip and start 
branching out just a wee bit.’” 
Pharmacist 4, primary care and community pharmacy, female.  
 
Nurse 3 reflected on the tension between the demands of evidence-based 
prescribing and the needs of patients seeking help. 
 
“But I think out of that there's a few specific things, you know, being a bit 
tougher and bit more robust and sticking to the, you know, sticking to the 
evidence and the guidelines as much as possible but trying to make that fit 
around the person that is, is anxious and worried and feeling you don't want 
to help them, you know.  So there's a bit of a juggling act really, but I'm 
hoping that will get better with time.” 
Nurse 3, primary care, male. 
 
Nurse 4 sometimes compared her prescribing practice with that of others 
 
“I sometimes think, you know, when I'm listening to other people speaking 
about things that I'm a bit sort of non-interventionist, you know, and you 
sort of think 'Gosh, well perhaps I should be, you know, doing more.’” 
Nurse 4, primary care, female. 
 
Broader targets for prescribing decision-making 
Not all decisions made were for individual patients.  Pharmacist 8 had started to 
take a broader approach, targeting certain drugs or classes of drugs for “de-
prescribing” according to evidence-based guidelines. 
 
“Most recently I've been, I've been, I've also been reducing doses of PPIs 
in patients, I've been stopping aspirin for primary prevention, that type of 
thing, not just ‘Here's more new medication.’” 
Pharmacist 8, primary care, female. 
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Dealing with uncertainty 
Often, participants’ response to uncertainty was to seek help from others, most 
often in primary care from a GP, or from another perceived expert.  At other 
times they would research the issue themselves. 
 
“I think we would know when to, when to jump ship and when to get extra 
advice.” 
Pharmacist 6, community pharmacy, female. 
 
“Just find time to search them and look them up and up-skill myself about 
it.  Yeah, so just CPD really, it's part of your, you do every day don't you?  
Every time you open a BNF it's a bit of CPD.” 
Pharmacist 9, primary care, female. 
 
Prescribing by proxy 
Occasionally participants decided not to make the prescribing decision 
themselves but instead made a recommendation or suggestion to another 
prescriber and ask him or her to write the actual prescription. 
 
“You know, sometimes I will say to the GPs that something’s not licenced 
so I'm not happy to prescribe it … but you still have a professional 
responsibility that you advised that.  I'm probably more likely to say 'It's 
not licenced, I wouldn't do and I would advise you don't do it either, if 
there's suitable alternative that we can use that's licenced’ but there isn't 
always.” 
Pharmacist 9, primary care, female.  
 
Summary of findings 
Participants were very generous, sharing their experiences, views, reflections 
and opinions on their prescribing decision-making over 9 hours of interviews.  
Throughout, they evidenced a rigorous, thoughtful and reflective approach, with 
their patients always at the centre.  Rich data were gathered, allowing multiple 
and sometimes contradictory influences to be uncovered.  These will be 
discussed in the next section. 
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4.4 Discussion 
 
4.4.1 Key findings 
 
Eight pharmacist independent prescribers and five nurse independent 
prescribers, experienced professionals from across the NHS Grampian area, were 
each interviewed for between 22 and 58 minutes about their experiences of 
making prescribing decisions, their views and reflections of influences on these 
decisions and their opinions on the impact of these influences on their prescribing 
decision-making.    
 
Participants prescribed in primary or secondary care or in community 
pharmacies.  All were very focused on the needs of their patients and put their 
welfare at the centre of prescribing decision-making.  Participants were often 
dealing with complexity in patients’ health or social circumstances and multiple 
and sometimes contradictory influences on prescribing decision processes were 
apparent.  Most of the 14 domains of the TDF (Cane, O’Connor and Michie 2012) 
were found to be influential as were participants’ previous experiences and multi-
disciplinary working.   
 
4.4.2 Strengths and limitations 
 
To the doctoral student’s knowledge this study is among the first to explore in-
depth influences on prescribing decisions by non-medical prescribers.  The 
doctoral student has previously published a systematic review of influences on 
prescribing decision-making among non-medical prescribers in the UK (McIntosh 
et al. 2013, McIntosh et al. 2014, McIntosh et al. 2016a); other research 
includes that by Maddox (Maddox, Tully and Hall 2010, Maddox 2011).  
 
The study has several strengths.    
 
4.4.2.1 Trustworthiness 
 
Qualitative research has been criticised as lacking rigour (Greenhalgh et al. 
2016) with ongoing debate about its suitability for inclusion in mainstream 
medical publications (Loder et al. 2016).  Qualitative research does not aspire to 
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be generalisable but rather to be trustworthy, and the concept of trustworthiness 
may be used to evaluate the quality of qualitative research (Guba 1981, Shenton 
2004). 
 
The steps taken during the design of the study to promote the four components 
of trustworthiness i.e. credibility, transferability, dependability and confirmability 
in the study (Guba 1981, Shenton 2004) are outlined in Chapter 2 and Table 
2.10.  
  
Credibility 
As in Chapter 2, the study was designed to enhance credibility.  It is felt that this 
was achieved: the supervisory team had relevant expertise, the interview 
schedule was developed from the literature with an appropriate theoretical 
underpinning, peer reviewed by senior non-medical and medical prescribers and 
used to gather data from volunteer participants across a wide range of settings.  
The doctoral student’s academic and professional qualifications and familiarity 
with the culture and practice of non-medical prescribing allowed her to establish 
a rapport with participants before and during the interviews.  Thorough analysis 
by two researchers, internal triangulation using data from all participants (Smith 
1999) and detailed consideration of findings in relation to the literature further 
enhance credibility.  External triangulation will be carried out using “overlapping 
methods” (Shenton 2004, p.71) i.e. Phases 2 and 3 of the study – see Chapter 5.   
 
Transferability 
No-one practises in isolation; all are affected by the context within which they 
practise as well as by broader influences.  In qualitative research the aim is not 
to achieve generalisability but it may be that findings are transferable i.e. 
relatable or relevant to others in a similar situation.  There is some debate about 
whether transferability is possible or whether findings are unique to each study 
(Shenton 2004).  The doctoral student feels that elements of her findings may 
resonate with others in similar positions to those of her participants and to that 
end has provided contextualising detail.   
 
Dependability  
Good research governance requires that sufficient detail is given to allow the 
work to be repeated by another researcher (Bowling 2002) and as in this thesis 
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provision of this level of detail enhances dependability.  Triangulation of data as 
above enhances dependability further.   
 
Confirmability 
Again provision of methodological detail enhances confirmability, as do internal 
and external triangulation.  Clear descriptions of what was done are given along 
with diagrammatic representations: Figure 4.2 shows the stages in the 
development of the interview schedule, Table 4.3 outlines the data analysis 
process and Figure 4.3 illustrates coding at principal and subordinate categories 
of analysis using NVivo®.  Clear diagrammatic illustration of research processes 
supports the confirmability of findings; it is important also to consider issues of 
bias and reflexivity (see later in this chapter and in Chapter 2). 
 
4.4.2.2 Design and theoretical underpinning of the interview schedule 
 
The interview schedule was developed in a thorough, step-wise manner from the 
literature including a systematic review (McIntosh et al. 2016a), the TDF (Michie 
et al. 2005, Cane, O’Connor and Michie 2012) and the views of experts.  Until 
recently, theoretical underpinning has been less common in much of pharmacy 
practice research compared to other disciplines but such underpinning is 
recognised as promoting quality and relevance in research (Stewart and Klein 
2016).  Dyson and colleagues compared the effectiveness of qualitative and 
quantitative research underpinned by the TDF with similar research in the 
absence of any theoretical basis.  They found some overlap but that TDF-
informed research elicited more and additional information compared to the 
atheoretical approach (Dyson et al. 2011).  The TDF has been used extensively 
to research health-related behaviours (Francis, Curran and O’Connor 2012) 
including prescribing errors (Duncan et al. 2012) and along with the literature 
provided the basis around which the interview schedule was developed.  The 
domains of the TDF were also used to prepare an initial coding framework for 
data analysis.  
  
4.4.2.3 Participants  
 
Participants were pharmacist independent prescribers in community pharmacy, 
primary care and secondary care, and nurse independent prescribers in primary 
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care, from across the NHS Grampian area.  They had extensive experience within 
their own professions (10 – 40 years) and almost all were also experienced 
independent prescribers (8 months – 11 years).  They prescribed for a wide 
range of conditions and patient groups in a variety of practice settings.  
Recruitment matched the professions of non-medical prescribers in NHS 
Grampian at the time of the study although not their relative proportions.  There 
appears to be little literature on prescribing by NMPs other than nurses and 
pharmacists and only nurse and pharmacist prescribers were identified in a 
recent Cochrane review of the effectiveness of NMP (Weeks et al. 2014).  
 
4.4.2.4 Participants’ contributions 
 
Social desirability bias is always possible (Sackett 1979) but participants spoke 
apparently freely and at some length, sometimes greatly exceeding the expected 
duration of the interview.  They shared a wide range of information, including 
some which did not always reflect well on them, and appeared to be speaking 
honestly.     
 
4.4.2.5 Data saturation 
 
From Figure 4.4 it appears that data saturation was likely to have been achieved.  
The analytical approach taken precluded the use of Francis’ method to establish 
this (2010); rather it facilitated a detailed examination of the data.  Principal 
categories of analysis were sub-divided into as many as 23 subordinate 
categories each, with 248 subordinate categories in total.  A process of mapping 
and interpreting of these resulted in 13 themes with 58 sub-themes.  
 
Francis suggests that an initial number of between five and ten interviews should 
be undertaken, with a minimum of an additional three after data saturation 
appears to have been reached.  Endorsement by pharmacist and non-medical 
prescribing Health Board Leads, a reminder e-mail and snowballing over a period 
of months resulted in 13 participants only, but this number is within Francis’ 
proposed method.   
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Study limitations  
Possible limitations will be considered for each phase of the method; bias is 
inherent in research and must be acknowledged and mitigated as far as possible 
(Sackett 1979) as must other limitations.  
 
4.4.2.6 Study design 
 
Data were generated in semi-structured interviews, using the same interview 
schedule throughout.  It is possible that relevant areas for questioning were 
omitted although the interview schedule was developed rigorously with input and 
review from relevant nursing, pharmacy and medical experts.  The doctoral 
student reflected on each interview and discussed them with her supervisory 
team; no lacunae were evident and the interview schedule was not amended.    
 
4.4.2.7 Recruitment 
 
Thirteen participants were recruited from around 664 NMPs in the NHS Grampian 
area at the time of the study; eight pharmacist prescribers and five nurse 
prescribers.  They represented all areas of practice except nurse prescribing in 
secondary care.  It is possible that those choosing to participate were different in 
some way from those choosing not to, for example they may have been more 
experienced or more confident in their role as prescribers.  It is also possible that 
the prescribing decisions of nurse prescribers working in secondary care might be 
influenced by different or additional influences to those of study participants.  No 
attempt was made to contact non-responders to explore any differences. 
 
4.4.2.8 Conduct of interview 
 
The doctoral student was aware that her background was likely to influence her 
research; see Chapter 2 Section 2.11 Reflexivity.  Participants knew she was a 
pharmacist and academic and this knowledge may have influenced their 
responses (Richards and Emslie 2000); social desirability bias (Sackett 1979) 
was also possible.  The doctoral student explained her role as a researcher 
before each interview and maintained a position of neutrality throughout; if 
participants seemed to seek her opinion she would reply “We’ll talk about that 
later” or a similar neutral phrase (Smith 2005).  
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The shared frame of reference between the doctoral student and participants did 
however facilitate a shared understanding of allusions and ideas (Britten 1995), 
for example “a Friday afternoon prescription”.  According to the interpretivism 
paradigm such a shared understanding is essential to the development of 
knowledge (Bunniss and Kelly 2010).   
 
It is possible that participants were subject to recall bias (selectively 
remembering certain information) and reporting bias (not answering certain 
questions) (Sackett 1979) during their interviews but they appeared to speak 
freely and answer questions fully.  
 
4.4.2.9 Bias during analysis and reporting of findings 
 
Bias during analysis of data was possible.  To mitigate this, supervisors and the 
doctoral student discussed the approach to analysis and analysed one transcript 
together.  Remaining transcripts were analysed by the doctoral student and one 
of supervisors SC, DS and KFM, with any disagreements being resolved by 
discussion.  The doctoral student then used NVivo® to support management and 
analysis; the use of such software has been found to facilitate analysis and 
increase rigour (Kelle, Prein and Bird 1995).   
 
Supervisor KFM is a psychologist with extensive experience in health-related 
research; Francis and colleagues recommended inclusion of a health psychologist 
in teams using the TDF in research (Francis, O'Connor and Curran 2012).    
 
4.4.3 Findings in relation to other studies 
 
As above, research in this area is somewhat limited but research on influences 
on medical prescribing decision-making is extensive.   
 
Maddox studied the prescribing decisions of NMPs working in primary and 
community care (Maddox 2011) and identified regulatory, patient and colleague 
factors, the prescribing culture and professional experience, training and 
information sources and logistical factors as influential.   
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Bradley carried out seminal research on factors influencing GPs' prescribing 
decisions which engendered feelings of discomfort for them (Bradley 1992a, 
Bradley 1992c).  This work led to a series of studies throughout the 1990s by 
Bradley and others culminating in a report for the Department of Health on 
improving doctor-patient communication about drugs (Stevenson et al.  2001). 
 
Findings will be discussed under Maddox’s categories of prescribing influences 
and in relation to other literature. 
 
4.4.3.1 Regulatory factors: evidence-based guidelines 
 
Latter and colleagues carried out a large-scale, although early, evaluation of 
nurse and pharmacist independent prescribing (Latter et al.  2010). Prescribers 
emphasised the importance of prescribing strictly according to evidence-based 
guidance and asserted that they did so.  Maddox’s NMP participants were guided 
primarily by such guidelines but stated that they would prescribe out with them 
based on personal experience, unsuitability of guidelines or patient-related 
factors (Maddox 2011).  Nurse prescribers treating otitis media in children and 
respiratory tract infections made similar prescribing decisions (Philp and Winfield 
2010, Rowbotham et al. 2012). 
 
Bradley’s research on medical prescribing was carried out before the burgeoning 
of evidence-based guidelines but all his participants experienced discomfort when 
prescribing for certain clinical conditions and from certain drug groups (Bradley 
1992a, Bradley 1992c).   
 
Participants in the present study relied on their knowledge of evidence-based 
national guidelines, local formularies and protocols when prescribing and also 
used a wide range of other paper and electronic resources to inform their 
decision-making.  All shared the environmental context of prescribing within NHS 
Grampian and participants in primary care in particular used the NHS Grampian 
Joint Formulary (NHS Grampian Medicines Management 2017) as a key resource.  
All participants also described using specific knowledge of particular patient 
groups and/ or conditions.  Participants were strongly influenced by evidence-
based guidelines but most described situations where they would prescribe other 
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than in accordance with these, based on their experience or on specific patient 
factors.   
 
There is concern that evidence-based guidelines developed for patients with a 
single clinical condition may not be suitable for those with multi-morbidities and 
about a “one size fits all” approach (McCartney et al. 2016).  Doctors prescribing 
in secondary care experienced discomfort when trying to prescribe according to 
evidence-based practice while incorporating their own clinical experience, 
possibly because they considered that evidence-based guidelines discounted the 
value of such experience (Lewis and Tully 2009).  In a mixed methods study 
among patients, GPs and prescribing advisors in the North of England, potential 
conflicts were identified between the use of evidence-based guidelines and 
maintaining a partnership between doctors and patients (Solomon et al. 2012).  
Participants in this study used their knowledge of guidelines to inform their 
prescribing but like non-medical prescribers, were subject to additional influences 
on their prescribing (Maddox 2011, Philp and Winfield 2010, Rowbotham et al. 
2012, McIntosh et al. 2016a). 
 
4.4.3.2 Patient factors 
 
Maddox’s NMP participants incorporated a number of patient-related factors into 
their prescribing, endeavouring to address patients’ concerns and improve 
adherence and hopefully outcomes while withstanding occasional patient 
pressure to prescribe inappropriately (Maddox 2011).  Bradley’s medical 
participants (1992a, 1992c) described feelings of discomfort arising from patient 
factors including prescribing for those at extremes of age, their relationship 
(good or bad) with the patient and when prescribing to maintain the doctor-
patient relationship.  Subsequent research has identified a mis-match between 
prescribers’ perceptions of patient expectations from the consultation and what 
patients actually wanted (Britten and Ukoumunne 1997, Little et al. 2004, 
Coenen et al. 2006).  Cribb and Barber (1997, p.294) described the tension 
between perceived patient “wants” and “needs” as "one of the handful of 
fundamental questions in the philosophy of health”.   
 
The social influence of the patient was important and participants described 
different types of relationships.  Some prescribing for acute conditions might not 
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have met the patient before; others were able to establish longer-term 
relationships over a period of weeks, months or sometimes years.  Deeper GP-
patient relationships have been found to increase the number of issues raised 
during a consultation with likely benefits to the patient (Merriel et al. 2015).  GPs 
have "holding relationships" with some patients, providing support without the 
expectation of a cure (Cocksedge et al. 2011 p. e484); it may be that NMPs 
managing patients' long-term conditions are establishing similar relationships.   
 
The doctor-patient relationship has been found to be a key influence on GPs' 
prescribing (Butler et al. 1998, Stevenson et al. 1999, Britten et al. 2000, Little 
et al. 2004, Petursson 2005, Lucas et al. 2015, Strumiło et al. 2016, Horwood et 
al. 2016) and that of consultants prescribing in secondary care for long-term 
conditions (Lewis and Tully 2011).  Some GPs admit to sometimes prescribing to 
maintain the doctor-patient relationship with resulting feelings of discomfort 
(Bradley 1992a, Horwood et al. 2016).  This may particularly be the case with 
antibiotics although some GPs prescribing for sore throats asserted that they did 
not prescribe antibiotics in response to patient pressure.  They did however 
prescribe antibiotics in response to "pressured clinical contexts", and were 
generally comfortable with their decisions (Kumar, Little and Britten 2003, 
p.138).   
 
Some participants in this study admitted to prescribing antibiotics occasionally in 
the absence of clear clinical need, with potential long-term adverse 
consequences for the patient and society (Costelloe et al. 2010, Leibovici, Paul 
and Ezra 2012).  A retrospective study of dispensing data indicated that on 
average 20% of dispensed prescriptions written by nurse prescribers in Scotland 
are for antibiotics, with some evidence of good practice (Ness et al. 2015).  This 
is clearly an important issue about which there has been concern over at least 
the last 25 years. 
 
Participants believed that trust between the prescriber and patient was key to 
the relationship and would promote good outcomes.  Medical prescribers similarly 
value a relationship of trust with their patients (Cocksedge et al. 2011, Ashdown 
et al. 2016) as do NMPs (Philp and Winfield 2010).  Patients' own expressed 
goals were important, with some participants prescribing out with guidelines to 
allow patients to achieve these.  Participants believed themselves capable of 
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doing this and were influenced to do it by their beliefs about the likely 
consequences for the patient and their goal of putting the patient first.       
 
At other times participants described feeling subject to social pressure from 
patients or their families to prescribe, as participants thought inappropriately, 
particularly for antibiotics; not all believed themselves capable of resisting this 
pressure.  Again doctors have reported perceiving similar pressure and 
responding by prescribing antibiotics in the absence of clear clinical need (Butler 
et al. 1998, Britten et al. 2000, Little et al. 2004, Lewis and Tully 2011, Lucas et 
al. 2015, Fletcher-Lartey et al. 2016).  Strategies proposed for improving 
antibiotic stewardship include approaches to strengthen prescribers' decision-
making in such circumstances (National Institute for Health and Care Excellence, 
2017b). 
 
4.4.3.3 Colleague factors 
 
Maddox's participants described being influenced by colleagues, particularly GPs, 
with some nurse prescribers reporting pressure to minimise costs in their 
prescribing.  They sought informal advice or referred the patient to the GP where 
they felt it necessary, otherwise they reported that GPs had little influence on 
their practice (Maddox 2011).  In a small scale, in-depth study nurse prescribers 
in general practice described pressure to prescribe from GPs, patients and 
reception staff as a "major demand" (Cousins and Donnell 2012, p.226).  They 
resisted it by refusing to prescribe out with their competence.   
 
Participants in the present study did not report pressure from their colleagues.  
Rather they worked well in the environmental context of multi-disciplinary 
teams, with those in primary care regarding the opportunities offered by GPs for 
advice, support and referral as a valuable resource.  Several also described 
seeking support from external experts with specialist knowledge.  Participants 
were respectful of the professional roles of colleagues with little mention of 
questioning doctors' prescribing decisions.  Participants' beliefs about the 
consequences of their prescribing decisions extended to colleagues as well as 
about consequences for the patient and for themselves.   
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Non-medical prescribing with its developing professional roles has been seen by 
some as challenging the medical hierarchy (Weiss 2011, Cooper et al. 2012) but 
medical prescribers in secondary care have also felt constrained in their 
prescribing decision-making by the views of more senior colleagues (Lewis and 
Tully 2009).  Participants were aware of and learned from the roles and 
prescribing decision-making of other NMP colleagues.  The behaviour or opinions 
of peers have also been found to influence medical prescribers (Bradley 1992a, 
Jacoby, Smith and Eccles 2003, Gunnarsdóttir and Kinnear 2005) and peer 
teaching has been recognised as being effective in promoting the use of 
evidence-based guidelines (Chauhan et al. 2017).  
 
Participants found colleagues and others very valuable resources particularly 
when faced with complex or otherwise challenging prescribing decisions and 
sometimes were influenced by their beliefs about their own capabilities to refer 
the patient on to others whom they perceived as having more expertise.  A 
recent interview–based exploration of GPs, nurses and pharmacists as 
prescribers in primary care found differences in the extent to which practices 
accommodated and adapted to non-medical prescribing; where this was done 
successfully all benefited from the resultant multi-disciplinary working (Weiss et 
al. 2016).  Pharmacist participants working in nurse- and pharmacist-led wards 
in secondary care sought advice and support primarily from other pharmacist 
prescribers, including through informal discussions about prescribing-related 
issues from which all benefitted.  They made little reference to the role of 
doctors.  Adigwe and colleagues (2013, p.21) reported on non-medical 
prescribers prescribing for pain in primary and secondary care and identified the 
importance of “safety and support within the prescribing environment” provided 
by their colleagues; this would resonate with participants.     
 
4.4.3.4 Prescribing culture and professional experience 
 
Maddox's participants were influenced by the prescribing decisions of doctors in 
primary and secondary care.  At the same time they could be quite critical of 
some of the prescribing of GP colleagues which they perceived as sometimes 
inappropriate (Maddox, Tully and Hall 2010, Maddox 2011).  Nurse prescribers 
treating self-limiting respiratory tract infections felt frustrated and unsupported 
when GPs prescribed antibiotics following the nurse prescribers’ decision that 
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there was no clinical need (Rowbotham et al. 2012).  Doctors too are influenced 
by peers' prescribing (Bradley 1992a, Jacoby, Smith and Eccles 2003, 
Gunnarsdóttir and Kinnear 2005) and also by feedback on their prescribing data 
from leaders in the profession (Guthrie et al. 2016, Hallsworth et al. 2016).  
 
In addition to using national condition-specific guidelines and the NHS Grampian 
Joint Formulary participants also described using local formularies.  In primary 
care individual practice formularies were developed from the NHS Grampian Joint 
Formulary; such shared resources and the social influence of informal discussions 
with colleagues encouraged the development of a very local culture of 
prescribing.  For those in secondary care ward formularies, developed with input 
from at least one participant, were similarly influential. 
 
Maddox's participants did not identify past experience as a strong influence on 
their prescribing, in contrast with those of Rowbotham (Rowbotham et al. 2012) 
and others (Cullinan et al. 2014, Cabral et al. 2015, Ashdown et al. 2016) and 
including participants in this study.  All participants were experienced 
practitioners and, except one, experienced prescribers.  All described the 
influence of their experience when making prescribing decisions, which provided 
background and specific knowledge and enhanced participants' prescribing 
confidence.  On occasion and like other NMPs (McIntosh et al. 2016a) some 
prioritised experiential knowledge over evidence-based guidelines where this was 
perceived to benefit patients.  GPs have used their experience to manage their 
perception of tension between the requirements of evidence-based medicine and 
the needs of individual patients (Tonkin-Crine, Yardley and Little 2011, Solomon 
et al. 2012, Cullinan et al. 2014) and in response to clinical uncertainty when 
treating children with respiratory tract infections (Horwood et al. 2016). 
 
4.4.3.5 Training and information sources 
 
Maddox's participants did not identified training as a specific influence on their 
prescribing decisions and nor did participants in the present study.  Participants 
used a wide range of online and paper resources to inform their prescribing 
decision-making.  
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4.4.3.6 Logistical factors  
 
Some of Maddox's participants described appointment time pressures as 
influencing their prescribing while others with longer appointments did not.  
NMPs have traditionally had longer appointments than GPs although this may be 
changing.  Time pressures have been reported in GP consultations (Cocksedge et 
al. 2011), sometimes impacting on prescribing decisions (Horwood et al. 2016).   
 
Primary care pharmacist participants' inability to prescribe electronically was a 
major issue for them.  On occasion one chose not to prescribe but instead 
ordered the prescription through the practice repeat prescription service, 
impacting on the patient's ability to access their medicines in a timely manner.  
One of the main drivers for non-medical prescribing was to improve patients' 
access to medicines (Crown 1999) and it seems inexplicable that almost 20 years 
later this is still not possible, although a pilot scheme started in November 2016.    
 
4.4.3.7 Additional participant-related influences 
 
Maddox did not appear to describe the influence of specific aspects of her 
participants on their prescribing decision-making.  The use of the TDF in 
development of the interview schedule and as the basis for the initial framework 
for data analysis facilitated identification of additional participant-related 
influences. 
 
Knowledge 
Participants made use of a wide knowledge-base when prescribing.  Knowledge 
of the patient was key; their clinical condition, their previous experience of 
treatment and their expectations were identified as central influences.  These 
elements are included in the British Pharmacological Society’s Ten principles of 
good prescribing (British Pharmacological Society 2010) and the Royal 
Pharmaceutical Society Competency Framework for all prescribers (Royal 
Pharmaceutical Society 2016).  They contribute to a patient-centred approach 
(Lehman et al. 2015) which is favoured by patients (Little et al. 2001) and likely 
to contribute to better patient outcomes (Calderwood 2016).  Lack of knowledge 
has contributed to prescribing errors among junior doctors (Lewis et al. 2014). 
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Skills  
Participants' skills, particularly communication and interpersonal skills, also 
strongly influenced the prescribing decisions they made.  Participants considered 
themselves proficient in these skills although some described challenges when 
negotiating with patients.  Some pharmacist prescribers lacked clinical 
examination skills and relied on others for these.  Concern has been expressed 
previously about pharmacist prescribers' lack of clinical examination skills 
(General Pharmaceutical Council 2016) and this is a focus in the GPhC learning 
outcomes and indicative content for pharmacist prescribing courses (General 
Pharmaceutical Council 2017c).  Doctor-patient communication has been 
extensively studied (Stevenson et al. 2001) with some concern that the use of 
different "voices" has contributed to misunderstandings (Barry et al. 2001, 
Cabral et al. 2014).  Exploring patients' ideas, concerns and expectations may 
reduce prescribing (Matthys et al. 2009); pharmacist and nurse prescribers in 
primary care in England have been found to respond to more of patients' cues 
and concerns than GPs (Riley et al. 2013).  Communication skills are among the 
non-technical skills identified as necessary to allow junior doctors to prescribe 
safely (Dearden et al. 2015). 
  
Professional roles and identities 
Participants described their professional roles and identities as influencing their 
approach to making prescribing decisions.  They benefitted from their previous 
professional experience and were aware of the additional responsibilities inherent 
in the prescribing role.  Maddox's participants’ willingness to take on these 
responsibilities was influenced by their perceived competence (Maddox 2011); 
this was also the case in the present study.  Interestingly, although there are 
now over 5000 pharmacist prescribers, (personal communication General 
Pharmaceutical Council 2016), the role of prescriber was barely mentioned in a 
recent exploration of pharmacists’ perceptions of their professional identity 
(Elvey, Hassell and Hall 2013). 
 
Beliefs about capabilities 
Participants’ beliefs about their capabilities were influential: they were confident 
but very aware of their limitations and careful not to prescribe for conditions out 
with their competence.  Non-medical prescribers, as all prescribers, must 
prescribe within their self-assessed area/s of competence (Royal Pharmaceutical 
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Society 2016) but resisting pressure to prescribe out with these area/s can be 
challenging.  Pharmacist prescribers in Northern Ireland asserted that their 
naturally cautious approach to prescribing helped them to stay within their 
competence (McCann et al. 2012a) while nurse prescribers in primary care 
described self-imposed limitations on their prescribing (Bowskill, Timmons and 
James 2013).  Both these approaches resonate with those of participants in this 
study.  Participants felt confident in their ability to prescribe safely and 
effectively, were clear about their boundaries and were certain that they would 
not prescribe beyond these.  Participants’ beliefs about their capabilities are 
supported by the findings of a recent Cochrane review which established that 
non-medical prescribers delivered comparable prescribing outcomes to those of 
medical prescribers across a range of conditions (Weeks et al. 2014).   
 
Goals and intentions 
Participants' goals were to put the patient first and optimise patient care.  They 
intended to do this by involving patients in discussions, encouraging self-
management and taking a rigorous, evidence-based approach when making 
prescribing decisions.  The patient is at the centre of the Competency Framework 
for all prescribers (Royal Pharmaceutical Society 2016) and in the British 
Pharmacological Society 10 Principles of Good Prescribing (2010). 
 
Memory, attention and decision processes 
Participants described the attention to detail required when making prescribing 
decisions and the strategies they employed to support the associated cognitive 
demands.  Technology was felt to offer some solutions and participants described 
taking a step-wise approach during prescribing decision-making.  Complexity was 
felt to be particularly challenging.  Historically pharmacist prescribers have 
prescribed in discrete clinical areas (General Pharmaceutical Council 2016) 
whereas nurse prescribers have more often prescribed for a wider range of 
conditions (Latter et al. 2010, Coull et al. 2013).  More recently primary care 
pharmacists working in doctors’ practices have taken on wider prescribing 
responsibilities, including for those with multi-morbidities (NHS Education for 
Scotland 2017a).  A shortage of GPs and an aging population with increasing 
health and social care needs mean that the way in which healthcare is delivered 
will change (Imison, Castle-Clark and Watson 2016) and it is likely that 
complexity will increase for non-medical and medical prescribers.   
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Environmental context and resources 
Environmental context and resources have been considered under Regulatory 
factors: evidence-based guidelines and colleague factors.   
 
Emotion 
Although some participants claimed not to be influenced by emotion, others 
described feeling empathy towards patients in difficult circumstances and 
obtaining satisfaction from helping them to achieve their goals.  A systematic 
review of patient experience of GPs’ empathy found this correlated well with 
patient satisfaction, enhanced enablement and improved clinical outcomes 
(Derksen, Bensing and Lagro-Janssen 2013). 
 
In contrast, some participants in primary care reported feeling relentless patient 
pressure resulting in negative emotions and sometimes in what they described as 
inappropriate prescribing.  Participants treating self-limiting infectious conditions 
particularly reported feeling pressure to prescribe antibiotics.  In the literature, 
pressure to prescribe, most often from patients, has been identified over a 
number of years as a stressor for medical (Little et al. 2004, Lewis and Tully 
2011,) and non-medical prescribers (Philp and Winfield 2010, Cousins and 
Donnell 2012, Scrafton, McKinnon and Kane 2012).   
 
Behavioural regulation 
Participants practiced reflectively.  They were aware of their responsibilities as 
prescribers and particularly of the requirement to prescribe only in their areas of 
competence, and were clear that they would do so.  The Competency Framework 
for all prescribers emphasises this need to prescribe only within self-assessed 
competence (Royal Pharmaceutical Society 2016).  None the less nurse 
prescribers have reported feeling under pressure to take on additional 
prescribing for example in signing regular repeat prescriptions (Cousins and 
Donnell 2012, Scrafton, McKinnon and Kane 2012). 
 
4.4.4 Summary 
 
This chapter has reported Stage 2 Phase 1 of the programme of research, a 
qualitative, theoretically-driven exploration of influences on the prescribing 
decision-making of NMPs by means of semi-structured interviews.  Development 
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of the interview schedule was informed by the literature and by use of the TDF; 
this along with robust research methods and governance enhances the 
trustworthiness of findings.  Participants’ prescribing decision-making was 
influenced by most but not all of the domains of the TDF; there was some 
overlap and some linking between domains.   
 
It is important to note that the focus of this phase of the programme of research 
was broad: participants’ descriptions of their experiences of making prescribing 
decisions, their views and reflections of influences on these decisions and their 
opinions on the impact of these influences.   
 
A full exploration of influences on their prescribing decision-making required an 
additional, narrower focus on actual prescribing decisions made, and this was 
achieved in Phases 2 and 3 of the programme of research: 
 
 Phase 2: self-recorded reflections on individual prescribing decisions 
participants felt were noteworthy in some way 
 
 Phase 3: semi-structured interviews based on these recorded reflections 
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Chapter 5 Phases 2 and 3 of study 
 
5.1 Introduction 
 
 
This chapter will report on Phases 2 and 3 of the study: participants’ self-
recorded reflections on prescribing decisions which they judged to be noteworthy 
(Phase 2) and interviews based on these recorded reflections (Phase 3).  Again 
the focus throughout was on participants' experiences, their perceptions of 
influences on their prescribing decision-making and the impact of these 
influences.   
 
The aim was to explore participants’ experiences and perceptions of influences 
on their prescribing decision-making in relation to noteworthy prescribing 
decisions. 
 
The objectives were to explore: 
 
 participants' in-depth descriptions of their experiences of making 
prescribing decisions 
 
 their views and reflections of influences on the prescribing decisions they 
make 
 
 their opinions on the impact of these influences on their prescribing 
decision-making  
 
5.2 Methods 
 
5.2.1 Research design 
 
As before an inductive, phenomenological approach was taken, this time using a 
novel method of data generation.  A brief orientation summary of the research is 
given below with more detail following. 
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Phase 2 
In Phase 2 of the study participants from Phase 1, all of whom had agreed to 
take part in Phases 2 and 3, were given digital recorders and asked to record 
reflections on “one or two” of their prescribing decisions which they regarded as 
noteworthy in some way in relation to their practice.  
 
Phase 3 
In Phase 3 participants were interviewed by the doctoral student about their 
Phase 2 reflections.  
  
5.2.2 Setting and sampling frame 
 
Again the study was carried out in primary and secondary care and in community 
pharmacies across the NHS Grampian area.  The sampling frame was 
participants in Phase 1 of the study who had consented to taking part in Phases 2 
and 3 of the study.  
 
5.2.3 Recruitment  
 
All participants in Phases 2 and 3 had already read the participant information 
sheet (Appendix 4.1) and completed the study-specific online recruitment and 
consent form (Snap Surveys 2016) as part of their initial recruitment.  They had 
consented to participating in all three phases of the study and to having their 
interviews and reflections recorded and anonymised data disseminated.      
 
5.2.4 Reflections and interviews: data processing, transcription and data 
storage and data generation. 
 
5.2.4.1 Data processing, transcription and storage   
 
In Phases 2 and 3 data were processed, transcribed and stored as in Phase 1 
except that the doctoral student transcribed the Phase 2 recordings herself and 
checked them for accuracy.     
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5.2.4.2 Data generation Phase 2: self-recorded reflections 
 
At the end of their Phase 1 interviews participants were shown by the doctoral 
student how to use the Olympus® WS-832 digital voice recorder and also given 
written instructions on how to use it (see Appendix 5.1).   
 
In the participant information letter (Appendix 4.1) participants were told “I will 
ask you to record your reflections after two prescribing decisions you make over 
the following four weeks; you may choose what to record but should not include 
any patient-identifiable information.”  When speaking to participants at the end 
of their Phase 1 interviews the doctoral student asked participants to record “one 
or two” reflections within the following four weeks on prescribing decision/s 
which they felt were noteworthy in some way in relation to their practice.  The 
doctoral student did not give any further direction as she wanted to leave the 
selection/s entirely up to participants.  Participants were asked to record the 
reflection/s after the consultation then to contact the doctoral student to arrange 
collection and return of the recorders.   
 
5.2.4.3 Data generation Phase 3: interviews based on Phase 2 reflections 
 
Design of interview schedule 
Following transcription and checking of each participant’s Phase 2 reflection/s the 
doctoral student read each several times along with their Phase 1 interview 
transcript.  She considered the Phase 2 reflection/s in relation to the Phase 1 
interview, the domains of the TDF and the additional Phase 1 themes of 
experience and multi-disciplinary working.  The doctoral student developed some 
generic questions for use each time “You said … Can you say a bit more about 
this, please?”  She contextualised these for each reflection and identified key 
sections and aspects which she wanted to explore using more specific 
questioning.  The doctoral student prepared an interview schedule based on each 
Phase 2 recording by annotating the relevant transcription electronically using 
track changes with questions which she would ask.  During the interview there 
was scope to ask additional supplementary questions where the doctoral student 
felt this was appropriate.  Two examples of these annotated reflections used as 
interview schedules may be seen in Appendix 5.2.  These were chosen as 
illustrating the approach taken by the doctoral student when preparing for the 
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interview; note that supplementary questions would also be asked as seemed 
appropriate.  
 
 
Phase 3 interviews based on Phase 2 reflections 
The doctoral student e-mailed each participant to arrange a suitable day and 
time for the Phase 3 interview, which at participants’ requests were again held in 
their workplaces.  On the day of the interview the same standard operating 
procedure as in Phase 1 (Appendix 4.3) was used but in addition the participant 
and the doctoral student listened to the recording/s prior to each interview so as 
to refresh participants’ memories of their reflections.  Each participant was then 
interviewed by the doctoral student who as above used an electronic version of 
the annotated Phase 2 reflection to guide the interview.  This was done to 
facilitate the interview process; the doctoral student found the text and 
annotations easier to read on the laptop screen than they would have been on 
paper.   
 
5.2.4.4 Data analysis 
 
Transcripts were analysed using the same Framework Approach as in Phase 1 
(Ritchie et al. 2014).  Although the TDF domains of optimism and reinforcement 
were not perceived by participants in Phase 1 interviews as influential they were 
retained in the coding frame for completeness.  The additional Phase 1 themes of 
multi-disciplinary working and experience were also included.  
 
One transcript (Nurse 5, 1st reflection) was discussed and analysed by TM, SC, 
DS and KFM together to agree the approach to coding.  Remaining transcripts 
were analysed by the doctoral student and one of SC, DS and KFM and any 
differences in coding resolved by discussion.  
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Table 5.1 Stages in thematic analysis of Stage 3 transcripts using the Framework 
Approach (Ritchie et al. 2014) 
Step Process 
Data familiarisation Recordings were listened to by the doctoral student 
after each interview, during transcription accuracy 
checking and during analysis.  Transcripts were 
similarly read, annotated and reviewed repeatedly by 
the doctoral student and her supervisory team to allow 
familiarisation with the data and to facilitate analysis 
Identifying constructs 
(categories of 
analysis) 
TDF domains + additional Phase 1 themes of multi-
disciplinary working and experience were used a priori 
as principal categories of analysis and additional 
emerging principal and subordinate categories added as 
transcripts were coded.  Coding was done by the 
doctoral student and by one of the supervisory team; 
duplicate analysis of transcripts was shared.  Coding 
was discussed and agreed with any disagreements 
being resolved through discussion   
Indexing Use of NVivo® software facilitated creation and ordering 
of principal and subordinate categories of analysis 
creating hierarchies 
Charting 
 
Representative illustrative quotations were selected 
from the categories of analysis.  These quotations were 
reviewed, discussed and agreed by the supervisory 
team  
Mapping and 
interpreting 
Principal and subordinate categories of analysis were 
considered in relation to each other and grouped 
thematically, creating themes and sub-themes.  This 
allowed influences on participants’ prescribing decision-
making to be elucidated 
 
 
5.2.4.5 Processing transcripts using NVivo® 
 
NVivo® 10 (QSR International Pty Ltd. 2016) was again used by the doctoral 
student to facilitate data handling and analysis, including identification and later 
use of agreed representative quotations (Creswell 2013).  This was an iterative 
process.  Based on the doctoral student’s experience in analysing Phase 1 
transcripts, fewer subordinate categories of analysis were created during analysis 
of Phase 3 interviews.  Figure 5.1 shows the broad coding of Phase 3 interviews 
and illustrates the detailed coding of the principal categories of analysis 
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“environmental context and resources” and “knowledge”, producing subordinate 
categories.  Note that “delayed prescriptions” was used as a data cache for 
future use. 
 
 
Figure 5.1 Screen shot showing coding of Phase 3 transcripts in NVivo® 10 
   
5.3 Findings 
 
5.3.1 Summary of Phase 2 reflections  
 
All Phase 1 participants except Pharmacist 6 recorded one, two or three 
reflections on prescribing decisions they had made which they considered 
noteworthy in relation to their practice.  Pharmacist 6 had agreed to participate 
in all three phases of the study but withdrew after Phase 1 due to pressure of 
work.  Nurse 2 recorded two reflections and returned the recorder to the doctoral 
student; she then recorded a third reflection, had it transcribed and sent it to the 
doctoral student by e-mail.  Recorded reflections lasted between 1 minute 31 
seconds and 10 minutes 30 seconds; one participant recorded all three 
reflections together and some made multiple partial recordings of the same 
reflection.  Of note, none of the participants contacted the doctoral student after 
collection of their digital recorders to ask whether what they had done was 
appropriate, suggesting that they had no doubt about the suitability of their 
reflections.  Table 5.2 details the duration of participants’ Phase 2 self-recorded 
reflections.      
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Table 5.2 Phase 2 self-recorded reflections: participants and duration of 
recordings  
Participant Reflection 1 Reflection 2 Reflection 3 
Pharmacist 2 2 minutes 45 seconds ____ ____ 
Pharmacist 3 6 minutes 6 seconds ____ ____ 
Pharmacist 4 3 minutes 14 seconds 4 minutes 39 seconds ____ 
Pharmacist 5 3 reflections,  
10 minutes 30 seconds 
in total 
As in Reflection1 As in Reflection 1 
Pharmacist 6 Did not participate in 
Phase 2 
____ ____ 
Pharmacist 7 3 minutes 25 seconds 7 minutes 36 seconds ____ 
Pharmacist 8 1 minute 52 seconds ____ ____ 
Pharmacist 9 1 minute 32 seconds 2 minutes 14 seconds ____ 
Nurse 1 2 minutes 3 seconds 3 minutes 4 seconds ____ 
Nurse 2 
(multiple 
recordings) 
3 minutes 44 seconds  2 minutes 19 seconds 1 transcribed and 
sent in by Nurse 2 
Nurse 3 7 minutes 28 seconds 3 minutes 1 second ____ 
Nurse 4 
(multiple 
recordings) 
9 minutes 59 seconds 6 minutes 48 seconds 3 minutes 
Nurse 5 1 minute 31 seconds 1 minute 12 seconds ____ 
 
 
Participants’ reflections encompassed a very wide range of prescribing decisions 
made, as is shown in Table 5.3 (page 225) below.   
 
Transcriptions of two self-recorded reflections are included below: Pharmacist 5, 
reflection no.2 and Nurse 1, reflection no.2.  These reflections were selected by 
the doctoral student as evidencing many of the domains of the TDF found 
influential in Phase 1 and the sort of patient-centred, multi-disciplinary approach 
to prescribing decision-making participants described taking throughout the 
study.  The remainder of Phase 2 transcripts are given in Appendix 5.3.   
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Pharmacist 5 reflection no. 2  
Reflection on a prescribing decision involving multi-disciplinary team working for 
a patient with advanced heart failure. 
 
“My second reflection was during my heart failure clinic recently.  I’ve a fairly 
new patient and she’s a very frail, elderly patient, Stage NYHA 3 [New York Heart 
Association] heart failure.  She’s an amputee also.  She presented on an extra 
appointment because she’d had orthopnoea and was now showing PND 
[paroxysmal nocturnal dyspnoea].  She had been unable to lie in her bed and 
was sleeping on an arm chair.  When I examined her she was full of fluid and she 
was taking her furosemide em, as well as she could em, so that she could get to 
the bathroom but I’m not convinced she was taking the complete, full dose. 
 
Her renal function was very poor and her eGFR was 30 although her potassium 
was OK.  She was clearly having an exacerbation so I had to prescribe for this 
patient and I was comfortable to prescribe for her because I was able to examine 
her and I knew what I was doing, I felt competent.  The son had managed to 
bring her in with real difficulty and this, this was because she had to try and get 
her, her leg on because she was an amputee and of course her stump was even 
full of fluid so it was a desperate situation and we didn’t want to admit her to 
hospital because she had recently had an exacerbation and was admitted for a 
stay and was keen for me to try and keep her out of hospital where possible.   
 
What I did was talk to her about the need for really, really good compliance on 
her furosemide and I prescribed her some more furosemide.  I also added in 
spironolactone 25 and commenced her on this and explained how that would 
work and what type of medication it was and the need for compliance.  What I 
would have liked to give this patient was metolazone but because her renal 
function was so poor I didn’t feel comfortable that I could give the metolazone so 
I actually referred her to the local cardiologist to be seen as soon as possible, 
and he saw her then she presented again in another week and he said it was OK 
to go ahead with the metolazone with close monitoring. So because I had his 
opinion as well, I went ahead with the metolazone. 
 
Normally I would be comfortable to do that but the renal function was really poor 
and I was putting more pressure on it with increasing the compliance on the 
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furosemide and commencing her on the spironolactone.  I reviewed the patient 
again and we were able to get the district nurses to call and keep a very, very 
close eye every three days on the renal function, because, on reflecting back, 
that was one of the reasons I was very happy to look after this patient because I 
had the cooperation of the cardiologist and also the cooperation of the district 
nurses willing to do the, the U and Es [urea and electrolytes], bloods and I knew 
that I could have the lady in, brought in by her son so that I could examine the 
patient, and she, I saw again, actually, today and she is doing really well.  So on 
reflection, I feel that I, we have kept this lady out of hospital and she is on the 
mend and improving, albeit with very, very close monitoring so I think quality of 
life-wise, we have improved things for this lady.  She’s able to lie down in bed 
with quite a few pillows and she has been kept out of hospital which is really, 
really important for her.” 
 
Nurse 1 reflection no 2 
Reflection on a decision to prescribe diclofenac suppositories for a patient 
receiving palliative care. 
 
 “I had a patient with terminal GI cancer.  She wasn't used to taking medication, 
she was quite naive with medication and she had previously had chemo so was 
still suffering the after-effects of having a metallic taste of everything in her 
mouth.  She didn't really want a lot of pain killers although she was experiencing 
increased pain and really had asked for sort of anti-inflammatories because she 
had perceived this pain as inflammation coming from her tumours.  She had 
previous experience of using suppositories for constipation, again she just 
seemed to prefer using the, the rectal route to treat her constipation rather than 
trying anything orally.  And I think with her advancing cancer that she'd really 
come off of med, come off managing to take very much by mouth at all.   
 
I went to see her and she was complaining of increased pain and I made the 
decision we should maybe try and use Voltarol® suppositories for her, because 
this was a patient who was quite experienced in using suppositories, although 
not for, for pain.  She did have 'just in case' medication in the house and she 
also had a bottle of Oramorph® which she, she hadn't even opened. 
The alternatives were to set up a syringe driver.  One of the, the influences on 
my prescribing for this that, we actually had a, quite a bad weekend of snow 
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forecast and she lives in a very rural area so I was a bit concerned that if we 
were to set up a syringe driver, would we physically manage to be there, to, you 
know, within 24 hours to fill this up?  
 
She was opioid naive, as I, as I said earlier, so really wasn't appropriate to be 
thinking about giving her IM injections of, of controlled drugs.  She'd had a quite 
a rough week, with a lot of emotional exhaustion and although she hadn't been 
eating much that week we, neither the patient or myself were unsure if this was 
actually coming up to her end of life care or whether she was just exhausted so I 
didn't want to rush in with a syringe driver either. 
 
I prescribed a certain dosage, I, I did actually phone the chemist, just to see if 
they had this type of medication in stock because it's quite an unusual 
medication to prescribe.  He did have one however it wasn't the, the usual dose, 
I normally would have prescribed 75mg twice a day.  He only had 100mg 
available so I made a decision to prescribe 100mg just once a day for her.  It 
was an unusual prescription for me to write but it meant that the patient had her 
pain, had an option to, to try and control her own pain over the weekend, and it, 
it worked quite well, so that was.”    
 
5.3.2 Summary of Phase 3: interviews based on participants’ Phase 2 self-
recorded reflections. 
 
As described, participants were interviewed about their Phase 2 reflections.  
Table 5.3 below gives the details of participants, the duration of each interview 
and the prescribing decisions chosen by them for reflection.
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Table 5.3 Stage 3 interviews: participants, duration of each interview and prescribing decisions they chose for reflection   
Participant Duration of interview Area for reflection 
Pharmacist 2 35 minutes  
41 seconds 
The influence of a Medical Registrar on Pharmacist 2’s decision about which antibiotic to prescribe for 
an infected post-operative wound  
Pharmacist 3 33 minutes  
7 seconds 
Prescribing a new oral then an intravenous magnesium supplement for a patient receiving 
chemotherapy 
Pharmacist 4 
no.1 
29 minutes 15 
seconds 
Re-starting tiotropium for a patient with COPD; the tiotropium had previously been stopped by the 
patient’s GP 
Pharmacist 4 
no.2 
33 minutes  
31 seconds 
In community pharmacy, refusing a second request for an emergency supply of a salbutamol inhaler 
Pharmacist 5 
no.1 
15 minutes 
9 seconds 
Difficulty of eliciting sufficient information to make a prescribing decision for an Eastern European 
patient taking warfarin who didn’t speak English 
Pharmacist 5 
no.2 
13 minutes  
21 seconds 
Multi-disciplinary team working for a patient with advanced heart failure whose quality of life was 
rapidly deteriorating 
Pharmacist 5 
no.3 
11 minutes  
54 seconds 
Hand-writing prescriptions considered time consuming, unprofessional and a barrier to timely provision 
of medicines 
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Participant Duration of interview Area for reflection 
Pharmacist 7 
no.1 
5 minutes  
58 seconds 
Prescribing malarial prophylaxis for a patient in a community pharmacy travel clinic; described by 
Pharmacist 7 as a straightforward consultation 
Pharmacist 7 
no.2  
19 minutes  
18 seconds 
Prolonged discussions about travel medicine requirements with a patient in a community pharmacy 
travel clinic 
Pharmacist 8 26 minutes  
33 seconds 
Responding to a patient’s request to stop her antihypertensive medicine as the patient thought she was 
taking too many tablets  
Pharmacist 9 
no.1 
12 minutes  
31 seconds 
Responding to a request to prescribe Gaviscon® liquid for a very young and premature infant.   
Pharmacist 9 
no. 2 
15 minutes  
40 seconds 
Prescribing allopurinol for a patient with gout: the importance of careful monitoring and clear 
communication 
Nurse 1  
no.1 
23 minutes  
1 second 
Treating over-granulating tissue at the site of a percutaneous endoscopic gastrostomy for a terminally 
ill patient 
Nurse 1  
no. 2 
23 minutes  
56 seconds 
Prescribing diclofenac suppositories for a terminally ill patient nearing the end of her life 
Nurse 2 
no.1 
16 minutes  
25 seconds 
Prescribing for increasing and distressing breathlessness in a patient with pulmonary fibrosis 
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Participant Duration of 
interview 
Area for reflection Duration of interview Area for reflection 
Nurse 2 
no.2 
12 minutes  
47 seconds 
Prescribing for colicky pain and flatulence  in a patient with pancreatic cancer   
Nurse 2  
no.3 
18 minutes  
39 seconds 
Prescribing for a patient with vulval cancer who was experiencing heavy bleeding and pain. The patient 
was already receiving treatment for a deep vein thrombosis 
Nurse 3 
no.1 
11 minutes  
52 seconds 
Managing a request by a new patient for tapentadol, a Schedule 2 Controlled Drug.  A GP colleague 
had recently refused this request 
Nurse 3  
no.2 
8 minutes  
24 seconds 
Prescribing for a child requiring antibiotics for a sore throat.  The child had been allergic to first and 
second line antibiotics already prescribed for this episode  
Nurse 4  
no.1 
13 minutes  
52 seconds 
Managing a mother’s request for antibiotics for a child with intermittent fever who was not particularly 
unwell 
Nurse 4  
no.2 
13 minutes  
36 seconds 
 A life threatening situation due to a patient inadvertently taking an overdose of opiates from her 
multi-compartment compliance aid 
Nurse 4 
no.3  
9 minutes  
34 seconds 
Managing a request for antibiotics from the wife of a patient who was not unwell 
Nurse 5  
no.1 
7 minutes  
2 seconds 
Managing a patient’s request to reduce the dose of simvastatin he was taking 
Nurse 5  
no.2 
10 minutes  
26 seconds 
Managing a patient’s request for an antibiotic in case a healthy post-operative wound got infected 
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5.3.3 Thematic analysis of interviews  
 
As in Phase 1 (Chapter 4) transcripts were analysed thematically using the 
Framework Approach (Ritchie et al. 2014).  The framework of principal 
categories of analysis developed in Phase 1 was used as the initial coding 
framework for these Phase 3 interviews; although the TDF domains of optimism 
and reinforcement were not perceived by participants in Phase 1 interviews as 
influential they were retained in the initial coding framework for completeness.  
The additional Phase 1 themes of multi-disciplinary working and experience were 
also retained as principal categories of analysis.   
 
On analysis again neither optimism not reinforcement emerged as influences on 
participants’ prescribing decision-making.  “Complexity”, encompassing patients’ 
clinical conditions, therapeutic choices, clarity of information presented and 
patients’ wider concerns was added to the framework of principal categories of 
analysis.  Note that as in Chapter 4 “Delayed prescriptions” had been added as a 
data cache for possible future use; it did not emerge as an influence on 
participants’ prescribing decision-making. 
 
Again as in Phase 1 the principal and subordinate categories of analysis which 
emerged from the data were considered in relation to each other, allowing the 
identification of themes and sub-themes.  Table 5.3 shows the themes and sub-
themes identified as being influential in the prescribing decisions participants 
chose for reflection.   
 
Table 5.4 Themes and sub-themes identified from Phase 3 interviews as 
influences on participants' prescribing decisions  
Theme Sub-theme 
Knowledge Knowledge of the condition 
Knowledge of the medicine 
Knowledge of the patient 
Skills Communication skills 
Calculation skills 
Clinical assessment skills 
Dealing with a complex emergency situation 
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Theme Sub-theme 
Social/ professional 
role and identity 
Role as a nurse 
Role as a pharmacist 
Role as prescriber 
Roles of other healthcare professionals 
Beliefs about 
capabilities 
Confident in own ability 
Lack of confidence in own ability  
Capable in addressing patients’ wishes 
Beliefs about 
consequences 
Consequences for the patient 
Consequences for the patient and for the prescriber 
Consequences for colleagues 
Intentions Patient benefit 
Follow evidence-based guidelines 
Provide reassurance 
Try to mitigate prescribing against the evidence 
Take account of patients’ intentions 
Goals Patient benefit 
Allow natural healing/ don’t treat 
Balance between evidence-based medicine and patients’ 
wishes 
Treat patient in most appropriate setting 
Memory, attention 
and decision 
processes 
Remembering clinical information 
Unreliability of memory 
Attending to patients’ wishes 
Using available information 
Step-wise decision-making process 
Heuristics 
Previous experience 
Environmental 
context and 
resources 
Colleagues and other healthcare professionals 
Evidence-based resources 
Availability of laboratory testing 
Availability of medicines from pharmacies 
Practice setting and physical environment 
Social influences Colleagues 
The patient and patient’s family 
Emotion Feeling worried 
Feeling uncomfortable 
Feeling satisfaction 
Feeling empathy and sadness 
Behavioural 
regulation 
Stay within competence 
Minimise prescribing of antibiotics 
Reflection 
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Theme Sub-theme 
Multi-disciplinary 
working 
Advice from pharmacists 
Working with nurses 
Ancillary help 
Experience Experience of clinical condition 
Experience in general 
Others’ experiences 
Complexity Patient's clinical condition  
Therapeutic choices 
Unclear or incomplete history 
Patients’ wider concerns 
 
 
5.3.3.1 Knowledge 
 
Participants considered themselves knowledgeable in their prescribing 
areas and described in their reflections how they used this knowledge.  
Knowledge of the condition being treated, the patient and of medicines were 
important influences, allowing prescribers to tailor their prescribing 
appropriately.   
 
Knowledge of the condition 
Pharmacist 2’s patient was being given an intravenous antibiotic for an  
infected wound.  She described the knowledge she used to judge that it  
would be appropriate to change this to an oral antibiotic and the consequent 
benefit to the patient.   
 
“Well vancomycin's obviously an intravenous antibiotic and the, once 
the infection has or is showing signs of response that there wasn't as 
much puss discharge, his legs weren't as red as they were before, he 
wasn't developing temperatures.  All those things show that the 
infection was settling to such a point that he could be switched to an 
       oral option to allow him to go home, ‘cause obviously with intravenous 
antibiotics he has to stay in hospital.” 
Pharmacist 2, secondary care, female. 
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Nurse 3 was treating a patient with a hypersensitivity reaction to penicillin and 
knew what the next step should be.   
 
“It was quite straightforward, you know, hypersensitivity really, you know 
just a bit of a prickly rash, vomiting, diarrhoea, you know, not too unusual 
so we decided to stop penicillin and I went to the second one on the 
formulary.” 
Nurse 2, primary care, male. 
 
NMPs must practice within their own self-assessed areas of competence.  
Pharmacist 4 recognised when her knowledge was insufficient and referred 
patients on in those circumstances.   
 
“It’s not the first time I've come across cases of angina, or query heart 
failure, not that I'm expert in that but, I would generally know that these 
symptoms are not the same as COPD, there's something else going on, so 
would refer back to the doctor on that.” 
  Pharmacist 4, primary care and community pharmacy, female. 
 
Knowledge of the medicine 
Nurse 1 and her patient had decided that diclofenac would be an appropriate 
drug to treat what her patient perceived as inflammation.  Nurse 1 based her 
selection of the rectal route of administration on her knowledge of the drug’s side 
effect profile and on the patient’s preference. 
 
“So when I was thinking well I have to get diclofenac into her, she doesn't 
really want to take anything orally and also if she's not eating then it's not 
really safe for her to be taking it because you’re supposed to have it with 
meals.” 
Nurse 1, primary care, female. 
 
Nurse 2, prescribing to try to alleviate her patient’s frightening breathlessness, 
chose lorazepam based on her knowledge of its pharmacokinetics.  
 
“That's the particular drug that we were recommended again, when I was 
studying breathlessness, that it was recommended that we used lorazepam 
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because it could be halved and it could be giving in such a small dose 
because it could be absorbed sublingually.” 
 Nurse 2, primary care, female. 
 
Pharmacist 2 was faced with a dilemma where what she knew about an 
antibiotic’s suitability for her patient contrasted strongly with what she knew 
about the attitude of the Registrar on the ward to that particular antibiotic.  
 
“I was sort of looking to, there's a great big list of sensitivities and I was 
going through and I'd say ‘Well, can't, he's penicillin allergic, he can't have 
that’ and then I came to the, the doxycycline.  I thought ‘Oh doxycycline, 
that's probably quite a good option’ and then I thought ‘Oh no.’  I just 
ended up thinking to myself ‘No’, ‘cause I know that somebody's going to 
come along and say ‘Oh’, you know, ‘Why, how did you go for that?', you 
know, ‘We're not sending him home on that.'”  
       Pharmacist 2, secondary care, female. 
 
Knowledge of the patient 
Participants took into account what they knew about their patients’ 
circumstances and their preferences for care when prescribing.  Nurse 1 
described what she knew about her patient and her attitude to taking medicines.  
 
“She was about 69 years old, she was a farmer’s wife who'd been a teacher, 
a very practical lady, very matter of fact about everything that was 
happening, didn't want to go into hospital … I think she was quite resistant 
to using medication, she wasn't the type of person that takes a painkiller for 
a headache, for example.” 
Nurse 1, primary care, female. 
 
Nurse 3 similarly evaluated his patient’s attitude towards tapentadol, the 
controlled drug he had requested.  
 
“He came in with a crutch, he was struggling to walk … He was sort of, I 
think ‘cause he'd been on [tapentadol] for so long this was his other crutch 
if you like.  You know, he was, he was quite worried being off it I think.” 
Nurse 3, primary care, male.   
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Nurse 4 was asked for antibiotics by the mother of a child with an intermittent 
fever; Nurse 4 took into account not just the child’s symptoms but also what she 
knew of the mother’s circumstances. 
 
“She [the child] did have a fever.  It wasn't all the time, it was responding, 
it was responding to paracetamol and ibuprofen and then she [the mother] 
was worried she was going to be working all weekend and she wanted the 
girl treated.” 
Nurse 4, primary care, female. 
 
When Nurse 4 was called out to visit an elderly patient by her son part of her 
difficulty was that she had no up to date information about the patient. 
 
“He said she was lethargic and she'd been vomiting and he hadn't indicated, 
you know, often people say ‘I need somebody out right away’ you know, 
and he hadn't said anything like that.  I suppose I was sort of thinking she's 
not a particularly well lady.  I knew she was having, I know she'd had 
chemo and radiotherapy in the past, I knew she had bisphosphonate 
treatment as well, and I didn't, I hadn't seen her for a while so I didn't 
exactly know at what stage of all of that she was at.” 
Nurse 4, primary care, female. 
 
Pharmacist 7 prescribes for travel medicine, where knowledge of the patient’s 
travel plans is essential to allow the appropriate recommendations to be made.  
He reflected on a consultation where this information was not available.  
 
“Essentially the, the lad couldn't tell me exactly where he was going and 
when.” 
 Pharmacist 7, community pharmacy, male.    
 
5.3.3.2 Skills 
 
Participants described using a range of skills to inform their prescribing decision-
making, particularly communications skills but also skills in physical assessment, 
calculations and the ability to balance complex, conflicting responsibilities.   
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Communication skills 
Nurse 2 explained to her patient how she hoped the drug tranexamic acid might 
work to control the patient’s bleeding.   
 
“Just really saying to her ‘Well, you know, in respect of your, the bleeding 
that you're having we can try this drug which works at capillary level, 
which will hopefully reduce the bleeding that you're experiencing.’  And I 
explained it was used for ladies whose periods were very heavy and, you 
know, that's why we knew it could at times be beneficial and we would 
hope that it would be effective for her and it wouldn't stop the bleeding 
but it might reduce it and make it less frightening and alarming for her.  
And I said ‘Was she happy with that?’” 
Nurse 2, Primary care, female. 
 
Nurse 4 had a phone consultation with the mother of a sick child during which 
she tried to assess the child’s illness and any need for a face to face consultation.     
 
“I was sussing out what the story was and deciding what to do next so, and 
it all sounded that she was well and I was trying to just advise the mum 
over the phone and say ‘All is well’ but she was insisting on being seen.” 
Nurse 4, primary care, female.  
 
Pharmacist 7 had a very frank conversation with his teenage patient to clarify the 
possible risks he might face during his overseas trip.  
 
“The key thing was to be absolutely upfront and spell things out in plain 
English.  So we had to highlight the risks around tattoos, around sex, sexual 
activity and around drug use, so by spelling it out, you know, he was of an 
age where straight talking wasn't a problem so we could have a straight 
conversation and he understood exactly what the risk were and if he 
chooses to then behave in a way that puts himself at risk he does so 
knowing the risks and that's the best we can do sometimes.” 
Pharmacist 7, community pharmacy, male. 
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In reflecting on her difficult interaction with a medical colleague Pharmacist 2 
identified the need to develop her consultation skills to prepare for possible 
future interactions with medical prescribers. 
 
“But there probably isn't anyone who could essentially go in and overrule a 
Registrar or a Consultant, but they may be able to support me to develop 
skills to almost negotiate or, if I felt that that was, that was what I needed.” 
Pharmacist 2, secondary care, female.  
 
Calculation skills 
Pharmacist 3 was prescribing Magnaspartate®, a new oral magnesium 
supplement in sachet form rather than the usual Maalox® suspension, and 
wanted to check that she had prescribed the correct dose. 
 
“What I also did was I checked the BNF for the magnesium content of 
Maalox® and we usually give, kind of, 20 to 40mls a day of Maalox®, and I 
checked the magnesium content of the sachets and made up an equivalent 
so it was double check for myself as well to make sure I was supplying an 
equivalent supplementation to what I had clinic experience of prescribing 
before.  So yeah, I checked up the two of those and that's how I did it.”   
Pharmacist 3, secondary care, female.  
     
Clinical assessment skills 
Pharmacist 5 considered that she had good clinical assessment skills but felt that 
her ability to have efficient patient consultations was compromised by her 
inability to generate computerised prescriptions.  
 
“Well I do things quite quickly, you know, as you're putting the cuff on 
you're asking some lifestyle questions and having a look at their legs before 
you turn back to the computer and, yeah, it's.  I'd like to think it's quite 
efficient but, but the actual writing just lets you down at the end of the 
consultation, I think.  Some people actually ask ‘Are you not going to print 
them? You've got a printer there.’” 
       Pharmacist 5, primary care, female. 
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Dealing with a complex emergency situation 
Nurse 4 was faced with a life-threatening emergency when she made her house 
call and described her conflicting responsibilities at that time. 
 
“I've had lots of experience of this over the years and those minutes while 
you're waiting for an ambulance are always difficult ‘cause you're sort of, 
you don't know what's happened often, you're trying to piece together the 
story, you're trying to deal with relatives and you're trying to think what to 
do and so it's, you know.” 
 Nurse 4, primary care, female. 
 
5.3.3.3 Social/ professional role and identity 
 
Participants’ professional roles as nurses, pharmacists and prescribers were 
influential.  Participants valued the role of prescriber for the opportunity it gave 
to care more directly for their patients but reported being acutely aware of the 
attendant additional responsibility.  A professional hierarchy was particularly 
problematic for one participant.   
 
Role as a nurse 
Nurse 1 reflected on the importance of meeting her patient’s expectation of the 
role of a nurse.   
 
“It's the whole bit as well about you have to always appear confident in 
front of your patients … Obviously the patient doesn't want a nurse coming 
and going ‘Oh my God, what's this?’ You know what I mean?” 
 Nurse 1, primary care, female.  
 
Nurse 1 also described making use of a particular sort of knowledge which she 
claimed as specific to nurses. 
 
“I tried to use something very simple, it maybe sounds really simple but I 
think it's often the daft wee things that nurses are really good at sorting.” 
Nurse 1, primary care, female. 
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Pharmacist 3, working in a nurse- and pharmacist-led ward, saw her nursing 
colleagues very much as partners to be involved in prescribing decision-making.  
“They're taking responsibility as well by administering the drug so they have 
to be confident that what they're doing is correct too, so they should be 
involved in, in, in those discussions too.” 
       Pharmacist 3, secondary care, female. 
 
Role as a pharmacist 
Pharmacist 4 compared the role of non-medical prescribers to that of medical 
prescribers and perceived a discrepancy.  
 
“And as non-medical prescribers, do we actually think we're as good as 
doctors? We might be in certain areas, I'm quite confident with the bits that 
I do but anything out with that haven't got, well, I've got a clue ‘cause I'm a 
pharmacist.” 
Pharmacist 4, primary care and community pharmacy, female. 
 
Role as prescriber 
Participants very much valued their prescribing roles and the benefits they could 
bring as prescribers to their patients.  At the same time they were aware of the 
additional responsibility prescribing brought and how that influenced their 
decision-making.  One pharmacist described how her inability to generate 
prescriptions electronically affected her perception of her role.  
 
Nurse 1 reflected on the benefit she and her patient experienced from her ability 
to prescribe.   
 
“I was glad I had the flexibility and being a prescriber really helped I think 
with that because having to come back and maybe negotiate that [using 
diclofenac suppositories] with a doctor who didn't know the patient, they 
might've queried why I was asking for it to be honest because, you know, 
‘Oh, just tell her to take her Oramorph®.’ It's like ‘Well, she's palliative, you 
know, she's got cancer so just to tell her to take her Oramorph®, that's 
what we give dying patients’ and sometimes that's not always what dying 
patients want, you know.” 
Nurse 1, primary care, female.  
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Nurse 3 described feeling additional pressure as a prescriber and what he did to 
mitigate that when writing up his notes of the consultation.  
 
“I think particularly as a nurse prescriber we're probably slightly more 
under the spotlight, and I think, you know, because it was, albeit I had lots 
of advice from the pharmacist, but it was my name on the prescription, I 
signed for it and issued it and what have you and so, probably put a bit 
more justification than you would do normally.” 
Nurse 3, primary care, male.  
 
Pharmacist 3 similarly felt additional pressure as a prescriber and compared 
prescribing to her previous role as a pharmacist.  
 
“And I think there's a big difference when you're prescribing or advising as 
a pharmacist.  When you've got that pen in your hand and you're putting 
your name to it there's a whole different feeling associated with that and it 
shouldn't, ‘cause if you're advising a doctor to prescribing, you know, you 
should be taking equal responsibility for that, you know, you're guiding, 
potentially a junior doctor, who's got very little experience, you know, you 
should, but it does feel different when your name, you know, you're putting 
your name to it.” 
Pharmacist 3, secondary care, female. 
 
Pharmacist 8 was clear about her responsibility as a prescriber and how she 
would respond in the event of what she perceived as an inappropriate patient 
request.  
 
“If you're the prescriber at the end of the day the buck stops with you 
whether the patient says ‘I want it’ or not and, I haven't had to do this yet, 
but it would be potentially a case of ‘Well I'm sorry, I’m not prescribing that 
for you.’” 
Pharmacist 8, primary care, female.  
 
Pharmacist 7 acknowledged experiencing a difficulty during patient-centred 
consultations. 
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“Yeah, and that I think was part of the learning, that we like to be right, 
anyone in health care likes to be right, that's just the nature of how we 
have to think.  So when I give someone advice and they choose not to take 
it I've got to get over my professional pride and accept that it's their 
decision.” 
Pharmacist 7, community pharmacy, male. 
 
Pharmacist 5 felt very strongly that hand writing prescriptions was unsafe; where 
she felt she had insufficient time to do this she used an alternative method to 
generate the prescription and had it signed by a GP.  She did not consider this as 
prescribing.   
 
“It's just, it’s just not possible to hand write so many items in the time 
really, and not very safe, ‘cause you've got to write.  We've then to enter 
them on the system and press F9 twice so that you've actually issued it, so 
you've got to, you've got to be careful that you've documented everything 
as well as showing that you've given the prescription, as well as hand write.  
So I must admit we just get the prescription team to run them off quite 
often but that's not very professional, you know.  I'd like to do the whole 
job, certainly at this stage, you know, a number of years down the line.” 
Pharmacist 5, primary care, female. 
 
Roles of other healthcare professionals. 
Albeit that participants were independent, autonomous prescribers they were 
subject to direction from those they perceived as clinical experts.  Participants 
found it difficult to challenge this.  Nurse 5 explained the reason for differences 
in statins prescribed for patients in her area.  
 
“Well, that's a difficult one, ‘cause we do try and follow the Grampian 
Formulary but then, he's the cardiologist in charge of them so we have to 
go with him as well.  So it's difficult to know which one, so if they were 
getting started off on a statin here, for any other reason, it would be 
simvastatin, but if he starts them on atorvastatin we just leave it.” 
Nurse 5, primary care, female. 
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Pharmacist 2 felt that the opinion of a Medical Registrar made it impossible for 
her to prescribe an evidence-based, licensed antibiotic to treat her patient’s 
infected wound.  
 
“…essentially you have your own knowledge base and your own experience 
but you've really got to work within the confines that, that the senior 
medical staff have as well, unless you can influence them in another way 
but yeah, you really, and it probably isn't until I've become a prescriber that 
I really appreciated how much you do feel confined by what the senior 
medical team, you know, by what their opinions are and what they prefer 
and what they like and don't like.” 
       Pharmacist 2, secondary care, female. 
 
5.3.3.4 Beliefs about capabilities 
 
Participants’ reflections evidenced differing levels of beliefs about their capability 
in making prescribing decisions.  In general they felt very capable, often because 
of familiarity with the situation, and believed they could make a difference to 
their patients but they were aware of their limitations and when to seek help. 
Some chose to reflect on situations where they had been aware of a lack of 
competence and on how they dealt with that.   
 
Confident in own ability 
Nurse 4 was confident in her ability to assess a child who presented with an 
intermittent fever. 
“Very confident.  I mean she was really well and, and I, I thought mum was 
happy when she went out that, you know, all’s well and mum was a bit 
apologetic when she came in because the child was obviously running 
around and, you know, growling like a lion at me.  Doing sort of ‘Arrghh.’ … 
It’s something that I deal with multiple times every day so yeah, confident.” 
Nurse 4, primary care, female. 
 
Pharmacist 3 felt very confident in prescribing an oral magnesium supplement for 
her patient, although much less so when required to prescribe the supplement 
for intravenous administration.  
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“And obviously because I'm so used to prescribing lots of different oral 
products and oral treatments, you know, it's, it's, you get very comfortable 
doing that.” 
Pharmacist 3, secondary care, female. 
 
“Well I prescribed per protocol but it's not something I usually have to 
prescribe. It's not something we generally have to deal with in the out- 
patient setting and, you know, I'm quite confident in advising on the 
magnesium infusions in the in-patient setting as well but there's, there's 
usually a medical staff that write it, or we guide them to write it up and 
they sign it.” 
Pharmacist 3, secondary care, female.  
  
Lack of confidence in own ability  
Participants felt less certain about their ability when making certain other 
prescribing decisions, often due to unfamiliarity with some aspect.  Nurse 3 
described his feelings when deciding to prescribe a previously-unknown 
controlled drug for a new patient. 
 
“There's always that bit of doubt when you've just looked something new 
up.  You always worry that you've maybe missed something or, you know, 
missed the point but.  Confident enough to give it to him but not enough 
that I would've, you know, bet my life on it at that point I don't think.  It 
didn't feel that particularly comfortable I suppose just ‘cause it's something, 
you know, controlled drug, quite strong and things.  I was happy enough to 
do it.  I think I'd covered, you know, the basics but obviously not as 
confident as I would've been prescribing something I knew more about.” 
Nurse 3, primary care, male. 
 
Where participants did not feel themselves capable they involved others, 
sometimes referring the patient on. 
 
“I felt it was the safest way.  I'm not sure I did it the best way, but I was 
adamant that I wasn't going to be looking after that patient on my own, 
no.” 
Pharmacist 5, primary care, female. 
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Capable in addressing patients’ wishes 
Participants did their best for their patients.  Pharmacist 5 described taking 
account of her patient’s wishes regarding treatment for her heart failure.   
 
“Even beyond that, you know, you can still do something with furosemide 
IV injection is another possibility, but yeah, until we've done everything we 
can, unless the patient feels that they would like to just be admitted, and 
they feel quite scared, but this lady didn't, she wanted to, to be at home, 
so, so yeah. I wasn't keen to admit her and she wasn't keen to go.” 
Pharmacist 5, primary care, female. 
 
5.3.3.5 Beliefs about consequences 
 
Participants’ reflections suggested that they put their beliefs about the 
consequences for the patient at the centre of their prescribing and this appeared 
as a strong influence.  They were also aware of consequences for themselves and 
for colleagues; after a difficult week one participant had to consider the 
consequences for her colleagues and make an uncomfortable prescribing 
decision. 
   
Consequences for the patient 
Nurse 5 was asked by a patient whether he could reduce the dose of simvastatin 
he took.  After discussion Nurse 5 agreed and wrote a new prescription; she was 
not concerned about any possible impact on the patient’s cholesterol.   
 
“I don't think it'll be much different actually, that's what I expect but, we'll 
wait and see.  ‘Cause he'd, he has quite a good lifestyle, he golfs quite a 
few times a week, he walks, plenty exercise and he's got a fairly good diet 
so I'm not expecting a huge rise in his cholesterol.” 
Nurse 5, primary care, female. 
 
Nurse 1 and her patient hoped that the decision to use diclofenac suppositories 
rather than strong opiates via a syringe driver would ensure a peaceful weekend 
for the patient and her family.   
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“But I think sometimes they could be a wee bit more creative about what 
they're putting into these patients because, you know, something like a 
diclofenac suppository, it just worked really well over that weekend and it 
avoided having to use a lot of controlled drugs, having to get a lot of 
strangers into the house.” 
Nurse 1, primary care, female. 
 
Nurse 2’s patient was experiencing a very dry mouth with her opiate analgesic; 
Nurse 2 decided to switch to another opiate in the hope that that would alleviate 
this. 
   
“I was hoping that just changing the preparation, because I have found in 
the past, when we've changed a preparation from one opioid to another, 
that often it suits the person, for whatever it is.” 
Nurse 2, primary care, female.   
Nurse 2 was also aware that her prescribing for another patient might result in 
polypharmacy, which she wanted to avoid. 
 
“Do you know, if I give him something that's going to act against his, his 
laxatives but then also cause a really dry mouth and he, you know, I'm 
going to end up prescribing him some artificial saliva to make up for that 
[laughs], and so it goes on and the patients just become totally bogged 
down with, with medications so, yeah, that was part of the process of 
reasoning to it.” 
Nurse 2, primary care, female.  
 
Nurse 4 had been asked to make a house call to an elderly, frail patient.  When 
she arrived she had no idea what had happened but very quickly realised that 
unless she did something the patient would die.    
 
“I've never, never come across a morphine toxicity like that before so.  And 
of course you don't know, even, you can formulate ideas on what you think 
it might be but you don't 100% know and so anything you do is a bit 
experimental really and, you know, certainly, you know, giving the Narcan® 
and I didn't know whether it was going to help or not help or anything 
really.” 
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Nurse 4, primary care, female. 
 
Pharmacist 2’s concern about feeling compelled to prescribe an unlicensed and 
possibly less-suitable antibiotic for her patient was driven in part by her 
expectation that forcing the issue and prescribing her first choice might delay the 
patient’s discharge from hospital.  
 
“But I thought if, if I prescribe and [the Registrar’s] not happy with it he 
may make the decision not to discharge the patient home which isn't good, 
for anyone really, particularly not for the patient if they've got to stay in 
longer.” 
Pharmacist 2, secondary care, female.  
 
Pharmacist 3, prescribing an intravenous infusion product for the first time, was 
very aware of the possible consequences for the patient of errors in the 
prescription.   
 
“In an intravenous product it's, you're working out a calculation for the 
volume to add to the bag, you need to make sure the bag, you've got 
enough volume in your diluent because if it's, you know if it's too 
concentrated is that going to cause an extravasation for the patient. Also 
the administration rate, is it gonna [sic] cause side effects if it's given too 
fast or too slow etc.” 
Pharmacist 3, secondary care, female. 
 
Consequences for the patient and for the prescriber 
Nurse 3 was treating a child with a bacterial sore throat who had been allergic to 
the first and second line antibiotics.  He considered the consequences for the 
child when deciding whether to try a third antibiotic.  He also considered whether 
he needed to get help from a colleague and decided he did, recognising a 
possible consequence for him as prescriber. 
 
“I felt that on balance the child was more likely to become unwell from not 
being treated and that's why we used the clarithromycin. … Yeah, I thought 
I better ask ‘cause it was getting a bit weird and wonderful so I didn’t want 
to get into trouble. ” 
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 Nurse 3, primary care, male. 
 
Consequences for colleagues 
Sometimes participants had to consider possible consequences for colleagues as 
well as the patient when making prescribing decisions.  At the end of a difficult 
week Nurse 4 was faced with fierce demands for an antibiotic from the wife of a 
healthy, symptom-free patient, just in case he developed a chest infection.  To 
protect her colleagues from further difficulty with the woman Nurse 4 prescribed 
an antibiotic as a delayed prescription which could not be dispensed until the 
following day.  She fully expected the patient to take it regardless of his 
condition.   
 
“I just said to him I didn't think he should start it at the moment. I said, 
‘You know, you're fine just now, but,’ I said ‘If your chest gets worse, if you 
feel you're coughing up sputum and, you know, things are going downhill 
then to start it’ and I just explained it would be, he wouldn't get it until 
tomorrow. … ‘Cause I know occasions where I have given delayed scripts in 
the past that's exactly what's happened, they've just gone out and taken it 
and, and then you get them back saying 'Oh, it didn't agree with them' or 
whatever.  So, which is a reason why I don't generally give delayed scripts 
either but on this occasion I decided that was probably the best thing to 
do.” 
Nurse 4, primary care, female. 
[A delayed prescription in this context is one which is post-dated, preventing the patient 
from having it dispensed that day but allowing this possibility should the condition 
deteriorate over the following days] 
 
5.3.3.6 Intentions and 5.3.3.7 Goals 
 
In Phase 1 interviews the research team perceived some overlap between the 
domains of intentions and goals.  It was not always straightforward to 
differentiate between them or to do this consistently and they were therefore 
considered together.  In Phase 3 interviews, differences between these domains 
were identified more readily by the research team.  This may be because in 
Phase 2 and 3 participants were reflecting on actual prescribing decisions made 
rather than considering theoretical influences; their intentions and goals may 
have been more to the fore in their reflections.  Participants’ goals were 
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identified as being broader and longer-term, albeit that the episodes of care 
being considered were sometimes quite brief, whereas intentions generally 
referred to short term actions which participants felt were likely to help to 
achieve their goals for that patient or more generally.   
 
5.3.3.6 Intentions 
 
Intentions were considered as participants’ behaviours which contributed to the 
achievement of their own or their patients’ goals.  Again participants had their 
patients at the heart of their prescribing and intended to do their best for them.  
They described following evidence-based guidelines, trying to mitigate 
prescribing against the evidence and taking account of patients’ intentions. 
 
Patient benefit 
Pharmacist 5 explained her intention to prescribe a complex combination of 
drugs requiring intensive monitoring which she felt would improve her patient’s 
condition long term.  
 
“The metolazone if we, if we use that combined with the loop diuretic you 
get a very good diuresis but with her renal function I wasn't sure if I could 
just do that.  And I wanted to give her the spironolactone ‘cause she was 
Stage 3 [NYHA] and that would give her long term benefit.” 
Pharmacist 5, primary care, female. 
 
Following evidence-based guidelines 
Pharmacist 3’s prescribing in a specialist area was influenced by a very strict 
protocol which she intended to follow. 
   
“So again, as well as per protocol, if their levels drop before a certain, if the 
levels drop below a certain level and they're symptomatic you should 
initiate IV treatment so that's what I wanted to do.” 
Pharmacist 3, secondary care, female. 
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Providing reassurance 
Nurse 4 is a nurse practitioner and was speaking on the phone to the mother of a 
child with an intermittent fever.  Her intention was to reassure the mother but 
this proved difficult.  
“I was sussing out what the story was and deciding what to do next so, and 
it all sounded that she was well and I was trying to just advise the mum 
over the phone and say ‘All is well’ but she was insisting on being seen.” 
Nurse 4, primary care, female.  
 
Trying to mitigate prescribing against the evidence 
In her second reflection Nurse 4 outlined her decision to prescribe what she 
thought was an un-necessary antibiotic prescription in response to patient 
pressure.  She wrote a delayed prescription and described how she intended it 
should be used. 
 
“And so I, as, you know, I'm not, I'm not used to doing it, but I did sort of 
consciously think ‘Well, I know, I think people usually give it two days 
delayed’ but because it was Sunday I thought I better do it for Saturday.  I 
just, I just thought ‘We'll have other issues if we, if they can't get it on the 
Sunday and there's hassles, you know, she'll be in complaining again.’” 
Nurse 4, primary care, female. 
 
Taking account of patients’ intentions 
Pharmacist 7 had to take into account his patient’s intention not to follow his 
advice on appropriate travel medicines.  
 
“So the initial consultation highlighted the key recommendations and that 
formed part of the recommendation.  When he then came back the second 
time, he had agreed to that part, but not to the other parts.” 
Pharmacist 7, community pharmacy, male.   
 
5.3.3.7 Goals 
 
Participants were reflecting on discrete prescribing decisions made either within 
an episode of care or as part of on-going management of patients’ long term 
conditions.  Whichever was the case they expressed broad goals which influenced 
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their prescribing; these concerned achieving patient benefit, treating 
appropriately in the most appropriate setting and balancing evidence-based 
medicine and the patients’ wishes. 
 
Patient benefit 
Nurse 1 explained that some patients were reluctant to take medicines at all, 
even when they were indicated for serious conditions.  She then explained how 
she took account of what she perceived as her patient’s goal when making her 
prescribing decision. 
 
“We often have to encourage people to use drugs and we start with basic 
ones like paracetamol and ibuprofen and then we can build them up to the 
more controlled drugs but I had tried that with her in the past, just sort of 
saying 'Well maybe try taking the paracetamol’, but she’d refused that.”  
Nurse 1, primary care, female.   
 
“She just wanted to be on her own that weekend with the family.  I think if 
I'd given her the option she would've put up with the pain rather than 
having a lot of interference over that weekend.  So this was just, you know, 
trying to alleviate some of the pain and let her have her last weekend with 
her family.” 
Nurse 1, primary care, female. 
 
Allow natural healing/ don’t treat 
Sometimes participants felt that ‘no treatment’ was the best treatment.  
 
“I think sometimes it's the whole bit about not prescribing something. So 
letting something just naturally heal itself and get on with it, you know, it's, 
I think it's probably the best bet.” 
Nurse 1, primary care, female. 
 
Balance between evidence-based medicine and patients’ wishes 
Pharmacist 8 reflected on two opposing goals: those of evidence-based practice 
and of the patient. 
“We discussed the risks, you know, of why we try and control the risk 
reduction and why we try and control blood pressure, cholesterol, those 
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kind of things and I felt she understood and that, you know, she was 
cognitively aware and could make that informed decision that ‘Actually I 
don't want to take anything further.’” 
Pharmacist 8, primary care, female. 
 
Treat patient in most appropriate setting 
As part of ensuring best care for their patients participants wanted to ensure that 
treatment would be provided in the most appropriate setting.  Pharmacist 5 
explained the rationale for her heart failure clinic.  
 
“But the aim of the clinic is really to keep patients free of exacerbations but 
to keep them out of hospital, to try and treat them in the primary care 
setting, that's really the aim of our clinic, is to do what we can here.” 
Pharmacist 5, primary care, female. 
 
Nurse 4 described her feelings on finding out that the child with intermittent 
fever whom she had assessed as not requiring antibiotics had then been taken to 
the out of hours service where she had been prescribed them. 
 
“Annoyed.  Yeah, it is annoying ‘cause I think it encourages people to keep 
coming then, you know, if they, if they, if they think ‘Oh, I'll get it at A&E’ it 
means that, that it encourages, you know, further contacts at A&E ‘cause, 
which is what we don't want, which is what we're all striving to avoid.” 
Nurse 4, primary care, female. 
 
Only Nurse 5, discussing with a patient his desire to reduce his statin dose, 
appeared to have the goal of sticking to the formulary. 
 
“Really just the, you know, the knowledge of the SIGN guidelines and the 
practice protocol, you know, that the lower cholesterol the better for 
cardiovascular, less clots, things like that, so, you know, telling him that.” 
Nurse 5, primary care, female. 
 
Pharmacist 3, explaining her decision to discuss her prescribing decision with a 
medical colleague, described her personal goal.   
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“To be totally honest, I wanted to cover myself because I had recognised 
that she needed intravenous treatment, or the protocol recommended 
intravenous treatment and if I didn't act on that and something happened 
to the patient I would be responsible for that so I went to someone senior 
to me to get advice.” 
Pharmacist 3, secondary care, female. 
 
5.3.3.8 Memory, attention and decision processes 
 
In these reflections participants described some of the thinking processes which 
informed their prescribing decision-making.  As experienced practitioners they 
had a rich fund of memories of previous experiences on which to draw although 
one or two were aware that their memories might not always be reliable and 
described approaches taken to compensate for that.  Participants paid attention 
to various and varied sources of information.  Most described taking what 
seemed to be a careful, rigorous and step-wise approach in their decision 
processes although heuristics and played a part in familiar situations and again 
previous experience was important. 
 
Memory 
 
Remembering clinical information 
Nurse 4, faced with a woman dying from a suspected opiate overdose, 
remembered essential information about using the antidote Narcan®. 
 
“And I remember, you know, the discussions, talks about Narcan® that it's 
very short lived when given IV and that, to always follow up with an IM 
dose.  I don't know why I remember that.  And I always carry two, I just 
carry two Narcan®.  I suppose that's so that I'd remember to give the 
second dose.” 
 Nurse 4, primary care, female. 
 
Unreliability of memory 
Sometimes participants were less sure of the accuracy of their memories, as with 
Pharmacist 9, prescribing for a very young and premature infant.  
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“‘Cause sometimes your brain tricks you and you're never sure whether 
you're making this up or whether you have seen this before.  And I did 
think I had seen it before which is why I went to the [name of children’s 
hospital] ‘cause I knew it had come from them.  If I wasn't making it up it 
had come from them, the whole liquid preparation.  And when she said to 
me that it was for breastfeeding women it kind of all just made perfect 
sense really.” 
Pharmacist 9, primary care, female. 
 
Pharmacist 2 prescribed in a nurse- and pharmacist-led ward but within the 
confines of a prescribing culture dictated by senior doctors.  She described the 
difficulty of remembering Consultants’ preferences and how she and colleagues 
managed this.  
 
“It is quite tricky, it's remembering which Consultant likes what and which 
Consultant likes something else.  We've actually got a chart up on the wall 
that tells us for somethings so that we remember.” 
Pharmacist 2, secondary care, female. 
 
Attention 
Participants paid attention to and took account of a wide range of information 
when making prescribing decisions.   
 
Attending to patients’ wishes 
Information about the patient’s wishes, however expressed, was important.  
Nurse 5 had a patient who was very keen to reduce the dose of his statin.  
 
“I would've, yeah, I might've contemplated ‘cause his cholesterol was so 
low, 3.2, but he was right in on it at the beginning before I had ever 
thought of it.  I just said, you know, your cholesterol’s 3.2, and he pounced 
on me, he pounced on me there and said, you know, about reducing it.” 
Nurse 5, primary care, female. 
 
Pharmacist 8 described becoming more accepting of patients’ wishes which 
contrasted with the recommendations of evidence-based guidelines.  
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“So I am much more relaxed in, in a lot of circumstances, that if the patient 
is aware and they understand why we're suggesting it but they say 
‘Actually, no I don't want it.’ It's their choice.” 
Pharmacist 8, primary care, female.  
 
Nurse 1 was influenced by her patient’s suggestion of the rectal route of 
administration for an anti-inflammatory drug. 
 
“… when we came time to think about diclofenac I wouldn't normally have 
thought of suppository, it was her that gave me the idea.” 
Nurse 1, primary care, female. 
 
Using available information 
Nurse 1 described her thinking when trying to decide on the strength of 
suppository to prescribe, based on local availability and her perception of the 
patient’s and family’s best interest.  
 
“Actually I could just phone the pharmacist in [name of town] and see what 
they've got in stock.  And I phoned and he said ‘Oh I've got some but 
they're 100mgs’ and I thought ‘That's not a great dose but that's probably 
better than the family getting stressed out and spending all their last 
weekend going about trying to access a 75mg dose’ so that was why she 
got the 100.” 
Nurse 1, primary care, female. 
 
Nurse 3 had some difficulty deciding how to respond to a request for strong pain 
killers from a new patient and was reassured when the patient produced a 
previously dispensed packet. 
 
“There was a label on the box that was recently dated and I thought ‘Oh, 
you couldn't have got that without somebody sort of having provided it for 
him’ so, yeah, I was happy enough.” 
Nurse 3, primary care, male.  
 
Decision-making processes 
Participants described some of their decision-making processed very clearly.  
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Step-wise decision-making process  
Nurse 1 had taken a step-wise approach to treating her patient’s over-
granulating tissue. 
 
“So that, that was why I decided, well you know, the first option of just 
leaving it well alone hadn't worked, the second option of, of using a mild 
cream, a mild honey ointment hadn't worked so now we were really 
bringing on the strong guns.” 
Nurse 1, primary care, female. 
 
Pharmacist 2 took great care when calculating the amount of magnesium to 
prescribe for an intravenous infusion.  
 
“I think just ‘cause I hadn't done it before, it was the first time I'd 
prescribed the intravenous fluids I was triple, quadruple checking 
everything and obviously because there's a calculation involved as well of 
how much of magnesium to add to the bag.” 
 Pharmacist 3, secondary care, female.  
 
Heuristics  
Sometimes decision-making was informed by heuristics rather than by the 
evidence.    
“’Cause generally we would say ‘Right, it's most likely to be’ ‘cause of the 
type of wound it is, we would say ‘It's most likely to be a skin commensals 
organism so it's most likely to be a staff or strep’ so it'd be a flucloxacillin, 
vancomycin, that's what we, it'd be standard and usually most patients 
respond really well to it.” 
Pharmacist 2, secondary care, female.  
 
Previous experience 
Fortunately not all decisions were difficult to make; familiarity with prescribing 
the medicine in a different context or with the situation itself both facilitated the 
process.  Pharmacist 4 is an experience community pharmacist as well as a 
prescriber.  
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“So my idea is if I can sell it to you over the counter I fail to see why I can't 
prescribe it ‘cause it's no different from counter prescribing.” 
Pharmacist 4, primary care and community pharmacist. 
 
Pharmacist 7 described one travel medicine consultation as very straightforward.    
 
“I'd been there before, in fact that patient, when they came and presented, 
they presented with a scenario that they had presented with several times 
previously.” 
Pharmacist 7, community pharmacy, male.   
 
5.3.3.9 Environmental context and resources 
 
The environmental context within which participants made their decisions was 
important.  Participants worked in multi-disciplinary teams and sought advice 
from colleagues, especially GPs for those in primary care, using them as valued 
resources to augment and confirm their own decision-making in the event of 
uncertainty. There seemed to be less mention of referring to evidence-based 
guidelines and little mention of the Grampian Joint Formulary compared with 
Stage 1 interviews.  Knowledge of such guidelines seemed tacit and participants 
rather described consulting more specialist guidance when needed.  The setting 
for prescribing decision-making could be influential where this precluded access 
to important information; the location of pharmacies and their stock held could 
also influence the decisions made.  In one case the patient’s home setting was a 
key influence given a poor weather forecast.  
  
Colleagues and other healthcare professionals 
All participants worked in teams and colleagues, particularly GPs in primary care, 
were regarded as a valuable resource influencing some prescribing decision-
making.   
 
Some participants like Pharmacist 5 specifically described having a GP mentor 
while others did not, but all valued the input of medical and other colleagues.   
 
“Again, we've got a GP mentor and he's a cardiac GP, for the practice really, 
so he was aware of what I was doing with her.  I mean, after she'd gone 
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[the patient], you know, I sometimes give updates, so I'd given an update.  
He agreed with what I'd done.” 
Pharmacist 5, primary care, female. 
 
Nurse 5 sought help from a GP when trying to reassure a patient with a large but 
healthy post-operative wound on his neck.  
 
“But he [the patient] said ‘Well, maybe it's okay today but what if it's like 
this tomorrow or the next day?  It means I've to come back.’  And that was 
when I did speak to the GP about it just to hopefully back me up, which she 
did, and we discussed the possibility of a delayed script so it would, you 
know.  Explained when to take it and if it did get more swollen or he felt 
unwell or pyrexial just to start taking before he actually came back to us.” 
Nurse 5, primary care, female.  
 
Pharmacist 3 was uncertain whether her patient’s deteriorating condition 
necessitated a return to hospital and asked a medical colleague for help.  
 
“It was either gonna [sic] go two ways.  The doctor would've phoned and 
made her come in or I, or they would've said it was okay for her to stay at 
home and then obviously I've discussed with someone senior who's taken 
responsibility for that care and we've made a joint decision that it's safe 
enough for her to stay at home.  So that was the rationale for that.” 
Pharmacist 3, secondary care, female. 
 
Pharmacist 4 consulted with a range of experts including other pharmacists 
through her membership of a professional organisation.  
 
“I do have people I can talk to and I'm also in UKCPA [United Kingdom 
Clinical Pharmacy Association] so I know Consultant pharmacists down in 
England, they don't have that post in Scotland, who are respiratory 
consultants.  So it's not the first time I've sent off an e-mail to them and 
said ‘Any, any ideas?’” 
       Pharmacist 4, primary care and community pharmacy, female. 
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Nurse 2 had a specialist role and worked across several practices.  She described 
the difference in her approach in a practice where she didn’t normally work and 
in one where she did.   
 
“I spoke to the GP, because it's a practice that I don't normally work with I 
felt I should discuss it with the GP and he was absolutely fine, but, yes, I 
involved him in as well.  As I say, because I don't know the practice and I 
didn't feel I could just barge in and say ‘Well, I'm changing things’, although 
he had asked us to see the lady, but I didn't want just to, just professional, 
etiquette and courtesy really.” 
Doctoral student: and if it had been a practice where you were familiar with the 
doctors and so on, would you still have consulted them or would you just? 
“I probably wouldn't, I would probably just have done it and then 
documented in the patient's notes that I had done that.” 
       Nurse 2, primary care, female.  
 
Nurse 2 also consulted experts out with her own immediate sphere; for her the 
local hospice was a source of advice and support.  
 
“I mean if, if I had been really troubled by it and thought ‘Do you know, I 
can't do this on my own’, I would've phoned [name of hospice] and spoken 
to the pharmacist there or [name of doctor] who's the, one of the palliative 
care Consultants there.” 
       Nurse 2, primary care, female.  
 
Evidence-based resources 
Nurse 3 had prepared his own resource which he and his colleagues used during 
discussions with patients or their families about the need for antibiotics. 
 
“It [the Centor criteria for predicting bacterial infection in acute sore 
throats] is in the Clinical Knowledge Summary thing that we use quite a bit 
so I made a poster to put on the wall just so we can, ‘cause quite often 
parents will argue till they're blue in the face that they need something so 
we can say ‘Well, you know, that's what we work from.’” 
Nurse 3, primary care, male.  
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[Clinical Knowledge Summary is an online resource prepared by the National 
Institute for Health and Care Excellence for primary care healthcare professionals.] 
 
More specialist evidence-based resources were used to inform certain prescribing 
decisions.  Pharmacist 9, prescribing Gaviscon® liquid for a very young and 
premature infant, used specialist local guidance.  
 
“I do think I contacted other sources and was able to contact a specialist, 
which effectively is what the pharmacist at the [name of children’s hospital] 
is, and there was, there is NHS Grampian guidance on the use of this 
product because it's the protocol that they use in [name of children’s 
hospital].  Yes, I take a bit more personal responsibility when I'm 
prescribing an unlicensed medicine but there is evidence for its more 
common use in that specialist area and with the backing of a specialist and 
written guidance in NHS Grampian I felt more comfortable with it.” 
       Pharmacist 9, primary care, female.  
 
Pharmacist 3, prescribing for a patient receiving chemotherapy whose 
magnesium level was falling, appreciated having clear guidance to inform her 
prescribing decision.  
 
“So again, as well as per protocol, if their levels drop below a certain, if the 
levels drop below a certain level and they're symptomatic you should 
initiate IV treatment so that's what I wanted to do.” 
       Pharmacist 3, secondary care, female. 
 
Availability of laboratory tests 
Nurse 5 described the laboratory test data which she took into account when 
consulting with her patient wishing to reduce the dose of his statin.   
 
“They [blood lipid levels] get done a week or two beforehand so that we've 
got the results, the full blood count, U and E's, LFTs, lipids and glucose, 
fasting glucose, so we have all the results for the clinic so we can speak 
about them then and relate them to medication and symptoms.” 
       Nurse 5, primary care, female. 
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Availability of medicines from pharmacies 
Some participants described being influenced in their prescribing by what they 
knew of the likely availability of specific medicines through pharmacies. Nurse 2 
made her selection of a buccal analgesic in this way.   
“…actually the Actiq® lozenge I think, I'm sure I prescribed that one 
because that's the one that [name of hospital] has in their pharmacy… and, 
you know, [name of village], it was going to already be the next day before 
they could get it anyway.” 
       Nurse 2, primary care, female.  
 
Practice setting and physical environment 
The patient for whom Pharmacist 3 was prescribing was judged well enough to 
have her magnesium infusion in the out-patient setting; this influenced the 
prescribing decision.   
 
“That's the protocol, so, magnesium, the slower you give it the better 
results you get ‘cause you get better uptake, so the, ideally it's over 12, 10 
hours, but you can give it a lot quicker.  So just to do with timing of the day 
unit, when it was open, we decided on 8 hours and that's the longest we 
were able to give it to her over for the time that we were open.” 
       Pharmacist 3, secondary care, female. 
 
Pharmacist 4, working as a community pharmacist and dealing with a second 
request for an emergency supply of salbutamol inhaler, also felt that her decision 
was influenced by her practice setting. 
 
“It's more difficult in the shop ‘cause you don't have a lot of background 
information and he wasn't one of our patients so we didn't have a PMR on 
him, apart from this emergency prescription that we'd done two days 
earlier, which was a bit of a giveaway I have to say.” 
Pharmacist 4, primary care and community pharmacy, female. 
 
The weather and the location of the patient’s home were less-obvious but 
important influences on the decision Nurse 1 made to prescribe diclofenac 
suppositories in preference to administering analgesics via a syringe driver.  The 
patient was a farmer’s wife and lived a long way up in the hills.  
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“And we'd had discussions because we knew that particular weekend that 
there was snow forecast and that's always a bit of a worry, you know, when 
you've got any patients but particularly those in the out-lying regions, you 
know.  ‘Can I physically get to the end of your road?’” 
       Nurse 1, primary care, female.    
 
5.3.3.10 Social influences 
 
Social influences and particularly the influence of patients and sometimes their 
families were important.  Participant’s reflections suggested that as far as 
possible, and as far as they judged appropriate, patients’ ideas, concerns and 
expectations about their condition were addressed carefully.  Sometimes the 
ideas and concerns of family members and their expectations for antibiotics were 
problematic and resulted in possibly inappropriate (delayed) prescribing of 
antibiotics.  Participants reporting this were concerned about possible short and 
long-term consequences for the patient and others.   
 
Colleagues 
Nurse 1 described feeling under pressure from her colleagues and consequently 
the patient, when treating an over-granulating wound at the site of a PEG 
feeding tube. 
 
“There was a bit of influence I think on me because my staff nurse was so 
concerned as well, she was.  I did feel a bit of pressure from her, thinking 
'You know, she's really expecting me to do something now' and because 
she'd gone and got me and put me in front of the patient the patient was 
almost expecting something a wee bit stronger as well.” 
       Nurse 1, primary care, female. 
  
Pharmacist 2 was concerned about her medical colleague’s likely response to the 
antibiotic prescribing decision she wanted to make.  She was aware too of a 
hierarchy which made it difficult for her to challenge her colleague’s attitude. 
 
“Because I felt that … that the Reg, one of the, well particularly one of the 
Registrars, I thought they might come along and change or disapprove of 
one of the treatment choices.  So, yes, I was left with a choice of two, but I 
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almost felt I wasn't left with a choice because I didn't feel I could go down 
one route because of what other people thought about it.” 
Pharmacist 2, secondary care, female. 
 
“I always feel that if it's a Registrar whose, whose influence, or who's 
making the decision it should be someone on the same grade or above if 
you're wanting to try and influence them to come round to.  But obviously if 
you go to two or three Registrars and they all say no, they don't agree with 
you twice then it's kind of right.” 
Pharmacist 2, secondary care, female. 
         
Nurse 2, prescribing in a specialist area, was often asked for advice by others 
including GPs.  
 
“Often he, you know, particularly this GP'll say ‘I just want to see if you've 
got any suggestions, if we can, you know, if we can make things any better 
for this person, or if you would change anything.’” 
       Nurse 2, primary care, female. 
 
Pharmacist 9 had also considered her colleagues’ feelings and patient pressure 
but in a different way.  She issued what she considered an unnecessary 
prescription for an antibiotic in response to the behaviour of a patient’s wife 
towards practice staff, and reflected on her feelings afterwards.   
 
“But the practice manager after seeing the wife, I think she'd had a really 
hard time with the wife and had sort of commented to me that she'd said 
‘I'll pay for the antibiotics’, you know, jokingly, but yeah, she'd had a 
difficult time with her.” 
Pharmacist 9, primary care, female. 
 
“Perhaps I'm weak, perhaps I should've just, you know, done the education 
bit but I, I don't know, it's so.  It’s difficult enough educating people when 
they haven't got fixed ideas about things but when you've got them and 
they've got a fixed idea it's really hard.  And we're up against it all day long, 
you know, we, we really, it's, it's something that's just constant all day and 
it is hard keeping it up.” 
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Pharmacist 9, primary care, female. 
 
The patient and patient’s family 
The social influence of the patient was a strong influence on participants’ 
decision-making and all put the patient at the centre of their prescribing.  Nurse 
2 prescribed taking account of her patient’s desire not to be overly sedated.   
 
“She's a very happy, smiley lady, lovely woman, and her family and her 
friends meant a great deal to her, so while she also wanted to be pain free 
she didn't want to be knocked out all the time because she still wanted to 
be able to interact with her visitors.” 
       Nurse 2, primary care, female. 
 
Pharmacist 7 felt that educating his patient about the health risks of various 
behaviours was important.  
 
“So we had a conversation about the kind of activities he might be involved 
in which would increase his risk and once he understood, in plain English, 
what to do and not to do, he was able to make a, a, well, what I thought 
was a, a value judgement.” 
       Pharmacist 7, community pharmacy, male.  
 
Pharmacist 8 listened to her patient’s priorities and respected them. 
 
“She was very strong in her views and didn't, I guess if I had pushed and if 
it was something critical to her health I, she may have been persuaded but 
I didn't feel, I didn't feel the need, or the desire, to push her into taking 
something that she clearly wasn't happy to take.” 
       Pharmacist 8, primary care, female.  
 
Patients’ family members could also contribute to influencing participants’ 
prescribing decision-making.  Nurse 2 described the input of her patient’s 
husband. 
 
“Yes, her husband was present during the visit and he, he, he was adding 
wee bits on and you know, he was saying, you know, it was quite a 
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distressing side effect for her, if indeed that's, it was the Oramorph® 
causing it, seemed to be in relation to her having taken it that her mouth 
became very, very dry so she would drink…” 
Nurse 2, primary care, female. 
 
Nurse 4 dealing with a dying woman described the difficulties of trying to meet 
the needs of the patient and her son. 
 
“And he was sort of pacing around shouting and saying ‘Oh, she's not been 
well for ages and something's got to be done’, you know, so there was, it 
was kind of dealing with him and dealing with her at the same time.” 
Nurse 4, primary care, female.  
 
5.3.3.11 Emotion 
 
Participants included and discussed the emotions they felt during the incidents of 
care they chose for reflection.  Participants worried about the possible impact of 
some of their prescribing decisions on patients and felt uncomfortable about 
others.  On the other hand they felt their prescribing roles allowed them to make 
a difference to patients’ lives and found this satisfying and rewarding, if 
sometimes emotionally challenging.   
  
Feeling worried 
Pharmacist 2 worried about the impact on the patient of her preferred choice of 
antibiotic; she also worried about the un-licensed status of what she suspected 
she would prescribe instead.  
 
“What my worry was, if I prescribed it and the, the wound wasn't 
responding as quickly as maybe the registrar wanted it to, possibly 
because he had it in the back of his mind he didn't like the antibiotic, I 
wouldn't want him to jump in quickly and change the antibiotic and not 
give it the time to work because of his sort of negative connotations for 
the antibiotic and then you end up with a patient who's getting chopping 
and changing treatment and ends up in hospital longer … The only slight 
concern I had [about prescribing cotrimoxazole] was that, obviously, 
cotrimoxazole is unlicensed in the UK.” 
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         Pharmacist 2, secondary care, female. 
 
Pharmacist 3 had prescribed an oral magnesium supplement and her patient had 
gone home, then Pharmacist 3 learned that the patient’s magnesium level was 
falling.  
 
“And then by the time the results came back she'd gone home so it was 
like ‘Oh my God.’  Diff, you know, it was difficult, like what I said, I wanted 
her to come back straight away because symptomatic, drop, levels are 
dropping.  I was worried she was going to become maybe clinically 
unwell.” 
Pharmacist 3, secondary care, female. 
 
Pharmacist 4, having refused to make an emergency supply of a salbutamol 
inhaler, worried about the consequences.  
 
“I did actually worry about it a wee bit afterwards, I was fully expecting a 
phone call from some irate GP chappy to say ‘What on earth were you 
thinking of?’ you know, etc, but no, nothing ever happened so I was 
right.” 
Pharmacist 4, primary care and community pharmacy, female. 
 
Feeling uncomfortable 
Nurse 4 described how her emotional state at the end of a long week influenced 
the decision she made to prescribe a delayed antibiotic in response to pressure 
from the wife of a patient.  She also described her feelings afterwards. 
 
“Yeah, I just, I think I just felt so battered that week with other things 
that had gone on, I thought ‘I don't think we can handle the wife just 
causing hassle’ so I thought probably the best way would be a delayed 
script.” 
Nurse 4, primary care, female. 
 
“I didn't like doing it. I, you know when you've decided somebody doesn't 
need something it's, it's annoying to have to give it but, sometimes in this 
job you can't do the right thing.  It’s just, you know, if you don't give, 
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something happens and then, you know, you're made to feel guilty and if 
you do give it, you know, it's, you can't, you can't do the right thing 
sometimes.” 
Nurse 4, primary care, female.  
 
Pharmacist 5 described how her inability to prescribe electronically impacted on 
her sense of whether or not she was actually prescribing.  
 
“Aye, but sometimes you know they're coming to sit in and they're very 
obviously with the clinic and then you're handwriting and they're like ‘Why 
are you not printing it?'  We can't really, so I don't know, it's really 
frustrating. … I probably wouldn't really [consider it as prescribing], 
probably wouldn't, although I've done all the background work. I probably 
wouldn't because it hasn't got my signature on it, so I probably wouldn't, 
no, no.  It's a shame.” 
         Pharmacist 5, primary care, female. 
 
Feeling satisfaction  
Nurse 1 described her satisfaction at having the ability to prescribe in a difficult 
situation.   
 
“So I think I really appreciated being able to prescribe exactly what we 
thought would be a good idea at the time and it worked really well.” 
Nurse 1, primary care, female. 
 
Pharmacist 8 felt satisfied after agreeing with her patient to stop the patient’s 
antihypertensive drug.  
 
“I felt quite happy as well because I knew it, it was what the patient 
wanted.  Yeah, and I felt it was a, it was a good outcome all round.  I 
know her blood pressure wasn't at the magic number but in looking at the 
patient as a whole and holistically, I think it was, it was a good outcome.” 
Pharmacist 8, primary care, female. 
 
Pharmacist 5 was also satisfied with the outcome of her prescribing for her 
patient with heart failure. 
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“If you get a bit of fluid off and combine with the spironolactone often we'll 
find they're more comfortable and they're not wakening up breathless.  
Yeah, so that was what happened in this case which was rewarding.” 
Pharmacist 5, primary care, female.  
 
Feeling empathy and sadness 
Nurse 2 described being able to relate to the fears of her patient with 
breathlessness. 
 
“I suppose just, I felt empathy toward her because I do understand how 
frightening it is.” 
Nurse 2, primary care, female. 
Nurse 1 became upset when describing the circumstances of the patient for 
whom she prescribed diclofenac suppositories. 
 
“Yeah, just because she'd had such a rough week.  She'd had a horrible 
emotional week where, I mean she, you know, as I sort of said she was a 
very practical, down to earth sort of lady and we didn't do a lot of tears 
[laughs].  She'd be laughing now if she could see me sitting crying about 
her.” 
Nurse 1, primary care, female. 
 
5.3.3.12 Behavioural regulation 
 
Participants appeared to have reflected very carefully on the noteworthy 
prescribing decisions they had made.  Some described aspects of self-monitoring 
and action planning, for example in connection with staying within areas of self-
assessed competence, minimising prescribing of antibiotics and seeking 
additional training to support prescribing decision-making. 
 
Staying within competence 
Pharmacist 5 explained her reluctance to prescribe warfarin for her Eastern 
European patient.  
 
“I'm always very cautious to make sure you don't prescribe out with the 
comfortable competence area.” 
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         Pharmacist 5, primary care, female. 
 
Minimising prescribing of antibiotics 
Nurse 4 described the impact of antimicrobial stewardship policies on her 
prescribing and that of her colleagues.  
 
“Trying to educate health care professionals to avoid giving antimicrobials 
and I think, you know, our prescribing as a practice here is low and we, 
you know, we're very, very conscious of it here but it's not the same 
everywhere.”   
Nurse 4, primary care, female. 
 
Reflection 
Finally, Pharmacist 2 reflected on her experience of being influenced by the 
opinions of a more senior colleague.  
 
“It's really made me think about how, you know, how I take on other 
people's perceptions of what you should and shouldn't prescribe and, and 
making sure that, I suppose in this scenario I could take this on board and 
make a, still make a valid treatment choice for the patient but there may 
be situations where you can't and to make sure you don't allow that to 
essentially influence your prescribing choice in a negative way so that 
you're, you're not, doing what's best and what's most evidence-based and 
that'll give the patient the best benefit.”  
Pharmacist 2, secondary care, female. 
 
5.3.3.13 Multi-disciplinary working 
 
All participants practised within multi-disciplinary teams and within a wider multi-
disciplinary context.  Team dynamics were important and generally participants 
described working with colleagues and others in a collaborative and positive way.  
Participants described the influence of pharmacists, nursing colleagues and 
ancillary help to support their prescribing decision-making.   
 
Pharmacist 5 listed the colleagues in her practice who had been directly involved 
with the care of her patient with advanced heart failure; this is included as an 
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illustration of one aspect of multi-disciplinary working, but it also appears within 
other themes.    
 
“Well the lead nurse also participates in the heart failure clinic, so she was 
involved in her care, and the GPs had seen her also.  Now I'm trying to 
remember back, I'm sure she's also diabetic so the doctor that deals with 
that would've seen her.  She had a few call outs from the surgery so there 
would've been a few different, different GPs and actually also the nurse 
practitioner had been out at her as well, and has been out since, yeah, so, 
yeah, quite a few people would be seeing her.” 
Pharmacist 5, primary care, female. 
 
Members of the multi-disciplinary team were valued for the support they 
provided to participants who were making difficult prescribing decisions.  This 
could be information on therapeutic choices, where pharmacists played a key 
role, ancillary support or ensuring a team-based approach to treatment.   
 
Advice from pharmacists 
Nurse 3 was treating a child with a sore throat caused by a bacterial infection; 
the child had been prescribed and been allergic to the first and second line 
antibiotic treatment.  Nurse 3 was uncertain what to prescribe for the child and 
described seeking help from the practice pharmacist. 
 
“So that obviously presented quite a challenge for where we went next 
cause the formulary doesn’t really offer an alternative after that [second 
line therapy].  So it involved a lot of digging through the BNF and, to be 
honest, I wasn't able to make a firm conclusion.  I had to get the practice 
pharmacist to come and have a look at it with me.” 
Nurse 3, primary care, male. 
 
Pharmacist 9 similarly sought help from members of the wider team when 
considering a request to prescribe Gaviscon® sachets for a very young and 
premature infant.  
 
 250 
 
“Yeah, phoned Drug Info or phoned [name of children’s hospital] or phone 
the pharmacist that’s a specialist in the area on the ward that they're in, 
yeah, quiet happily.” 
Pharmacist 9, primary care, female. 
 
Working with nurses 
Pharmacist 3 described the importance of involving her nursing colleagues in her 
decision to prescribe intravenous magnesium supplementation for a patient 
experiencing a side effect of chemotherapy.  Pharmacist 5 similarly recognised 
the importance of a multi-disciplinary approach.   
 
“It was just trying to engage with them as well and bring them into the, 
the process without my just saying ‘This is what you have to do’, you 
know.  It should be, you know, collaborative and discussing with them too 
that they were happy giving it.” 
Pharmacist 3, secondary care, female. 
  
“Even with the district [nurses] they're in the same building, yeah, and I 
think you have to have the cooperation of all the team.  You can't just 
prescribe and hope for the best.” 
Pharmacist 5, primary care, female. 
 
Ancillary help 
Other members of the multi-disciplinary team provided valued prescribing 
support by carrying out blood and other tests which would inform participants’ 
prescribing decision-making.  
 
“So again the phlebotomist could check.  At the same she did fasting 
glucose, cholesterol, weight, she checked his U and Es [urea and 
electrolytes] as well for his kidney function and she's able as well to do 
the, the cardiovascular disease risk assessment ‘cause it's on the 
computer, the ASSIGN score.” 
Pharmacist 9, primary care, female. 
 [ASSIGN is a cardio-vascular disease risk scoring system]. 
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5.3.3.14 Experience 
 
Participants were all experienced practitioners and all but one experienced 
prescribers; some described using previous experience to inform their prescribing 
decision-making.  Participants described the influence of clinical and practice 
experience and also described benefitting from the experience of others.  
 
Experience of clinical condition 
Pharmacist 9 described how her experience in treating gout gave her confidence 
when speaking to her patient about the condition. 
 
 “I've looked at gout quite a lot actually ‘cause again the clinic that I ran as a 
cardiovascular clinic, and gout and cardiovascular disease tend to run 
alongside so gout’s an area I've kind of added onto my cardiovascular profile 
if you like.  Because, because you see it a, a lot of the elderly people we have 
in sometimes present with gout as well so it's an area that I have looked at 
so, yeah.  I was very confident to speak to him about it.” 
 Pharmacist 9, primary care, female. 
   
Nurse 2 prescribes for patients receiving palliative care and explained how 
sometimes just having an effective remedy to hand is sufficient to help 
patients. 
 
 “Often I find that just prescribing the lorazepam and them having that wee 
bottle in the house is enough to calm them down sufficiently that they don't 
actually ever use it.” 
 Nurse 2, primary care, female. 
 
Practice experience 
Pharmacist 4 is a very experienced prescriber and has run prescribing clinics 
since 2005.  She found this experience helpful in giving her confidence to  
re-start tiotropium for a patient with COPD where this had been stopped  
the patient’s GP. 
 
“So I am quite comfortable with that but then I've been around for  
a while so I suspect a lot of it's to do with my, my experience of dealing 
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with other healthcare professionals.”   
Pharmacist 4, primary care and community pharmacy, female. 
 
Pharmacist 4 also used her experience when deciding whether or not to 
make an emergency supply of a salbutamol [bronchodilator] inhaler to 
the same patient two days after a previous supply.   
 
“And if in doubt I would've given it, but no, no, that young lad, that 
particular young man, you've got to be joking.  I've been around long 
enough to know a scam when I see one.” 
Pharmacist 4, primary care and community pharmacy, female. 
 
Others’ experiences  
For Pharmacist 2, the influence of a medical colleague’s previous experience with 
the antibiotic doxycycline was so strong that it dictated her selection of another 
antibiotic.  
 
“He just doesn't like it.  He feels that, it's doxycycline that he doesn't 
approve of, it's a bacteriostatic antibiotic, so he feels that if it's 
bacteriostatic it's not going to have as good effect as a bactericidal 
antibiotic and he has had previous experience of that particular antibiotic 
not working very well.” 
Pharmacist 2, secondary care, female. 
    
5.3.3.15 Complexity 
 
During analysis the complexity of the prescribing decisions chosen for reflections 
became apparent.  This could be in relation to the patient’s clinical condition or 
pharmacotherapy, an unclear or incomplete history, their social or other 
circumstances, their wider concerns behind the condition being treated, the 
availability of support from other members of the multi-disciplinary team and so 
on.  Participants described making their prescribing decisions taking in to account 
this complexity.  It is considered under the following headings: 
 
 patient's clinical condition or pharmacotherapy 
 unclear or incomplete history 
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 patients’ wider concerns 
 
Patient’s clinical condition or pharmacotherapy  
Pharmacist 5 described the difficulty of balancing the risks and potential harm of 
medicines in a patient with advanced heart failure. 
 
“It's always a case of balance, giving the diuretics and getting them, trying 
to getting them towards symptom free and yet being aware of what the 
renal function is, but we can do, if the district nurses are willing, we can 
do like bloods say every three day and that's the kind of thing we do if 
we've got them on a high level of medication.” 
Pharmacist 5, primary care, female. 
 
Nurse 2 was treating a patient with vulval cancer who was experiencing very 
heavy bleeding.  The patient was already taking an anti-coagulant for an 
unrelated condition and she and Nurse 2 were concerned about possibly 
dangerous overlap between therapies.   
 
“I was really trying to elicit from her what she saw as her main problems 
and I think physically the two things that really scared her were the fact 
that she bled and would she bleed to death.  Would she start walking 
about one day and she would bleed so much she would die?  But if we 
stopped her dalteparin [anticoagulant] which she was on, would she just 
drop dead like that because a blood clot moved?  And she was very 
frightened of that.” 
Nurse 2, primary care, female. 
 
Unclear or incomplete history 
Pharmacist 5 was asked to see a temporary patient who was requesting warfarin.  
The patient couldn’t speak English and even with the Language Line translation 
service it was almost impossible for Pharmacist 5 to make sense of the 
information gleaned from the patient.  In the end Pharmacist 5 decided not to 
prescribe for the patient but to pass her on to a GP colleague.   
 
“She [the patient] couldn't tell me exactly the condition, maybe that was 
the problem with the translator as well, but they couldn't actually tell me 
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the condition that the doctor was treating, just that she'd had it at home 
and she was definitely on it, which I actually didn't believe, because of the 
INR, and the fact it'd been a gynae [sic] doctor that had given them.  But 
she couldn't tell the background and I thought ‘Has it been for post-
operative or something?’, but it was bizarre.  It didn't fit the normal 
indications that we normally prescribe for.” 
Pharmacist 5, primary care, female. 
 
Patients’ wider concerns 
Sometimes much more lay behind what appeared to be a relatively 
straightforward, discrete condition.  Nurse 1 was treating over-granulation at a 
PEG tube insertion site and described the critical importance of this to the 
patient.  
 
“She came home to die basically and we did support her for 4 months, 
which was a massive undertaking for the team.  So she already had a lot 
of anxieties about this PEG feed ‘cause she kind of knew that if this wasn't 
working then the alternative was she was going to have to go back into 
hospital for her care.  So I really didn't want to give her any more distress 
because it wasn't going to input much, you know, but in her eyes it was a 
problem with the feed and if she had problems with the feed then she 
wasn't going to be able to live at home independently.” 
Nurse 1, primary care, female.  
 
5.4 Discussion  
 
5.4.1 Key findings  
 
All but one of the Phase 1 participants recorded reflections on what they 
considered to be prescribing decisions noteworthy in relation to their practice 
(Phase 2) and were subsequently interviewed about them  
(Phase 3).  Pharmacist 6 withdrew after Phase 1 due to pressure of work.  
Twenty four reflections were made in total; participants made one, two or three, 
ranging in duration from approximately 1 minute 12 seconds to 7 minutes 36 
seconds.  Some participants made multiple partial recordings meaning that 
accurate allocation of time for each reflection was impossible.   
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The prescribing decisions participants made and chose for reflection were 
informed by all the domains of the TDF except optimism and reinforcement; 
additional influences of multi-disciplinary working, experience and complexity 
were also evident.  Participants chose to reflect mainly on what from their 
descriptions were complex prescribing decisions involving vulnerable patients, 
multiple morbidities, a lack of information and/ or the need for creative thinking 
to ensure the best outcome for the patient.  Prescribing was not always in 
accordance with guidelines or usual practice. 
 
5.4.2 Strengths and limitations 
 
The study has several strengths.   
 
5.4.2.1 Study design 
 
In Phase 2 participants recorded reflections on one, two or three prescribing 
decisions which they felt were noteworthy in some way in relation to their 
practice.  They were given no further guidance on areas for reflection so as to 
minimise any possible influence from the doctoral student on the areas chosen 
(Sackett 1979).  In Phase 3 participants were interviewed about their reflection/s 
by the doctoral student; an account of the development of the interview 
schedules is given earlier in this chapter.  Every effort was made to remain true 
to the transcriptions and to be mindful of the TDF and other themes identified 
during analysis of Phase 1 transcripts.  
 
5.4.2.2 Breadth of areas chosen by participants for reflection 
 
Reflections encompassed prescribing decisions made by pharmacist and nurse 
prescribers working in a range of practice settings and for a wide range of clinical 
conditions.  They included patients from shortly after birth to those nearing the 
end of their lives.  One reflection was on an acute life or death situation; others 
were concerned with prescribing for less serious acute conditions or with aspects 
of the management of long term conditions.  In contrast to other studies using 
modified critical incident methods, participants were not asked to reflect on any 
particular type of prescribing decision.  Interviews based on the reflections 
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similarly were very broad, with the focus on the entire reflection rather than any 
one aspect. 
 
5.4.2.3 Trustworthiness   
 
Trustworthiness (Guba 1981, Shenton 2004) will be considered as a measure of 
quality in this qualitative research, followed by consideration of credibility/ 
trustworthiness checks developed specifically to assure the quality of research 
using modifications of Flanagan’s critical incident technique (1954, Butterfield et 
al. 2005).   
 
General aspects of study design which contribute to overall trustworthiness have 
been discussed in Chapter 2 (Table 2.10) and Chapter 4 and will not be 
considered again here.  Specific aspects of Phase 2 and 3 which enhance 
trustworthiness are discussed below.  
 
Credibility 
Shenton (2004) asserts that to enhance credibility the research method selected 
should be well established and have been used in comparable research.  As 
outlined in Chapter 2, although very loosely based on Flanagan’s critical incident 
technique the methods used to gather data in Phase 2 and 3 were novel i.e. self-
recorded reflections by NMPs on prescribing decisions which they felt were 
noteworthy in relation to their practice, and semi-structured interviews based on 
these reflections.  None the less other studies have used various modifications of 
the critical incident technique to explore specified categories of prescribing 
decisions for example decisions engendering discomfort in participants  
(Bradley 1991, Bradley 1992a, Allery, Owen and Robling 1997, Lewis and Tully 
2009, Lewis and Tully 2011, Bowes et al. 2012, Lewis et al. 2014, Maddox et al. 
2016).  Credibility was also enhanced by offering participants in Phase 1 the 
opportunity to participate in Phases 2 and 3; one participant declined, suggesting 
that those who participated wished actively to do so.  Participants were 
encouraged to be honest and sometimes recorded reflections which did not 
necessarily show them in a good light.  Iterative questioning was used; in 
contrast to the semi-structured interview schedule use throughout Phase 1 
interviews, each Phase 3 interview schedule was developed directly from a Phase 
2 reflection as well as the literature, the TDF and findings from Phase 1.  
Participants listened to their reflections immediately before each interview, 
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allowing member checking of their reflections and preparing them for the 
interview. 
 
Transferability 
To promote transferability it is important that sufficient detail and thick 
description are provided to allow the reader to decide on the transferability of 
findings to another setting.  The combination of data from Phase 1 interviews, 
using a theoretically-derived interview schedule, with transcriptions of 
participants’ reflections (above and Appendix 5.3) and data from interviews 
based on these provides contextualising details.  
 
Dependability 
Dependability and credibility are closely linked (Shenton 2004); to enhance 
dependability Shenton suggests the use of “overlapping methods” p.71 as has 
been done in this three phase study, as well as the provision of details of the 
research design and implementation, data gathering and “reflective appraisal” 
p.72.  
 
Confirmability 
In qualitative research confirmability is promoted by acknowledging and 
minimising bias.  A reflexive approach (see Foreword and Chapter 2), detailed 
description of what was done and why, rigorous and explicit analysis and 
triangulation of data have all been incorporated into this study and contribute to 
confirmability of findings.  
 
5.4.2.4 Credibility/ trustworthy checks in critical incident research  
 
As in Chapter 2, Butterfield 2005 and colleagues have developed a series of 
credibility checks which enhance the robustness of critical incident-based 
research.  Of these, the following were included in the design of Phases 2 and 3, 
again enhancing the credibility and trustworthiness of findings: 
 
 interviewing participants after thematic categorisation of their of “critical 
incident” recording 
 
 verbatim transcribing of recorded interviews  
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 duplicate analysis of a sample of data (in this case, all data) 
 
 reviewing of tentative themes by relevant experts 
 
 establishing theoretical agreement by reference to the literature   
   
Study limitations 
 
Limitations in the design of Phase 1 of the study were considered in Chapter 4.  
Those relevant to Phases 2 and 3 will be considered here. 
 
5.4.2.5 Recruitment 
 
All but one of the participants in Phase 1 took part in Phases 2 and 3, 
representing again a broad range of experiences and practice settings.  
Pharmacist 6 chose not to participate in Phases 2 and 3; she prescribes for 
substance misuse and it is possible that her prescribing decision-making might 
be subject to additional or different influences from those of participants. 
 
5.4.2.6 Participants’ contributions 
 
Participants recorded detailed reflections on prescribing decisions which they felt 
were noteworthy in some way.  No other direction was given and no-one asked 
for clarification or about the suitability of their reflections, suggesting that all 
were clear and satisfied with what they had done.  Some participants chose only 
to reflect on one prescribing decision, most on two and some on three 
prescribing decisions i.e. more than was requested.  Reflections encompassed a 
wide range of issues.  Again social desirability bias was possible (Sackett 1979) 
but again participants appeared to speak freely and honestly, at times revealing 
aspects of their behaviour which were not necessarily flattering.   
 
5.4.3 Discussion in relation to the literature 
 
As in Chapter 2, various modifications of Flanagan’s critical incident study 
(Flanagan 1954) have been used to explore prescribing decision-making over the 
last 16 years (Bradley 1991, Bradley 1992a, Bradley 1992c, Allery, Owen and 
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Robling 1997, Prosser, Almond and Walley 2003, Prosser and Walley 2006, Lewis 
and Tully 2009, Lewis and Tully 2011, Lewis et al. 2014, Maddox et al. 2016).  
The TDF has also been used to explore prescribing decision making by medical 
prescribers (Duncan et al. 2012, Sargent et al. 2017).  These studies used semi-
structured and unstructured interviews and specified the focus of the incident, for 
example uncomfortable prescribing decisions, prescribing errors or delayed 
prescriptions for antibiotics.  None left the choice of incident entirely to the 
participant.   
Findings from Phase 3 interviews will be considered in relation to relevant 
research including that which used modifications of Flanagan’s critical incident 
method and the TDF.  
 
5.4.3.1 Complexity 
 
In Phase 1, complexity appeared as a sub-theme within the domains beliefs 
about capabilities and memory, attention and decision processes.  In 
participants’ Phase 2 reflections and Phase 3 interviews based on these 
complexity emerged as a strong theme.  It is not known how participants 
selected the noteworthy prescribing decisions for reflection but there was great 
diversity among the decisions chosen, and several had elements of complexity.  
One participant chose to reflect on two prescribing decisions on travel medicine, 
one of which he described as being much more complex than the other.  
Throughout the study and in different ways, participants described putting the 
patient at the centre of their prescribing decision-making.  Dutch GPs asserted 
that a patient-centred approach was particularly beneficial in managing 
multimorbidity but that “diagnostic and therapeutic complexities” were a barrier 
to this (Luijks et al. 2012 p.e509).  A focus group study of patients’ perceptions 
of pharmacist prescribing found that patients were generally positive about 
pharmacist prescribing but preferred a multi-disciplinary team approach, 
particularly in relation to complex conditions (McCann et al. 2012b).  
 
Complexity is recognised as contributing to risks of medicines misadventure, 
particularly when combined, as it often is, with multimorbidity and polypharmacy 
(Scottish Government Model of Care Polypharmacy Working Group 2015).  Nurse 
4’s encounter with a patient near death as a result of taking too many tablets 
inadvertently is a prime example of this.   
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In relation to complexity, evidence-based medicine has been criticised as 
sometimes not reflecting the realities of complex patient groups with multiple 
morbidities (Tumilty, Walker and Tumilty 2014, Dumbreck et al. 2015).  The 
Competency Framework has been recommended as supporting prescribing for 
patients with long term conditions and complex polypharmacy (Picton, Loughrey 
and Webb 2016).   
 
5.4.3.2 Knowledge 
 
Knowledge of the condition being treated, of medicines and of the patient were 
important influences on participants’ prescribing decision-making.  Little specific 
mention was made of knowledge of evidence-based guidelines but the step-wise 
approach described by some participants suggested a detailed knowledge of 
these.  Where participants knew they lacked knowledge or felt the condition was 
out with their competence they referred the patient on, generally to a doctor, 
thus doing their best to ensure appropriate treatment.  Some non-medical 
prescribers have described feeling under pressure from colleagues to prescribe 
for conditions out with their competence for example in clinical complexity 
(McCann et al. 2012a, Bowskill, Timmons and James 2013); better 
understanding of the role of non-medical prescriber among the multi-disciplinary 
teams was felt be helpful in dealing with this (Cousins and Donnell 2012). 
 
Nurses 1 and 2 reflected on prescribing decisions which had been informed by 
their knowledge of a specific drug’s pharmacology or pharmacokinetics.  In 
contrast, other nurse non-medical prescribers have identified a lack of knowledge 
of pharmacology or therapeutics as problematic (Creedon et al. 2009) and have 
highlighted this as a deficiency in their university education (Creedon et al. 2009, 
Scrafton, McKinnon and Kane 2012, Abuzour, Lewis and Tully 2015, Abuzour, 
Lewis and Tully 2017).  Others have identified a desire among nurse prescribers 
for continuing professional development in pharmacology (Courtenay and Gordon 
2009, Weglicki and Reynolds 2015) and in prescribing–related legislation 
(Weglicki and Reynolds 2015).   
 
Even where nurse prescribers asserted that they were knowledgeable and 
confident about commonly used medicines in their areas of practice they were 
found to lack appropriate pharmacological knowledge (Offredy, Kendall and 
Goodman 2008).  In 2011 the Royal College of Physicians recommended 
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improved pharmacological education for all medical and nurse prescribers (Royal 
College of Physicians 2011). 
 
Participants varied in their levels of knowledge of the patients they selected for 
reflection; this would be expected as some were responding to acute conditions 
while others were managing patients longer term.  Knowledge of the patient will 
be discussed under the social role of the patient. 
 
Prosser and Walley (2006) in a critical incident study identified four types of 
knowledge influencing hospital doctors’ prescribing of new drugs: scientific 
knowledge, social knowledge, knowledge of the patient and experiential 
knowledge.  These map well to the types of knowledge participants identified as 
influential i.e. of the condition, the medicines and the patient, particularly when 
the importance they ascribed to experience (considered later) is included.  A 
recent systematic review of expertise development of pharmacist and nurse 
prescribers in the UK determined that “knowledge, skills and attitudes are an 
integral part of learning and prescribing within a complex social context” 
(Abuzour, Lewis and Tully 2017, p.10). 
 
5.4.3.3 Skills 
 
Communication, calculation and clinical assessment skills influenced participants’ 
prescribing decision-making; in one case a participant’s skill in managing a 
complex, life threatening situation was key to a successful outcome.  
 
Communication skills 
“The consultation” is one of two domains in the prescribing competency 
framework for all prescribers (Royal Pharmaceutical Society 2016) and 
communication skills are recognised as key to an effective consultation.  
Communication skills are among the non-technical skills which it has been 
posited might reduce prescribing errors (Ross, Patey and Flin 2013, Dearden et 
al. 2015).   
 
Participants gave details of their communication during the consultation in their 
reflections, sometimes including what appeared to be their original words.  Only 
Pharmacist 2 reflected on any deficiency in her communication skills, when she 
reported considering taking additional training to help her to negotiate better 
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with a senior colleague about treatment options.  Participants dealing with 
requests for unjustified antibiotics acknowledged their lack of success in 
dissuading the patient or family member from their quest, and found this 
frustrating.  Patient demand for antibiotics is recognised as a challenging issue 
for prescribers and will be discussed under the social influence of the patient.    
 
Concern has existed for some time about GPs’ consultations skills; in the late 
1990s misunderstandings were common (Britten et al. 2000) and it was found 
that GPs and their patients could be speaking a different language during 
consultations, with GPs using the “voice of medicine” while patients used the 
“voice of the life world” (Barry et al. 2001, p.487).  More than a decade later, a 
systematic review found a similar disconnect in communication between GPs and 
parents seeking antibiotics for their children (Cabral et al. 2014).   
 
A study among nurse prescribers in dermatology found that the nurse prescribers 
and doctors working with them felt that the nurses’ communication style was 
different to that of doctors.  Specialist dermatology nurses were felt to have the 
better consultation skills although the nurses were less good at involving patients 
in their prescribing decisions and giving information about side effects 
(Courtenay, Carey and Stenner 2009).  By contrast participants in the present 
study reported providing information about medicines to their patients to 
promote shared decision making, including discussing mechanisms of action and 
side effects.  
 
Riley and colleagues studied the extent to which GPs, pharmacist and nurse 
prescribers responded to patients’ emotional cues and concerns in primary care 
consultations (Riley et al. 2013).  They found that both nurse and pharmacist 
prescribers identified more of these than GPs, notwithstanding that pharmacists 
had much longer consultations, and responded in a supportive and positive way.  
Kaldijian (2010) asserts that clinical judgment which incorporates patients’ goals 
and values is likely to improve clinical decision making.  Participants in the 
present study described identifying and responding to patients’ emotions and 
concerns about their conditions, particularly but not only in patients nearing the 
end of life.  This will be considered further under social influence.   
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Calculation skills 
Pharmacist 3 described in detail the steps she took to ensure her calculations 
were correct when prescribing oral then intravenous magnesium 
supplementation for her patient.  Knowledge-based mistakes including 
prescribing the wrong dose of a drug contributed to prescribing errors among 
junior doctors (Lewis et al. 2014); working in “error-producing conditions” such 
as busy wards contributed to their errors, demonstrating the importance of the 
environmental context.    
 
Clinical assessment skills 
Some reflections included information about participants’ clinical assessment 
skills.  These are a core part of nurses’ education and training and the ability to 
use these within prescribing has been found to contribute to professional 
satisfaction among nurse prescribers (Coull et al. 2013).  Nonetheless there is a 
demand among nurse prescribers for continuing professional development 
opportunities in assessment and diagnostic skills (Creedon et al. 2015).  Nurses 
3 and 4, experienced nurse practitioners dealing with acute conditions, appeared 
to use an initial rapid assessment based on experience followed by a more in-
depth deductive assessment when assessing their patients’ need for antibiotics.  
Nurse 5 similarly was easily able to assess her patient’s wound as quite normal, 
despite its dramatic appearance.  This two stage assessment approach was 
identified among nurse prescribers and GPs in primary care dealing with 
respiratory tract infections (Horwood et al. 2016).  Horwood and colleagues 
asserted that a stronger evidence-base and some additional training were 
needed to support these nurse prescribers and GPs in making appropriate 
decisions in the treatment of these conditions.   
 
Finally Nurse 4 reflected on a critical situation where she had to draw on all her 
skills and experience to help her patient, demonstrating her expertise as a 
prescriber (Abuzour, Lewis and Tully 2017) and more generally as a clinician. 
 
Some pharmacist participants felt they had appropriate physical assessment 
skills; Pharmacist 5 described herself being “pretty fast” in carrying out physical 
assessments in her patients.  Other pharmacist participants relied on nursing 
colleagues for help with physical assessment and one described how his inability 
to understand laboratory test results could be a barrier to his prescribing.  
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Pharmacist prescribers in secondary care have been found to rely on doctors for 
diagnosis (Tonna et al. 2010) and physical examination of patients (Tonna et al. 
2010, Abuzour, Lewis and Tully 2015); this may be appropriate to their roles in 
secondary care.  Concern has been expressed about pharmacist prescribers’ lack 
of clinical assessment skills (Latter et al. 2012); this is being addressed by the 
General Pharmaceutical Council in their requirements for Pharmacist 
Independent Prescribing courses (General Pharmaceutical Council 2017c) and by 
NHS Education for Scotland who offer a core clinical assessment skills course for 
pharmacists (NHS Education for Scotland 2017b). 
 
5.4.3.4 Social/ professional role and identity 
 
Participants reflected on their roles as nurses and pharmacists, sometimes 
linking particular aspects of their knowledge to their role.  Nurse 1 was a district 
nurse and thought that nurses excelled at sorting the “daft wee things”, ascribing 
particular qualities to their knowledge.  The knowledge of district nurses has 
been described in a doctoral thesis as “unique” (Bain 2015). 
 
Participants very much valued their roles as independent prescribers and the 
benefits they felt this brought to their patients.  At the same time they were 
aware of and sometimes concerned about the inherent additional responsibilities.  
Participants in this study felt that clear documentation was important in 
supporting and being able to defend prescribing decisions, particularly when it 
was felt these might be challenged; this is a key element of good prescribing 
governance (Royal Pharmaceutical Society 2016).   
 
The two pharmacist participants working in secondary care were already 
accustomed to making prescribing recommendations to medical prescribers as 
part of their wider roles as hospital pharmacists.  Pharmacist 3 articulated the 
difference between advising a doctor on writing a complicated fluid prescription 
and writing it as a prescriber herself, emphasising her unease in this new role.  
Medicines optimisation is a key role for many hospital pharmacists, involving 
identifying and addressing sub-optimal prescribing among other elements.  Both 
the King’s Fund Medicines Optimisation. Making it safe and sound (Duerden, 
Avery and Payne 2013) and the Scottish Polypharmacy Guidance (Scottish 
Government Model of Care Polypharmacy Working Group 2015) however 
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emphasise the responsibility of all healthcare professionals in medicines 
optimisation. 
 
More pharmacist prescribers work in hospital than in primary care or community 
pharmacy (Phelps et al. 2014, NHS Education for Scotland  2017a) with most of 
their prescribing concerned with medicines reconciliation (Baqir et al. 2015).  A 
lack of organisational support and lack of a clear role have been identified as 
reasons for non-prescribing by nurse and pharmacist prescribers (McIntosh et al. 
2015).  In 2013 around a quarter of all pharmacist prescribers were not 
prescribing at all and 40% of those who did so prescribed for five or fewer 
patients each week (Phelps et al. 2014). In Scotland in 2016, 48.8% of 
pharmacist prescribers were actively prescribing (NHS Education for Scotland 
2017a).  In a recent survey of pharmacists’ perceptions of their roles “prescriber” 
was not mentioned at all (Elvey, Hassell and Hall 2013); it may be that one of 
the barriers to pharmacists implementing prescribing may be pharmacists 
themselves.      
 
One small scale study of experienced district nurses who were independent 
prescribers found that while they valued the autonomy and consequent job 
satisfaction the role gave, they experienced increased work-related stress.  They 
also felt undervalued in that their salaries had not risen to reflect their additional 
responsibilities (Downer and Shepherd 2010).  Another small study among 
experienced nurse practitioner independent prescribers again found increased 
work-related stress levels among participants as well as enhanced feelings of 
autonomy and job satisfaction (Cousins and Donnell 2012).  
    
5.4.3.5 Beliefs about capabilities 
 
Participants’ reflections demonstrated that they felt themselves very capable 
when making prescribing decisions in familiar situations but sometimes less-so in 
the face of uncertainty.  Where this was perceived to be particularly troubling 
participants would seek help from a colleague; this practice is reflected in the 
literature.  Nurse prescribers working in the area of mental health conditions 
described themselves as deliberately cautious in their prescribing (Funnell, Minns 
and Reeves 2013) as did pharmacist prescribers in Northern Ireland (McCann et 
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al. 2012a) and all identified the importance of working within a multi-disciplinary 
team.  
 
5.4.3.6 Beliefs about consequences 
 
The diagrammatic representation of Competency Framework for all prescribers 
has the patient at the centre (Royal Pharmaceutical Society 2016) and the 
central importance of consequences for the patient came out strongly in 
participants’ reflections about the prescribing decisions they made.  They used 
their knowledge of conditions, medicines, their patients, and their own previous 
experience to consider the likely consequences for their patients and seemed 
always to put them first.   
 
Patients or their family members seeking antibiotics in the absence of clinical 
need did not necessarily agree with their prescribers’ assessment of their health.  
On occasion participants issued delayed prescriptions for antibiotics in response 
to pressure for them and to prevent anticipated poor consequences of not 
prescribing them.  Nurse 4 found herself writing a delayed antibiotic prescription 
in response to pressure from a patient’s wife for the sake of her colleagues; they 
had had a difficult week and Nurse 4 anticipated further difficulties and 
unpleasant consequences for them if she refused.  Nurse 5 did similarly when 
she prescribed antibiotics for a healthy wound, in anticipation of unpleasantness 
over the weekend.  Hospital doctors have also been found to prescribe un-
necessarily in response to pressure from the patient, family members or others, 
sometimes for the sake of maintaining harmony in their multi-disciplinary team 
(Lewis and Tully 2011).  GPs, trainee GPs and nurse prescribers issued delayed 
prescriptions in response to clinical uncertainty and patient pressure (Peters et 
al. 2011b).  They did this infrequently, preferring that the patient re-consult if 
symptoms did not resolve.   
 
Clinical uncertainty was identified in a systematic review as an important 
influence on nurse prescribers’ decisions whether or not to prescribe antibiotics 
(Ness et al. 2016).  There was no clinical uncertainty in participants’ reflections; 
one prescribed antibiotics in response to patient need and two in response to 
demands from patients’ family members.  This pressure will be considered 
further in social influence and multi-disciplinary team working. 
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In contrast to this study where participants put consequences for their patients 
at the core of their prescribing decision-making, possible consequences for the 
patients was only one sub-theme identified in a simulated recall exploration of 
junior doctors’ decision-making in secondary care (Bull, Mattick and 
Postlethwaite 2013).  These doctors had a number of differing and sometimes 
competing priorities and types of decisions to make.  They were focused on 
caring for individual patients but were aware of the wider organisational context 
within which they worked, including the need to present themselves in a good 
light to superiors.  Participants in this study made little mention of how others 
might perceive their prescribing decision-making. 
 
5.4.3.7 Goals and intentions 
 
As described in Chapter 4, the research team found difficulty in differentiating 
between participants’ goals and intensions during analysis of Phase 1 interviews.  
Others have found similar difficulty (Cane, O’Connor and Michie 2012) and goals 
and intentions have been re-assigned as the domains of the TDF have been 
developed over time (Michie et al. 2005, Cane, O’Connor and Michie 2012, Huijg 
et al. 2014a).  This will be discussed further in Chapter 6. 
 
In Phase 2 and 3 differences between participants’ goals and intentions seemed 
clearer, allowing them to be considered separately.  Participants were influenced 
by their goals, most broadly to benefit their patients; their intentions were 
identified as the ways in which they hoped to achieve their goals.  Sometimes 
this involved complex clinical decision-making, sometimes strictly following a 
protocol and sometimes trying to mitigate the effects of an unnecessary delayed 
prescription for an antibiotic.  Patients’ wishes were always considered but were 
not always paramount.   
 
There is a lack of research literature in prescribing which has used the TDF.  One 
study looked at prescribing errors among junior doctors (Duncan et al. 2012); 
neither goals not intentions were identified as relevant.  In another study, 
motivation and goals (Michie et al. 2005) were identified as influences on 
primary care practitioners’ behaviour in relation to human papilloma vaccination 
but were considered less relevant.  On the other hand goals and intentions were 
found to be likely influences on Australian GPs’ behaviour in relation to writing 
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delayed antibiotic prescriptions (Sargent et al. 2017).  Sargent and colleagues 
suggested that goals and intentions should be considered in interventions 
designed to increase delayed prescribing as a way to reduce the use of 
antibiotics.  
 
5.4.3.8 Memory, attention and decision processes   
 
The prescribing decisions made by participants were often complex and 
influenced by their memories of previous experiences, by the availability and 
their use of relevant information and most of the time by a deliberate approach 
taken in their decision making, although heuristics were used on occasion.  
Memory, attention and decision processes were found to be relevant in Duncan 
and colleagues’ investigation of prescribing errors among junior doctors and self-
monitoring of prescribing was suggested as an intervention which might reduce 
errors (Duncan et al. 2012).  None of the participants in this present study 
mentioned having made a prescribing error; their reflections evidenced rigorous 
approaches to making prescribing decisions, and the use of reflective practice.   
 
Pharmacist prescribers in three hospitals in England were found to have a 
prescribing error rate of 0.3% (Baqir et al. 2015) in comparison with error rates 
of 5% in general practice across England (Avery et al. 2012) and a mean of 
8.8% among hospital doctors, with trainee doctors significantly more likely to 
make prescribing errors than consultants (Ashcroft et al. 2015).  Causes of 
trainee doctors’ prescribing errors were multifactorial and included lack of 
knowledge and poor application of knowledge.  Hierarchical medical teams and a 
perceived culture where instructions from more senior staff may be followed 
blindly also contributed to errors.  Little appears to be known about prescribing 
error rates among nurse prescribers; an early evaluation of nurse and 
pharmacist independent prescribing found their prescribing to be safe and 
clinically appropriate (Latter et al. 2012) and a study of nurse prescribing in 
accident and emergency and sexual health departments found that 99.8% of 
prescriptions were clinically appropriate (Black 2012).  A review of nurse 
prescribing of antibiotics in Scotland 2007 – 2013 found that their prescribing 
appeared to be improving in line with best practice (Ness et al. 2015).  More 
recently nurse and pharmacist prescribers were found to be using patient-
centred management strategies with patients consulting for respiratory tract 
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infections.  The nurse and pharmacist prescribers met patient expectations 
except where patients reported expecting an antibiotic.  Patient satisfaction 
levels with consultations were high (Courtenay et al. 2017) 
 
5.4.3.9 Environmental context and resources 
 
The environmental context within which participants prescribed and the human 
and other resources they used to support their prescribing decision making were 
key influences on their prescribing decision-making.  All worked in multi-
disciplinary teams and colleagues, especially GPs for those prescribing in primary 
care, were a key source of advice and guidance, or perhaps just back-up in an 
attempt to resist patient pressure.  More widely, help was also sought from 
experts outside participants’ immediate teams.   
 
Other non-medical prescribers are supported by medical and other colleagues.  
Integration of nurse prescribing into practice in primary and secondary care was 
found to require trust between nurses and doctors and between nurses and 
employers (Bowskill, Timmons and James 2013).  Nurse prescribers’ autonomy 
in this study varied across settings but all received support from doctors.  Peer 
support and advice from doctors were found to influence primary care nurses 
prescribing for otitis media in children (Philp and Winfield 2010) and for 
respiratory tract infections within a no-antibiotic prescribing strategy 
(Rowbotham et al. 2012).   
 
Whereas in Phase 1 participants spoke about evidence-based guidelines and 
particularly the local NHS Grampian Joint Formulary as frequently used 
resources, in Phases 2 and 3 there was much less mention of these influencing 
participants’ prescribing decision-making.  Instead participants described seeking 
help when required either from GPs for those in primary care or from relevant 
experts.  One participant described the influence of the physical environment i.e. 
ward opening times on her prescribing of intravenous magnesium supplement.  
Another, asked to make a prescribing decision as a community pharmacist, felt 
the absence of what would have been relevant information due to her practice 
setting that day.     
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In the study of prescribing errors by junior doctors the environmental context 
within which they prescribed was found to be relevant to their making 
prescribing errors; elements included frequent interruptions, distractions and 
pressure of work (Duncan et al. 2012).  One participant in the present study 
described the relentless pressure she felt under as contributing to her decision to 
issue a delayed antibiotic prescription in the absence of clinical need.  Perhaps 
uniquely, Nurse 1’s practice setting in a farmhouse up in the hills and a forecast 
for bad weather were identified as explicit influences on her prescribing decision-
making.  
 
5.4.3.10 Social influences 
 
In their reflections participants described the social influences of colleagues and 
of their patients and patients’ families.   
 
Colleagues 
Some participants had a specific medical mentor but almost all valued the help 
and support of medical and other colleagues; Pharmacist 2 was the exception, 
feeling that her prescribing decision was dictated by a more senior medical 
colleague.  Nurse 4’s decision to prescribe antibiotics for the sake of her 
colleagues has already been discussed.  
 
Peer support is generally felt to be helpful but is not always available.  In a small 
scale study, district nurses working as independent prescribers identified 
frequent lack of organisational and peer support for their prescribing (Downer 
and Shepherd 2010).  An interview-based study of influences on NMPs’ 
prescribing decisions found that colleagues influenced their decisions about what 
to prescribe, although not their initial decision whether to (Maddox, Tully and 
Hall 2010).  Peers were found to be influential in GPs’ decisions to prescribe new 
drugs (Jacoby, Smith and Eccles 2003, Prosser, Almond and Walley 2003); and a 
peer feedback letter from the Chief Medical Officer in England to GPs prescribing 
high levels of antibiotics reduced their prescribing of these significantly 
(Hallsworth et al. 2016).   
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Patients and their families 
The social influence of patients or their families was important as was seen in 
Section 5.4.3.5 when participants prescribed antibiotics in response to patient or 
family pressure and to prevent bad consequences for their colleagues.  Across 
Scotland, between 2007 – 20013 nurse independent prescribers issued 20% of 
all prescriptions for antibiotics in primary care and it is anticipated that this will 
increase (Ness et al. 2015).  It is important that interventions are designed and 
delivered to promote antimicrobial stewardship to all prescribers and support 
them in making evidence-based decisions in this area.  
 
Some participants’ prescribing decision-making was influenced by their desire to 
allow their patients to enjoy limited remaining time with their family members.  
Participants were also influenced by their patients’ wishes to reduce or stop 
certain medicines, and were happy to discuss this with them so as to reach a 
concordant agreement.   
 
A synthesis of qualitative studies of medicines taking found that many patients 
were reluctant to take medicines, particularly for long term conditions (Pound et 
al. 2005).  Older adults with polypharmacy have been found to have contrasting 
views about their medicines, with some again concerned about long-term use 
and side effects (Clyne et al. 2017).  Shared decision-making as described by the 
two participants in this study has been found to facilitate de-prescribing (Jansen 
et al. 2016) and also to promote adherence (National Institute for Health and 
Care Excellence 2009).  In practice, Courtenay and colleagues (2011) found that 
in dermatology clinics, nurse prescribers’ provision of information and shared 
decision-making with patients contributed to increased concordance and clinic 
efficiency.  
 
The medical hierarchy in the form of a Registrar with strong views on appropriate 
antibiotic choices dictated the prescribing decision made by Pharmacist 2 and led 
her to prescribe an off-formulary, unlicensed antibiotic for her patient.  A 
systematic review of non-technical skills required by junior doctors to prescribe 
safely identified that challenging the prescribing of senior colleagues was 
“extremely difficult” (Dearden et al. 2015 p.1309).  Foundation Year 1 doctors 
found the hierarchical structure of medical teams made asking for prescribing 
advice difficult, leading to feelings of discomfort and also to errors (Lewis et al. 
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2014).  A TDF-based interview investigation of prescribing errors among trainee 
doctors found the domains of knowledge, social/ professional role and identity, 
social influences (including of senior staff) and environmental context and 
resources influential and suggested that interventions addressing these domains 
could be developed to improve prescribing (Duncan et al. 2012).   
 
Bourne and colleagues identified medical staff acceptance of the role as one of 
the challenges facing pharmacist prescribers in secondary care, among also 
many opportunities (Bourne, Baqir and Onatade 2016). 
 
5.4.3.11 Emotion 
 
Some participants in Phase 1 had acknowledged that emotion sometimes played 
a part in influencing their prescribing decision-making.  In Phase 2 participants 
had chosen their own “noteworthy” prescribing decision on which to reflect and 
several had chosen ones with an emotional aspect.  Despite an extensive 
literature search nothing was found linking emotion and prescribing decision-
making.   
 
5.4.3.12 Behavioural regulation 
 
Participants had been asked to reflect on a noteworthy prescribing decision they 
had made and within their reflections some described elements of behavioural 
regulation in relation to their prescribing.  Reflective practice is a requirement for 
all nurses, pharmacists and AHPs (Nursing and Midwifery Council 2015, Health 
and Care Professions Council 2016, General Pharmaceutical Council 2017d) and 
indeed all healthcare professionals.  The importance of reflection in improving 
prescribing practice is demonstrated by its inclusion in the Competency 
Framework for all prescribers; Competence 9.1 is “Reflects on own and others’ 
prescribing practice, and acts upon feedback and discussion” (Royal 
Pharmaceutical Society 2016, p.14).  A small scale study of nurse and 
pharmacist NMP students found that reflection on newly acquired knowledge in 
relation to previous knowledge and experience was helpful in contextualising 
what they learned and making it useful (Abuzour, Lewis and Tully 2015).   
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5.4.3.13 Multi-disciplinary team working 
 
All participants worked within multi-disciplinary teams and acknowledged and 
valued the support this provided.  Participants described sharing patient care 
with colleagues, and seeking colleagues’ advice and help when they felt this was 
needed.  Some participants described talking through their prescribing decisions 
informally with GP colleagues even when they were confident in their prescribing 
decisions, perhaps as a courtesy or to re-assure themselves.    
 
Adigwe and colleagues (2013, p.21) explored nurse and pharmacist prescribers’ 
prescribing for chronic pain and found that they similarly valued the support of 
colleagues.  Adigwe developed the theory “Safety and support within the 
prescribing environment” to describe this.  A team approach to patient care may 
be particularly valuable in patients with complexity and multiple morbidities 
(McCann et al. 2012b) and colleagues were identified as a valuable source of 
continuous professional development by nursing and allied health professionals 
with responsibility for prescribing (Weglicki and Reynolds 2015).   
 
Colleagues’ input is not always useful.  Nurse prescribers prescribing for self-
limiting respiratory tract infections found GP colleagues generally helpful but one 
felt let down when a GP prescribed an antibiotic after the nurse had judged that 
it wasn’t necessary (Rowbotham et al. 2012).  A hospital-based study into the 
discomfort of an evidence-based prescribing decision found that some, 
particularly junior doctors, felt uncomfortable when their interpretation of the 
evidence and hence their prescribing decisions were not congruent with those of 
superiors (Lewis and Tully 2009).  Pharmacist 2 would recognise this tension.  
 
5.4.3.14 Experience 
 
Participants were all experienced health care professionals and most were 
experienced prescribers.  Participants spoke about the benefit of their experience 
to their prescribing decision-making; that might be in relation to the patient’s 
clinical condition or more generally.  Pharmacist 2 described how the experience 
of another, more senior prescriber, influenced her prescribing; she also described 
reflecting on that experience and considering how she could learn from it.   
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GP and nurse prescribers found that experience in assessing severe respiratory 
tract infections in children enhanced their confidence in being able to identify 
seriously ill children who might then need antibiotics to treat their infection 
(Horwood et al. 2016).  In a vignette study, GPs asked to consider prescribing 
for a child with long term conditions and a flu-like illness were influenced by their 
previous experience of managing sick children (Ashdown et al. 2016).  
Experience also informed the prescribing decision-making of nurse prescribers in 
selecting the most appropriate antimicrobial for their patients (Ness et al. 2016).   
 
5.5 Summary 
 
This chapter has reported Stage 2 Phases 2 and 3 of the programme of research, 
a qualitative, theoretically-driven exploration of influences on the prescribing 
decision-making of NMPs.  Phase 2 captured participants’ self-recorded 
reflections on prescribing decision/s they had made which they considered 
noteworthy in relation to their practice.  In Phase 3 participants were interviewed 
about these reflections using a bespoke semi-structured interview schedule 
derived from their reflections, the TDF and the literature.  Again robust research 
methods and governance enhanced the trustworthiness of findings.   
 
Participants’ prescribing decision-making was again influenced by most but not 
all of the domains of the TDF; there was some overlap and some linking between 
domains.  Complexity in particular but also multi-disciplinary working and 
experience were also strong influences.   
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Chapter 6 Discussion 
 
6.1 Introduction 
 
In this final chapter of the thesis the overall aims of the programme of research 
and of the constituent parts will be restated.  Key findings will be summarised 
and consideration given to the strengths and limitations of the research 
programme.  Findings will be interpreted in relation to the literature and the 
impact of the research considered.  Areas for further research will then be 
identified.  Finally, at the end of this programme of research conclusions from it 
will be drawn.    
 
6.2 Aims of the programme of research 
 
The overall aim of the programme of research was to explore influences on 
prescribing decision-making among NMPs.  This was achieved in two stages: 
Stage 1, a systematic review of the literature and Stage 2, interviews with NMPs 
exploring influences on their prescribing decision-making in general and on 
specific prescribing decisions which they considered noteworthy in some way.  
 
6.2.1 Stage 1: systematic review  
 
(McIntosh et al. 2013, McIntosh et al. 2014, McIntosh et al. 2016b).  
The aim of the systematic review was: 
 
 to identify and characterise social and cognitive factors and perceived 
factors influencing the prescribing decision-making process among non-
medical prescribers. 
 
The objectives of the systematic review were:  
 
 to determine the social and cognitive influences on prescribing 
decision-making among supplementary and independent non-medical 
prescribers in the UK  
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 to report on the methodologies and methods used and quality of peer 
reviewed published studies in this area 
 
Key findings from Phase 1: systematic review 
The systematic review identified only three small-scale studies, none of which 
focused directly on influences on NMPs’ prescribing decision-making.  Studies 
were carried out in primary care, mainly among NMPs (almost all nurse 
prescribers) treating acute conditions such as otitis media and upper respiratory 
tract infections, although one used scenarios to explore nurse prescribers’ 
decision-making more broadly.  Prescribing decision-making was perceived as 
challenging and complex, and evidence-based guidelines and experience felt to 
be helpful in navigating this complexity.  Social and cognitive elements such as 
prescribers’ previous experiences, perceived patient pressure for antibiotics, 
patients’ socio-economic status and prescribers’ knowledge or lack of knowledge 
of the patient were also influential.  A team approach to prescribing was evident 
and peer support and encouragement from doctors was felt to be helpful in 
building participants’ confidence.   
 
All three studies took an interpretivist approach and used qualitative methods to 
explore NMPs’ prescribing decision-making although none of the studies 
specifically considered the processes of prescribing decision-making.  One study 
also included a quantitative, theoretically-derived element designed to explore 
participants’ pharmacological knowledge.  All studies were published within the 
last ten years and two since 2010 but all had methodological limitations.   
 
Recent literature 
Since the systematic review was carried out two other studies have been 
identified which would have met the inclusion criteria; their findings are 
considered below. 
 
Horwood and colleagues (2016) explored GPs’ and nurse prescribers’ prescribing 
decisions in consultations for children with respiratory tract infections.  
Prescribers based their decision on whether or not to prescribe on an initial quick 
examination of the child then detailed consideration.  Apart from cases where 
they perceived an antibiotic was definitely needed, the GPs and nurse prescribers 
would sometimes prescribe antibiotics where there was prognostic uncertainty or 
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where the child had been presented several times with the same illness.  On 
occasion they also prescribed antibiotics in response to time pressures, the 
approach of the weekend or to maintain their relationship with the child’s parent.  
The prescribers used a range of techniques to manage requests for antibiotics 
they thought inappropriate including refusing to prescribe or issuing a delayed 
prescription.  
 
Funnell, Minns and Reeves (2013) compared nurses’ and doctors’ prescribing 
habits in a mental health Trust in England.  Nurses reported that they took a 
more cautious approach than their medical colleagues and only a few made 
independent prescribing decisions.  Most followed the lead of the doctors and 
prescribed within narrow limits, for example titrating doses.  Those who did 
prescribe independently found their experience influenced their prescribing 
decisions.  Nurse prescribers asserted that they were more holistic and patient-
centred in their approach than doctors and that they communicated well with 
patients and with other members of the multi-disciplinary team. 
 
6.2.2 Stage 2 Phase 1: initial interviews with NMPs.  
 
The aim of this phase of the research was: 
 
 to explore participants’ experiences and perceptions of influences on their 
prescribing decision-making and the impact of these influences 
 
The objectives of this phase of the research were to explore: 
 
 participants' in-depth descriptions of their experiences of making 
prescribing decisions 
 
 
 their views and reflections of influences on the prescribing decisions they 
make 
 
 
 their opinions on the impact of these influences on their prescribing 
decision-making   
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Key findings from Stage 2 Phase 1: interviews with NMPs 
Participants prescribed as members of multi-disciplinary teams and in a variety 
of settings across community pharmacy and primary and secondary care.  They 
described prescribing decision-making as complex and often challenging with 
multiple and sometimes contradictory influences, and asserted that experience 
and team working helped them in their prescribing decision-making.  
Participants’ prescribing decision-making was influenced by almost all of the 
domains of the TDF.  They were aware of the additional responsibilities inherent 
in prescribing, employed a wide range of appropriate knowledge and skills and 
were determined to stay within their areas of competence.  They referred 
frequently to using evidence-based resources, particularly the NHS Grampian 
Joint Formulary (NHS Grampian Medicines Management 2017) as well as national 
guidelines.  Participants’ previous experience influenced their prescribing 
decisions and they took a rigorous, step-wise approach when making these 
decisions.  
 
Notwithstanding this, on occasion participants did prescribe out with evidence-
based guidelines.  Decisions to do so were not made lightly and were usually 
informed by the prescriber’s perception based on experience that this would be 
in the patient’s best interest.  Some participants did however prescribe in 
response to social influences for example patient or family pressure. 
 
6.2.3 Stage 2 Phases 2 and 3: participants’ reflections and interviews 
based on these 
 
Stage 2 Phases 2 and 3 of the study explored NMPs’ reflections on noteworthy 
prescribing decisions.  The aim of this phase of the research was: 
 
 to explore participants’ experiences and perceptions of influences on their 
prescribing decision-making in relation to noteworthy prescribing 
decisions. 
 
The objectives were to explore: 
 
 participants' in-depth descriptions of their experiences of making 
prescribing decisions 
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 their views and reflections of influences on the prescribing decisions they 
make 
 
 their opinions on the impact of these influences on their prescribing 
decision-making    
 
Key findings from Stage 2 Phase 2 and Phase 3: participants’ reflections and 
interviews based on these 
Participants chose to reflect on a wide range of prescribing decisions, often made 
in response to acute situations but also when treating patients’ long term 
conditions.  Most decisions involved complexity, in relation to the patient’s health 
or social circumstances, in relation to the multi-disciplinary team or to the 
participant’s working environment and sometimes in relation to combinations of 
these.  Some reflections were on decisions with the potential to cause inter-
professional conflict; others were on more positive aspects of multi-disciplinary 
working.  Some participants chose to reflect on the importance of clear 
communication and the need for/ availability of sufficient information on which to 
base prescribing decisions.   
 
Several reflections were on prescribing decisions made as the patient was 
drawing to the end of their life.  These in particular evidenced participants 
putting their patients at the heart of their prescribing, using their knowledge and 
understanding of the patients’ wishes as well as of their conditions when 
prescribing at this critical time.  Specific clinical knowledge seemed almost tacit; 
reflections were much more about participants’ prescribing decision-making and 
the consequences than about the use of resources such as evidence-based 
guidelines to support this.  Very often such decisions were particularly informed 
by participants’ previous experience.  Participants were mindful of their patients’ 
ideas, concerns and expectations about their conditions and treatment; the 
expectations of family members were problematic when they demanded what 
participants perceived as unnecessary antibiotics. 
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6.3 Strengths and limitations of doctoral research 
 
The programme of research has several strengths. 
 
6.3.1 Originality 
 
The systematic review carried out at the onset of the programme of research was 
registered with Prospero at the University of York (McIntosh et al. 2013) and the 
review subsequently published (McIntosh et al. 2014, McIntosh et al. 2016). 
 
As far as is known the primary research in this study is the first to have used a 
theoretically driven, two stage design to extend the knowledge base in this area.  
Participants were asked first about influences on their prescribing decision-
making in general then about specific prescribing decisions they considered 
noteworthy.  The absence of any direction about the sort of decisions participants 
should choose for reflection is also novel.  This allowed them freedom to reflect 
across a wide range of topics, from relatively routine consultations such as 
reducing the dose of simvastatin to a life-threatening medication related incident, 
and provided rich and varied data.  Participants’ reflections were played back to 
them immediately before they were interviewed about them; this element was 
included to refresh participants’ memories about their reflections and thus reduce 
the impact of any recall bias (Bowling 2002).   
 
6.3.2 Coherent study design 
 
The study benefits from a strong and coherent design throughout (Sackett and 
Wennberg 1997).  The need for primary research was identified after a 
systematic review of the literature on social and cognitive influences on NMP 
prescribing.   
 
The transcendental phenomenological approach taken was appropriate given the 
over-arching aim of the primary research to explore influences on the 
phenomenon of prescribing decision-making by NMPs.  A qualitative methodology 
facilitated in-depth exploration of these influences among a relatively small 
number of participants and within this, semi-structured interviews offered the 
opportunity for more openness than perhaps focus groups might have done.  
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Initial interviews explored general influences on participants’ prescribing 
decision-making; their later reflections on specific prescribing decisions which 
they regarded as noteworthy in relation to their practice, and interviews based 
on these, enabled a more specific focus.   
 
The use of the TDF in conjunction with the literature in planning the programme 
of research and in development of the semi-structured interview schedule for 
Stage 2 Phase 1 provided a strong, theoretically driven foundation likely to 
strengthen the research (Bradbury-Jones, Taylor and Herber 2014, Stewart and 
Klein 2016).  Development of the interview schedule over a period of months 
was again informed by reference to the literature and the TDF, and by 
discussions with relevant stakeholders including the pharmacist prescribing and 
non-medical prescribing Leads for NHS Grampian.  The schedule was reviewed 
by medical and non-medical experts in prescribing and in NMP education and was 
talked through as a sense check with practitioners whose professions and 
prescribing settings matched those of anticipated participants.  Finally the 
interview schedule was piloted.  This stepwise approach resulted in a robust 
schedule likely to elicit information which would answer research questions.   
 
Again contributing to coherence, an initial coding framework for Stage 1 
interviews was developed from the domains of the TDF and was augmented 
during analysis of transcripts.  The framework supported rigorous data analysis 
and was used again in the analysis of Stage 3 interviews.   
 
6.3.3 Trustworthiness  
 
Various steps were taken to augment the trustworthiness of the study (see 
Tables 2.10 and 2.11).    
 
 Credibility was enhanced by the use of an appropriate methodology and 
methods, a reflexive approach, knowledge of and attention to the 
background and culture of non-medical prescribing including previous 
research and the involvement of relevant experts in the study design 
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 Transferability was promoted by provision in this thesis of background 
contextualising data and detailed descriptions of what was done, while at 
the same time protecting the anonymity of participants 
   
 Dependability was engendered by the use of overlapping methods and by 
inclusion of detailed descriptions within the thesis   
 
 A reflexive and reflective approach including consideration of limitations, 
in-depth descriptions and the use of diagrams contributed towards 
confirmability of findings  
 
The study design also incorporated the approaches to trustworthiness in critical 
incident studies developed by Butterfield and colleagues (2005) over more than 
20 years’ experience of research using this method. 
 
6.3.4 Multi-disciplinary study 
 
Recruitment to the study was multi-disciplinary and participants represented the 
professions prescribing as NMPs within NHS Grampian at the time of the study.  
Participants’ practice settings were representative of those of other NMPs in NHS 
Grampian at the time of the study except that there were no participants who 
were nurse prescribers working in secondary care.  Notwithstanding the 
possibility of social desirability bias, participants appeared to answer honestly, 
sometimes revealing things which cast them in a less than flattering light.  They 
were also very generous with their time; only one withdrew from the study at the 
end of Phase 1 interviews due to pressure of work and in Phase 2 some recorded 
reflections on several prescribing decisions they had made. 
Limitations of the study will be considered next. 
 
6.3.5 Recruitment 
 
Recruitment was difficult and slow despite endorsement of the study by the NHS 
Grampian pharmacist and non-medical prescribing Leads, a reminder e-mail and 
encouraging participants to recruit colleagues; this last approach resulted in an 
additional four participants.  Data saturation appeared to have been reached but 
it is possible that inclusion of additional participants, particularly from other NMP 
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professions might have allowed additional themes to emerge and might have 
added to the transferability of findings.  Given that there were only nurse and 
pharmacist prescribers within NHS Grampian at the time of the study, this would 
have necessitated contact with other Health Boards to identify which if any had 
NMPs other than nurses and pharmacists followed by purposive sampling and 
successful recruitment.   
 
6.3.6 Study setting 
 
The study was carried out in one Health Board area in Scotland; interviewing 
participants from a wider base might have generated additional data.  No claims 
are made for generalisability but it is hoped that the steps taken to ensure 
trustworthiness and particularly the detail provided will promote transferability 
i.e. that others may find echoes of their own situations in the data and hence 
perhaps in the findings.   
 
6.3.7 Bias 
 
Bias is inherent in all research and is a threat to trustworthiness; the measures 
described to promote trustworthiness also minimise the potential for bias to 
impact on findings.  A reflexive approach throughout the research programme 
was necessary (Barry et al. 1999, Bradbury-Jones, Taylor and Herber 2014); this 
is considered in Reflexivity and in the foreword to this thesis.   
 
6.4 Interpretation of findings  
 
Table 6.1 summarises the themes identified as influencing NMPs’ prescribing 
decision-making in Stage 1, Stage 2 Phase 1 and Stage 2 Phase 3 of the 
programme of research 
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Table 6.1 Themes from Stage 1, Stage 2 Phase 1 and Stage 2 Phase 3 of the 
programme of research 
Stage 1 themes Stage 2 Phase 1 
themes 
Stage 2 Phase 3 
themes 
Consultations and 
prescribing challenging 
and complex. 
No evidence of 
pharmacological 
knowledge.  
Familiarity with 
commonly prescribed 
drugs. 
Evidence-based 
guidelines helpful but 
sometimes ignored. 
External influences also 
apparent. 
Experience helpful and 
sometimes prioritised 
over evidence-based 
guidelines. 
Team approach generally 
beneficial 
Knowledge  
Skills 
Social/ professional role 
and identity 
Beliefs about capabilities 
Beliefs about 
consequences 
Goals and intentions 
Memory, attention and 
decision processes 
Environmental context 
and resources 
Social influences 
Emotion 
Behavioural regulation 
Experience 
Multi-disciplinary 
working  
Knowledge 
Skills 
Social/ professional role 
and identity 
Beliefs about capabilities 
Beliefs about 
consequences 
Intentions 
Goals 
Memory, attention and 
decision processes 
Environmental context 
and resources 
Social influences 
Emotion 
Behavioural regulation 
Experience 
Multi-disciplinary 
working  
Complexity 
 
 
As may be seen from Table 6.1, Stage 1 the systematic review identified several 
broad influences on NMPs’ prescribing decision-making.  Only one of the studies 
included was underpinned by any reference to theory and that only in one 
element, and findings from all three studies lack specificity.  Use of the TDF 
throughout the design, implementation and analysis of Stage 2 Phase 1 and in 
the analysis of Phase 3 interviews allowed a much clearer and more detailed 
picture of influences to emerge. 
 
Both Stage 2 phases showed that all the domains of the TDF except 
reinforcement and optimism were influential.  Experience and multidisciplinary 
working emerged as additional influences in both phases, and complexity in 
Phase 3.  Differentiation between participants’ goals and intentions was unclear 
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in Phase 1 interviews.  For Phase 2 participants were asked to reflect on specific 
prescribing decisions and their goals and intentions were clearer in subsequent 
Phase 3 interviews; this might have been because of the specific focus on one 
noteworthy prescribing decision.  Complexity emerged as a strong theme in 
these Phase 3 interviews.  Some of the prescribing decisions participants chose 
for reflection might be regarded as suboptimal for example deciding whether to 
prescribe antibiotics or which antibiotic to prescribe, in response to social 
pressure.    
 
The benefit of the three phase approach may be seen by considering Pharmacist 
2’s reflection on deciding to prescribe an unlicensed, off-formulary antibiotic 
because of the over-riding social influence of her Registrar colleague.  In her 
Phase 3 interview Pharmacist 2 explained how she and her colleagues had lists in 
their office of Consultants’ and Registrars’ preferences so that they could ensure 
they were followed.  This was not mentioned at all during her 26 minute Stage 1 
interview; perhaps this influence on prescribing is so pervasive as not to be 
noticed or remarked on.  Pharmacist 2 went on to describe how she had reflected 
on the decision she made and on how she might seek help to change her 
approach in the future. 
 
“Knowledge” similarly emerged differently as a theme in Phase 1 compared to 
Phase 3.  As an example in Phase 1 participants referred to their prescribing 
decision-making being informed by knowledge of various evidence-based 
guidelines whereas in Phase 3 there was little specific mention of such guidelines.  
 
Another example would be the theme of “experience” which emerged in both 
Phase 1 and Phase 3 interviews as an influence.  In Phase 1 participants 
described how their prior experience enhanced their confidence as prescribers 
and informed their prescribing decision-making.  In Phase 3, Nurse 4 described 
drawing on all her experience to help her assess and deal with a life-threatening 
medication-related situation and make a prescribing decision which saved her 
patient’s life.  No other reflection was as dramatic but several participants 
described situations where they used their previous experience both as 
prescribers and as practitioners in making prescribing decisions which addressed 
their patients’ needs in complex and difficult situations.   
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Complexity was apparent in Phase 1 interviews within the themes "beliefs about 
consequences" and "memory, attention and decision processes" and was a 
common feature among many of the prescribing decisions participants chose for 
reflection in Phase 2.  Complexity could be multifaceted and participants 
described taking a patient-centred approach when making prescribing decisions, 
taking all elements into account.   
 
In a systematic review of GPs' perspectives on the management of patients with 
multimorbidity, Sinnott and colleagues (2013) found that organisation and 
fragmentation of healthcare, deficiencies in evidence-based guidelines, difficulties 
in ensuring patient-centred care and in achieving shared decision-making were 
particularly challenging.  Luijks and colleagues (2012) similarly described the 
importance of patient-centeredness among Dutch GPs managing multimorbidity.  
The GPs described the importance of taking an individualised, integrated 
approach with shared decision-making.  They were aware of the risks of 
polypharmacy and found this difficult to manage.  
  
Participants in this study evidenced a strongly patient-centred approach, listening 
to and engaging with their patients so as to meet their needs.  Fragmentation of 
care has been suggested as an unwanted consequence of changes in the delivery 
of healthcare (Smith 2010) but participants in this study identified 
multidisciplinary working as a key beneficial influence on their prescribing 
decision-making.  Participants were very aware of their own competence and 
described involving colleagues and others in their prescribing decision-making, 
both in general and in their noteworthy decisions where complexity was 
sometimes an integral part.  Several participants, pharmacists and nurses, 
described seeking the advice of pharmacists to inform their prescribing decision-
making and pharmacists and nurses described working in partnership with 
nursing colleagues.  The availability and support of the whole multi-disciplinary 
team was critical to Pharmacist 5’s ability to prescribe for her patient with heart 
failure in a way that enabled the patient to stay at home as she wished.    
 
6.5 Application of findings 
 
The TDF was used in Stage 2 of this programme of research to provide a 
theoretical understanding of participants’ experiences and perceptions of 
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influences on their prescribing decision-making, and the impact of these 
influences.  The aim was not to alter prescribing decision-making behaviour 
through development of an intervention.  However there was evidence that 
prescribing decision-making could on occasion be suboptimal and the use of the 
TDF allowed identification of influences on this behaviour.   
 
In Phase 1, participants’ knowledge of evidence-based guidelines emerged as a 
strong influence on their prescribing decision-making although on occasion they 
prioritised other elements over the dictates of evidence-based practice, where 
they perceived this was best for the patient.  In Phase 3 interviews it became 
apparent that the social influence of the patient or family member, or indeed a 
colleague, could result in participants making suboptimal prescribing decisions.  
Implementation of evidence-based guidelines such as those on appropriate use 
of antibiotics is likely to improve healthcare but is difficult and may require 
complex interventions.  The Medical Research Council recommends the use of an 
appropriate theoretical underpinning for development, implementation and 
evaluation of such interventions (Craig et al. 2008).   
 
The TDF has been used in a number of behaviour change and implementation 
studies to identify determinants of the behaviour being studied (Francis, 
O'Connor and Curran 2012) including in implementation of clinical quality 
interventions (Lipworth, Taylor and Braithwaite 2013).  It has also been used to 
understand adherence to evidence-based indicators of quality healthcare in 
primary care (Lawton et al. 2016) and in studies carried out across diverse 
clinical environments (Phillips et al. 2015).  One additional domain, the 
trustworthiness of the organisation promoting the behaviour change, has been 
suggested (Phillips et al. 2015).    
 
French and colleagues (2012) have developed theory-informed behaviour change 
interventions to promote the implementation of evidence into practice.  They 
used a four step approach to map the behaviour being targeted to suitable 
behaviour change techniques which could then be used in addressing the 
behaviour.  They give suggestions as to how this could be done.  As an example, 
GPs may be influenced by their perceptions of patient expectations to treat them 
out with evidence-based guidelines.  This barrier could be addressed by providing 
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patient handouts containing key information in plain English which GPs could use 
to augment their verbal advice.  The steps in the approach are: 
 
 identify the target for behaviour change 
 
 use the TDF to identify barriers and facilitators to change 
 
 select and use relevant behaviour change techniques to address these 
barriers and facilitators 
 
 evaluate the success or otherwise of the intervention 
 
In their work developing the behaviour change technique taxonomy Michie and 
colleagues (2015, p.94) recommended carrying out “behavioural diagnosis of the 
problem at hand” before attempting to develop behaviour change techniques.  
The present study provides new insights into influences on prescribing decisions 
made by NMPs, adding to the knowledge base.  It also offers behavioural 
diagnosis at least among study participants and provides a theoretically driven 
foundation for further research. 
 
6.6 Impact of the research 
 
The Research Councils UK (2014) classifies the impact of research according to 
its academic, social and economic impact.  Economic impact is not thought 
relevant and findings will be considered in relation to academic and societal 
impact.  
 
6.6.1 Academic impact 
 
Teaching 
The doctoral student is School Lead for pharmacist prescribing and for non-
medical prescribing and teaches cohorts of these students and V100 community 
nurse prescriber students throughout the year.  She has already used findings to 
inform her teaching on prescribing decision-making, including using Phase 2 
reflections to illustrate teaching points.  As an example influences on Nurse 1’s 
decision to prescribe suppositories for her patient were multi-factorial; this 
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provides an excellent example of a prescriber taking every piece of information 
she has into account for the benefit of her patient.   
 
The doctoral student hopes to work with colleagues in the School of Nursing and 
Midwifery to develop, use and evaluate teaching materials which it is hoped will 
stimulate in-depth reflection and discussion among students on the university’s 
pharmacist and non-medical prescribing courses around influences on prescribing 
decision-making.   
 
Findings from this programme of research have already been presented at 
national conferences (McIntosh et al. 2014, McIntosh et al. 2017) and the 
systematic review has been published (McIntosh et al. 2016).  Publication of this 
thesis and possibly additional papers reporting aspects of the study will hopefully 
inform education, training and practice more widely.    
 
6.6.2 Social impact 
 
Non-medical prescribers are integrated into all sectors of healthcare provision 
and make a vital contribution to patient care.  It is important that influences on 
their prescribing decision-making are understood so that they may be supported 
to follow best practice.  Other things being equal, prescribing according to 
evidence-based guidelines is likely to represent the best clinical care for most 
patients, notwithstanding the need for personalised and shared decision-making.  
Participants in this study were aware of and used local and national guidelines to 
inform their practice but on occasion chose to prescribe out with these.  This may 
or not have been appropriate but may have broader societal consequences.  As 
an example, sub-optimal or un-necessary prescribing of antibiotics has cost 
implications and potentially by adding to antimicrobial resistance may impact on 
present and future generations (Leibovici, Paul and Ezra 2012, World Health 
Organisation 2014, Armstrong et al. 2016).  This and other research may be 
used to inform educational and other interventions designed to support 
prescribers and promote antimicrobial stewardship (National Institute for Health 
and Care Excellence 2017b). 
 
One or two of participants’ reflections had inter-professional aspects.  In a review 
of reviews of behaviour change interventions and policies directed at primary 
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healthcare providers Chauhan and colleagues found that collaborative, team-
based approaches were effective (Chauhan et al. 2017).  Given that medical 
prescribers also prescribe sub-optimally on occasion (Cullinan et al. 2014) 
interventions designed to support prescribers may usefully be delivered through 
inter-professional educational events such as NHS Education for Scotland 
practice-based small group learning meetings (NHS Education for Scotland 
2017c).   
 
 
6.7 Future research  
 
Healthcare provision in Scotland and in the rest of the UK is under relentless and 
increasing pressure.  People are living longer but not necessarily healthier lives 
resulting in increased morbidity and multi-morbidity.  Evidence-based treatment 
particularly in multi-morbidity can result in polypharmacy; whether appropriate 
or inappropriate this increases patients’ risks of medicines misadventure.  
Prescribing is “the main approach to the treatment and prevention of disease in 
modern healthcare” (British Pharmacological Society 2010) and it is vital that 
prescribing decision-making promotes safe, clinically effective and cost effective 
pharmacotherapy aligned with the British Pharmacological Society’s principles of 
good prescribing.  Bradley’s seminal work (1991, 1992a, 1992b and 1992c) 
identified that various types of prescribing decisions engendered discomfort 
among medical prescribers which might then influence their prescribing decision-
making.  Since then and despite the increasing primacy of evidence-based 
practice a wealth of research has demonstrated continuing areas of sub-optimal 
prescribing by doctors, often in the treatment of self-limiting respiratory tract 
infections.  This present study and previous research suggests that NMPs are 
subject to some of the same influences as doctors, with sometimes similar 
consequences.  More extensive research is needed into influences on prescribing 
decision-making by NMPs beyond this small scale, qualitative study.  This will 
promote further clarification including on possible “hidden” influences and 
facilitate the development of educational interventions to support optimal 
prescribing decision-making by NMPs and others.    
 
The way in which healthcare is delivered in the UK is changing, partly in 
response to demographic changes and to an on-going shortage of doctors in 
primary and secondary care.  Multi-disciplinary working as experienced by 
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participants in this study is now the norm and healthcare professionals must 
ensure that their practice reflects this.  Given the evidence of sub-optimal 
prescribing gathered over the last 25 years among medical and latterly non-
medical prescribers it is important to develop, test and implement educational 
interventions designed to address some of the hidden influences on prescribing 
decision-making.  As above, these interventions could be delivered to single 
professional or to multi-professional groups thereby promoting inter-professional 
exchange of ideas and experiences.         
  
Details of possible extensions to the present study based on the above are given.  
 
6.7.1 Proposal 1: Scotland or UK-wide survey of NMPs exploring influences 
on their prescribing; a mixed methods approach.   
 
Stage 1 
Most research using the TDF to study determinants of behaviour has used the 
interpretivist philosophy and qualitative methodology, most often using semi-
structured interviews to gather data.  Here the hope would be to survey a large 
number of NMPs across a wide geographical area so a positivist philosophy and 
quantitative methodology would be more appropriate.  A cross sectional survey 
of NMPs either in Scotland or throughout the UK could be carried out by means 
of a postal and/or online questionnaire.   
 
Sampling and recruitment of pharmacists in Scotland could be facilitated by NHS 
Education for Scotland who have a database of non-medical prescribers whom 
they have funded to do the training, in effect almost all NMPs in Scotland. No 
other such database exists and advice would be taken on the best way to identify 
and target other NMPs in Scotland and in the rest of the UK.   
 
The aims of the research would be: 
 
 to determine the key behavioural determinants of NMPs’ prescribing 
decision-making 
 to investigate NMPs’ views and experiences of their university-based 
training course    
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The research would gather data on: 
 
 participants’ demographics 
 their views on and experiences of influences on their prescribing decision-
making in general 
 their views on and experiences of influences on their prescribing decision-
making where they considered this “noteworthy” in relation to their 
practice  
 their opinions on the impact of these influences on their prescribing 
decision-making 
 their views and experiences of their NMP university course  
 how the NMP university course had prepared them to make prescribing 
decisions 
 any suggested improvements to the course 
 
A quantitative, questionnaire-based study would be developed from the literature 
and the 14 domains of the TDF, including studies which have used this method 
(Taylor et al. 2013, Taylor, Lawton and Conner 2013 and Huijg et al. 2014a).  
Huijg’s paper includes a “generic” questionnaire which may be adapted for use in 
TDF-informed quantitative research.  Data would be gathered using a 
combination of closed questions, Likert scale fixed choice response formats and 
open questions (Bowling 2002).  Quantitative data would be analysed using 
descriptive and inferential analysis (Bowling 2002); this would allow description 
of the sample and again depending on response rates and any statistical 
significance might allow more general inferences to be made.  The inclusion of 
questions about influences on prescribing decision-making in general and on 
noteworthy prescribing decisions might facilitate comparison of influences in 
these two different circumstances.  Inclusion of open questions would capture 
richer, qualitative data which would be used to expand and augment quantitative 
results (Bowling 2002).  Qualitative data would be analysed using a Framework 
Approach (Ritchie et al. 2014) developed from the literature including this study 
and the TDF.  
 
The nation-wide survey would be likely to gather valuable data from a wide cross 
section of NMPs, allowing characterisation and possibly the generation of 
statistically significant data.     
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Stage 2 
The research could be extended using mixed methods.  The second phase would 
use the interpretivism philosophy and a qualitative approach further to explore 
influences on NMPs’ prescribing decision-making.  Participants in the cross-
sectional survey would be asked whether they would be willing to take part in 
telephone interviews again focusing on influences on their prescribing decision-
making.  If so, they would be directed to a study-specific website which would 
contain information about the study to allow them to complete an online consent 
and copyright form; they would also be asked to provide demographic and 
contact details.    
 
A generic interview schedule would be designed based on the literature including 
this study and the TDF and focusing on influences on participants’ prescribing 
decision-making.  The schedule would be augmented with specific questions 
based on the participant’s questionnaire responses.   
 
Qualitative data from the questionnaire would again be analysed using a 
Framework Approach (Ritchie et al. 2014) developed from the literature including 
this study and the TDF. 
 
This second stage of the research would provide additional rich data on 
influences on prescribing decision-making by NMPs.  Overall, the study would 
provide valuable information on the key behavioural determinants of NMPs’ 
prescribing decision-making and on their views and experiences of their 
university-based training course which could be used to inform education, 
training and practice. 
 
6.7.2 Proposal 2: an educational intervention 
 
The doctoral student and colleagues teaching on RGU’s pharmacist prescribing 
and non-medical prescribing courses could work together to develop, implement 
and evaluate an educational intervention based on three or four of participants’ 
Stage 2 Phase 2 reflections.  The aim of the activity would be to encourage 
students’ critical thinking about possible influences on prescribing decision-
making.  
 
 294 
 
Scenarios would be selected through discussions with colleagues teaching on the 
courses, and videos made of each scenario.  These would be filmed in sections.  
Videos would show actors performing the selected scenarios and would stop just 
before the point where the prescriber made his or her decision.  Students would 
view one scenario at a time and work in small groups to discuss what they had 
seen, possible influences on the prescriber and how they themselves might 
respond.  This would be followed by a wider discussion facilitated by staff.  The 
videoed scenario would then continue, showing the prescriber thinking aloud, 
then what he or she actually did.  Again facilitated discussion would follow before 
the next scenario was shown.   
 
The activity would be evaluated by asking students to provide feedback at the 
end using post-it notes and flip charts to create talking walls (Parsell, Gibbs and 
Bligh 1998).  Headings would encourage recording of students’ responses to the 
scenarios, their opinions as to the usefulness of the teaching activity and 
suggestions as to how the activity might be improved or augmented.  Student 
feedback would be analysed using the Framework Approach (Ritchie et al. 2014) 
and used to inform development of this activity and others designed to enhance 
NMP students’ awareness of and ability to manage, influences on their 
prescribing decision-making.   
 
If scheduling allowed this activity would be delivered face to face and inter-
professionally but it could also be used for face to face teaching of pharmacist 
prescriber students and non-medical prescriber students separately.  It could 
also be prepared as an on-line activity with students encouraged to post their 
responses and engage with others at various points in an on-line discussion 
forum; this would allow inter-professional participation.  Weglicki and colleagues 
found that on-line learning was less popular with non-medical prescribers in 
meeting their CPD needs (Weglicki and Reynolds 2015).  Rather most welcomed 
face to face learning including informal debate as this allowed interaction with 
their peers.   
 
6.8 Conclusions 
 
At the end of this programme of research, what is now known and how does it fit 
with current guidance and policies on prescribing?  
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Participants in this study were nurse and pharmacist independent prescribers 
delivering healthcare for a wide range of patients across community pharmacy 
and primary and secondary care.  The design of the study, underpinned by the 
use of the TDF, allowed a rigorous and trustworthy exploration of influences on 
their prescribing decision-making and identification of the determinants of this 
behaviour.  
 
Participants were focused on doing their best for their patients and worked 
collaboratively with other healthcare professionals to achieve this.  They had 
appropriate knowledge and skills to make prescribing decisions, took a rigorous, 
reflective approach, were clear about their professional roles and capabilities and 
determined only to prescribe within their areas of competence.  Their prescribing 
decision-making was influenced by most of domains of the TDF and also by 
experience and multi-disciplinary working; the social roles of others including 
patients were sometimes particularly influential.  Complexity was a feature and 
an influence in many of their prescribing decisions. 
 
Reviewing findings from the study in relation to the British Pharmacological 
Society’s 10 Principles of Good Prescribing (British Pharmacological Society 
2010), participants were practising according to these principles.  They were 
almost always clear about the reasons for prescribing (excepting occasional 
antibiotic prescribing in response to patient or family demand, when none the 
less they might be clear although not satisfied).  They took into account the 
patient’s medication history and other factors before prescribing, in one case 
refusing to prescribe in the absence of sufficient information.  Their prescribing 
decision-making was patient-centred and took account of patients’ ideas, 
concerns and expectations.  Their selection of medicines was almost always 
based on the evidence, most often on local guidance although again there were 
anomalies.  Pharmacist prescribers were concerned about their inability to write 
prescriptions electronically although this is being addressed currently; one nurse 
prescriber described delaying her prescribing deliberately so that she could 
benefit from the functionality of her practice computer.  Participants were aware 
of the need for careful monitoring and clear communication and documentation 
of their prescribing decisions.  As prescribers and particularly perhaps as non-
medical prescribers they were aware of their limitations and determined only to 
prescribe within their areas of competence.   
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The Scottish Government’s Prescription for Excellence (2013) set out the 
ambition that by 2023 all patients in Scotland will have access to a clinical 
pharmacist independent prescriber.  Pharmacist prescribing is thus embedded in 
Scottish Government plans for healthcare provisions and in practice.  Prescribing 
by nursing is already embedded in practice and the NMC is consulting on their 
2030 Vision for Nursing (personal communication H. Bain).  
 
In Realistic Medicine (Calderwood 2016) Scotland’s Chief Medical Officer 
challenged doctors and by extension all healthcare professionals to take a 
personalised, patient centred approach, encouraging shared decision-making 
informed by evidence and reducing unnecessary variation in practice and 
outcomes.  Participants in this study were meeting these challenges.  They were 
determined to avoid patient harm and took a rigorous approach in making their 
prescribing decisions.  Patient-centred prescribing decision-making included 
stopping medicines which patients no longer wanted or thought necessary, after 
a discussion of the attendant risks.  By training and working as non-medical 
prescribers participants had already shown themselves dedicated to 
improvement and innovation in their practice.   
 
Improvement is always possible and it is hoped that this research exploring 
influences on the prescribing decision-making of non-medical prescribers will 
contribute to improvements in education, training and practice and ultimately to 
patient care.  
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Appendices 
 
Appendix 2.1 Recruitment e-mail 
 
Dear non-medical prescriber, 
 
While there are increasing numbers of non-medical prescribers we know very 
little about how they make their prescribing decisions and the influences on this.  
We are researching prescribing decision-making by non-medical prescribers and 
are sending all non-medical prescribers in the NHS Grampian area an invitation 
to participate in our research.  We hope that the findings from our research may 
help to improve education and training around prescribing decision-making and 
hence patient care.  We would be very grateful if you would agree to take part in 
our research.  This will be in three phases and you may choose whether to take 
part in one, two or all three phases.  These will be: 
 
Phase 1: a face to face interview focusing on influences on your prescribing 
decision-making 
Phase 2: you will be asked to record your thoughts on one or two prescribing 
decisions you make over a four week period 
Phase 3: a face to face interview based on the recording/s you make. 
 
You will be offered an honorarium (£25 Marks & Spencer vouchers) as a ‘thank 
you’ for taking part.  
 
It is hoped that Phase 1 interviews will start in September 2015; these will be 
held at a date, time and place convenient for you.   
 
For further information, and to complete the on-line consent form if you wish to 
participate, please visit our study website  
 
http://www.rgu.ac.uk/nmp-prescribing-decision-making 
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A short report on the research will be posted on the website and will be e-mailed 
to you along with a letter of thanks.  We would really appreciate your help and 
look forward to hearing from you.  
 
Kind regards, 
 
Trudi McIntosh 
Principal investigator, lecturer in Pharmacy Practice and PhD student 
School of Pharmacy and Life Sciences 
Robert Gordon University 
Aberdeen 
E-mail: t.mcintosh@rgu.ac.uk   Phone 01224 262582  
 
Scott Cunningham 
Principal supervisor and Senior Lecturer 
School of Pharmacy and Life Sciences 
Robert Gordon University 
Aberdeen 
E-mail: s.cunningham@rgu.ac.uk  Phone 01224 262533 
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Appendix 2.2 School of Pharmacy and Life Sciences initial ethics 
approval 
 
School of Pharmacy and Life Sciences Research Ethics Committee 
COMPLETED 4 September 2014 
 
Research Project Title 
An exploration of non-medical prescribers' experiences of and perspectives on 
influences on their prescribing decision-making, with a focus on social and 
cognitive influences. 
 
 
Dear Trudi, 
The School Research Ethics Committee recommends that there are no ethical 
issues with your project and you are able to proceed with your research and any 
further ethics applications. 
Should there be any amendments to this project during the research we would 
advise you to check with the chair of the ethics committee as to whether a 
further review would be required. 
We wish you well with your project. 
 
Regards 
Dr Lesley Diack 
On behalf of the School Ethics Review Panel 
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Appendix 2.3 School of Pharmacy and Life Sciences amendment 
ethics approval 
 
Dear Trudi 
 
The School Research Ethics Committee has assessed your amended application 
and the decision is that there are no ethical issues with your project.  
  
I can now confirm that you are able to proceed with your research and any 
further ethics applications.  
 
Should there be any further amendments to this project during the research we 
would advise you to consult with the convener of the ethics committee as to 
whether a further ethical review would be required.  
 
We wish you success with your project. 
 
 
Regards 
 
 
 
Convener of the School Ethics Review Panel 
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Appendix 2.4 Opinion of the North of Scotland Research Ethics 
Committee 
 
Received 13th August 2014 
 
 
Dear Trudi 
  
Thanks for getting back to me. 
  
As you are recruiting NHS Staff, your research project does not come under the 
Remit of the NHS Ethics Committee and would not require approval from 
ourselves.  It does however, require ethical review and I noted that you sent it to 
the School Ethics Committee. 
  
If you have any further questions, please don’t hesitate to contact me. 
  
Kind regards 
  
Rachel 
  
Rachel Venables PhD 
Scientific Officer  
NRES Committees – North of Scotland  
Summerfield House 
2 Eday Road 
Aberdeen 
AB15 6RE 
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Appendix 2.5 NHS Grampian Research and Development 
approval 
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Appendix 2.6 NHS Grampian Research and Development 
extension approval 
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Appendix 3.1 Systematic review protocol 
A systematic review of the social and cognitive influences on 
prescribing decision-making among non-medical prescribers  
Trudi McIntosh, Scott Cunningham, Derek Stewart, Katrina Forbes-
McKay, Dorothy McCaig  
  
Citation  
Trudi McIntosh, Scott Cunningham, Derek Stewart, Katrina Forbes-McKay, 
Dorothy McCaig. A systematic review of the social and cognitive influences on 
prescribing decision-making among non-medical prescribers. PROSPERO 
2013:CRD42013004729 Available from 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42013004729  
Review question(s) 
What are the social and cognitive influences on prescribing decision-making 
among supplementary and independent non-medical prescribers in the UK? 
What are the methodologies and methods used, and quality of peer-reviewed 
published studies into the social and cognitive influences on prescribing decision-
making among supplementary and independent non-medical prescribers in the 
UK? 
 
Searches 
Literature search strategy  
The search strategy has been developed iteratively through discussion with the 
research team and with subject-specific librarians. In addition the search 
strategies of several key systematic reviews in the separate areas of prescribing 
decision-making and non-medical prescribing were examined and relevant 
elements incorporated.  
Inclusion criteria:  
• Studies including supplementary and independent non-medical prescribers 
practising in the UK.  
• Studies focusing on the prescribing decision-making of these non-medical 
prescribers.  
• Peer-reviewed published studies reporting primary research and data 
generated from secondary research such as systematic reviews and meta-
analyses, should any be identified during the review process.  
• All study designs.  
• Papers published in English; since the focus is on studies carried out among 
participants in the UK this should not introduce publication bias.  
• Studies undertaken from 2003 onwards (date of implementation of 
supplementary and independent non-medical prescribing in the UK).  
Exclusion criteria  
• Studies including data from prescribers other than supplementary and 
independent non-medical prescribers where data are not reported according to 
profession of prescriber.  
• Studies focusing on the administration of medicines via Patient Group 
Directions.  
• Letters, opinions, editorials, descriptions of clinical practice.  
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Databases  
The following databases will be searched:  
MEDLINE, PsycARTICLES, Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), International Pharmaceutical Abstracts (IPA), Education 
Resources Information Centre (ERIC), The Cochrane Library, Google Scholar.  
Search terms  
Search terms including the following will be used to identify studies which 
explore social and cognitive influences on prescribing decision-making among 
non-medical prescribers:  
• Prescib*  
and  
• Pharmacist* or nurse* or physiotherapist* or podiatrist* or radiographer* or 
optometrist*  
and  
• Influenc* or decision* or decid* or judge* or factor*.  
Medical index subject headings (MESH terms) will also be used where 
appropriate.  
Citation searching, author searching and RSS feeds will be used to expand the 
search. In addition, electronic current awareness alerts have been set up with 
NHS Evidence, Google Scholar and with the British Library (‘Zetoc’ alerts).  
 
Link to search strategy 
http://www.crd.york.ac.uk/PROSPEROFILES/4729_STRATEGY_20130507.pdf 
 
Types of study to be included 
There will be no restrictions on the study designs; methodologies will include but 
not be limited to studies taking a phenomenological approach. 
 
 
 
Condition or domain being studied 
Non-medical prescribing is a relatively recent development in healthcare which 
allows non-medical healthcare professionals, mainly nurses and pharmacists but 
also others to prescribe for their patients. Prescribing decision-making can be 
complex and challenging; a scoping literature review identified a number of 
influences on medical prescribing decision-making but little appears to be known 
about this process in non-medical prescribers.  
This systematic review looking at social and cognitive influences on prescribing 
decision-making among non-medical prescribers will inform the development of a 
programme of doctoral study exploring non-medical prescribers’ experiences of 
and perspectives on ‘non-clinical’ influences on their prescribing decisions. The 
findings and subsequent programme of study will also contribute to the 
education, training and practice of non-medical prescribers. Non-medical 
prescribing has developed according to different models across the world 
reflecting the very different healthcare systems; given this variation in practice 
this review will focus only on supplementary and independent non-medical 
prescribing in the UK. 
 
Participants/ population 
Included: supplementary and independent non-medical prescribers in the UK; 
these encompass pharmacist, nurse, physiotherapist, podiatrist, diagnostic 
radiographer and optometrist prescribers.  
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Excluded: prescribing by supplementary and independent non-medical 
prescribers using patient group directions; prescribing by community nurse 
practitioners. 
 
Intervention(s), exposure(s) 
Prescribing decision-making  
A scoping literature search recently undertaken revealed that most research thus 
far has been carried out among medical prescribers in primary care, where 
indeed most prescribing occurs. General practitioners’ prescribing behaviour was 
first surveyed in 1949 (Dunlop 1952); since that time a wealth of research has 
been carried out. In 1992 Bradley published a study on ‘uncomfortable 
prescribing decisions’ among GPs in England and showed that their decisions 
were based on a variety of clinical and non-clinical factors including patient 
expectations, the doctor-patient relationship and the doctor's previous behaviour 
(Bradley 1992). GPs' discomfort around some of their prescribing decisions was 
multifactorial. Appropriate prescribing has been defined as a balance between 
the right technical properties, what patients want and the greater good (Cribb 
and Barber 1997). Decision-making around prescribing is complex and 
challenging; it is likely to be informed by a variety of influences including clinical 
guidelines but also including factors relating to social cognitive models of 
behaviour (Ogden 2007) and culture (Egede 2006).  
The evidence regarding non-medical prescribing is limited and equivocal; non-
medical prescribers assert that they adhere strictly to evidence-based practice 
yet this may not always be the case (Maddox 2011, Rowbotham et al. 2012). 
Non-medical prescribers come from a variety of professional backgrounds but 
unlike doctors, none comes from a tradition of paternalistic relationships with 
patients or from a position at the top of the healthcare hierarchy (Weiss and 
Fitzpatrick 1997, Weiss and Sutton 2009). It may be that their prescribing 
decisions are informed by different or additional influences to those of doctors 
and this is the proposed area of research.  
This review will include prescribing decision-making by non-medical prescribers 
but will exclude the use of Patient Group Directions by these prescribers. 
 
Comparator(s)/ control 
None. 
 
Context 
Supplementary and independent non-medical prescribing in the UK.  
Two models of non-medical prescribing will be included in this review: 
supplementary and independent prescribing; prescribing by community 
practitioner nurse prescribers will not be included. In 2011 there were 2,602 
pharmacist prescribers in the UK (Hassell 2012) and in 2013, 26,763 nurse 
independent/supplementary nurse prescribers and 1,447 nurse independent 
prescribers (Nursing and Midwifery Council, personal communication, 25th March 
2013)  
Supplementary non-medical prescribers treat an already-diagnosed condition 
within the bounds of a patient-specific clinical management plan agreed by the 
patient, the supplementary prescriber and an independent prescriber ie a doctor 
or dentist (Department of Health 2002). Independent non-medical prescribers 
are responsible for the clinical management including prescribing of a patient’s 
diagnosed or previously undiagnosed condition and may thus be responsible for 
diagnosis (Department of Health 2005); this has been a contentious issue, 
particularly among medical prescribers (Day 2005). At present in the UK suitably 
 342 
 
qualified nurses, pharmacists and optometrists may practise as independent or 
supplementary prescribers while physiotherapists, diagnostic radiographers and 
podiatrists may practise as supplementary prescribers. There are plans to extend 
both the range and scope of non-medical prescribing still further.  
 
 
Outcome(s) 
Primary outcomes 
Primary outcome: the identification and characterisation of social and cognitive 
factors and perceived factors that influence the prescribing decision-making 
process among non-medical prescribers. 
Not applicable. 
Secondary outcomes 
Secondary outcomes: a better understanding of these factors and perceived 
factors will contribute to the education, training and practice of non-medical 
prescribers and facilitate more informed decision-making in a new and 
increasingly important area of prescribing. More informed prescribing decision-
making will in turn lead to an improvement in patient care. A second secondary 
outcome will be the evaluation of the existing literature thereby adding to the 
body of knowledge in this area. 
Not applicable. 
 
Data extraction, (selection and coding) 
Process for study selection  
Duplicate studies retrieved from more than one database search will be removed. 
Study selection will then be a three stage process; reasons for exclusion will be 
documented at each stage. Decisions will be made independently by two 
members of the research team (the principal researcher plus one of three 
others); where there is disagreement this will be resolved by discussion and if 
necessary by consulting a third team member.  
The selection process will be piloted on 50 studies and the results of the pilot 
discussed with the research team. Any adjustments deemed necessary will be 
made and the selection process re-started if necessary. A flow chart summarising 
the study selection process including reasons for inclusion/ exclusion will be 
prepared.  
Stage 1: titles of all retrieved studies will be considered alongside inclusion and 
exclusion criteria. Studies which are clearly not relevant will be excluded, as will 
those which are relevant but which are excluded on the basis of inclusion and 
exclusion criteria. Where there is any doubt, studies will be included at this 
stage.  
Stage 2: abstracts of retained studies will be accessed and their relevance 
assessed according to the inclusion and exclusion criteria. Again where there is 
any doubt, studies will be included.  
Stage 3: full text of all studies retained at stage 2 above will be obtained and 
their relevance assessed according to the inclusion and exclusion criteria.  
Data extraction  
Electronic data extraction forms will be prepared based on the review questions 
and objectives and in consultation with research team members. Guidelines for 
their use will be prepared and the forms will be piloted before use. It is likely 
that fields will include:  
• Study title and author/s, participants (professions and numbers), setting, study 
design, response rate if appropriate and outcome of significance to the review 
question and objectives.  
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• Qualitative data will be extracted from papers included in the review using the 
standardised data and conclusions.  
Data extraction will be carried out by two members of the research team 
independently and results compared; where there is disagreement this will be 
resolved by discussion and if necessary by consulting a third team member.  
 
Risk of bias (quality) assessment 
Studies will be assessed using the relevant Critical Appraisal Skills Programme 
tool (CASP-UK, 2012) or the Strengthening the Reporting of Observational 
studies in Epidemiology (STROBE) checklist for cross-sectional studies (Institute 
of Social and Preventive Medicine 2009); all include clear guidelines for their use. 
Again, decisions will be made independently by two researchers; where there is 
disagreement this will be resolved by discussion and if necessary by consulting a 
third researcher.  
No papers will be excluded on the basis of assessed quality; influences identified 
in this systematic review will inform further doctoral study. 
 
Strategy for data synthesis 
Analysis will depend on the data that are available but is likely to involve a form 
of narrative synthesis; the appropriate method will be determined by the studies 
included (Centre for Reviews and Dissemination 2009). First a descriptive 
summary of studies will be presented in table form supported by narrative 
description; qualitative and quantitative studies will be reported separately at 
this stage. The tables will include details of study type, setting, numbers of 
participants and their professions, phenomena of interest, findings and an 
indication of study quality.  
Next studies will be grouped together according to elements derived from the 
review objectives. Analysis will identify themes across studies, comparing and 
contrasting them to allow synthesis of findings. Finally the review processes will 
be subjected to critical reflection (Centre for Reviews and Dissemination 2009) 
and recommendations made for future work.  
 
Analysis of subgroups or subsets 
None planned. 
 
 
 
Dissemination plans 
This review will form part of a programme of doctoral studies which it is hoped 
will inform education, training and practice of non-medical and perhaps medical 
prescribers. It is anticipated that the research will be written up and submitted 
for publication and it is also envisaged that the work will be disseminated via 
presentation at a suitable conference/s 
 
Contact details for further information 
Trudi McIntosh 
School of Pharmacy and Life Sciences,  
Robert Gordon University,  
Schoolhill.  
Aberdeen  
AB10 1FR 
t.mcintosh@rgu.ac.uk 
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Appendix 4.1 Participant information letter 
 
Dear participant [potential participant’s name], 
You are invited to take part in a research study exploring prescribing decision-
making by non-medical prescribers. Thank you for taking the time to read the 
following information carefully. It is important that you understand why the 
research is being done and what it will involve. Please ask if there is anything 
that is not clear or if you would like more information. Take your time to decide 
whether or not you wish to take part.  
 
What is the purpose of the study? 
We are interested in how non-medical prescribers make prescribing decisions.  
In particular, we want to gain a better understanding of the influences on their 
prescribing decision-making.  
 
Why have I been chosen? 
All non-medical prescribers employed by or contracted to NHS Grampian have 
been asked if they would like to take part in the study.  
 
Do I have to take part? 
No. Participation in this study is voluntary and you may withdraw from it at any 
time.  If you decide to take part we will offer you an honorarium (£25 in Marks 
and Spencer vouchers) in recognition of your contribution to the study. 
 
What will participation involve?  
We will ask for your name, e-mail address and phone number and brief 
demographic details so that we may contact you about your participation.  
There are three phases to the research; if you agree to participate you may 
choose whether to participate in one, two or all three phases.   
 
Phase 1  
In the first phase of the study, I will contact you to arrange a convenient date, 
time and place for me to come and interview you for no more than around 30 
minutes. The interview will be audio recorded and will explore influences on 
your prescribing decision-making.  At the end of the interview I will give you 
information about Phase 2 of the study.   
 
          The research team  
         Ms Trudi McIntosh 
         Dr Scott Cunningham 
 Prof Derek Stewart      
 Dr Katrina Forbes-McKay 
         Dr Dorothy McCaig 
         Mrs Linda Harper 
         Ms Wendy Robertson 
 
 
An exploration of prescribing decision-
making by non-medical prescribers. 
Contact: Trudi McIntosh e-mail t.mcintosh@rgu.ac.uk or phone 01224 262582       
or           Scott Cunningham e-mail s.cunningham@rgu.ac.uk or phone 01224 262533 
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Phase 2 
If you agree to take part in Phase 2 of the study I will give you a digital 
recording device and explain how to use it.  I will ask you to record your 
reflections after two prescribing decisions you make over the following four 
weeks; you may choose what to record but should not include any patient-
identifiable information.  I will collect the recording device from you and give 
you information about Phase 3 of the study.   
 
Phase 3 
If you agree to take part in Phase 3 of the study we will arrange a convenient 
date, time and place for me to come and interview you again for no more than 
about 40 minutes.  We will listen to your recordings from Phase 2 and I will 
interview you about what you said.  The interview will be audio recorded. 
 
Do I have to take part in all three phases of the study?  
No, you may choose whether or not to take part in each phase and may 
withdraw from the study at any time. Taking part in the study will not change 
your relationship with Robert Gordon University or with NHS Grampian Health 
Board or any other Health Board. 
 
What are the possible benefits of taking part? 
There is no direct benefit to you from participation in this study. However, it is 
hoped that findings will help to clarify prescribing decision-making by non-
medical prescribers and may inform education and training to provide support 
for prescribing decision-making.  
 
Will my contribution to this study be kept confidential?  
Yes.   
Any information with implications for patient safety will be discussed with the 
research team. 
 
What will happen to the results of the research study? 
We will send you a short report of the findings. The full findings of the study 
will form part of a PhD and may be published in a health care journal and 
presented at a conference.  
 
Who is organising and funding the research? 
This project is organised and funded by a Robert Gordon University-led 
research team. 
 
Who has reviewed the study? 
The wording of this information sheet and the consent form have been 
reviewed by members of the research team. The aims and objectives of the 
study have been reviewed by academic experts and approved by the Robert 
Gordon University Research Ethics Committee. The study has received NHS 
Research and Development approval.   
 
What next? 
If you decide to take part in the research, please keep this information for 
future reference. Please then complete the consent and copyright form. I will 
contact you to arrange a convenient date, time and place for you to help us 
with the research. 
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On behalf of the research team, thank you for your time and for 
reading this information. If you have further questions about this study 
please contact Trudi McIntosh on 01224 262582, e-mail 
t.mcintosh@rgu.ac.uk  or Scott Cunningham on 01224 262533, e-mail 
s.cunningham@rgu.ac.uk . 
 
Kind regards, 
 
 
Trudi McIntosh 
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Appendix 4.2 Interview schedule 
Interview schedule version 13 
Trudi McIntosh, RGU. 22nd March 2015 
 
Introduction 
Thank you for agreeing to take part in this interview.   
As you know I am interviewing you to find out about how you make prescribing 
decisions and what you think about when you’re making them.  As you will know 
from the information sheet and consent form, this interview is being audio 
recorded and I want to emphasise that what you say will be kept confidential.  
Please be aware however that if you choose to tell me something which has 
implications for patient safety this will be discussed with the research team 
including the NHS Grampian non-medical prescribing Leads. Are you still OK with 
that? 
 
Interview questions 
 
1) First, you’ve said you work as a [from demographic questionnaire]; please 
would you tell me a bit about the patient groups you prescribe for and the types 
of medicines you prescribe? 
 
2) Can you talk me through how you decide whether or not to prescribe for a 
patient?  
 
3) Once you've decided to prescribe something, can you talk me through how 
you decide what to prescribe? 
 
4) How confident do you feel in your ability to make these decisions? 
Prompt: can you tell me more about that? 
 
5) I’d like to know about how easy you find it to make prescribing decisions.  
Does this vary sometimes?  Please tell me more about this. 
 
6) Do you feel you have the necessary knowledge to decide what to prescribe?  
What sort of knowledge do you draw on? 
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Prompts: pharmacological /clinical/ procedural knowledge, lab tests or 
interpretation of lab tests, anything else. 
 
7) Do you feel you have the necessary skills to decide what to prescribe?  What 
sort of skills do you use? 
Prompts: communication skills, clinical assessment skills, anything else. 
 
8) Have you had occasions where you became aware that there was a gap in 
your knowledge in relation to prescribing decision-making?  
Can you tell me more about that?  
 
9) What about a skills gap; have you ever been aware that you lacked a 
particular skill in relation to prescribing decision-making or weren’t proficient in 
it? 
How do you deal with any of these gaps during the consultation? 
What about more generally? 
 
10) Can you tell me a bit about the information sources you use whilst making a 
prescribing decision?  
 
11) Are there things you might forget to consider when you’re making a 
prescribing decision?   
What about things that might distract you? 
 
12)  How does your expertise or experience both as a practitioner and as a 
prescriber influence your prescribing decision-making? 
 
13) Are there resources or ways of working that might have an effect on the 
prescribing decisions you make? 
Prompts: guidelines, local formularies, access to lab tests, ways of working eg 
single-handed vs team working, involving colleagues.  
 
14) I’m interested in finding out about whether other people might influence you 
when you’re making a prescribing decision.  
Prompt: how might other people’s opinions or practices or behaviour influence 
you when you’re making a prescribing decision? 
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Prompts: colleagues, patients, patient’s family, other healthcare professionals, all 
types of media 
Of these, who or what is the most influential? 
Why is this? 
 
15) Is there anything about where you work which influences the prescribing 
decisions you make?  
Prompts: things like facilities, local formularies or protocols, time available, 
staffing. 
 
16) How, if at all, might your emotions influence your prescribing decision-
making? 
Prompts: worried, concerned etc. 
 
We’re coming to the end of the interview now.   
 
17) Can you tell me about any possible consequences for the patient that might 
influence your prescribing decision-making? 
What about from your own point of view; are there any possible consequences 
for you which might influence your prescribing decision-making?   
Are there any possible consequences for others such as your colleagues or your 
employer that you might take into account? 
Of these possible consequences, which do you think might be the most 
influential?  
 
18) Before this interview, had you ever reflected on how you make prescribing 
decisions?  
 
19) And finally, I wonder if you can let me have your thoughts around how 
prescribing fits with current and future roles for [participant’s profession]? 
 
Thank you for your participation.  Is there anything else you would like to add? 
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Appendix 4.3 Standard operating procedure for interview 
 
Standard operating procedure for interviews 
 
E-mail the day before to confirm interview still suitable 
 
Check directions and journey time to agreed location for interview 
 
Prior to entering the building check both digital recorders are working  
 
Meet participant according to arrangements made, introduce self and confirm 
participant’s identity 
 
Explain purpose of interview and my role, respond to any questions from 
participant 
 
Read pre-amble, confirm that participant is happy to proceed 
 
Switch on both recorders, start the interview and check throughout that 
recorders are still recording 
 
At end of interview, switch off recorders, ask participant if s/he has any 
questions and thank participant 
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Appendix 5.1 Instructions for participants using the digital 
recorder 
 
 
          The research team  
         Ms Trudi McIntosh 
         Dr Scott Cunningham 
         Prof Derek Stewart     
         Dr Katrina Forbes-McKay 
         Dr Dorothy McCaig 
         Mrs Linda Harper 
         Ms Wendy Robertson 
 
 
An exploration of prescribing decision-making 
by non-medical prescribers. 
Contact: Trudi McIntosh e-mail t.mcintosh@rgu.ac.uk or phone 01224 262582       
or           Scott Cunningham e-mail s.cunningham@rgu.ac.uk or phone 01224 262533 
 
Thank you for agreeing to take part in this study.  In Phase 2 we would like you 
to record one or two short reflections on a prescribing decision you have made 
in the four weeks following your interview in Phase 1.  Please remember not to 
include any names or other details which might allow identification of any 
patients, colleagues etc.  Please also remember that any information with 
implications for patient safety will be discussed with the research team. 
 
Using the voice recorder 
 
Turning it on: while the voice recorder is turned off, slide the POWER/HOLD 
switch in the direction of the arrow.  Then  
 
Press the F1 (Home) button to display the (Home) screen. 
 
Press the +/- >> or << button to select the microphone (record) then press 
the OK button. 
 
The screen will show a list of folders with Folder A at the top.  Press OK. 
 
Point the built in microphone in the direction of the sound to record. 
 
Press the REC button to start recording.  
 
Press the STOP button when you want to stop recording.  
To check the recording has worked: 
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Select the file to play and press the OK button to start playback.  Press the 
STOP button to stop playback. 
 
Please switch off the recorder by sliding the POWER/HOLD switch in the 
direction of the arrow and holding it for at least half a second. 
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Appendix 5.2 Specimen annotated interview transcripts used 
for Phase 3 interviews 
 
Nurse 2 Reflection on a prescribing decision 
 
 
 
 
Nurse 2 Reflection on a prescribing decision - continued over 
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Pharmacist 3 Reflection on a prescribing decision – see over 
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Pharmacist 3 Reflection on a prescribing decision – continued over 
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Pharmacist 3 Reflection on a prescribing decision – continued over 
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 360 
 
Appendix 5.3 Participants’ Stage 2 reflections 
 
 
Nurse 1 first reflection  
 
Reflection on decision to over-treat, to treat over-granulation tissue. One of my 
staff nurses asked me to assess a PEG site which had dramatically over-
granulated over a weekend.  There had been previous over-granulation of tissue 
noted the week before and I had hoped it would rectify itself as this type of 
tissue often re-models itself without the need for treatment.  However, a few 
days previously it had become more noticeable and I had prescribed some honey 
ointment as recommended in the Grampian wound formulary.  I visited with my 
staff nurse and made a decision to change this now to a moderate corticosteroid 
cream which I prescribed. 
 
On reflection: what I was trying to achieve and why did I intervene? I didn't want 
the site to develop further complications.  I knew that the patient would be 
worried about any complications to her care through my past experience with her 
and I felt it would be better for her to have prompt treatment rather than 
adopting a 'wait and see' approach.  I felt em, the staff nurse was expecting me 
to provide a solution to what appeared to be was a deterioration to the site.  The 
honey dressing I had prescribed previously had been used effectively with 
another patient and initially I chose this because there were less side effects with 
the honey than with the steroid cream, however it obviously wasn't potent 
enough in this situation and so I felt I had to step up treatment.  
 
The influencing factors to this, were that I've had past experience with over-
granulated wounds.  I checked with the BNF first and the guidance that I 
received on PEG site complications produced by the company who provide the 
feed to the patients and I discussed this also with my wider team who agreed 
with my actions.  
  
On reflection as to what, how the experience would change my knowing, I think 
that I learned that some patients would benefit from stronger preparations for 
PEG site complications.  My staff nurse was introduced to the concept of over-
granulation tissue and some of the treatments that are available to treat them. 
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Nurse 1 second reflection  
  
Reflection on a decision to prescribe diclofenac suppositories for a palliative 
patient.   
 
I had a patient with terminal GI cancer.  She wasn't used to taking medication, 
she was quite naive with medication and she had previously had chemo so was 
still suffering the after-effects of having a metallic taste of everything in her 
mouth.  She didn't really want a lot of pain killers although she was experiencing 
increased pain and really had asked for sort of anti-inflammatories because she 
had perceived this pain as inflammation coming from her tumours.  She had 
previous experience of using suppositories for constipation, again she just 
seemed to prefer em using the, the rectal route to treat her constipation rather 
than trying anything orally.  And I think with her advancing cancer that she'd 
really come off of med, come off managing to take very much by mouth at all.   
I went to see her em, and she was complaining of increased pain and I made the 
decision we should maybe try and use Voltarol® suppositories for her em, 
because this was a patient who was quite experienced in using suppositories, 
although not for, for pain.  She did have 'just in case' medication in the house 
and she also had a bottle of Oramorph® which she, she hadn't even opened. 
 
The alternatives were to set up a syringe driver.  One of the, the influences on 
my prescribing for this that, we actually had a, quite a bad weekend of snow 
forecast and she lives in a very rural area so I was a bit concerned that if we 
were to set up a syringe driver, would we physically manage to be there to, you 
know, within 24 hours to fill this up?  
 
She was opioid naive, as I, as I said earlier, so really wasn't appropriate to be 
thinking about giving her IM injections of, of controlled drugs.  She'd had a quite 
a rough week, with a lot of emotional exhaustion and although she hadn't been 
eating much that week we, neither the patient or myself were unsure if this was 
actually coming up to her end of life care or whether she was just exhausted so I 
didn't want to rush in with a syringe driver either. 
 
I prescribed a certain dosage, I, I did actually phone the chemist, just to see if 
they had this type of medication in stock because it's quite an unusual 
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medication to prescribe.  He did have one however it wasn't the, the usual dose, 
I normally would have prescribed 75mg twice a day.  He only had 100mg 
available so I made a decision to prescribe 100mg just once a day for her.  It 
was an unusual prescription for me to write but it meant that the patient had her 
pain, had an option to, to try and control her own pain over the weekend, and it, 
it worked quite well, so that was.     
 
Nurse 2 first reflection  
 
Prescribing case no. 1 involves a 69 year old lady who was diagnosed with 
pulmonary fibrosis in 2011.  She has recently become more breathless and finds 
moving about at home more and more difficult because of this.  Her first concern 
which she voiced to me was that her oxygen concentrator only went up to four 
litres of ox-, delivering four litres of oxygen to her and she was requiring this 
more and more frequently.  So I reassured her that I would refer her on to the 
respiratory and oxygen therapy nurses who would then supply her with a 
concentrator which would supply a higher level of oxygen to her.  She then went 
on to describe her breathlessness and the attacks that she had when she wanted 
to do such things as have a shower or get dressed, or even indeed just walk 
from one room to the other in the house.  We talked about some non-
pharmacological help that she [recording stopped and re-started] 
 
…finds that tasks such as showering and getting dressed or even indeed moving 
from room to room in the house make it difficult for her to breathe and admitted 
to becoming a bit panicky when she became breathless.  We discussed non-
pharmacological ways of managing the breathlessness em, such as square 
breathing and relaxation, however she had already been given some Oramorph® 
solution from her GP to help with this and she said that while it did help she 
found that her mouth became very dry, em, with using the morphine.  
 
Following discussion with the lady and her husband, em, we agreed that it would 
be a very good idea for her to change her Oramorph® solution to another opioid 
and in this case Oxynorm® solution to see if that would indeed help with the dry 
mouth problems that she was experiencing as it was quite upsetting for her and 
she was finding that she was drinking so much she ended up having to get up to 
the bathroom an awful lot during the night. So we wondered if possibly using a 
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different preparation would help this side effect for her. The other drugs that 
[recording stopped and re-started] 
 
The other aspect of her breathlessness which was quite alarming for both her 
and her husband was that she felt quite anxious when she became breathless 
and although we talked about the likelihood of anything … [recording stopped 
and re-started] 
 
In order to give her something which should alleviate that anxiety I prescribed 
[recording stopped and re-started] lorazepam 1mg tablets which can be halved 
as they’re scored and advised her to use the half tablet, 500 micrograms, under 
her tongue to alleviate the breathlessness.  It is a useful drug in that … 
[recording stopped and re-started] 
 
sublingually when she felt that she became anxious.  I have often found that just 
having the tablets in the house are sufficient for the patients not to be so 
anxious, but it also is a very useful drug for anxiety and breathlessness and as it 
has a shorter half-life than diazepam it tends not to make the patients quite as 
sleepy.  
Nurse 2 second reflection  
 
Prescribing record number 2 relates to a 64 year old gentleman with pancreatic 
cancer.  On one of my recent visits to this gentleman he described em, a colicky, 
windy type of pain in his abdomen.  He’s already on Oxycodone® for pain relief 
which is normally successful but these were bouts of discomfort rather than what 
appeared to be something that would respond to the Oxycodone®.  After giving 
some consideration as to whether or not em, I should prescribe some Buscopan® 
Hyoscine butylbromide em, I decided against that since the side effects of, of dry 
mouth can be quite unpleasant and he was already burdened with quite a few 
symptoms for which he had to take medication.  So after some due consideration 
I prescribed him some mebeverine hydrochloride and some peppermint oil in 
order to try and sooth the discomfort without giving him side effects because he 
was already having [missing – recording stopped and re-started] 
 
…it is an antispasmodic and may have been helpful in this instance I was very 
aware of the potential side effects which include a dry mouth and I felt would 
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add to the burden of his problems.  I therefore prescribed him some mebeverine 
hydrochloride em, in the hope that it would help a bit if it was indeed muscle 
spasm which was causing the colicky discomfort and also added in some 
peppermint oil em, to try and help reduce the flatulence that he was 
experiencing. [Recording stopped and re-started] 
… some Colpermin® or peppermint oil to try and help with the discomfort as in 
my experience it does tend to help to reduce wind and windy pain. 
 
Nurse 3 first reflection  
 
My first prescribing decision relates to a former RAF gentleman that came in.  He 
was clutching some paperwork, he’d recently been discharged from the services 
and was looking to get some tapentadol, a strong opiate medication and not 
something we used very often, actually.  However, the story went he’d actually 
turned up two days previously and saw the duty doctor, one of the GPs, who’d 
actually declined to prescribe him the tapentadol because she didn’t feel it was 
line with our formulary and had given him some co-codamol, much lesser 
medication, and sent him on his way.  However, he’d represented because – in 
his words – he was in agony, and unable to manage without this strong 
medication and was actually starting to feel a little but unwell.  So he demanded 
to see somebody, and I got him. 
 
So having a chat with this guy, he was very keen on getting this tapentadol but 
when I read the GP’s notes she’d declined it because she couldn’t find any 
evidence of him being on it since 2013.  The thread to what she’d written was 
that I think there was a bit of a question mark over whether the gentleman was 
trying to seek drugs as opposed to manage his pain.  However, after spending a 
bit more time with him and chatting away I could clearly see that this had been a 
long term problem.  The paperwork he did have certainly mentioned some quite 
complex spinal neurological problems and pains that he’d had for many years.  
He’d been under several specialists and so on and so on.  Now to be fair he didn’t 
have an up-to-date prescription, but what he did have was a box and the 
dispensing label on the box was dated two months ago.  When I worked out the 
quantity and the prescription and what have you it all worked out almost to the 
day of what he’d been taken.  So I came to the conclusion that this guy is 
supposed to be on this medication. 
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Not really knowing what tapentadol was, really, to be honest, not something I’d 
worked with, but when I looked it up it certainly didn’t seem to be a good idea to 
be stopping it suddenly like that.  So I had to kind of make a decision at that 
point as to whether he was going to get a supply of this or not, and it was really 
difficult as the doctor had already effectively said no, I found it quite hard to go 
against that.  So trying to not to think about what she’d said, the doctor, and 
make an independent assessment.  On balance, I thought, he’s got conditions 
that aren’t going to clear up, so he’s still in pain, he’d been prescribed it within 
the last two months, and I thought the safest thing to do was to issue the 
gentleman with exactly enough tablets to take him up to a point where I could 
get him in to see a different GP.  So I booked the appointment myself there and 
then, and worked out that he could have, I think it was 12 tablets or something 
in between now and then.  I typed up a story for the GP who was going to be 
seeing him and attempted to request some more records from the RAF, which 
proved to be a little bit tricky but they are on the way.  Now interestingly, when 
the next GP saw him, the drugs were added to the repeat and he was allowed to 
continue on them.   
 
I think what I found interesting and particularly challenging about that was that 
he’d already been seen by a doctor and the gentleman wasn’t happy with what 
the doctor had said.  Obviously it came back to me, and you don’t really feel, as 
a non-medical prescribing, like going against what the GP had said however I 
had to do what I thought was right at the time; the gentleman was sore, he was 
starting to feel unwell because he didn’t have, I presume, he was experiencing 
some form of withdrawal, and I decided rightly or wrongly to prescribe it.  It’s 
not something I would normally prescribe, but I did.  I looked it up, found it in 
the BNF and I feel confident enough in what I did; however it’s not something 
that after assessing someone I would ever recommend or arrive at that 
conclusion of prescribing that medication had he not already been on it.  I think 
really I just had to make the best use of what I had and do what I thought was 
the right thing to do at the time; and there was an out strategy, it wasn’t just 
added to his repeat, I wasn’t confident to do that.  I just literally gave him 
enough to see him through until another GP appointment.  And I now believe 
things are much more stable, and he’s carrying on.   
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So yeah, quite an unusual one, controlled drug, not really very much 
information, a drug we’re not particularly familiar with and the doctor had 
already said “No” so it had a few different bits to it for me, but I think we got 
there in the end and I feel happy with the decision that I made, albeit a little 
difficult.  I had in my mind, how am I going to defend this when I’m speaking to 
the doctor next time?  But actually she was quite good and understood that I’d 
made a different assessment to her.   Perhaps by this time the gentleman had 
explained himself a bit better, had a bit more information, I don’t know.  So that 
was my first decision and I hope that was of some use. 
 
Nurse 3 second reflection 
 
The next decision I have relates to a six year old girl who had been seen by one 
of our practitioners here for a query tonsillitis.  At that point it wasn’t felt to be 
infected so she was sent away with simple measures, ibuprofen and 
paracetamol.  She was then, I think, presented to the out of hours service the 
following night for a worsening of symptoms and they’d commenced her on 
penicillin v which had unfortunately caused a bit of a reaction, and that’s how I 
came into contact with her.  It was quite a straightforward hypersensitivity, you 
know.  A bit of a prickly rash, vomiting, diarrhoea, you know, not too unusual.  
So we just decided to stop the penicillin and I went to the second one in the 
formulary and changed to erythromycin because.  She was still symptomatic and 
she definitely needed some treatment so that’s, that’s what I did.  However, next 
morning, back again.  The erythromycin had caused a similar reaction, different 
enough for us to be satisfied that it wasn’t a continuation of anything else, it was 
related to the erythromycin.   
 
So that obviously presented quite a challenge for where we went next, ‘cause the 
formulary doesn’t really offer an alternative after that.  So it involved, involved a 
lot of digging through the BNF and to be honest, I wasn’t able to make a firm 
conclusion.  I had to go and get the practice pharmacist to come and have a look 
at it with me.  And again her first recommendation was “Does the kid still need 
to be treated?” to which “Yes” was the answer.  Therefore we after a lot of 
deliberation and looking settled for clarithromycin because that was felt to be, 
you know, the next nearest alternative.  It presented quite a challenge of 
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management really because again clarithromycin was not something I would 
have been prescribing routinely due to our formulary not advocating its use 
particularly, and also it was difficult because I haven’t come across too many 
people that are either allergic or over-sensitive to the first and second line 
treatments.  So she ended up with something quite sort of unusual I would say, 
for a sore throat. And this had to be accompanied by a reasonably good write-up 
as to why, you know, this drug was used, and it really was, you know, a case of 
doing the least harm.  I had to weigh up, well, what’s going to cause the most 
harm, you know, giving the clarithromycin with the associated kind of, you know, 
side effects and potential resistance and all the things we hear about from the 
microbiologists, or not treating the child. And I felt that on balance the child was 
more likely to become unwell from not being treated, and that’s why we used the 
clarithromycin.  But I think that without the support of the pharmacist I would 
have found that one quite a difficult one to manage.   
 
Nurse 4 first reflection  
 
Hello, and I’m going to tell you about a case of a female child, two years and six 
months old who I did not prescribe for. Mum phoned in on the morning of the 
13th of May and told the receptionist that the child was feverish and lethargic. 
When I phoned mum back to triage the call, Mum said that she was eating and 
drinking well, did have a fever but it wasn’t all the time, it was responding to 
paracetamol and ibuprofen but that she was very concerned about it because she 
was going to be working all weekend and she wanted her treated. So she was 
insisting on being seen so she came in in the afternoon, and the child was really 
well looking when she came in, running around the surgery, growling and 
pretending to be a lion. She was apyrexial, she had a clean tongue, runny nose, 
no cervical lymph nodes, her ears looked fine, heart rate was 120 and her chest 
was clear. She had a patch of eczema on the back of her neck and some flaky 
skin but other than that, looked really well. Her throat looked a bit red and her 
tonsils were sort of enlarged but there was no sign of any pus or anything and as 
I say she was running around and looking well. So I just gave mum some 
reassurance really, told her to continue the treatment that she’d been doing, so 
treating the fever when it arose, plenty of fluids, vitamin C drinks and things and 
gave really a worsening statement to come back if there were any further 
problems. 
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The next day, in the evening, mum phoned NHS 24. NHHS 24 sent a 999 
ambulance out for the child, and the child was seen in A&E … (I’m just looking to 
see what happened) So there were a few yellow spots at the back of the throat, 
the child was less active than she had been and…. I don’t have the A&E notes but 
she was admitted to the paediatric ward with a 3 day history of coryza, reduced 
appetite and one day history of lethargy and high temperatures despite regular 
paracetamol. She was taking fluids but not food. On arrival in the ward, her obs 
were normal, she was alternating between being sleepy and miserable and alert 
and playing well. Tonsils were enlarged with an exudate present and throat 
swabs were taken. She was not dehydrated and was taking oral fluids well on the 
ward. 
 
Mum’s main concern was that she would not be able to give [name of child] any 
antipyretics overnight as her last dose on the day was due in the early evening. 
She had reportedly been told that [name of child] was not allowed ibuprofen by a 
respiratory specialist; however, [name of doctor] advised that there would be no 
problem giving her ibuprofen as she had previously been given it with no issues 
in her admission in November last year. [Name of child] remained settled and 
apyrexial on the ward with a good oral intake and she was discharged home with 
open access to the ward. 
 
It says in the letter that she was advised to continue the antibiotics that A&E had 
started so she must have had antibiotics at some point – it’s not clear to me how 
that happened. There was a throat swab taken in A&E on that day. Anyway, the 
child was discharged the next day and then she came in to the practice I think, 
after that, and saw my colleague… No, she spoke to somebody on the phone, 
that was right, and the throat swab had come back with just normal flora, so no 
requirement for any treatment. I think the child was on erythromycin at the time 
and my colleague had said that this wasn’t required as the throat swab was 
clear. So that was an interesting, one, you know, after already being advised and 
seen in the practice that all of that happened afterwards. 
 
Nurse 4 second reflection  
 
I’ve got another patient I’m going to tell you about – I don’t know whether this is 
of interest to you or not but I thought it was an unusual one which you may want 
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to include. A lady called [patient’s name] who is 65, she’s got quite a long 
history; predominantly osteoporosis, type 2 diabetes, and more recently multiple 
myeloma. It’s a lady who I know quite well. We had a call-out from the son on 
the 24th of March this year, and the story was that she was sick and lethargic and 
the son wanted her seen at home. It didn’t sound like a particularly urgent visit, 
so I spent a bit of time in the surgery doing some other triage work before I 
went out to visit her. Anyway on arrival at the house, the son opened the door, 
and I could hear him shouting at his mum as I opened that door to me. The son 
was quite angry when I got there, saying, “I don’t know how we’re supposed to 
cope with this, I mean this has been going on for ages and she’s not well, 
something should be done about it” but behind him when he was speaking I 
could see that his mother was lying on the sofa looking really really ill. 
 
By this time I was in the house, and I asked, “How long has she been like this?” 
and he said, “Oh, ages, weeks, months”. By this time I was shaking [patient’s 
name] and saying, “[patient’s name], it’s [Nurse 4’s name] here, can you open 
your eyes?” And she was unconscious! So I said to the son, “Well how long has 
she been unconscious like this?” I don’t think he had realised that she was 
actually unconscious. So I said to him, “I’m going to get an ambulance and you 
can tell me what’s been happening once I’ve done that.” So I called an 
emergency ambulance, meanwhile I was trying to think what to do. I was trying 
to get her over onto her side because she had a big string of drool hanging from 
her mouth and she was really only opening her eyes to painful stimuli, she 
wasn’t really responding other than that at all. 
 
So while we were trying to figure out what had been happening, the son said 
that she’d had some IV bisphosphonates in the day leading up to this as part of 
her treatment, and he said she’s always a bit confused after the bisphosphonate 
treatment. While he was telling me that he suddenly realised that she’d emptied 
her Dosette® box for the day – so she’d potentially had quite a lot of morphine, 
she was on Oxycontin® 60mg of modified release twice a day as well as 
levothyroxine, fluoxetine, omeprazole, simvastatin, paracetamol, diazepam and 
gabapentin. So he thought she’d possibly taken a whole day of medication. So I 
was sort of standing there, thinking what to do, and I thought it’s not a situation 
I’ve ever come across before. Her pupils were small, but not pin-point, so I 
thought perhaps I could have been dealing with morphine toxicity but I didn’t 
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know for sure. In my bag I actually had some Narcan®, so I got an IV line in and 
I gave her 400micrograms of Narcan® IV, having never used it before. But she 
responded to that, she opened her eyes and sat up within a minute and started 
trying to vomit, but she was nevertheless much more alert. So one thing that I 
remembered about Narcan® was that you should always follow it up with an IM 
dose because it is short-lived when it’s given IV. So I gave her another 400 
micrograms IM. By which time the ambulance had arrived, and the ambulance 
crew took her out to the ambulance and I was speaking to the family. I then 
went out to my car but the ambulance was still there, so I went in the back of 
the ambulance to see what was going on. She was still looking very very poorly, 
but more alert than she had been, and the crew were wondering whether she 
could possibly have sepsis. So I said that’s certainly possible, so she went off to 
[name of hospital] and I went on and finished my morning work.  
 
I got called into [name of town] later on so on the way to that call I went in to 
[name of hospital] to see [name of patient] in A&E. She was sat up on the trolley 
looking really well, and knew me instantly when I walked in and was talking to 
me. Obviously the emergency had sort of passed by this time, she had 
responded really well to the Narcan® and we’d been correct that she had had a 
morphine toxicity. So that was an interesting one for me because I’d never ever 
come across that before and it was a fluke, in a way, that I’d been carrying 
Narcan around with me for ten years and never ever used it. So after thinking I 
might stop carrying it I’ve decided to continue! 
 
Nurse 4 third reflection 
 
Hi Trudi, it’s [name of nurse] here again – I think you should come and do a 
week with us here, you’d see all sorts of stuff! I’m going to tell you about 
another case, just in case the other two weren’t what you wanted. This is a story 
about a chap who was 58, the consultation happened last Friday on top of a 
week of us having a pretty difficult time in the surgery here, particularly with 
patients complaining, storming in, speaking to the practice manager because 
they didn’t get what they wanted and all sorts of things. So we were pretty 
frazzled by the end of last week, when a woman came in and demanded to see 
the practice manager – this was first thing in the morning. She spoke to the 
practice manager who said she wanted to know how to manipulate our system so 
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that she would get her husband an appointment with [name of doctor]. Anyway, 
the practice manager explained that [name of doctor] was fully booked, it was 
his last day before he was going on holiday so there was no chance of seeing 
him, but if it was an urgent thing she could be seen by one of the emergency 
team. Anyway, the wife was ranting on an saying that he would definitely need 
antibiotics because he’d got a problem with his chest, he’d been in hospital with 
his chest before and he would definitely need antibiotics and she wouldn’t be 
happy if he didn’t get them. 
 
The chap duly came in and was seen by me. As I say, he was 58, well-looking 
guy. He had a history of asthma and osteoarthritis, oesophagitis and dyspepsia. 
He appeared well, he had a bit of a cough which had started a week ago, he was 
saying that he was worried it would go into his chest because he’d been in 
hospital with pneumonia before. He had no sore throat, occasional sputum; he 
looked well, had a bit of a hoarse voice, his temperature was 37, pulse was 80 
bpm, SpO2 wasn’t working I’ve noted down, but his chest sounded clear. I 
reassured him about his current situation and I gave him a delayed script, really 
just because we felt that we couldn’t cope with the wife complaining again. I 
suspect he probably went home and took it straight away, but I hope that’s 
interesting for you! 
 
Nurse 5 first reflection 
 
A 70-year-old male patient attended my cardiovascular clinic for his annual 
review. He had a CABG three years ago for angina symptoms. Since his surgery 
he has had no angina or breathlessness and leads a fairly active life with a good 
diet. His lipids are checked annually and have always been fine, with his 
cholesterol fairly low. The latest reading was 3.2 [mmol/L]. At the clinic, he 
asked if he could reduce the dose of his statin as he is not keen to take them 
with all the bad press they get. He was taking atorvastatin 40mg daily. After 
discussion about the benefits of statins with CV disease, I agreed to patient 
pressure to reduce the dose to atorvastatin 20mg daily, as his blood results were 
okay. I explained the guidelines of ischaemic heart disease and practice protocol, 
I stressed his lipids should be rechecked in 6 months to ensure his bloods are 
still okay on the lower dose. He agreed to do this. 
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Nurse 5 second reflection 
 
A 65-year-old male patient attended 4 days post-op of removal of a Warthin’s 
tumour from his right salivary gland. As his wife thought it was more swollen 
around the wound, they thought it was probably infected. On examination there 
was no inflammation or discharge from the wound. He was apyrexial and not 
feeling unwell. It did not appear swollen at all. As he was very concerned that 
the wound may get more swollen and painful, I agreed to a delayed script for 
flucloxacillin 500mg four times a day, only to be taken if he became unwell; if 
the swelling did get worse; inflamed or if there was a discharge from the wound. 
I also checked with a GP who checked the wound and agreed with my decision. 
 
Pharmacist 2 reflection 
 
[My] reflection is a prescription that was left up to me to, to decide what to 
prescribe for a patient who had a leg wound infection after having a bypass graft.  
The patient was penicillin allergic so we had started them on vancomycin which 
was originally my choice as well, empirically, and then we got some sensitivities 
back from a wound swab, we were going to switch him to oral. Obviously the 
penicillin allergy played a huge part in the choice of antibiotics but I was sort of 
left with a choice of two or three antibiotics as oral options and I found myself 
being put off prescribing one particular antibiotic even though it would have been 
a, a totally valid treatment choice because one of our registrars really doesn’t 
like it.   
 
And it seemed very strange to me to, to avoid prescribing something because 
someone else doesn’t like it.  But, I, I didn’t really want to prescribe it for it then 
not to work because of being influenced by his views, but also, I kind of felt that 
I didn’t want to prescribe it because I didn’t then want one of the senior medical 
staff to come round and disprove [sic] of my choice or, potentially not feel 
comfortable with the way the patient was being treated.  
 
So in the end, went with co-trimoxazole which was a completely valid treatment 
choice but potentially an antibiotic which leaves the patient open to more side 
effects, than doxycycline, which was the other option but the sternal wound 
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infection, not sternal, the leg wound infection responded really well to the 
antibiotics and both the registrar and consultant are very pleased with how the 
patient has progressed.  
 
 Pharmacist 4 first reflection  
 
A few days ago I saw a COPD patient who was referred to me for his annual 
review and didn’t seem to be doing terribly well.  We went over his medication 
and I discovered that his tiotropium had been stopped by the GP after I had seen 
his for his review the previous year when I had put him on [emphasis] to 
tiotropium. 
 
He was one of those patients that’s probably had quite severe COPD for a 
number of years but had never been to the doctor to ask about it or had always 
just ignored it.  So that’s why it was kind of a late onset tiotropium and his 
condition was quite bad, so he certainly needed to be on it and the GP had asked 
him “How are you getting on with it?  Is it doing you any good?” and he’d said 
“Well, I don’t really know doctor I haven’t noticed much difference.” Ah, so the 
GP decided to stop it well of course the real reason he hadn’t noticed much 
difference [half-laughing] is that he’s really got quite severe COPD so he’s not a 
miracle worker.  So then you’re stuck with the, dilemma, do you put him back on 
that particular medication because you know that’s the correct medication he 
ought to be on, due to the guideline, custom and practice, experience etc and 
you know that long-term that particular drug will be good for him and will 
certainly help to maintain his lung function, or do you stick with what the doctor 
has decided because after all he is the GP. 
 
So, needless to say because of my experience and knowledge on, in this 
particular disease I completely ignored what the doctor’d decided [laughs] and I 
put the man back on the tiotropium having explained to him at some length why 
I was doing that and the necessity of being on this and the good that it would do 
him et cetera, et cetera, et cetera. 
 
So, I think that this can often be a, an awkward situation for a non-medical 
prescriber, because we tend to think of the GP as the final decision-maker, 
unless the patient’s obviously getting referred to a consultant.  And, it can be a 
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bit difficult, and I do think you have to have a certain amount of confidence 
[emphasis] to be able to make that decision, and decide for yourself, as opposed 
to re-referring back to the GP for another decision or, e-mailing the GP or 
discussing it with the GP.  Had I been in the same building as the GP I might well 
then have had a discussion with him, but as it was, I was conducting the clinic in 
the shop and the patient came from a surgery that was some considerable 
distance away.  And quite frankly I didn’t really see the point in it, I just felt that 
the GP had made that decision, based on what the patient had said, without 
really thinking about the implications, or the guidelines that were available.  And 
perhaps, doesn’t know as much about COPD as I do. 
So I went ahead and I prescribed it and explained all that to the patient, and he’s 
quite happy and I’m living in hope, and I did document that in the journal, for 
the computer, so that if anybody else came across this they would see why I’d 
made those decisions. 
 
Pharmacist 4 second reflection  
 
A second situation, arose just a few days ago.  It was actually in the community 
pharmacy and I had a patient who came rushing in and decided that he needed 
another salbutamol inhaler, which we had given him two days previously as 
emergency supply.  
[Sound of knocking].  
Sorry, I got interrupted there.  So to start again, a couple of days ago I had a 
patient who came in to the shop and wanted a salbutamol inhaler, and I 
discovered that we’d already given him a supply two days previously as an 
emergency supply, probably on the Thursday evening because the surgery was 
shut and he said he had finished it over the two days. So needless to say I was 
somewhat horrified.  He was standing there looking at me and appeared to be 
perfectly normal, wasn’t breathless, wheezing, anything like that, did not appear 
to be going blue [emphasis] by any stretch of the imagination so I said no, and if 
he wanted something else he would have to see a GP and he could dial 111 [NHS 
Grampian out of hours number]. 
 
So you’re left with that situation, and it has happened to me before, where a 
patient is insisting [emphasis] on having a drug, particularly an inhaler, which is 
a very difficult situation to find yourself in, it’s not like giving somebody a 
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painkiller, and you feel, should I give them the inhaler, because I’m worried that 
they might have an attack, or, do I not give them the inhaler because I feel that 
they’re abusing the situation.  And if you look in any computer at a surgery, you 
will always find people that over-use reliever inhalers, and their blue inhaler, 
generally speaking. And this is really difficult to quantify and difficult to make 
decisions.   You, one part of you is well aware that the patient is abusing the 
situation, is over-using a medication, has not been for a review or check-up.  On 
the other side of the coin is, should you withhold a medication that could save 
their life, should they have an acute attack.  And I think this is quite hard for 
every [emphasis] prescriber, let alone a non-medical prescriber. 
 
Now, if that had been a different pharmacist speaking to that patient they might 
well have felt obliged to give the inhaler, based on the fact that it was a 
Saturday, there was no GP open, and the, there was the potential [emphasis] for 
that patient to become quite seriously ill, without the inhaler.  I think I had the 
huge advantage of obviously having quite a bit of experience.  I could tell just by 
listening to him that he was not in any acute distress.  He wasn’t gasping for 
breath, he wasn’t wheezing, there was no obvious signs and apparently he was 
actually at his work and nipped out in his lunch hour.  So I suspect that his 
overuse of the salbutamol is more of a psychological panic situation rather than a 
genuine asthma attack. 
 
So I didn’t give it to him and I gave him the telephone number for the NHS24 
should he feel the need.  And I suspect he may well have gone to another 
pharmacy and spun a different story and got an emergency supply.  
 
He will get caught out eventually of course, because we always fax through the 
prescriptions that we’ve given as emergency supply and eventually, hopefully 
[emphasis] the surgery will start to notice that this is becoming a bit of a 
pattern. 
 
And again I think that very much comes down to experience, assessing a patient, 
knowing when to prescribe, when not to prescribe, and refusing medication is 
sometimes just as important as actually prescribing it, depending on the 
particular situation that you find yourself in.  And certainly there is always the 
NHS24 out of hours service, should there be an emergency. But in, in general 
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that can be quite difficult and I do think that prescribers are sometimes put 
under pressure by patients “Could you just give me this while you’re there?” and 
you have to be so careful that you’re only prescribing within your own 
competency.  So, that is a bit of a dilemma.  I made a particular decision, based 
on the circumstances and my assessment of that patient. And I have enough 
confidence in myself, but I could quite understand that somebody, without that 
background, would find that a difficult option, and might well either have decided 
to given, give a prescription, or perhaps a phone GMeds [NHS Grampian out of 
hours service] and got a doctor’s opinion.   
 
Pharmacist 5 first reflection 
 
The first one would be an Eastern European patient who was slotted in to my 
anti-coag [sic] clinic.  I found that she had no English and we had to use the, the 
Language Line.  She produced a box of warfarin with some left in it, em, but she 
had poor English and even on the Language Line we couldn’t actually establish 
what the definite indication for the warfarin was.   
 
I’d had no choice but to see her because I do the clinic so I had gone ahead and 
done her INR which was 1, which would indicate to me that she actually wasn’t 
taking the warfarin, although she insisted that she was and the warfarin had 
been prescribed in her own country for her. 
 
I should say that she was a temporary patient, em temporary resident, and so 
we had to go ahead.  Because I wasn’t clear on the indication, I didn’t prescribe 
the warfarin on this, on this occasion.  To me she, it wasn’t clear that she was 
actually taking the warfarin herself so could I trust the information?  She was a 
very poor historian and even from Language Line I wasn’t getting the information 
I was looking for, just that she had been on it for some time from her own 
doctor.   
 
I was in a real dilemma, thinking back, because if I didn’t prescribe the warfarin 
and it was for something like AF then I was putting this patient at risk of a stroke 
by non-prescribing, however if I did prescribe and I, I didn’t know the indication 
then I wasn’t em, doing my job properly.  I have a duty of care to the patient but 
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only if I’m comfortable and I know the medication is definitely indicated and safe 
for the patient.  
 
The patient did have some tablets left so I did her an INR.  She told me she took 
one a day so I increased the dose and then I, I referred her to the, the GP.   
 
Reflecting back, I had possibly inconvenienced the patient because I didn’t 
prescribe more warfarin but I did prescribe a new dose for her so I maybe didn’t, 
fulfil what she was looking for.  However, this patient is still with us, she was 
here for a month so she is still presenting and we’re asking her to give us some 
details from her own doctor and to get something sent across and we’re actually 
still waiting for this.  So I have recently said that I am not comfortable to provide 
the prescription for warfarin but I, I have been under pressure to do her INRs 
and then pass the, the  details through to the prescription team and the doctor 
signs the warfarin.  So not ideal, but I think that this is the safest way that I can 
look after this patient until we have a bit more detail on her.  So the reason I 
prescribed was to reduce her risks but also very tentatively.  I only prescribed a 
dose, but I didn’t actually give her a prescription. 
 
Pharmacist 5 third reflection 
 
My third reflection is quite a simple one within my BP clinic this week and this 
was a patient, with hypertension only, no other co-morbidities, and I’ve seen 
them on a few occasions and I’ve gradually added in and titrated up medication 
following CVD risk and lifestyle discussions.  The patient is now on three anti-
hypertensives plus a statin and aspirin. 
 
I saw this patient very recently and I’ve been seeing this patient for over a year.  
I was running, reflecting back, I was, I, I didn’t actually, I saw this patient and 
assessed them but I didn’t actually prescribe as far as giving them a piece of 
paper, a prescription.  The reason I, I didn’t, I was very comfortable to do so, 
because I had assessed the patient, done the lifestyle, the BP, examined the 
ECG, I’d examined and reviewed her recent bloods, but the reason I didn’t do 
this was because we still don’t have the electronic prescribing facility in our 
clinics.  The doctors and the prescribing nurses do but not the prescribing 
pharmacist, myself.  So, I was running late and reflecting back that would be one 
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of the reasons as well.  I was running late in the clinic and the, to hand write five 
items after having done all the documentation and the consultation is, is quite 
impossible really within the ten minute appointment. So on this occasion I did as 
I often have to do.  I just pass through to the prescription team.  I run off a re-
order slip and pass it through and the prescription team do the prescription and 
of course the doctor signs it because it’s on their number.  It's not possible to do 
an electronic prescription on my number.   
 
So, reflecting back it’s a real disappointment that we don’t have the facility, 
something like 12 years down the line, and it’s, it’s a shame.  Maybe not quite as 
much as 12, but certainly ten or eleven anyway.  This would really help us in the 
clinic and would allow me to be much more professional and allow the patient not 
to be inconvenienced to have to go back to the pharmacy but could leave with 
the prescription every single time.   
 
Reflecting back, if it had just been one item I would have done the prescription 
of course, as I had been doing as I titrated up her meds, but now she was 
requiring her statin and aspirin and three items so the time to write out two 
paper prescriptions with the five items on it is just so cumbersome. So at the 
moment the only way I can run on time sometimes is to pass it through to my 
colleagues. 
 
Pharmacist 7 first reflection 
 
This is [name of pharmacist] from [name of pharmacy] reflecting on a 
prescribing decision made today.  This was a very, simple scenario that we had, 
a patient whose work involves them being abroad for repeated visits, and they 
are in an area of the world where malaria is prevalent. The prescribing decision, 
was, a essentially repeat prescribing because we have, have that same 
conversation several times.  The whole process was very simple, very automatic, 
in so far as this was a scenario I was comfortable with and I really felt as if this 
was a, a normal extension of my every day practice.   
 
The reasons for that I guess were the fact that I had previously done the 
research to identify safety and appropriate treatment so there was very little 
clinical need to, to re-visit any of those issues. Simply it was a case of checking 
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with the patient his duration, confirming with him his usage, ensuring he was 
using the treatment appropriately and getting a very simple and quick 
agreement with the patient as to what his needs were and how to progress.  So 
the prescribing follows very simply, essentially in line with any prescribing that I 
would be involved in with regard to patient care where the patient presents and 
requires me to advise on treatment.  The fact that I was supplying a prescription 
only medicine was almost superficial.  The, the, I guess that comes down to 
where I am in terms of my comfort zone, so this was a very comfortable process 
today, and felt as if this was a good, normal extension of my normal 
pharmaceutical practice. 
 
Pharmacist 7 second reflection 
 
This was a, a relatively complex patient that I was dealing with, where the initial 
discussions over his care had been made in conjunction with one of the nursing 
team from his GP practice.  After some discussion the, the nurse had been in 
touch with myself and passed information to me asking if I would take up follow 
on care from her initial consultation.  The patient had a complex travel 
programme and this was not set in stone, so he still had some variables built in 
to the itinerary. What that does create is a degree of uncertainty within the 
prescribing so what I had to do was, was take a fair bit of time just to explore 
the levels of risk that the patient felt that he would be putting himself into and I 
then had to try and gauge his, his feeling with regard to how the risk could be 
minimised.  So for example some of the potential concerns that we had over his 
travel plans were things which were dictated largely by his behaviour, things that 
he wasn’t able to verbalise, or he maybe didn’t know, for example with regard to 
Hepatitis B where his behaviour was, was critical to his risk.  The difficulty I have 
there is I feel that I need to act to provide the safest possible options for him but 
at the same time ultimately it is his decision over his care.   
 
So I’d felt a little bit uncomfortable because he was quite non-committal for 
example with regard to his Hep B plans but yet was much more enthusiastic 
about Japanese encephalitis having explored the risks with regard to a stay in 
Thailand.  So there were, there was a real mix of feelings within the, the 
discussions that we had.  Part of, of what I was doing I felt very comfortable 
with, very secure with.  I felt that the patient was making a good decision based 
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on safety, and I was happy to support that and prescribe accordingly.  Other 
elements of his, of the plan I felt less comfortable with, in so far as he was 
choosing not to take additional vaccinations and my preference would have been 
that he had, purely on the basis that once I had exercised my duty I would have 
known that, that he was a safe as he possibly could be.   
 
So the, the challenge I had was that in that that fairly complex situation in which 
he was protecting himself against one nasty and not against another, and I 
struggle with that dichotomy, where he’s, he seems to be making decisions that 
don’t follow the rational guidance that I had given him.  Ultimately of course I’ve 
got to accept the, the decision of the patient, we have to agree a level of 
concordance and, and we were able, as I say after a significant discussion, to 
agree a plan and he has been willing to comply with that and seems now quite 
happy with where we’re going and what we’re doing. 
 
So, yeah, quite a tricky one.  One that on reflection I feel that I was able to give 
the best advice and ultimately the patient had to take the advice on board and 
accept the treatment or reject the treatment based on the best advice that was 
available to them.  One thing I was keen to do was to give him some thinking 
time, which we did, and I felt that that was really important, because sitting 
down and having lots of information thrown at you, just all within a half hour slot 
can be quite daunting, can be difficult to take in.  So the discussions were 
followed up, just to ensure that he was happy with the, the plan, and I, that 
gave me a bit more, a bit more security, I guess, in my decision making and I 
felt a bit more comfortable with that, despite the, that, that he had thought 
about it but hadn’t changed his mind, he was only going to follow part of the 
vaccination programme.  So a bit more challenging and certainly one that, that 
made me reflect but I think the key thing that I took from it, and my learning, 
was to ensure the patient was given adequate time, and in this case he had time 
to reflect, he had time to think things through and if he had chosen to discuss 
the, the scenario with anyone else he might have wanted to, so that, that was a 
positive for me.  So yeah, good learning and overall, comfortable with the 
outcome.  
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Pharmacist 8 reflection 
 
During my hypertension clinic this afternoon one of my patients was a 76 year 
old female currently taking atenolol 25mg and ramipril 10mg for hypertension.  
Actually was on a number of other medications including azathioprine, 
prednisolone, aspirin, alendronic acid and Calceos® tablets from memory.   
 
During the consultation, she informed me that she hadn’t [emphasis] been 
taking her alendronic acid or Calceos® and had also stopped taking simvastatin, 
having had an illness where she just felt she was taking too many tablets. Blood 
pressure today was just over QOF target at 155/88 and through the conversation 
previously regarding number of tablets, I had a chat with the lady and my 
[emphasis] thoughts were that we would not [emphasis] be looking to increase 
her antihypertensive medication given her current thoughts on tablet taking.  
Added to that the impact that she had previously tried amlodipine and felodipine 
as well as doxazocin with adverse effects, thereby limiting the options that we 
had anyway; also currently taking furosemide for oedema so difficult to then add 
in any further antihypertensive.    
 
Patient was actually quite happy with this thought and I think quite relieved that 
I had said I was not going to increase her antihypertensives, and we agreed that 
this was the best course of action in this case was, was not [emphasis] to 
prescribe any further medication.  
 
Pharmacist 9 first reflection 
 
My first reflection is on a paediatric prescription that I was requested to do. The 
request came in from the parent, having been discharged from the [name of 
children’s hospital] in [name of city]. Her child was born at 31 weeks + 4 [days] 
and they were now presenting looking for a prescription at 1 month and 3 weeks. 
The prescription request was for Gaviscon® liquid, which is a very unusual 
prescription to be giving a child of that age.  Obviously we are used to seeing 
Gaviscon® sachets used for reflux in children, and I checked the BNF and did 
remember previously querying quite a few years ago with the pharmacist in 
[name of hospital] so I decided to phone the pharmacist in [name of hospital] 
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just to confirm what was happening here with Gaviscon® liquid. They were able 
to confirm that it was their preferred formulation of choice when babies were 
predominantly being breastfed and weren’t already using a bottle when they had 
reflux. So, based on that and looking at the BNF for children I was able to quite 
happily prescribe Gaviscon® liquid to this infant. 
 
Pharmacist 9 second reflection 
 
This case was a 35 year old gentleman requesting a prescription for allopurinol 
that had been given by the doctor for gout.  On looking at his record and 
speaking to him, I realised that he hadn’t had his urate levels checked since 
commencing his allopurinol.  He was currently on a dose of 100mg once a day, 
and it wasn’t clear that he was actually taking it regularly although he was 
requesting his non-steroidals for the treatment of his acute attacks.   
 
Anyway, I spoke to him on the phone and obviously discussed all the risk factors 
for gout and arranged for him to increase his dose, as he was still symptomatic 
on the 100mg a day despite taking it regularly and using naproxen as well.  He 
increased his dose and we arranged for his urate levels to be checked one month 
later.  I also arranged for his risk factors to be assessed, so for him to have 
some bloods done for fasting glucose, his cholesterol levels so we could do his 
cardiovascular risk factors, his blood pressure and weight.  He was already 
addressing some of these issues, including his alcohol intake and I was quite 
happy to prescribe the higher dose of allopurinol for him.  I made sure that he 
had an appointment to come in and that he was clear what he was doing.  I also 
printed out a leaflet for him about gout and the risk factors and treating it and 
taking his medication regularly.  He seemed really happy with the advice that he 
was given.  Anyway that’s my second reflection; quite happy to prescribe the 
allopurinol.  
 
 
 
 
 
 
